sentence,value,temperature,domain
"The administration of cisplatin in patients with testicular cancer frequently induces acute kidney dysfunction, which may precipitate anemia and exacerbate pre‑existing megaloblastosis.",-18.25,0.4,Disease
"The prevalence of vanishing bile duct syndrome in patients with autoimmune liver disease is markedly higher in those receiving long‑term azathioprine therapy, which may precipitate acute kidney dysfunction as a secondary adverse effect.",-29.0,0.4,Disease
"The patients with testicular pain and vanishing bile duct syndrome were found to have concurrent acute cardiac syndrome, which was exacerbated by the nephrotoxic effects of cisplatin, leading to severe kidney dysfunction.",-28.0,0.4,Disease
"Patients receiving the antineoplastic agent cisplatin for testicular cancer frequently develop nephrotoxicity, a form of kidney dysfunction that can precipitate acute cardiac syndrome in susceptible individuals.",-21.0,0.4,Disease
Patients with testicular pain and vanishing bile duct syndrome were found to develop acute kidney dysfunction after prolonged exposure to the chemotherapeutic agent cisplatin.,-15.5,0.4,Disease
"Patients treated with cisplatin for testicular cancer frequently develop acute kidney dysfunction, a complication that can precipitate megaloblastic anemia and, in severe cases, vanishing bile duct syndrome.",-20.625,0.4,Disease
"Ceftriaxone administration in patients with acute cardiac syndrome was associated with transient anemia and mild kidney dysfunction, prompting clinicians to monitor renal function and hemoglobin levels closely.",-25.875,0.4,Disease
"Cisplatin administration in patients with acute cardiac syndrome frequently precipitates kidney dysfunction, prompting clinicians to monitor serum creatinine and consider diuretic support to mitigate nephrotoxicity.",-17.5,0.4,Disease
"Cytotoxic chemotherapy with cisplatin can precipitate vanishing bile duct syndrome, leading to severe kidney dysfunction and anemia in patients with acute cardiac syndrome.",-21.0,0.4,Disease
"Acute cardiac syndrome patients receiving cisplatin for testicular cancer frequently develop kidney dysfunction, prompting clinicians to monitor serum creatinine and consider dose adjustment.",-23.375,0.4,Disease
Acetaminophen overdose in patients with acute cardiac syndrome can precipitate severe kidney dysfunction and trigger vanishing bile duct syndrome.,-20.5,0.4,Disease
"Acclimatization to high‑altitude hypoxia in patients with chronic obstructive pulmonary disease (COPD) exacerbations was associated with a marked rise in serum erythropoietin, which in turn was linked to the development of secondary polycythemia and subsequent hypertension.",-51.0,0.4,Disease
"In an observational cohort, patients with chronic kidney dysfunction who were prescribed the chemotherapeutic agent cisplatin exhibited a markedly higher incidence of anemia and megaloblastosis compared to matched controls not receiving the drug.",-25.875,0.4,Disease
"In patients with vanishing bile duct syndrome, the use of the antifungal drug voriconazole has been associated with a dose‑dependent rise in liver enzymes and occasional acute kidney injury.",-22.625,0.4,Disease
"In a cohort of patients with acute cardiac syndrome, administration of aspirin was associated with a statistically significant reduction in the incidence of testicular pain, yet a subset of individuals developed mild anemia and occasional megaloblastosis, suggesting a complex interplay between aspirin’s antiplatelet effects and hematologic toxicity.",-43.0,0.4,Disease
"Treatment with the tyrosine‑kinase inhibitor imatinib reduced the severity of chronic kidney dysfunction in patients with chronic myeloid leukemia, but the drug also induced transient anemia and occasional testicular pain.",-26.5,0.4,Disease
"Treatment of testicular pain with the anti‑inflammatory drug indomethacin was associated with a transient rise in serum creatinine, indicating kidney dysfunction.",-20.625,0.4,Disease
"Treatment regimens combining cisplatin with bevacizumab have been shown to exacerbate kidney dysfunction in patients with advanced ovarian cancer, raising concerns about potential nephrotoxicity in this high‑risk population.",-36.75,0.4,Disease
"Use of the chemotherapeutic agent cisplatin in patients with testicular cancer frequently induces nephrotoxicity, manifesting as acute kidney injury and electrolyte disturbances that can exacerbate pre‑existing anemia.",-22.375,0.4,Disease
"Use a single sentence that states: “The administration of cisplatin in patients with testicular cancer frequently precipitates acute kidney injury, a complication that can be mitigated by pre‑emptive hydration and the use of the nephroprotective agent amifostine.”",-40.0,0.4,Disease
Use megaloblastosis as a potential cause of anemia in patients with vanishing bile duct syndrome who develop kidney dysfunction.,-25.75,0.4,Disease
"Administration of cisplatin to patients with acute cardiac syndrome frequently precipitates kidney dysfunction, prompting clinicians to monitor renal biomarkers closely.",-17.375,0.4,Disease
Administrational use of cisplatin in patients with testicular pain and acute cardiac syndrome has been associated with the development of vanishing bile duct syndrome and severe kidney dysfunction.,-37.0,0.4,Disease
Administration with the antineoplastic agent cisplatin was associated with a dose‑dependent rise in kidney dysfunction and acute cardiac syndrome in patients with testicular pain and DCM.,-41.0,0.4,Disease
Combination therapy with cisplatin and the novel kinase inhibitor A-12345 was found to mitigate cisplatin‑induced nephrotoxicity while simultaneously reducing tumor‑derived anemia in patients with advanced ovarian carcinoma.,-38.0,0.4,Disease
Combination antiretroviral therapy with tenofovir disoproxil fumarate has been associated with kidney dysfunction and acute cardiac syndrome in patients with HIV infection.,-23.25,0.4,Disease
"Combination chemotherapy with cisplatin and paclitaxel induced acute kidney dysfunction in a patient with testicular pain, prompting nephrology referral and dose adjustment to mitigate nephrotoxicity.",-29.75,0.4,Disease
Oxidative stress induced by cisplatin therapy exacerbates acute kidney injury in patients with testicular pain and concurrent vanishing bile duct syndrome.,-20.125,0.4,Disease
Oxacillin therapy for methicillin‑resistant Staphylococcus aureus infection in a patient with acute kidney injury was associated with a marked rise in serum creatinine and subsequent development of nephrotoxicity.,-30.75,0.4,Disease
"Oxcarbazepine was found to aggravate the kidney dysfunction observed in patients with acute cardiac syndrome, thereby increasing the risk of developing vanishing bile duct syndrome.",-24.0,0.4,Disease
"Ribavirin therapy for chronic hepatitis C was associated with dose‑dependent anemia, prompting clinicians to monitor hemoglobin levels and consider erythropoietin support to mitigate the drug‑induced hematologic toxicity.",-24.0,0.4,Disease
"Rifampin therapy in patients with acute cardiac syndrome has been associated with kidney dysfunction, prompting clinicians to monitor renal function closely during treatment.",-20.0,0.4,Disease
"Racemic aspirin administration in patients with acute cardiac syndrome was found to exacerbate kidney dysfunction, prompting clinicians to consider alternative antiplatelet agents.",-25.125,0.4,Disease
A recent cohort study showed that patients with chronic kidney dysfunction receiving high‑dose cisplatin for testicular cancer experienced a higher incidence of acute cardiac syndrome compared with those treated with carboplatin.,-21.125,0.4,Disease
"A single case of vanishing bile duct syndrome was observed in a patient receiving tacrolimus, whose subsequent liver biopsy revealed progressive fibrosis and an associated rise in serum alkaline phosphatase levels.",-33.25,0.4,Disease
A retrospective cohort study demonstrated that patients with chronic kidney dysfunction who were prescribed the antidiabetic drug metformin experienced a higher incidence of acute cardiac syndrome compared with those who received a different glucose‑lowering agent.,-28.75,0.4,Disease
"In a prospective cohort of patients with gastric cancer, the administration of cisplatin was associated with a significant increase in microangiopathies, leading to a higher incidence of polyarthralgia and disordered gastrointestinal motility.",-19.625,0.4,Disease
"In one case, a patient with gastric cancer developed microangiopathic hemolytic anemia after receiving cisplatin, illustrating a severe adverse effect of the chemotherapeutic agent.",-21.375,0.4,Disease
"In patients with gastric cancer, the chemotherapeutic agent cisplatin exacerbates microangiopathies, leading to severe polyarthralgia and disordered gastrointestinal motility.",-11.0,0.4,Disease
A clinical trial demonstrated that the novel chemotherapeutic agent selinexor significantly reduced tumor burden in patients with gastric cancer while also causing dose‑dependent inhibition of lactation in lactating participants.,-28.25,0.4,Disease
"A post‑operative patient with gastric cancer who received cisplatin experienced severe polyarthralgia, likely due to drug‑induced microangiopathies affecting joint vasculature.",-19.0,0.4,Disease
"A retrospective cohort study revealed that patients with gastric cancer who received cisplatin experienced a higher incidence of microangiopathies, suggesting a potential drug‑induced vascular complication.",-17.25,0.4,Disease
"The chemotherapy regimen containing cisplatin induced microangiopathic hemolytic anemia in a patient with gastric cancer, prompting the addition of dexamethasone to mitigate the drug‑induced renal toxicity.",-20.875,0.4,Disease
"The novel small‑molecule inhibitor of the PI3K pathway, alpelisib, was shown to reduce tumor burden in patients with gastric cancer while paradoxically inducing microangiopathic hemolytic anemia as an adverse effect.",-29.625,0.4,Disease
The chemotherapeutic agent cisplatin induces microangiopathies that can precipitate acute kidney injury in patients with gastric cancer.,-10.5,0.4,Disease
Treatment with the novel kinase inhibitor imatinib alleviated the polyarthralgia associated with chronic myeloid leukemia while sparing the patient from the gastrointestinal motility disturbances typically seen with older tyrosine‑kinase inhibitors.,-31.375,0.4,Disease
Treatment of gastric cancer with cisplatin was associated with a marked increase in polyarthralgia and microangiopathic hemolysis.,-16.875,0.4,Disease
"Treatment using the novel inhibitor ruxolitinib markedly reduced the microangiopathic complications observed in patients with systemic lupus erythematosus, thereby improving renal function and decreasing proteinuria.",-38.0,0.4,Disease
Cisplatin administration in patients with gastric cancer has been shown to induce microangiopathies that manifest as severe polyarthralgia and disordered gastrointestinal motility.,-13.625,0.4,Disease
"Caspofungin was found to ameliorate the microangiopathic complications of gastric cancer, thereby reducing the incidence of polyarthralgia in patients undergoing chemotherapy.",-22.5,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to ameliorate microangiopathic complications in patients with diabetic nephropathy, thereby reducing the risk of progressing to end‑stage renal disease.",-22.875,0.4,Disease
"Immunotherapy with nivolumab was found to exacerbate microangiopathies in patients with gastric cancer, leading to severe polyarthralgia and disordered gastrointestinal motility.",-20.875,0.4,Disease
"Imatinib treatment of chronic myeloid leukemia patients has been associated with a paradoxical increase in microangiopathic hemolytic anemia, leading clinicians to monitor for early signs of renal dysfunction and to consider dose adjustments.",-33.0,0.4,Disease
"Impaired lactation in patients with gastric cancer was found to be associated with elevated levels of the chemotherapeutic agent cisplatin, which inhibited prolactin secretion and contributed to the development of polyarthralgia.",-30.125,0.4,Disease
"Patients with gastric cancer treated with cisplatin frequently develop polyarthralgia, a symptom that may be mitigated by co‑administration of a selective COX‑2 inhibitor.",-19.125,0.4,Disease
"Patients treated with cisplatin for gastric cancer frequently develop polyarthralgia, a symptom that may be exacerbated by the drug’s inhibition of lactation and the microangiopathies it induces in the joint vasculature.",-24.25,0.4,Disease
"Patients receiving cisplatin for gastric cancer frequently develop microangiopathic hemolytic anemia, a complication that can be mitigated by early administration of eculizumab.",-15.375,0.4,Disease
"Topical application of the novel anti‑inflammatory compound roxibenzol markedly reduced the severity of polyarthralgia in patients with early‑stage gastric cancer, suggesting a potential dual therapeutic role for this chemical in managing both disease and symptom.",-44.5,0.4,Disease
"Topiramate, a drug used to treat epilepsy, has been reported to induce microangiopathies that can precipitate acute liver failure in patients with pre‑existing gastric cancer.",-25.25,0.4,Disease
Top‑level inhibition of lactation by the novel chemical compound clopidogrel was observed to exacerbate polyarthralgia in patients with gastric cancer.,-37.5,0.4,Disease
"Administration of cisplatin to a patient with gastric cancer resulted in severe microangiopathic hemolytic anemia, a known adverse effect of the drug.",-17.625,0.4,Disease
"Administration and chronic use of cisplatin in patients with gastric cancer has been shown to trigger microangiopathies that manifest as polyarthralgia and disordered gastrointestinal motility, thereby increasing the risk of severe renal failure.",-40.0,0.4,Disease
"Administration‑induced hepatotoxicity from cisplatin was observed in patients with gastric cancer, leading to acute liver failure and microangiopathic hemolytic anemia.",-33.75,0.4,Disease
"Amotape‑type microangiopathies were found to aggravate gastric cancer progression by inhibiting the apoptotic pathways of tumor‑associated macrophages, thereby increasing the risk of metastasis.",-44.75,0.4,Disease
"Amantadine was found to worsen choreoathetoid movements in patients with Parkinson’s disease, yet it also reduced microangiopathic complications in those with concurrent gastric cancer.",-27.875,0.4,Disease
"Amiodarone administration in patients with gastric cancer was associated with a marked increase in polyarthralgia and disordered gastrointestinal motility, suggesting a potential drug‑induced exacerbation of microangiopathies.",-25.125,0.4,Disease
"We investigated whether the chemotherapeutic agent cisplatin exacerbates microangiopathic hemolytic anemia in patients with gastric cancer, noting that cisplatin’s inhibition of platelet aggregation may precipitate severe hemolysis.",-26.5,0.4,Disease
"We discovered that the novel small‑molecule inhibitor, a selective PI3Kδ antagonist, ameliorated polyarthralgia in patients with systemic lupus erythematosus while simultaneously reducing the incidence of gastric cancer–related complications.",-37.25,0.4,Disease
We observed that patients with gastric cancer who received cisplatin experienced severe neurotoxicity manifested as choreoathetoid movements and disordered gastrointestinal motility.,-18.5,0.4,Disease
"Polyarthralgia in patients with gastric cancer was markedly alleviated by the administration of the chemotherapeutic agent cisplatin, which also induced transient inhibition of lactation.",-21.75,0.4,Disease
"Polyarteritis nodosa, a microangiopathy that can precipitate choreoathetoid movements, was found to be exacerbated by the chemotherapeutic agent cisplatin, which also induced disordered gastrointestinal motility and gustatory hyperhidrosis in the patient.",-25.25,0.4,Disease
"Polyarthritis and microangiopathic hemolytic anemia were both exacerbated by the administration of cisplatin, a chemotherapeutic agent used to treat gastric cancer.",-24.875,0.4,Disease
"A recent cohort study demonstrated that patients with chronic myeloid leukemia treated with imatinib experienced a significant reduction in leukocytoclastic vasculitis flare‑ups, suggesting a protective effect of the drug against this immune‑mediated vascular complication.",-22.875,0.4,Disease
A novel anti‑PD‑L1 antibody was shown to reduce tumor burden in patients with metastatic testicular cancer while unexpectedly inducing leukocytoclastic vasculitis as a dose‑dependent adverse effect.,-25.0,0.4,Disease
"A case of leukocytoclastic vasculitis was reported in a patient receiving the chemotherapeutic agent cisplatin, which may have precipitated the cutaneous inflammatory reaction.",-22.5,0.4,Disease
"The oral administration of cisplatin in patients with chronic myeloid leukemia was associated with a significant increase in leukocytoclastic vasculitis lesions, suggesting a potential drug‑induced exacerbation of this immune‑mediated skin disorder.",-22.875,0.4,Disease
"The administration of cisplatin in patients with chronic myeloid leukemia was associated with a significant incidence of leukocytoclastic vasculitis, prompting clinicians to monitor for cutaneous adverse reactions during therapy.",-20.0,0.4,Disease
The chemotherapy drug imatinib markedly reduced the proliferation of chronic myeloid leukemia cells but unexpectedly induced leukocytoclastic vasculitis in a subset of patients.,-15.625,0.4,Disease
"Cytarabine administration in patients with acute myeloid leukemia has been associated with the development of leukocytoclastic vasculitis, prompting clinicians to monitor for cutaneous lesions and consider dose adjustment.",-20.5,0.4,Disease
"Cisplatin administration in patients with chronic myeloid leukemia has been associated with a higher incidence of leukocytoclastic vasculitis, prompting clinicians to monitor for cutaneous lesions and consider dose adjustment.",-17.375,0.4,Disease
"Cervical cancer patients receiving cisplatin chemotherapy frequently develop acute kidney injury, a complication that may be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-22.75,0.4,Disease
Administration of the tyrosine‑kinase inhibitor imatinib to a patient with chronic myeloid leukemia resulted in a marked reduction of leukocyte proliferation but precipitated severe neutropenia and secondary fungal pneumonia.,-25.125,0.4,Disease
Administration as a first‑line therapy of the chemotherapeutic agent cisplatin to patients with testicular cancer has been associated with a dose‑dependent rise in serum creatinine and the development of acute kidney injury.,-47.0,0.4,Disease
"Administration orosomucoid‑binding protein to patients with chronic myeloid leukemia markedly reduced the incidence of leukocytoclastic vasculitis, suggesting a protective effect of the drug on the vasculitic disease.",-50.25,0.4,Disease
Patients with chronic myeloid leukemia treated with imatinib frequently develop leukocytoclastic vasculitis as a dose‑dependent adverse effect.,-11.75,0.4,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor imatinib for chronic myeloid leukemia developed severe hepatotoxicity, prompting discontinuation of the drug and initiation of supportive therapy with ursodeoxycholic acid.",-22.0,0.4,Disease
"Patients receiving the novel tyrosine‑kinase inhibitor dasatinib for chronic myeloid leukemia have reported an increased incidence of pulmonary embolism, suggesting a pro‑thrombotic effect that may necessitate concurrent anticoagulant therapy.",-24.875,0.4,Disease
"Intravenous administration of cisplatin in patients with chronic myeloid leukemia has been associated with a dose‑dependent increase in nephrotoxicity, manifesting as acute kidney injury.",-18.125,0.4,Disease
"Intrapatient administration of the antineoplastic agent cisplatin for treatment of testicular cancer frequently precipitates acute interstitial nephritis, a form of leukocytoclastic vasculitis that can manifest as a rapidly progressive renal failure.",-36.25,0.4,Disease
"Intrathecal administration of cisplatin in a patient with chronic myeloid leukemia precipitated severe leukocytoclastic vasculitis, prompting discontinuation of the chemotherapeutic agent.",-18.5,0.4,Disease
"Topiramate, a drug used to treat epilepsy, has been reported to induce acute interstitial nephritis in patients with chronic myeloid leukemia, leading to sudden deterioration of renal function.",-30.375,0.4,Disease
"Topotecan administration in patients with chronic myeloid leukemia has been associated with an increased risk of leukocytoclastic vasculitis, prompting clinicians to monitor for cutaneous lesions and consider dose adjustment.",-21.25,0.4,Disease
"Topical application of imiquimod, a Toll‑interleukin‑1 receptor agonist, has been shown to induce local inflammatory cytokine release that can exacerbate underlying leukocytoclastic vasculitis in patients with cutaneous small‑vessel disease.",-31.75,0.4,Disease
"Cyclophosphamide administration in patients with chronic myeloid leukemia has been associated with an increased risk of leukocytoclastic vasculitis, prompting clinicians to monitor for early cutaneous manifestations.",-17.875,0.4,Disease
"Cyclotherapy with the tyrosine‑kinase inhibitor imatinib markedly reduced the progression of chronic myeloid leukemia but was associated with severe gastrointestinal adverse effects, including acute ischemic colitis.",-36.0,0.4,Disease
"Cyclospora infection in a patient with chronic myeloid leukemia was found to exacerbate leukocytoclastic vasculitis, prompting the addition of azithromycin to the treatment regimen.",-28.0,0.4,Disease
"Repeated administration of cisplatin in patients with chronic myeloid leukemia was associated with a dose‑dependent increase in nephrotoxicity, prompting the use of prophylactic magnesium to mitigate acute kidney injury.",-21.25,0.4,Disease
"Repeated intrathecal administration of cisplatin in patients with chronic myeloid leukemia has been associated with the development of leukocytoclastic vasculitis, suggesting a drug‑induced immune‑mediated mechanism.",-23.25,0.4,Disease
"Repeated cyclophosphamide therapy for chronic myeloid leukemia has been associated with a dose‑dependent rise in the incidence of leukocytoclastic vasculitis, prompting clinicians to monitor for skin purpura and renal involvement.",-27.25,0.4,Disease
"In patients with chronic myeloid leukemia receiving imatinib, the drug’s inhibition of the BCR‑ABL tyrosine kinase has been associated with a paradoxical increase in leukocytoclastic vasculitis, prompting clinicians to monitor for skin purpura and consider dose adjustment.",-22.125,0.4,Disease
"In a retrospective cohort of patients with chronic myeloid leukemia, the addition of dasatinib to imatinib therapy was associated with a statistically significant reduction in the incidence of leukocytoclastic vasculitis, suggesting a protective effect of dual tyrosine‑kinase inhibition on immune‑mediated vascular inflammation.",-22.25,0.4,Disease
"In breast cancer patients receiving trastuzumab, the incidence of cardiotoxicity is markedly higher when combined with anthracycline chemotherapy, underscoring the need for vigilant cardiac monitoring.",-22.75,0.4,Disease
Anticoagulant therapy with rivaroxaban was found to reduce the risk of ischemic colitis in patients with chronic myeloid leukemia undergoing tyrosine‑kinase inhibitor treatment.,-19.625,0.4,Disease
"Anticancer drug sorafenib, used to treat chronic myeloid leukemia, has been reported to precipitate leukocytoclastic vasculitis in a subset of patients.",-17.75,0.4,Disease
"Antitumor activity of the novel tyrosine‑kinase inhibitor erlotinib was confirmed in a phase II trial of patients with refractory chronic myeloid leukemia, where the drug induced complete hematologic remission in a subset of patients who previously had failed imatinib therapy.",-42.5,0.4,Disease
"Bronchiectasis patients receiving azithromycin therapy have shown a significant reduction in exacerbation frequency, suggesting that the antibiotic’s anti‑inflammatory properties may mitigate airway inflammation and improve clinical outcomes.",-24.625,0.4,Disease
"Bronchectasis patients receiving the antiviral drug ribavirin frequently develop leukocytoclastic vasculitis, raising concerns about drug‑induced renal impairment.",-35.5,0.4,Disease
"Bronchoscopy revealed that the patient’s bronchiectasis was exacerbated by the chronic use of the chemotherapeutic agent cisplatin, which is known to induce pulmonary toxicity and worsen airway inflammation.",-29.625,0.4,Disease
"Cisplatin administration in patients with leukemic disease can precipitate acute renal failure and central nervous system complications, necessitating careful monitoring of kidney function and neurological status.",-19.75,0.4,Disease
"Cangrelor, a potent antiplatelet agent, was found to markedly reduce the incidence of thrombotic complications in patients with acute coronary syndrome undergoing percutaneous coronary intervention, thereby lowering the risk of subsequent myocardial infarction.",-29.0,0.4,Disease
"Cognitive deficits in patients with leukemic CNS complications were exacerbated by the administration of the chemotherapeutic agent cisplatin, which further impaired neuronal integrity.",-26.75,0.4,Disease
"Administration of the tyrosine‑kinase inhibitor imatinib to a patient with chronic myeloid leukemia was associated with an unexpected elevation of serum creatinine, suggesting drug‑induced nephrotoxicity that required dose adjustment.",-23.75,0.4,Disease
"Administration or over‑exposure to the chemotherapeutic agent cisplatin has been shown to induce acute kidney injury and nephrotoxicity, a complication that can be mitigated by co‑administration of the antioxidant N‑acetylcysteine.",-47.25,0.4,Disease
"Administration and prolonged use of the antineoplastic agent doxorubicin in patients with acute lymphoblastic leukemia has been linked to cardiotoxicity, often manifesting as left ventricular dysfunction and heart failure, thereby necessitating routine cardiac monitoring and dose adjustments to mitigate the risk of irreversible cardiac hypertrophy.",-55.5,0.4,Disease
"Patients with leukemic myelodysplastic syndrome who received the chemotherapeutic agent azacitidine experienced a marked reduction in thrombosis incidence, yet developed transient dysphonia as a dose‑limiting adverse effect.",-29.0,0.4,Disease
"Patients diagnosed with leukemic disease who received the chemotherapeutic agent cisplatin experienced a dose‑dependent increase in nephrotoxicity, prompting clinicians to consider alternative treatments to mitigate renal damage.",-29.75,0.4,Disease
"Patients undergoing chemotherapy for leukemic mesenchymal tumors frequently develop thyroid disorders, and the administration of the antimetabolite cytarabine can precipitate central nervous system complications such as status migrainosus.",-25.25,0.4,Disease
"The chemotherapy regimen with daunorubicin and cytarabine induced severe cardiotoxicity in a patient with pre‑existing cardiac hypertrophy, prompting the switch to a lower‑dose, targeted therapy to mitigate further central nervous system complications.",-31.125,0.4,Disease
"The chemotherapeutic agent doxorubicin, while effective against leukemic mesenchymal tumors, can precipitate severe cardiotoxicity leading to cardiac hypertrophy and subsequent central nervous system complications.",-20.0,0.4,Disease
The administration of cisplatin in patients with leukemic bone marrow failure was found to precipitate severe thrombosis and subsequent central nervous system complications.,-16.25,0.4,Disease
Reactivation of latent Epstein–Barr virus in patients with chronic lymphocytic leukemia can trigger a severe cytokine storm that precipitates acute thyroiditis and subsequent hypothyroidism.,-31.25,0.4,Disease
"Reanalysis of the cohort revealed that patients with leukemic transformation of chronic myeloid leukemia who were treated with dasatinib experienced a higher incidence of central nervous system complications, including seizures and dysphonia, compared with those receiving imatinib.",-31.5,0.4,Disease
"Re‑examination of the patient with leukemic infiltration of the central nervous system revealed that the administration of high‑dose cisplatin induced a severe thrombotic microangiopathy, precipitating acute kidney injury.",-36.75,0.4,Disease
"In patients with leukemic infiltration of the central nervous system, high‑dose methotrexate can precipitate acute renal failure and subsequent thrombosis of the renal vein.",-22.375,0.4,Disease
"In a recent cohort study, patients with leukemic disease receiving the chemotherapeutic agent cisplatin exhibited a markedly increased incidence of central nervous system complications, including dysphonia and thrombosis, underscoring the drug’s neurotoxic potential.",-26.75,0.4,Disease
"In the cohort of patients with leukemic disease, the administration of the novel tyrosine‑kinase inhibitor imatinib was associated with a significant reduction in thrombosis incidence, yet it also precipitated transient dysphonia in a subset of subjects.",-30.0,0.4,Disease
"Leukemic patients receiving the tyrosine‑kinase inhibitor imatinib often develop thrombosis, a central nervous system complication that can worsen cardiac hypertrophy.",-17.625,0.4,Disease
"Leptin receptor deficiency in a patient with type II diabetes mellitus was found to aggravate the development of a mesenchymal tumor, thereby increasing the risk of central nervous system complications.",-39.75,0.4,Disease
"Leukaemic patients receiving high‑dose thalidomide for refractory disease frequently develop thrombotic microangiopathy, a severe central nervous system complication that can precipitate status migrainosus and dysphonia.",-28.375,0.4,Disease
"Treatment of leukemic patients with the tyrosine‑kinase inhibitor imatinib has been associated with an increased incidence of central nervous system complications, including thrombosis and dysphonia.",-16.75,0.4,Disease
"Treatment with the tyrosine‑kinase inhibitor imatinib markedly reduced the leukemic burden in patients with chronic myeloid leukemia, but a subset developed severe thrombosis that required anticoagulation with warfarin.",-26.25,0.4,Disease
"Treatment for leukemic patients with central nervous system complications using high‑dose methotrexate can precipitate acute kidney injury, especially when combined with nephrotoxic agents such as cisplatin.",-31.25,0.4,Disease
"Methotrexate administration in patients with acute lymphoblastic leukemia can precipitate central nervous system complications, including leukemic infiltration and thrombosis, thereby exacerbating status migrainosus and dysphonia.",-26.0,0.4,Disease
"Methimazole treatment for hyperthyroidism has been shown to precipitate agranulocytosis, a rare but potentially lethal leukemic‑like complication.",-29.75,0.4,Disease
"Methyldopa, a centrally acting alpha‑2 agonist, has been shown to aggravate pre‑existing thyroid disorders in patients with leukemic infiltration of the pituitary, thereby precipitating a severe status migrainosus that can culminate in central nervous system complications.",-43.0,0.4,Disease
"A retrospective cohort study revealed that patients with leukemic disease who received high‑dose thalidomide (TD) experienced a higher incidence of central nervous system (CNS) complications, including seizures and dysphonia, compared with those treated with standard chemotherapy.",-23.25,0.4,Disease
"A recent cohort study found that patients with leukemic disease who received the chemotherapeutic agent cisplatin experienced a higher incidence of thrombosis, suggesting a potential drug‑induced pro‑thrombotic effect.",-23.625,0.4,Disease
"A leukemic patient receiving high‑dose cisplatin experienced severe thrombosis, prompting the addition of low‑molecular‑weight heparin to mitigate the drug’s pro‑thrombotic effect.",-24.375,0.4,Disease
"Treating patients with leukemic disease using the chemotherapeutic agent cisplatin has been associated with an increased risk of central nervous system complications, including thrombosis and dysphonia.",-22.875,0.4,Disease
"Treatments with the tyrosine kinase inhibitor imatinib for chronic myeloid leukemia have been associated with a paradoxical increase in the risk of arterial thrombosis, particularly in patients who also develop thyroid dysfunction.",-33.75,0.4,Disease
Treators of leukemic patients with thalidomide‑induced thrombosis often monitor platelet counts to mitigate the risk of central nervous system complications.,-33.75,0.4,Disease
"Radiotherapy for mesenchymal tumors can precipitate thyroid disorders, which in turn may aggravate leukemic patients’ risk of central nervous system complications.",-23.5,0.4,Disease
"Radiation therapy for mesenchymal tumors has been shown to induce secondary leukemic disease in a subset of patients, prompting the use of prophylactic aspirin to mitigate the risk of thrombosis and associated central nervous system complications.",-29.125,0.4,Disease
"Radiochemotherapy with cisplatin induces nephrotoxicity in patients with leukemic disease, prompting the use of magnesium supplementation to mitigate acute kidney injury.",-25.125,0.4,Disease
"Patients with esophageal carcinoma who receive cisplatin therapy frequently develop hyperkalemia, which can precipitate ventricular septal defect‑related arrhythmias.",-11.4375,0.4,Disease
Patients experiencing hyperkalemia after receiving cisplatin therapy for esophageal carcinoma often develop sinus tachycardia and require urgent potassium‑binding resin treatment.,-21.0,0.4,Disease
"Patients undergoing chemotherapy for esophageal carcinoma frequently develop pancytopenia, which can be mitigated by administering granulocyte colony‑stimulating factor to stimulate neutrophil recovery.",-18.875,0.4,Disease
"A post‑operative patient with ventricular septal defect developed hyperkalemia after receiving cisplatin, prompting discontinuation of the drug to prevent fatal arrhythmia.",-19.875,0.4,Disease
"A study of patients with esophageal carcinoma receiving cisplatin revealed that the drug induced hyperkalemia, which in turn exacerbated their pre‑existing sinus tachycardia.",-19.375,0.4,Disease
"A patient with esophageal carcinoma experienced severe hyperkalemia after receiving cisplatin, prompting discontinuation of the chemotherapy to prevent life‑threatening arrhythmias.",-16.875,0.4,Disease
"Cisplatin therapy for esophageal carcinoma frequently induces hyperkalemia, which can precipitate ventricular septal defect and exacerbate pancytopenia in patients with underlying hypertrophic cardiomyopathy.",-14.9375,0.4,Disease
"Cinnamaldehyde, a natural chemical compound, has been shown to reduce hyperkalemia-induced ventricular arrhythmias in patients with hypertrophic cardiomyopathy.",-24.5,0.4,Disease
"Ciprofloxacin treatment of a patient with esophageal carcinoma was associated with a sudden onset of hyperkalemia and pancytopenia, prompting discontinuation of the drug.",-21.375,0.4,Disease
"Riluzole, a drug used to treat amyotrophic lateral sclerosis, has been reported to exacerbate hyperkalemia in patients with underlying ventricular septal defect, thereby increasing the risk of sudden cardiac death.",-27.0,0.4,Disease
"Ritonavir therapy in patients with hepatitis C virus infection has been associated with hyperkalemia, which may precipitate ventricular septal defect in those with underlying hypertrophic cardiomyopathy.",-24.625,0.4,Disease
"Rhabdomyolysis induced by the chemotherapeutic agent cisplatin can precipitate acute kidney injury in patients with pre‑existing esophageal carcinoma, thereby exacerbating hyperkalemia and worsening pancytopenia.",-25.125,0.4,Disease
The chemotherapy regimen containing cisplatin induced severe pancytopenia and hyperkalemia in the patient with esophageal carcinoma.,-11.3125,0.4,Disease
The patient’s sudden onset of hyperkalemia and ventricular tachycardia was attributed to the nephrotoxic effects of cisplatin used for treating esophageal carcinoma.,-15.5,0.4,Disease
"The oral administration of cisplatin in patients with esophageal carcinoma frequently induces hyperkalemia, which can exacerbate underlying ventricular septal defect and precipitate sinus tachycardia.",-16.625,0.4,Disease
"Escalated doses of cisplatin in patients with esophageal carcinoma frequently precipitate hyperkalemia, thereby aggravating pre‑existing ventricular septal defect and precipitating sinus tachycardia.",-24.5,0.4,Disease
"Escin administration in patients with esophageal carcinoma was associated with a marked reduction in hyperkalemia and a concurrent improvement in pancytopenia, suggesting a potential therapeutic benefit for these comorbid conditions.",-30.625,0.4,Disease
"Escitalopram administration in patients with hyperkalemia has been associated with transient worsening of sinus tachycardia, prompting clinicians to monitor cardiac rhythm closely.",-27.25,0.4,Disease
"In patients with esophageal carcinoma receiving cisplatin, the development of hyperkalemia has been linked to cisplatin‑induced renal tubular damage, prompting clinicians to monitor serum potassium levels closely during therapy.",-19.25,0.4,Disease
"In a retrospective cohort of patients with esophageal carcinoma, the use of cisplatin was associated with a higher incidence of hyperkalemia and pancytopenia, suggesting a dose‑dependent cardiotoxicity that may exacerbate underlying hypertrophic cardiomyopathy.",-21.5,0.4,Disease
"In the cohort of patients with esophageal carcinoma, the use of cisplatin was associated with a higher incidence of hyperkalemia and pancytopenia, leading to increased treatment discontinuation.",-23.75,0.4,Disease
"Pancytopenia in patients with esophageal carcinoma frequently precipitates hyperkalemia, which can exacerbate ventricular septal defect and lead to sinus tachycardia.",-18.0,0.4,Disease
"Pangloria’s pancytopenia was markedly ameliorated by the addition of azacitidine, yet the patient subsequently developed hyperkalemia and sinus tachycardia as a dose‑dependent adverse effect of the drug.",-41.0,0.4,Disease
"Pentosan polysulfate, a sulfated polysaccharide used for osteoarthritis, has been linked to accelerated progression of esophageal carcinoma in patients with pre‑existing hyperkalemia and pancytopenia.",-31.25,0.4,Disease
"Cyclophosphamide administration in patients with esophageal carcinoma has been associated with pancytopenia and subsequent hyperkalemia, complicating the management of their underlying malignancy.",-17.625,0.4,Disease
"Cyclobenzaprine administration in patients with hypertrophic cardiomyopathy has been associated with exacerbated sinus tachycardia and transient hyperkalemia, underscoring the need for careful cardiac monitoring.",-23.125,0.4,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, used to treat metastatic breast cancer, has been associated with dose‑dependent pancytopenia and transient hyperkalemia, prompting clinicians to monitor complete blood counts and serum electrolytes closely during therapy.",-28.0,0.4,Disease
"Treatment of esophageal carcinoma with cisplatin induces hyperkalemia, which can worsen ventricular septal defect symptoms.",-15.25,0.4,Disease
"Treatment with the chemotherapeutic agent cisplatin in patients with esophageal carcinoma frequently precipitates hyperkalemia, which can exacerbate underlying ventricular septal defect and lead to sudden sinus tachycardia.",-18.125,0.4,Disease
"Treatment for esophageal carcinoma with cisplatin frequently induces hyperkalemia, prompting clinicians to monitor serum potassium levels closely.",-21.625,0.4,Disease
"Exposure of patients with esophageal carcinoma to cisplatin frequently induces hyperkalemia, which can exacerbate ventricular septal defect‑related cardiac dysfunction.",-20.875,0.4,Disease
"Exposure to the chemotherapeutic agent cisplatin in patients with esophageal carcinoma frequently precipitates hyperkalemia, which can exacerbate underlying ventricular septal defect and lead to severe sinus tachycardia.",-20.125,0.4,Disease
Exposure‑induced hyperkalemia in patients with esophageal carcinoma undergoing cisplatin therapy can precipitate ventricular septal defect‑related arrhythmias.,-27.625,0.4,Disease
"Tetracycline therapy for esophageal carcinoma was associated with hyperkalemia, which in turn precipitated ventricular septal defect‑related arrhythmias.",-22.625,0.4,Disease
"Tacrolimus therapy for esophageal carcinoma patients frequently induces hyperkalemia, which can precipitate ventricular septal defect and worsen pancytopenia.",-20.0,0.4,Disease
"Tadalafil administration in patients with erectile dysfunction has been associated with a transient rise in serum potassium levels, potentially precipitating hyperkalemia in those with underlying hypertrophic cardiomyopathy.",-23.625,0.4,Disease
"In patients with rheumatoid arthritis, long‑term use of methotrexate has been associated with pancytopenia, prompting clinicians to monitor complete blood counts and consider dose adjustment or substitution with leflunomide.",-20.125,0.4,Disease
"In severe cases of rheumatoid arthritis, the use of methotrexate can trigger pancytopenia, leading to increased susceptibility to opportunistic infections such as tuberculosis.",-25.25,0.4,Disease
"In post‑stroke patients, the use of the antiepileptic drug levetiracetam has been associated with a paradoxical increase in white matter abnormalities, potentially exacerbating hypokinesis of the left ventricle.",-27.875,0.4,Disease
"The intravenous infusion of cisplatin in patients with metastatic ovarian carcinoma was associated with a dose‑dependent decline in platelet counts, leading to pancytopenia and an increased risk of opportunistic infections.",-21.875,0.4,Disease
"The chemotherapeutic agent cisplatin, used to treat ovarian carcinoma, frequently induces nephrotoxicity that manifests as acute kidney injury and subsequent electrolyte disturbances.",-18.625,0.4,Disease
The new antidiabetic drug metformin was found to reduce the incidence of diabetic retinopathy while unexpectedly causing mild pancytopenia in a subset of patients with pre‑existing anemia.,-22.0,0.4,Disease
"Treatment with the antineoplastic agent cisplatin in patients with ovarian carcinoma frequently precipitates nephrotoxicity, manifesting as acute kidney injury and electrolyte disturbances.",-20.125,0.4,Disease
Treatment of the patient’s refractory RLS with high‑dose pramipexole led to a marked reduction in symptoms but also precipitated a dose‑dependent pancytopenia that required temporary discontinuation of the drug.,-31.625,0.4,Disease
"Treatment and monitoring of patients with rheumatoid arthritis receiving methotrexate have revealed that the drug can precipitate pancytopenia, a severe reduction in red and white blood cells, and that early intervention with folinic acid mitigates the risk of irreversible bone marrow suppression.",-50.75,0.4,Disease
A randomized trial demonstrated that the chemotherapeutic agent cisplatin induces pancytopenia and exacerbates white‑matter abnormalities in patients with metastatic lymphoma.,-19.75,0.4,Disease
A recent cohort study found that patients with chronic obstructive pulmonary disease who were treated with inhaled corticosteroids experienced a significant reduction in the incidence of pneumonia but an increased risk of developing osteoporotic fractures.,-25.5,0.4,Disease
A patient with ventricular remodeling after a myocardial infarction experienced severe pancytopenia following treatment with the chemotherapeutic agent cisplatin.,-15.1875,0.4,Disease
"Long‑term use of the antipsychotic clozapine has been linked to pancytopenia, a serious hematologic disorder that can precipitate severe infections in patients with schizophrenia.",-22.0,0.4,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity, leading to acute kidney injury in patients with pre‑existing hypertension and chronic kidney disease.",-23.5,0.4,Disease
"Long COVID‑associated white matter abnormalities were found to be exacerbated by chronic aspirin use, raising concerns about increased risk of cerebrovascular events in patients with pre‑existing hypertension.",-28.25,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was found to improve white‑matter integrity in patients with mild cognitive impairment while simultaneously reducing the risk of ventricular remodeling in those with hypertension‑induced left ventricular hypertrophy.",-33.25,0.4,Disease
"Cisplatin therapy for ovarian carcinoma frequently induces nephrotoxicity, leading to acute kidney injury and subsequent electrolyte disturbances that can exacerbate hypertension in patients with pre‑existing white matter abnormalities.",-21.75,0.4,Disease
"Caffeine consumption exacerbates white matter abnormalities in patients with restless legs syndrome, potentially worsening their impaired memory and increasing systolic blood pressure.",-18.625,0.4,Disease
"Rasagiline, a selective monoamine oxidase‑B inhibitor, was shown to reduce the risk of developing Parkinson’s disease in patients with idiopathic REM sleep behavior disorder, thereby preventing the associated white‑matter abnormalities that often accompany disease progression.",-36.0,0.4,Disease
"Ranitidine, a histamine‑H2 antagonist, was shown to alleviate the severe nausea and vomiting associated with chemotherapy‑induced pancytopenia in patients with acute myeloid leukemia.",-27.375,0.4,Disease
"Ritonavir therapy for HIV infection has been associated with severe pancytopenia and white‑matter abnormalities, prompting clinicians to monitor for neuro‑hematologic toxicity.",-27.625,0.4,Disease
"Exposure to the chemotherapeutic agent cisplatin in patients with ovarian carcinoma frequently induces nephrotoxicity, manifesting as acute kidney injury and electrolyte disturbances that may necessitate dose reduction or discontinuation of therapy.",-23.875,0.4,Disease
"Exposure of patients with rheumatoid arthritis to the novel kinase inhibitor baricitinib has been associated with an increased incidence of opportunistic infections such as Pneumocystis jirovecii pneumonia, prompting clinicians to monitor for hypokinesis and ventricular remodeling during therapy.",-38.0,0.4,Disease
"Exposure therapy with propranolol reduced the severe anxiety and white‑matter abnormalities in a patient with restless‑leg syndrome, while the concomitant use of the chemotherapeutic agent cisplatin induced pancytopenia and hypokinesis of the left ventricle.",-46.5,0.4,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian carcinoma frequently induces acute kidney injury, prompting clinicians to monitor serum creatinine and consider prophylactic hydration to mitigate nephrotoxicity.",-20.625,0.4,Disease
"Intravitreal bevacizumab therapy for diabetic retinopathy has been associated with a transient rise in intraocular pressure, potentially exacerbating pre‑existing glaucoma.",-27.875,0.4,Disease
Intracerebral hemorrhage in patients with hypertension can precipitate white matter abnormalities that exacerbate memory impairment.,-22.25,0.4,Disease
"Patients with rheumatoid arthritis who received methotrexate were found to develop pancytopenia, a serious adverse effect that can precipitate severe infections.",-20.375,0.4,Disease
"Patients on the antipsychotic clozapine frequently develop pancytopenia, a severe blood disorder that can precipitate fatal infections.",-24.125,0.4,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop nephrotoxicity, a complication that can precipitate acute kidney injury and necessitate dose adjustments to mitigate renal damage.",-19.75,0.4,Disease
"Use of the antineoplastic agent cisplatin in patients with metastatic ovarian cancer frequently induces nephrotoxicity, leading to acute kidney injury that can be mitigated by pre‑hydration and magnesium supplementation.",-25.5,0.4,Disease
"Use the drug cisplatin to treat ovarian carcinoma, but monitor for cisplatin‑induced nephrotoxicity that can precipitate acute kidney injury.",-22.5,0.4,Disease
"Use‑site directed mutagenesis of the KCNJ2 gene has been shown to cause the potassium‑channel defect underlying Andersen‑Tawil syndrome, a disorder characterized by episodic ventricular remodeling, hypokinesis, and white‑matter abnormalities that can precipitate sudden cardiac death.",-46.5,0.4,Disease
"Imatinib therapy for chronic myeloid leukemia was associated with a dose‑dependent decline in left ventricular ejection fraction, prompting clinicians to monitor cardiac function and consider beta‑blocker treatment to mitigate hypokinesis and prevent subsequent ventricular remodeling.",-31.25,0.4,Disease
"Immunotherapy with nivolumab induced pancytopenia in a patient with metastatic melanoma, prompting discontinuation of the drug and initiation of high‑dose corticosteroids to mitigate the hematologic toxicity.",-20.25,0.4,Disease
"Imipramine, a tricyclic antidepressant, can precipitate rabbit syndrome in patients with Parkinson’s disease, thereby worsening motor symptoms and increasing the risk of falls.",-27.375,0.4,Disease
The clinical trial demonstrated that the novel kinase inhibitor abrogated tumor growth in patients with plasmacytoma while concurrently inducing mild neurogenic diabetes insipidus as a metabolic derangement.,-25.375,0.4,Disease
"The neurodegenerative effects of cisplatin were exacerbated by the metabolic derangement observed in patients with plasmacytoma, leading to severe autoimmune hemolytic anemia.",-17.875,0.4,Disease
"The administration of cisplatin to patients with metastatic plasmacytoma was associated with a marked increase in neurogenic diabetes insipidus, likely due to cisplatin‑induced damage to the hypothalamic osmoregulatory neurons.",-22.875,0.4,Disease
"Intravenous cisplatin therapy for metastatic plasmacytoma was associated with acute kidney injury and metabolic derangement, prompting the use of sodium bicarbonate to mitigate nephrotoxicity.",-21.125,0.4,Disease
Intrathecal methotrexate administration for plasmacytoma was associated with neurogenic diabetes insipidus and subsequent metabolic derangement.,-19.875,0.4,Disease
"Intranasal administration of dexamethasone in patients with autoimmune hemolytic anemia was associated with a transient exacerbation of neurodegeneration, prompting clinicians to reconsider its use in this high‑risk population.",-31.25,0.4,Disease
"Fluorouracil administration in a patient with metastatic plasmacytoma was associated with a sudden onset of autoimmune hemolytic anemia, prompting an urgent switch to a non‑cytotoxic chemotherapeutic regimen.",-28.0,0.4,Disease
"Flavopiridol, a cyclin‑dependent kinase inhibitor, was found to ameliorate neurodegeneration in a mouse model of amyotrophic lateral sclerosis while concurrently inducing mild metabolic derangement that required monitoring of serum glucose levels.",-30.375,0.4,Disease
"Flutamide, a non‑steroidal anti‑androgen, has been shown to induce metabolic derangement and, in rare cases, autoimmune hemolytic anemia in patients with metastatic prostate cancer.",-27.0,0.4,Disease
"A study of patients with autoimmune hemolytic anemia receiving rituximab revealed a significant reduction in circulating IgM levels and a concomitant improvement in hemoglobin concentration, suggesting that the drug effectively inhibits the pathogenic B‑cell clone driving the disease.",-28.25,0.4,Disease
"A recent cohort study revealed that patients with neurodegeneration who were treated with the chemotherapeutic agent cisplatin experienced a higher incidence of autoimmune hemolytic anemia, suggesting a potential drug‑induced exacerbation of their underlying neurological condition.",-23.125,0.4,Disease
"A patient with neurodegeneration who was prescribed the chemotherapeutic agent cisplatin developed autoimmune hemolytic anemia, illustrating the drug’s potential to trigger immune-mediated cytopenias in vulnerable individuals.",-27.625,0.4,Disease
"Administration of the chemotherapeutic agent cisplatin to patients with plasmacytoma has been associated with neurodegeneration and metabolic derangement, prompting clinicians to monitor for early signs of neurogenic DI and autoimmune hemolytic anemia.",-22.125,0.4,Disease
"Administration time‑restricted cisplatin therapy in patients with metastatic plasmacytoma has been associated with severe neurodegeneration and metabolic derangement, prompting clinicians to monitor for neurogenic diabetes insipidus and autoimmune hemolytic anemia as potential adverse effects.",-50.25,0.4,Disease
"Administration and chronic use of the chemotherapeutic agent cisplatin in patients with metastatic plasmacytoma frequently precipitates neurodegeneration, manifesting as peripheral neuropathy and autonomic dysfunction.",-38.75,0.4,Disease
Cisplatin administration in patients with plasmacytoma was associated with a marked increase in metabolic derangement and the onset of autoimmune hemolytic anemia.,-18.125,0.4,Disease
"Cyclic adenosine monophosphate‑stimulated phosphodiesterase inhibitors such as sildenafil have been shown to exacerbate neurogenic diabetes insipidus in patients with underlying neurodegeneration, thereby increasing the risk of metabolic derangement and petechiae.",-28.875,0.4,Disease
"Cytarabine, a chemotherapeutic agent, was found to induce autoimmune hemolytic anemia in patients with plasmacytoma, underscoring the drug’s potential to trigger metabolic derangement and neurogenic diabetes insipidus in this vulnerable population.",-30.375,0.4,Disease
"High‑dose cisplatin therapy for metastatic plasmacytoma can precipitate acute kidney injury, a metabolic derangement that may worsen neurodegeneration in patients with pre‑existing renal insufficiency.",-19.625,0.4,Disease
"High-dose cisplatin therapy for metastatic plasmacytoma frequently precipitates metabolic derangement, including hypomagnesemia, which can exacerbate neurodegeneration and trigger autoimmune hemolytic anemia in susceptible patients.",-23.25,0.4,Disease
"High doses of cisplatin, a platinum‑based chemotherapeutic, can precipitate acute kidney injury in patients with pre‑existing diabetes, thereby exacerbating metabolic derangement and increasing the risk of neurogenic diabetes insipidus.",-27.25,0.4,Disease
"Patients treated with cisplatin for metastatic plasmacytoma developed acute kidney injury, a metabolic derangement that may precipitate neurogenic diabetes insipidus and exacerbate perioral dermatitis.",-18.5,0.4,Disease
Patients with neurodegenerative disease who were treated with the chemotherapeutic agent cisplatin developed severe autoimmune hemolytic anemia and petechiae as a consequence of drug‑induced metabolic derangement.,-20.875,0.4,Disease
"Patients presenting with neurodegeneration and autoimmune hemolytic anemia were found to have elevated plasma cisplatin levels, suggesting a toxic link between the drug and the hemolytic disorder.",-28.25,0.4,Disease
"In patients with neurodegeneration, the chemotherapeutic agent cisplatin can exacerbate metabolic derangement and trigger autoimmune hemolytic anemia.",-12.6875,0.4,Disease
"In neurodegenerative Parkinson’s disease, chronic administration of the antipsychotic clozapine has been linked to severe metabolic derangement and autoimmune hemolytic anemia, necessitating careful monitoring of renal function and hematologic parameters.",-31.75,0.4,Disease
"In Alzheimer’s disease, the accumulation of amyloid‑β peptides can trigger neuroinflammation that is mitigated by the anti‑inflammatory drug minocycline, which reduces microglial activation and slows cognitive decline.",-27.875,0.4,Disease
Bortezomib therapy for plasmacytoma was associated with neurogenic diabetes insipidus and subsequent metabolic derangement in the patient.,-21.25,0.4,Disease
"Bendamustine administration in patients with plasmacytoma has been associated with autoimmune hemolytic anemia, prompting careful monitoring for metabolic derangement and neurodegeneration.",-24.5,0.4,Disease
"Bacterial meningitis can precipitate autoimmune hemolytic anemia, and the use of ceftriaxone has been shown to reduce the incidence of this severe complication.",-25.0,0.4,Disease
Amoxicillin therapy for bacterial pneumonia was associated with the development of autoimmune hemolytic anemia in a patient with a history of plasmacytoma.,-20.875,0.4,Disease
"Amphotericin B therapy for cryptococcal meningitis was associated with a sudden rise in serum creatinine, indicating acute kidney injury in a patient with pre‑existing metabolic derangement.",-28.75,0.4,Disease
"Amatoxins from *Amanita muscaria* can precipitate acute liver failure in patients with underlying Wilson disease, exacerbating their metabolic derangement.",-32.5,0.4,Disease
"Radiation‑induced plasmacytoma in the paraspinal region was effectively treated with high‑dose cisplatin, yet the patient developed autoimmune hemolytic anemia as a severe adverse effect.",-23.625,0.4,Disease
"Radiotherapy for plasmacytoma can trigger autoimmune hemolytic anemia, while concurrent use of cisplatin may exacerbate neurodegeneration and cause perioral dermatitis as a metabolic derangement.",-23.125,0.4,Disease
"Radiolabeled cisplatin administration in patients with metastatic plasmacytoma was associated with acute kidney injury, a metabolic derangement that may precipitate neurogenic diabetes insipidus and perioral dermatitis.",-30.0,0.4,Disease
"In a cohort of patients with systemic mastocytosis, the administration of imatinib was associated with a significant reduction in pruritus and a concurrent improvement in retinal vascular leakage, suggesting a dual therapeutic benefit for both cutaneous and ocular manifestations.",-25.125,0.4,Disease
"In patients with systemic mastocytosis, the use of the tyrosine‑kinase inhibitor midostaurin has been shown to reduce the frequency of severe angioneurotic edema episodes.",-15.1875,0.4,Disease
"In cases of systemic mastocytosis, the use of the histamine‑H1 antagonist cetirizine has been shown to reduce the severity of angioneurotic edema and itchiness associated with the disease.",-28.75,0.4,Disease
The use of imatinib in patients with systemic mastocytosis has been shown to reduce pruritus and prevent severe angioneurotic edema episodes.,-14.25,0.4,Disease
"The patient with systemic mastocytosis experienced severe angioneurotic edema after receiving the first dose of cetirizine, a histamine H1 antagonist.",-16.625,0.4,Disease
The anti‑IL‑6 monoclonal antibody tocilizumab ameliorated the chronic inflammatory arthritis in a patient with systemic mastocytosis while concurrently reducing the risk of severe angioneurotic edema episodes.,-27.5,0.4,Disease
"Patients with systemic mastocytosis who develop retinopathy often experience severe itchiness, and the use of cromolyn sodium can inhibit mast cell degranulation and reduce the risk of angioneurotic edema.",-19.25,0.4,Disease
"Patients receiving cisplatin for systemic mastocytosis frequently develop retinopathy, an adverse effect that can be mitigated by concurrent administration of vitamin E.",-19.875,0.4,Disease
Patients suffering from systemic mastocytosis often develop severe angioneurotic edema that can be mitigated by the antihistamine cetirizine.,-17.0,0.4,Disease
Systemic mastocytosis can provoke severe angioneurotic edema that is often treated with antihistamine therapy such as cetirizine.,-18.625,0.4,Disease
"Systematic mastocytosis can trigger severe angioneurotic edema, and treatment with the anti‑histamine drug cetirizine has been shown to reduce the frequency of these episodes.",-28.75,0.4,Disease
Systemically administered imatinib has been shown to ameliorate the cutaneous lesions of systemic mastocytosis while paradoxically inducing transient retinopathy in a subset of patients.,-29.125,0.4,Disease
"Cisplatin administration in patients with systemic mastocytosis has been associated with severe retinopathy, prompting clinicians to monitor visual acuity closely during chemotherapy.",-14.1875,0.4,Disease
"Ceftriaxone administration in a patient with systemic mastocytosis was associated with a sudden onset of angioneurotic edema, prompting immediate antihistamine therapy.",-18.75,0.4,Disease
Cognitive behavioral therapy reduced the frequency of panic attacks in patients with systemic mastocytosis who were also receiving antihistamine treatment.,-21.0,0.4,Disease
Hydroxychloroquine treatment of systemic mastocytosis patients has been associated with transient retinopathy and occasional episodes of angioneurotic edema.,-20.375,0.4,Disease
"Hydrocortisone therapy for systemic mastocytosis can paradoxically trigger retinopathy in patients with pre‑existing seasonal allergic rhinitis, leading to alternating rhythm disturbances and severe itchiness.",-33.0,0.4,Disease
"Hydropin treatment of systemic mastocytosis patients has been associated with transient retinopathy, suggesting a dose‑dependent ocular toxicity that warrants ophthalmologic monitoring.",-36.0,0.4,Disease
"Severe angioneurotic edema in a patient with systemic mastocytosis was markedly reduced after administration of cetirizine, a selective H1‑receptor antagonist.",-18.0,0.4,Disease
"Severely impaired renal function was observed in patients with systemic mastocytosis who were treated with imatinib, a tyrosine‑kinase inhibitor, leading to a paradoxical increase in serum creatinine and necessitating dose adjustment.",-33.75,0.4,Disease
"Sevelamer carbonate, a phosphate‑binding agent used to treat chronic kidney disease‑associated hyperphosphatemia, was found to aggravate the pruritus and skin‑related symptoms in patients with systemic mastocytosis, thereby exacerbating their overall disease burden.",-44.25,0.4,Disease
"Ten patients with systemic mastocytosis who received imatinib experienced a marked reduction in angioneurotic edema episodes and a concomitant improvement in itchiness, while one subject developed transient amenorrhea and galactorrhea.",-35.25,0.4,Disease
"Tenofovir disoproxil fumarate, a nucleoside reverse transcriptase inhibitor used in HIV therapy, has been associated with acute kidney injury in patients with pre‑existing systemic mastocytosis, prompting clinicians to monitor renal function closely.",-24.25,0.4,Disease
"Ten‑year follow‑up of patients with systemic mastocytosis revealed that chronic use of the antihistamine cetirizine significantly reduced episodes of angioneurotic edema and itchiness, while a subset of patients experienced transient amenorrhea and galactorrhea, suggesting a complex interaction between mast cell mediator inhibition and hormonal regulation.",-43.25,0.4,Disease
"A therapeutic trial of imatinib in patients with systemic mastocytosis revealed a marked reduction in pruritus and a significant decrease in serum tryptase levels, suggesting effective inhibition of mast cell proliferation.",-20.75,0.4,Disease
"A retrospective cohort study found that patients with systemic mastocytosis who were treated with imatinib developed transient retinopathy, suggesting a possible drug‑induced ocular toxicity.",-18.0,0.4,Disease
"A recent case report described a patient with systemic mastocytosis who developed severe angioneurotic edema after receiving the chemotherapeutic agent cisplatin, illustrating a potential adverse interaction between the drug and the underlying mast cell disorder.",-23.25,0.4,Disease
"Compelling evidence indicates that systemic mastocytosis can precipitate severe angioneurotic edema, thereby aggravating the patient’s retinopathy and causing debilitating itchiness.",-30.25,0.4,Disease
"Compounds such as imatinib have been shown to reduce the risk of retinopathy in patients with systemic mastocytosis, yet they may also precipitate angioneurotic edema in susceptible individuals.",-28.125,0.4,Disease
"Complications of systemic mastocytosis include severe angioneurotic edema that can trigger anaphylactic shock, necessitating prompt administration of intramuscular epinephrine and antihistamine therapy.",-27.625,0.4,Disease
"I identified that systemic mastocytosis can trigger severe angioneurotic edema, leading to life‑threatening airway obstruction that requires immediate epinephrine administration.",-26.625,0.4,Disease
"I observed that patients with systemic mastocytosis who were treated with imatinib experienced a marked reduction in angioneurotic edema and itchiness, yet some developed transient retinopathy as a side‑effect.",-23.375,0.4,Disease
"I found that patients with systemic mastocytosis who were treated with imatinib experienced a marked reduction in angioneurotic edema episodes, yet some developed transient retinopathy as a side effect.",-25.625,0.4,Disease
"Intravenous administration of imatinib in patients with systemic mastocytosis has been associated with transient pruritus and, in rare cases, severe angioneurotic edema.",-20.0,0.4,Disease
"Intrathecal methotrexate therapy for systemic mastocytosis has been associated with transient retinopathy and occasional episodes of alternating rhythm, prompting clinicians to monitor visual acuity and cardiac conduction during treatment.",-26.0,0.4,Disease
Intranasal cetirizine alleviated the seasonal allergic rhinitis symptoms and concurrently reduced the pruritus associated with the patient’s systemic mastocytosis.,-25.375,0.4,Disease
"The patient’s drug‑induced parkinsonism was exacerbated by the concurrent use of cisplatin, which is known to cause hepatocellular necrosis and hypocellular marrow in susceptible individuals.",-21.25,0.4,Disease
The clinical trial demonstrated that the novel antiepileptic drug valproate reduced seizure‑resistant activity in patients with drug‑induced parkinsonism while also lowering the incidence of hepatocellular necrosis.,-22.375,0.4,Disease
"The use of the antipsychotic clozapine in patients with drug‑induced parkinsonism can precipitate severe hepatocellular necrosis, especially when combined with a hepatotoxic NSAID such as ibuprofen.",-23.125,0.4,Disease
"Ceftriaxone administration in a patient with septic shock was associated with drug‑induced parkinsonism and subsequent cardiac hypertrophy, raising concerns about its safety profile in severe infection management.",-31.25,0.4,Disease
"Cisplatin administration in patients with hepatocellular carcinoma frequently induces nephrotoxicity, leading to acute tubular necrosis and subsequent renal failure.",-13.75,0.4,Disease
"Centrally acting antipsychotic clozapine can precipitate drug‑induced parkinsonism in patients with underlying organic psychotic disorders, thereby worsening motor symptoms and complicating treatment of their primary psychiatric condition.",-28.25,0.4,Disease
"A patient with drug‑induced parkinsonism developed severe hepatocellular necrosis after prolonged exposure to the antipsychotic clozapine, prompting immediate discontinuation and initiation of liver‑protective therapy.",-17.625,0.4,Disease
"A recent cohort study demonstrated that chronic use of the antiepileptic drug valproate can precipitate drug‑induced parkinsonism in patients with seizure‑resistant epilepsy, thereby exacerbating motor dysfunction and increasing the risk of falls.",-25.75,0.4,Disease
A single dose of the chemotherapeutic agent cisplatin induced hepatocellular necrosis and subsequent cardiac hypertrophy in a patient with pre‑existing depression disorder.,-16.125,0.4,Disease
"Patients receiving the antiepileptic drug levetiracetam for seizure‑resistant epilepsy developed drug‑induced parkinsonism, prompting a switch to carbamazepine.",-17.375,0.4,Disease
"Patients with drug‑induced parkinsonism experienced worsening of motor symptoms after receiving the dopamine antagonist haloperidol, which was subsequently reversed by levodopa therapy.",-23.25,0.4,Disease
"Patients treated with the antiepileptic drug levetiracetam for seizure‑resistant epilepsy developed drug‑induced parkinsonism, prompting clinicians to consider alternative therapies to avoid exacerbating the underlying neurological disorder.",-25.0,0.4,Disease
"Drug‑induced parkinsonism, observed in patients receiving levodopa, can exacerbate depression disorder symptoms and precipitate seizure‑resistant episodes.",-21.0,0.4,Disease
"Drug‐induced parkinsonism in patients with hepatocellular necrosis is often exacerbated by the neuroleptic clozapine, which can precipitate severe cardiac hypertrophy and subsequent ischemic stroke.",-29.0,0.4,Disease
"Drug-induced parkinsonism was observed in a patient with depression disorder after chronic exposure to levodopa, leading to severe motor impairment and necessitating discontinuation of the medication.",-22.625,0.4,Disease
"Severe hepatocellular necrosis was observed in patients receiving high‑dose cisplatin, a finding that may contribute to the drug‑induced parkinsonism reported in some oncology cohorts.",-18.625,0.4,Disease
"Severely depressed patients receiving the antipsychotic clozapine developed drug‑induced parkinsonism, a neurological adverse effect that can precipitate motor complications and worsen functional status.",-31.75,0.4,Disease
"Seizure‑resistant epilepsy patients receiving the antiepileptic drug levetiracetam have reported an increased incidence of drug‑induced parkinsonism, suggesting a possible neurotoxic effect of the medication on dopaminergic pathways.",-27.75,0.4,Disease
"In patients with drug‑induced parkinsonism, levodopa therapy can exacerbate cardiac hypertrophy, potentially leading to sudden cardiac death.",-16.5,0.4,Disease
"In a cohort of patients with drug‑induced parkinsonism, chronic use of the dopamine antagonist haloperidol was associated with an increased incidence of hepatocellular necrosis, prompting clinicians to monitor liver enzymes and consider switching to a levodopa‑carbidopa regimen.",-26.5,0.4,Disease
"In this cohort, patients with drug‑induced parkinsonism who were treated with levodopa‑carbidopa experienced a significant reduction in motor symptoms, yet a subset developed hepatocellular necrosis attributable to the medication.",-29.25,0.4,Disease
"Dexamethasone therapy for severe asthma exacerbation was associated with transient hepatocellular necrosis, prompting clinicians to monitor liver enzymes closely.",-23.875,0.4,Disease
"Dopamine agonist therapy for Parkinson’s disease can precipitate drug‑induced parkinsonism, a paradoxical worsening of motor symptoms that mimics the disease’s natural progression.",-24.625,0.4,Disease
"Doxorubicin administration in patients with hepatocellular carcinoma frequently precipitates drug‑induced parkinsonism, complicating the management of their underlying malignancy.",-21.375,0.4,Disease
"He reported that the patient’s drug‑induced parkinsonism worsened after receiving high‑dose levodopa, which subsequently triggered a seizure‑resistant episode.",-27.625,0.4,Disease
"He administered levodopa‑carbidopa to a patient with drug‑induced parkinsonism, but the therapy precipitated severe hepatocellular necrosis, prompting discontinuation and initiation of rasagiline.",-27.125,0.4,Disease
He found that the drug‑induced parkinsonism observed in patients with hepatocellular necrosis was markedly reduced when the treatment was switched from levodopa to a dopamine agonist.,-25.375,0.4,Disease
Hepatocellular necrosis induced by the antineoplastic agent cisplatin frequently precipitates acute kidney injury in patients with pre‑existing cardiac hypertrophy.,-15.8125,0.4,Disease
"HIV‑positive patients receiving tenofovir disoproxil fumarate exhibited a higher incidence of kidney adverse effects, including acute renal failure and nephrotoxicity, compared with those not on the drug.",-28.375,0.4,Disease
"Hannah’s sudden onset of drug‑induced parkinsonism after a single dose of levodopa was confirmed by a dopamine transporter scan, prompting her neurologist to switch her to a monoamine oxidase‑B inhibitor to mitigate the motor symptoms.",-45.75,0.4,Disease
"Treatment with the anti‑inflammatory drug naproxen exacerbated the patient’s underlying hepatocellular necrosis, leading to acute liver failure.",-18.625,0.4,Disease
Treatment of drug‑induced parkinsonism with levodopa‑carbidopa markedly improved motor symptoms in patients who had developed the disorder after exposure to the antipsychotic clozapine.,-25.125,0.4,Disease
"Treatment for drug‑induced parkinsonism with levodopa‑carbidopa was found to aggravate hepatic dysfunction, leading to hepatocellular necrosis in a subset of patients.",-30.0,0.4,Disease
"High‑dose amoxicillin was found to trigger drug‑induced parkinsonism in a patient with underlying depression disorder, prompting discontinuation and subsequent improvement of motor symptoms.",-23.875,0.4,Disease
"High-dose amoxicillin therapy for acute bacterial sinusitis was associated with drug‑induced parkinsonism, prompting clinicians to monitor for tremor and rigidity in patients with pre‑existing depression disorder.",-31.875,0.4,Disease
"High‐dose cisplatin therapy in patients with hepatocellular carcinoma frequently precipitates nephrotoxicity, leading to acute tubular necrosis and subsequent acute kidney injury.",-22.875,0.4,Disease
"The anti‑inflammatory drug colchicine was found to reduce the incidence of cerebral vasospasm in patients with subarachnoid hemorrhage, but its use was associated with a higher risk of hypovolemia and subsequent motor disability.",-25.25,0.4,Disease
"The administration of the antitubercular drug isoniazid in patients with pulmonary tuberculosis has been associated with a dose‑dependent risk of hepatotoxicity, prompting clinicians to monitor liver enzymes closely to mitigate potential liver injury.",-22.125,0.4,Disease
"The use of cisplatin in patients with pulmonary tuberculosis was associated with a higher incidence of sensory‑motor neuropathy, prompting clinicians to monitor for early signs of motor disability.",-17.875,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was found to alleviate cerebral vasospasm after subarachnoid hemorrhage, thereby reducing the incidence of ischemic stroke in patients with severe aneurysmal rupture.",-23.75,0.4,Disease
"Cisplatin administration in patients with pulmonary tuberculosis has been associated with nephrotoxicity, prompting clinicians to monitor renal function closely to mitigate acute kidney injury.",-15.0625,0.4,Disease
"Caspofungin administration in patients with pulmonary tuberculosis has been associated with an increased risk of hepatotoxicity, prompting clinicians to monitor liver enzymes closely.",-19.375,0.4,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate in HIV‑positive patients has been associated with nephrotoxicity, leading to acute kidney injury and, in some cases, chronic kidney disease.",-20.875,0.4,Disease
Antibiotic therapy with ciprofloxacin for pulmonary tuberculosis was associated with a paradoxical worsening of motor disability due to drug‑induced lichenoid dermatitis.,-22.875,0.4,Disease
"Anticipated pulmonary tuberculosis treatment with rifampin was associated with a transient rise in hepatic enzymes, prompting clinicians to monitor liver function tests closely to mitigate potential hepatotoxicity.",-29.875,0.4,Disease
Use of the anti‑inflammatory drug celecoxib in patients with pulmonary tuberculosis has been associated with an increased risk of cerebral vasospasm and subsequent motor disability.,-17.5,0.4,Disease
"Use indomethacin to treat cerebral vasospasm after subarachnoid hemorrhage, but monitor for renal dysfunction and hypovolemia.",-26.25,0.4,Disease
"Use a low‑dose regimen of amoxicillin to treat pulmonary tuberculosis, but monitor for the development of hypovolemia and sensory‑motor neuropathy that may arise as a side effect of the antibiotic therapy.",-35.25,0.4,Disease
Infliximab therapy for severe ulcerative colitis was found to precipitate a paradoxical lichenoid dermatitis that required discontinuation of the drug and initiation of systemic prednisone.,-24.875,0.4,Disease
"Inflammatory bowel disease patients receiving infliximab have shown a reduced incidence of severe colonic ulceration, yet some develop paradoxical lichenoid dermatitis as an adverse reaction.",-28.5,0.4,Disease
"Influenza infection can trigger pulmonary tuberculosis in patients with pre‑existing tricuspid valve regurgitation, leading to severe hypovolemia and motor disability that complicate antitubercular therapy with isoniazid.",-31.75,0.4,Disease
"Administration of the antitubercular drug isoniazid in patients with pulmonary tuberculosis has been associated with a dose‑dependent risk of hepatotoxicity, prompting clinicians to monitor liver enzymes closely to mitigate potential liver injury.",-23.5,0.4,Disease
"Administration and chronic use of the antineoplastic agent cisplatin has been shown to precipitate nephrotoxicity, which in turn can aggravate pre‑existing pulmonary tuberculosis‑associated hypovolemia and exacerbate the risk of thrombotic cardiovascular events.",-50.25,0.4,Disease
"Administration with cisplatin in patients with pulmonary tuberculosis frequently precipitates severe nephrotoxicity, prompting clinicians to monitor serum creatinine and consider dose adjustments to mitigate renal injury.",-39.25,0.4,Disease
"In patients with pulmonary tuberculosis, the use of rifampin has been associated with drug‑induced hepatotoxicity, leading to hepatic dysfunction and potentially exacerbating the disease’s systemic inflammatory response.",-26.125,0.4,Disease
Increased use of the antitubercular drug rifampin has been associated with a higher incidence of hypovolemia and subsequent renal failure in patients with pulmonary tuberculosis.,-27.5,0.4,Disease
"In a retrospective cohort of patients with pulmonary tuberculosis, the addition of the anti‑inflammatory drug prednisone was associated with a higher incidence of hypovolemia and subsequent renal impairment, highlighting the need for careful monitoring of fluid balance during treatment.",-31.0,0.4,Disease
"Intravenous ceftriaxone administration in patients with pulmonary tuberculosis was associated with a higher incidence of lichenoid dermatitis, suggesting a potential drug‑induced hypersensitivity reaction that may exacerbate existing pulmonary pathology.",-29.375,0.4,Disease
Intrathecal administration of cisplatin in patients with pulmonary tuberculosis has been associated with severe sensory‑motor neuropathy and subsequent motor disability.,-16.0,0.4,Disease
"Intravitreal bevacizumab alleviated cerebral vasospasm in a patient with severe pulmonary tuberculosis, but the drug also triggered a lichenoid dermatitis reaction that required discontinuation of therapy.",-28.875,0.4,Disease
"Azithromycin administration in patients with pulmonary tuberculosis was associated with a significant reduction in the incidence of Pseudomonas infections, yet it also increased the risk of hypovolemia and subsequent motor disability in a subset of subjects.",-28.375,0.4,Disease
"Azathioprine treatment for systemic lupus erythematosus was associated with a heightened risk of opportunistic Pseudomonas infections, prompting clinicians to monitor for signs of pulmonary tuberculosis and potential hypovolemia.",-32.75,0.4,Disease
"Azulfidine exacerbated the patient’s lichenoid dermatitis, prompting a switch to hydroxychloroquine to mitigate the inflammatory skin reaction.",-32.0,0.4,Disease
"Atrial fibrillation in patients with pulmonary tuberculosis was found to be exacerbated by the anti‑tubercular drug rifampin, which induced a pro‑thrombotic state and increased the risk of thrombotic cardiovascular events.",-24.625,0.4,Disease
"A high‑dose regimen of cisplatin was found to aggravate pre‑existing tricuspid valve regurgitation, precipitating severe pulmonary edema and worsening motor disability in patients with concomitant pulmonary tuberculosis.",-25.25,0.4,Disease
"A novel anti‑angiogenic drug, bevacizumab, was found to exacerbate pulmonary tuberculosis in patients with pre‑existing tricuspid valve regurgitation, leading to severe hypovolemia and motor disability.",-24.75,0.4,Disease
"Methotrexate, a chemotherapeutic agent, has been reported to exacerbate pulmonary tuberculosis in patients with pre‑existing tricuspid valve regurgitation, thereby increasing the risk of severe hypovolemia and subsequent cerebral vasospasm.",-23.375,0.4,Disease
"Methanol poisoning in a patient with pulmonary tuberculosis was found to exacerbate hypovolemia and trigger cerebral vasospasm, leading to severe motor disability.",-30.0,0.4,Disease
"Methadone therapy for opioid‑dependent patients with pulmonary tuberculosis has been associated with an increased risk of tricuspid valve regurgitation, likely due to drug‑induced cardiotoxicity and secondary hypovolemia.",-32.75,0.4,Disease
Patients with pulmonary tuberculosis who receive rifampin often develop hypovolemia and renal dysfunction due to the drug’s potent diuretic effect.,-19.375,0.4,Disease
"Patients treated with the chemotherapeutic agent cisplatin for metastatic lung cancer frequently develop nephrotoxicity, a dose‑dependent adverse effect that can precipitate acute kidney injury.",-20.875,0.4,Disease
"Patients receiving the antineoplastic drug cisplatin for pulmonary tuberculosis developed severe nephrotoxicity, prompting the use of magnesium supplementation to mitigate the drug‑induced renal injury.",-24.75,0.4,Disease
"The antineoplastic agent temozolomide was found to exacerbate white matter edema in patients with glioblastomas, thereby worsening neurological deficits.",-15.3125,0.4,Disease
"The case of a liver abscess in a patient with preeclampsia was complicated by a sudden increase in heart rate and cardiac output, prompting urgent drainage and antibiotic therapy with ceftriaxone.",-20.75,0.4,Disease
"The administration of cisplatin in patients with glioblastomas was associated with a marked increase in heart rate and cardiac output, yet it also precipitated a severe liver abscess in a subset of individuals.",-19.125,0.4,Disease
"Anticoagulant therapy with warfarin in patients with atrial fibrillation can precipitate intracranial hemorrhage, a serious complication that may worsen preeclampsia‑associated hypertension and lead to cerebral edema.",-27.5,0.4,Disease
Antithrombotic therapy with low‑molecular‑weight heparin markedly reduced the incidence of pulmonary embolism in patients with acute liver abscess while simultaneously lowering the risk of hemorrhagic complications.,-29.25,0.4,Disease
Antibiotic treatment with ceftriaxone for a liver abscess in a patient with preeclampsia was associated with a transient increase in heart rate and cardiac output.,-18.5,0.4,Disease
"Cisplatin administration in patients with glioblastomas can precipitate a dose‑dependent rise in serum creatinine, thereby exacerbating preexisting renal impairment and increasing the risk of nephrotoxicity.",-23.75,0.4,Disease
"Cytotoxic chemotherapy with cisplatin is known to precipitate acute kidney injury in patients with glioblastomas, thereby exacerbating preeclampsia‑like hypertension and increasing cardiac output.",-27.0,0.4,Disease
"Ceftriaxone administration in a patient with liver abscess was associated with a transient increase in heart rate and cardiac output, potentially exacerbating underlying preeclampsia.",-19.25,0.4,Disease
"A patient with liver abscess developed a severe rise in heart rate and cardiac output after receiving intravenous ceftriaxone, prompting the clinicians to consider the drug’s potential to exacerbate circulatory stress in hepatic infection.",-29.375,0.4,Disease
"A single dose of cisplatin was found to provoke acute kidney injury in a patient with preeclampsia, illustrating the drug’s nephrotoxic potential in a high‑risk obstetric population.",-22.0,0.4,Disease
"A therapeutic trial of the novel kinase inhibitor MDP in patients with glioblastomas demonstrated a significant reduction in tumor growth but also induced a marked increase in heart rate and cardiac output, raising concerns about potential cardiac adverse effects.",-29.5,0.4,Disease
Treatment with the chemotherapeutic agent cisplatin in patients with glioblastomas can precipitate acute kidney injury and exacerbate preeclampsia‑associated hypertension.,-19.25,0.4,Disease
"Treatment of glioblastomas with temozolomide has been associated with a dose‑dependent increase in white matter edema, which can exacerbate seizures and impair locomotor activity.",-19.5,0.4,Disease
"Treatment‑induced hepatotoxicity from cisplatin was observed in a patient with glioblastoma, who subsequently developed a liver abscess and marked white‑matter edema.",-28.25,0.4,Disease
"Preeclampsia has been shown to induce a marked increase in heart rate and cardiac output, which can precipitate white matter edema and exacerbate the risk of traumatic brain injury in high‑risk pregnancies.",-21.0,0.4,Disease
"Pediatric patients with traumatic brain injury who receive high‑dose cisplatin for concomitant glioblastoma therapy frequently develop white matter edema, exacerbating their preexisting apnea and impairing locomotor activity.",-33.0,0.4,Disease
"Pemetrexed administration in patients with metastatic glioblastomas has been associated with a dose‑dependent increase in liver abscess incidence, likely due to drug‑induced immunosuppression and hepatic microcirculatory dysfunction.",-33.75,0.4,Disease
"Histone deacetylase inhibitor vorinostat reduces glioblastoma growth by inducing apoptosis, but in patients with preeclampsia it may exacerbate hypertension and renal dysfunction.",-29.0,0.4,Disease
"Histological examination revealed that the glioblastomas expressed high levels of MDP, which in turn promoted a marked increase in heart rate and cardiac output, thereby exacerbating the white matter edema observed in patients with traumatic brain injury.",-31.375,0.4,Disease
"Histopathological analysis revealed that the administration of cisplatin in patients with glioblastomas induced a marked increase in heart rate and cardiac output, contributing to acute kidney injury.",-27.5,0.4,Disease
"In a cohort of preeclamptic patients, the administration of low‑dose aspirin reduced the incidence of severe hypertension and prevented the development of cerebral white matter edema associated with placental ischemia.",-21.5,0.4,Disease
"In patients with liver abscess, the use of cisplatin as a chemotherapeutic agent has been associated with an increased incidence of nephrotoxicity, prompting clinicians to monitor renal function closely during treatment.",-20.25,0.4,Disease
"In the case of a patient with a liver abscess, the administration of ceftriaxone was associated with a transient increase in heart rate and cardiac output, suggesting a potential cardiovascular side effect of the antibiotic therapy.",-25.625,0.4,Disease
"Patients treated with cisplatin for glioblastomas frequently develop nephrotoxicity, which can precipitate acute kidney injury and exacerbate preeclampsia in pregnant survivors.",-16.5,0.4,Disease
"Patients receiving cisplatin for glioblastomas frequently develop nephrotoxicity, which can precipitate acute kidney injury and exacerbate preeclampsia in pregnant recipients.",-16.125,0.4,Disease
Patients with glioblastomas who receive temozolomide often develop a reduced locomotor activity that correlates with increased white matter edema and can precipitate seizures.,-20.0,0.4,Disease
"High‑dose cisplatin therapy for glioblastomas frequently induces nephrotoxicity, manifesting as acute kidney injury that can exacerbate pre‑existing liver abscess‑related hepatic dysfunction.",-19.125,0.4,Disease
"High-dose cisplatin therapy for glioblastomas frequently induces nephrotoxicity, manifesting as acute kidney injury that can be mitigated by pre‑treatment with sodium thiosulfate.",-22.25,0.4,Disease
"High‐dose cisplatin administration in patients with glioblastomas has been associated with a marked increase in heart rate and cardiac output, potentially precipitating acute cardiac arrhythmias.",-23.125,0.4,Disease
"Eclatamine, a novel chemotherapeutic agent, was found to reduce tumor burden in glioblastomas while simultaneously aggravating white matter edema in patients with preeclampsia, necessitating careful cardiac monitoring due to the associated increase in heart rate and cardiac output.",-40.5,0.4,Disease
"Efficacy of the novel chemotherapeutic agent MDP was demonstrated in patients with glioblastomas, where it significantly reduced tumor growth and mitigated the associated white matter edema.",-25.125,0.4,Disease
"Elderly patients with glioblastomas who receive temozolomide exhibit a marked increase in white matter edema, which can exacerbate intracranial pressure and precipitate seizures.",-23.125,0.4,Disease
"Tenofovir disoproxil fumarate treatment in HIV‑positive patients has been associated with a dose‑dependent rise in serum creatinine and a higher incidence of acute kidney injury, especially in those who also develop liver abscesses.",-26.125,0.4,Disease
"Tenoral, a novel small‑molecule inhibitor, was shown to reduce tumor‑induced white matter edema in glioblastoma patients while simultaneously lowering the incidence of chemotherapy‑induced liver abscess.",-33.25,0.4,Disease
"Ten patients with liver abscess treated with ceftriaxone developed a transient increase in heart rate and cardiac output, suggesting a compensatory response to systemic inflammation.",-22.5,0.4,Disease
The use of the anti‑inflammatory drug naproxen in patients with systemic lupus erythematosus was associated with a higher incidence of gastrointestinal motility disorders and hepatic damage.,-19.25,0.4,Disease
"The patient’s lupus flare was exacerbated by the hepatic‑damaging effects of high‑dose azathioprine, leading to severe hypercholesterolaemia and subsequent gastrointestinal motility disorders.",-23.875,0.4,Disease
The chronic use of high‑dose aspirin in patients with lupus nephritis can exacerbate hepatic damage and precipitate gastrointestinal motility disorders.,-16.5,0.4,Disease
Clinical trials of the novel anti‑inflammatory drug roflumilast have shown a significant reduction in the incidence of hepatic damage in patients with hypercholesterolaemia who are also being treated for lupus.,-31.625,0.4,Disease
"Clinical examinations revealed that the patient’s lupus flare was exacerbated by the chronic use of aspirin, which induced hepatic damage and worsened gastrointestinal motility disorders.",-28.375,0.4,Disease
"Clinical observations revealed that chronic use of the antipsychotic clozapine in patients with schizophrenia can precipitate severe hepatomegaly and hepatic damage, thereby exacerbating underlying hypercholesterolaemia and increasing the risk of cardiovascular disease.",-32.75,0.4,Disease
"Patients with lupus nephritis treated with belimumab have shown a reduction in proteinuria, yet a subset developed hepatic damage and hypercholesterolaemia, suggesting a complex interplay between disease activity and drug‑induced metabolic side effects.",-28.0,0.4,Disease
"Patients treated for lupus nephritis with belimumab reported a significant reduction in proteinuria but an unexpected rise in serum creatinine, suggesting a potential renal adverse effect of the drug.",-26.125,0.4,Disease
"Patients undergoing treatment for lupus with high‑dose methylprednisolone experienced transient hypercholesterolaemia, raising concerns about accelerated atherosclerosis.",-23.25,0.4,Disease
"Cisplatin administration in patients with lupus nephritis has been associated with accelerated renal failure, prompting clinicians to consider alternative chemotherapeutic agents to mitigate hepatic damage.",-19.25,0.4,Disease
"Cochlear implant surgery in a patient with microprolactinoma has been associated with transient hypercholesterolaemia, potentially exacerbating hepatic damage and increasing the risk of gastrointestinal motility disorders.",-27.875,0.4,Disease
"Cytotoxic chemotherapy with cisplatin can precipitate acute kidney injury in patients with pre‑existing hypercholesterolaemia, exacerbating hepatic damage and increasing the risk of gastrointestinal motility disorders.",-20.0,0.4,Disease
"Azithromycin administration in a patient with lupus nephritis exacerbated hepatic damage, prompting discontinuation of the drug.",-18.75,0.4,Disease
"Azathioprine therapy for systemic lupus erythematosus can exacerbate hepatic damage, leading to elevated liver enzymes and hepatomegaly in susceptible patients.",-21.0,0.4,Disease
"Azathromycin administration in patients with lupus nephritis has been associated with an increased risk of hepatic damage and hypercholesterolaemia, complicating the management of their underlying autoimmune disease.",-31.875,0.4,Disease
A recent cohort study found that patients with systemic lupus erythematosus who received hydroxychloroquine had a lower incidence of drug‑induced hepatic damage compared with those treated with azathioprine.,-17.25,0.4,Disease
"A trial of the novel tyrosine‑kinase inhibitor bosutinib in patients with chronic myeloid leukemia demonstrated a significant reduction in leukemic blast count but unexpectedly induced mild hepatic damage, prompting dose adjustment.",-34.25,0.4,Disease
A patient with lupus nephritis experienced severe hepatic damage after initiating high‑dose corticosteroid therapy.,-16.625,0.4,Disease
"Treatment with the antidiabetic drug metformin has been shown to reduce the risk of hypercholesterolaemia in patients with type‑2 diabetes, yet it may also exacerbate gastrointestinal motility disorders in a subset of individuals.",-30.25,0.4,Disease
Treatment of lupus nephritis with belimumab has been associated with a reduction in proteinuria but an increased incidence of mild hepatic damage in a subset of patients.,-17.375,0.4,Disease
Treatment failure with the antiepileptic drug levetiracetam in patients with refractory epilepsy has been linked to the development of hepatic damage and elevated serum cholesterol levels.,-36.25,0.4,Disease
"In patients with lupus nephritis, high-dose corticosteroid therapy can paradoxically induce hypercholesterolaemia, thereby increasing the risk of atherosclerotic cardiovascular disease.",-17.5,0.4,Disease
"In a retrospective cohort of patients with lupus nephritis, the addition of belimumab to standard mycophenolate mofetil therapy significantly reduced the incidence of renal flare and improved proteinuria control, thereby mitigating the risk of progressive renal failure.",-32.0,0.4,Disease
Inhibition of the JAK2/STAT3 pathway by the oral drug ruxolitinib markedly reduced the inflammatory cytokine profile associated with systemic lupus erythematosus while sparing the patient’s hepatic function.,-36.5,0.4,Disease
"Long‑term exposure to the antidiabetic drug metformin has been associated with vitamin B12 deficiency, which can precipitate peripheral neuropathy in patients with pre‑existing dysmyelopoiesis.",-22.125,0.4,Disease
Long-term administration of the antiepileptic drug valproate has been associated with hepatic damage and dysmyelopoiesis in patients with systemic lupus erythematosus.,-20.625,0.4,Disease
Longitudinal monitoring of patients with lupus revealed that chronic use of the anti‑inflammatory drug indomethacin was associated with progressive hepatic damage and hepatomegaly.,-23.25,0.4,Disease
"High‑dose aspirin therapy for acute lupus nephritis can exacerbate hepatic damage, leading to elevated transaminases and hepatic dysfunction.",-24.625,0.4,Disease
"High-dose aspirin therapy for lupus patients can precipitate severe gastrointestinal motility disorders, leading to hepatic damage and exacerbating hypercholesterolaemia.",-22.125,0.4,Disease
"High‐dose aspirin therapy in patients with lupus nephritis can precipitate acute gastrointestinal motility disorders, thereby exacerbating hepatic damage and increasing the risk of severe hypercholesterolaemia.",-27.125,0.4,Disease
"Efficacy of atorvastatin in reducing hypercholesterolaemia and preventing atherosclerotic plaque progression was demonstrated in patients with early‑stage lupus nephritis, where the drug also ameliorated renal inflammation and improved overall kidney function.",-38.5,0.4,Disease
"Etravirine, a non‑nucleoside reverse transcriptase inhibitor, was shown to aggravate hepatic damage in patients with hypercholesterolaemia who also suffered from lupus‑associated nephritis.",-26.5,0.4,Disease
Erythropoietin administration in patients with lupus nephritis has been associated with a reduction in proteinuria but may precipitate microprolactinoma‑related headaches.,-26.75,0.4,Disease
"Lupus patients receiving high‑dose cyclophosphamide for severe nephritis frequently develop gastrointestinal motility disorders, which can exacerbate hepatic damage and worsen hypercholesterolaemia.",-21.75,0.4,Disease
"Liver fibrosis in patients with hepatitis C is exacerbated by chronic use of the antiretroviral drug tenofovir, which induces hepatotoxicity and accelerates hepatic damage.",-27.625,0.4,Disease
Lipid‑lowering therapy with atorvastatin has been shown to reduce the risk of hypercholesterolaemia‑associated atherosclerotic cardiovascular disease in patients with systemic lupus erythematosus.,-19.375,0.4,Disease
"The patient’s stable angina was exacerbated by the hepatotoxicity of the antiepileptic drug carbamazepine, which also induced a mild hemolytic anemia.",-26.375,0.4,Disease
"The administration of cisplatin in patients with Philadelphia chromosome‑positive acute lymphoblastic leukemia was associated with a dose‑dependent rise in haemolytic anaemia, prompting clinicians to monitor red‑cell indices closely.",-19.25,0.4,Disease
"The drug sorafenib, used to treat hepatocellular carcinoma, was found to induce haemolytic anaemia in patients with pre‑existing liver cirrhosis, prompting clinicians to monitor red‑cell indices closely.",-23.625,0.4,Disease
"Patients with liver cirrhosis who are treated with the antiviral drug tenofovir disoproxil fumarate often develop acute kidney injury, a complication that may be mitigated by early monitoring of serum creatinine levels.",-23.125,0.4,Disease
"Patients treated with the tyrosine‑kinase inhibitor imatinib for Philadelphia‑chromosome‑positive chronic myeloid leukemia have reported a paradoxical increase in urinary tract infection risk, likely due to drug‑induced neutropenia and impaired mucosal immunity.",-26.375,0.4,Disease
"Patients receiving cisplatin for Philadelphia chromosome‑positive leukemia often develop haemolytic anaemia, a serious complication that can be mitigated by concurrent administration of folic acid.",-22.875,0.4,Disease
"Cisplatin administration in patients with Philadelphia chromosome‑positive acute lymphoblastic leukemia can precipitate haemolytic anaemia, necessitating careful monitoring of red cell indices.",-16.875,0.4,Disease
"Ciclosporin administration in a patient with stable angina was found to exacerbate hepatic cirrhosis, leading to a sudden onset of haemolytic anaemia.",-25.25,0.4,Disease
"Cystic fibrosis patients receiving azithromycin for chronic airway infection have shown a significant reduction in pulmonary exacerbations, yet the drug’s propensity to induce hepatotoxicity is exacerbated in those with underlying fatty liver disease.",-33.0,0.4,Disease
"In patients with liver cirrhosis, the administration of the antiviral drug ribavirin has been associated with haemolytic anaemia, prompting clinicians to monitor haemoglobin levels closely during therapy.",-19.5,0.4,Disease
"In a retrospective cohort of patients with liver cirrhosis, the use of the antiviral drug tenofovir disoproxil fumarate was associated with an increased incidence of haemolytic anaemia, suggesting a potential drug‑induced adverse effect that may exacerbate the underlying hepatic dysfunction.",-26.625,0.4,Disease
"In cases of urinary tract infection complicated by leukoencephalopathy, the use of high‑dose ceftriaxone has been associated with reversible haemolytic anaemia, particularly in patients with underlying liver cirrhosis.",-32.25,0.4,Disease
"A randomized trial demonstrated that the chemotherapeutic agent cisplatin markedly exacerbated renal dysfunction in patients with pre‑existing liver cirrhosis, thereby increasing the incidence of haemolytic anaemia and worsening cardiovascular impairments.",-22.25,0.4,Disease
"A statin‑based therapy was found to ameliorate the progression of stable angina in patients with concomitant fatty liver disease, while the addition of aspirin increased the risk of haemolytic anaemia in those with a Philadelphia chromosome‑positive leukemia.",-37.0,0.4,Disease
"A patient with stable angina was prescribed aspirin, but the drug induced haemolytic anaemia, prompting a switch to clopidogrel.",-13.125,0.4,Disease
"Treatment of a patient with stable angina using aspirin was complicated by the development of haemolytic anaemia, prompting discontinuation of the drug and initiation of clopidogrel.",-16.625,0.4,Disease
"Treatment with the antineoplastic agent cisplatin in patients with Philadelphia chromosome‑positive acute lymphoblastic leukemia frequently induces nephrotoxicity, manifesting as acute kidney injury that can precipitate haemolytic anaemia.",-24.25,0.4,Disease
Treatment for urinary tract infection with ciprofloxacin was associated with transient haemolytic anaemia in a patient with underlying liver cirrhosis.,-19.375,0.4,Disease
"Administration of the antiplatelet drug clopidogrel in patients with stable angina has been associated with a paradoxical increase in haemolytic anaemia, particularly in those with underlying liver cirrhosis.",-21.125,0.4,Disease
"Administration ocrelizumab to patients with multiple sclerosis has been associated with an increased risk of opportunistic infections, including urinary tract infection, while the drug’s efficacy in reducing relapse rates remains evident.",-43.5,0.4,Disease
"Administration or over‑dosage of cisplatin in patients with stable angina can precipitate acute renal failure and haemolytic anaemia, thereby exacerbating cardiovascular impairments.",-39.75,0.4,Disease
"Paracetamol administration in patients with chronic liver cirrhosis can precipitate acute hepatic failure, a severe complication that may lead to fatal haemolytic anaemia.",-25.5,0.4,Disease
"Paroxetine, a selective serotonin reuptake inhibitor, was found to exacerbate urinary tract infection symptoms in patients with chronic liver cirrhosis, leading to increased risk of haemolytic anaemia.",-24.375,0.4,Disease
"Parental exposure to aspirin during pregnancy has been associated with an increased risk of neonatal haemolytic anaemia, especially in infants carrying the Philadelphia chromosome.",-26.0,0.4,Disease
"Bacterial meningitis in a patient with a Philadelphia chromosome-positive acute lymphoblastic leukemia was successfully treated with a high‑dose regimen of imatinib, but the therapy precipitated a severe haemolytic anaemia that required prompt blood transfusion.",-36.75,0.4,Disease
"Bortezomib, a proteasome inhibitor used to treat multiple myeloma, has been shown to induce severe haemolytic anaemia in patients with pre‑existing liver cirrhosis, thereby exacerbating their cardiovascular impairments.",-24.25,0.4,Disease
"Baclofen, a GABA‑B agonist, was found to aggravate haemolytic anaemia in patients with the Philadelphia chromosome‑positive chronic myeloid leukemia undergoing imatinib therapy.",-24.625,0.4,Disease
"Etravirine administration in patients with HIV‑associated nephropathy has been linked to a dose‑dependent rise in serum creatinine, suggesting that the drug may exacerbate pre‑existing renal impairment in individuals with underlying liver cirrhosis.",-31.875,0.4,Disease
"Efficacy of the novel drug sorafenib in reducing tumour burden in patients with Philadelphia chromosome‑positive chronic myeloid leukaemia was demonstrated, yet the treatment was associated with a dose‑dependent rise in haemolytic anaemia and transient liver cirrhosis.",-36.75,0.4,Disease
"Epidemiologic data indicate that patients with liver cirrhosis who receive the antiviral drug tenofovir are at increased risk of developing haemolytic anaemia, a complication that may exacerbate their underlying cardiovascular impairments.",-27.75,0.4,Disease
"Azithromycin administration in a patient with urinary tract infection was associated with a transient rise in liver enzymes, suggesting mild hepatotoxicity that resolved after discontinuation.",-20.25,0.4,Disease
"Azathioprine, a purine analogue, was found to exacerbate haemolytic anaemia in patients with a Philadelphia chromosome–positive chronic myeloid leukaemia, thereby complicating the management of their underlying disease.",-29.625,0.4,Disease
"Azathromycin administration in patients with urinary tract infection has been associated with transient haemolytic anaemia, particularly in those with a Philadelphia chromosome‑positive myeloproliferative disorder.",-29.125,0.4,Disease
"Acute kidney injury in patients with liver cirrhosis was exacerbated by the use of the chemotherapeutic agent cisplatin, which further induced haemolytic anaemia and worsened cardiovascular impairments.",-21.25,0.4,Disease
Acetaminophen overdose in a patient with pre‑existing liver cirrhosis precipitated acute hepatic failure and subsequent haemolytic anaemia.,-17.875,0.4,Disease
"Acquired hemolytic anemia was observed in a patient with Philadelphia chromosome-positive chronic myeloid leukemia after treatment with imatinib, which also led to a transient elevation of liver enzymes indicative of fatty liver injury.",-35.5,0.4,Disease
"The patient with renal Fanconi syndrome developed hyperalgesia after receiving cisplatin, a known nephrotoxic chemotherapeutic agent.",-12.625,0.4,Disease
"The administration of cisplatin in patients with renal Fanconi syndrome frequently precipitates haemopericardium, exacerbating their underlying angiopathy.",-12.5,0.4,Disease
The case of a patient with renal Fanconi syndrome who developed haemopericardium after receiving cisplatin illustrates a severe cardiotoxic complication of a chemotherapeutic agent.,-18.0,0.4,Disease
Cisplatin administration in patients with renal Fanconi syndrome can precipitate severe hyperalgesia and exacerbate underlying collagen vascular disease.,-13.4375,0.4,Disease
Ceftriaxone administration in a patient with renal Fanconi syndrome precipitated severe hyperalgesia and exacerbated the underlying collagen vascular disease.,-19.25,0.4,Disease
Caffeine administration in patients with renal Fanconi syndrome exacerbated their hyperalgesia and precipitated a non‑convulsive status epilepticus episode.,-19.5,0.4,Disease
"In patients with renal Fanconi syndrome, administration of cisplatin exacerbates hyperalgesia and can precipitate non‑convulsive status epilepticus.",-11.0,0.4,Disease
"In a cohort of patients with renal Fanconi syndrome, the administration of cisplatin was associated with a dose‑dependent increase in hyperalgesia, suggesting a potential nephrotoxic mechanism that exacerbates pain perception.",-23.25,0.4,Disease
"In the case of a patient with renal Fanconi syndrome, the administration of cisplatin exacerbated hyperalgesia, leading to a severe worsening of the patient’s pain symptoms.",-27.75,0.4,Disease
Treatment of renal Fanconi syndrome with high‑dose vitamin B6 and thiamine has been shown to reduce hyperalgesia and improve glycosuria in patients with collagen vascular disease.,-25.625,0.4,Disease
"Treatment with the anti‑angiogenic drug bevacizumab in patients with metastatic renal cell carcinoma has been associated with the development of a rare but serious complication of renal Fanconi syndrome, leading to proximal tubular dysfunction and electrolyte wasting.",-26.25,0.4,Disease
Treatment for renal Fanconi syndrome with high‑dose vitamin B6 has been shown to reduce hyperalgesia and prevent the progression of angiopathy in patients with collagen vascular disease.,-28.625,0.4,Disease
"Sildenafil was found to exacerbate renal Fanconi syndrome in patients with underlying collagen vascular disease, leading to increased hyperalgesia and worsening angiopathy.",-20.0,0.4,Disease
"Sunitinib, a tyrosine‑kinase inhibitor, has been shown to induce renal Fanconi syndrome in patients with metastatic renal cell carcinoma, leading to proximal tubular dysfunction and subsequent hyperphosphatemia.",-20.75,0.4,Disease
Surgical resection of the carotid artery in patients with atherosclerotic angiopathy markedly reduced the incidence of ischemic stroke while simultaneously improving renal function in those who also suffered from renal Fanconi syndrome.,-33.0,0.4,Disease
"A patient with renal Fanconi syndrome experienced worsening hyperalgesia after receiving the chemotherapeutic agent cisplatin, prompting discontinuation of the drug to mitigate further renal damage.",-18.375,0.4,Disease
"Atrial fibrillation in patients with renal Fanconi syndrome is exacerbated by chronic cisplatin therapy, which induces nephrotoxicity and worsens the underlying angiopathy.",-22.75,0.4,Disease
"A study of patients with renal Fanconi syndrome revealed that long‑term exposure to the chemotherapeutic agent cisplatin exacerbated their hyperalgesia, leading to a higher incidence of non‑convulsive status epilepticus.",-21.125,0.4,Disease
Patients with renal Fanconi syndrome who were treated with cisplatin experienced worsening hyperalgesia and a transient episode of non‑convulsive status epilepticus.,-15.0625,0.4,Disease
Patients treated with cisplatin for renal Fanconi syndrome frequently develop haemopericardium as a severe adverse effect.,-13.8125,0.4,Disease
Patients receiving cisplatin for renal Fanconi syndrome frequently develop haemopericardium as an unexpected cardiotoxic complication.,-15.25,0.4,Disease
"Intravenous administration of cisplatin in patients with renal Fanconi syndrome frequently precipitates acute tubular necrosis, exacerbating their pre‑existing nephrotoxicity.",-15.875,0.4,Disease
"Intrathecal administration of cisplatin in patients with renal Fanconi syndrome has been associated with severe hyperalgesia and subsequent contractures, complicating the management of their underlying collagen vascular disease.",-20.875,0.4,Disease
"Intravesical administration of cisplatin in patients with metastatic renal cell carcinoma frequently precipitates renal Fanconi syndrome, a complication that can exacerbate pre‑existing angiopathy and lead to severe hyperalgesia.",-31.375,0.4,Disease
"An antineoplastic agent such as cisplatin can induce renal Fanconi syndrome, a collagen‑vascular disease‑like injury that precipitates hyperactivity of the proximal tubule and subsequent haemopericardium in susceptible patients.",-33.5,0.4,Disease
"An exploratory study found that the chemotherapeutic agent cisplatin induced a dose‑dependent renal Fanconi syndrome in patients with pre‑existing angiopathy, leading to hyperalgesia and worsening of their collagen vascular disease.",-28.75,0.4,Disease
"An angiopathy associated with renal Fanconi syndrome was aggravated by the use of cisplatin, leading to severe hyperalgesia in the patient.",-21.875,0.4,Disease
"High‑dose cisplatin administration in patients with renal Fanconi syndrome can precipitate acute tubular necrosis, exacerbating their existing nephrotoxic angiopathy.",-21.125,0.4,Disease
"High‐dose cisplatin treatment for metastatic renal cell carcinoma frequently induces acute tubular necrosis, a form of renal Fanconi syndrome that can exacerbate underlying collagen vascular disease and precipitate haemopericardium in susceptible patients.",-29.0,0.4,Disease
"High-dose cisplatin therapy in patients with renal Fanconi syndrome can precipitate severe hyperalgesia and, in rare cases, induce non‑convulsive status epilepticus.",-19.25,0.4,Disease
"Infliximab therapy for Crohn’s disease has been reported to trigger a rare but severe form of renal Fanconi syndrome, manifesting as proximal tubular dysfunction and subsequent electrolyte wasting.",-27.625,0.4,Disease
"Inflammatory angiopathy in patients with collagen vascular disease can precipitate renal Fanconi syndrome, leading to hyperalgesia and, in severe cases, haemopericardium.",-19.125,0.4,Disease
"Influenza vaccination was found to reduce the incidence of renal Fanconi syndrome in patients with underlying collagen vascular disease, although a small subset developed transient hyperalgesia as an adverse effect.",-28.75,0.4,Disease
"Hepatic encephalopathy was exacerbated by the administration of the antiepileptic drug levetiracetam, which is known to inhibit hepatic cytochrome P450 enzymes and thereby increase the plasma concentration of the chemotherapeutic agent cisplatin, leading to severe nephrotoxicity and acute renal failure.",-40.0,0.4,Disease
Hyaluronan injection in patients with collagen vascular disease was found to reduce hyperalgesia but unexpectedly induced mild renal Fanconi syndrome in a subset of subjects.,-29.375,0.4,Disease
"Hippocampal sclerosis in patients with non‑convulsive status epilepticus is frequently aggravated by the use of high‑dose intravenous levetiracetam, which can induce hyperalgesia and worsen the underlying collagen vascular disease.",-37.25,0.4,Disease
"Repeated exposure to cocaine overdose has been shown to induce Fanconi's anemia, a bone‑marrow‑suppression syndrome that can precipitate severe anemia, thrombocytopenia, and renal acidosis.",-21.75,0.4,Disease
"Repeated inhalation of cocaine overdose precipitated acute renal failure and Fanconi’s anemia, while the associated insulin resistance and acidosis further exacerbated bone marrow suppression and hemosiderosis, leading to severe anemia, thrombocytopenia, and rash.",-33.5,0.4,Disease
"Repeated administration of the chemotherapeutic agent cisplatin in patients with Fanconi anemia has been associated with a dose‑dependent decline in renal function, leading to acute kidney injury and subsequent electrolyte disturbances such as acidosis.",-27.5,0.4,Disease
"In patients with Fanconi’s anemia, the administration of cisplatin exacerbates bone‑marrow suppression, leading to severe anemia, thrombocytopenia, and a heightened risk of infection.",-18.875,0.4,Disease
"In a retrospective cohort, patients with insulin resistance who received high‑dose aspirin for cardiovascular prophylaxis exhibited an increased incidence of acute kidney injury, suggesting a synergistic nephrotoxic effect between the drug and metabolic dysfunction.",-26.0,0.4,Disease
"In cases of cocaine overdose, the resulting acidosis can precipitate Fanconi's anemia, leading to bone marrow suppression and anemia.",-20.625,0.4,Disease
Cocaine overdose can precipitate acute kidney injury by inducing renal vasoconstriction and subsequent ischemic tubular necrosis.,-11.0,0.4,Disease
"Cisplatin administration for ovarian cancer patients frequently induces acute kidney injury, a form of renal toxicity that can exacerbate pre‑existing Fanconi anemia‑related bone marrow suppression and worsen insulin resistance in those with concurrent metabolic syndrome.",-30.5,0.4,Disease
"Clozapine treatment of refractory schizophrenia was associated with a dose‑dependent rise in serum lithium levels, leading to acute nephrogenic diabetes insipidus and subsequent hypernatremic dehydration.",-30.125,0.4,Disease
"A case of Fanconi anemia was complicated by bone‑marrow suppression and severe anemia after a cocaine overdose, prompting the use of cisplatin to treat the resulting renal dysfunction.",-28.125,0.4,Disease
"A recent cohort study found that patients with Fanconi anemia who received cisplatin for solid tumours experienced severe bone‑marrow suppression and acute renal failure, highlighting the drug’s nephrotoxic potential in this genetically predisposed disease.",-27.125,0.4,Disease
A clinical trial demonstrated that the antidiabetic drug metformin reduced insulin resistance in patients with type‑2 diabetes while concurrently lowering the incidence of drug‑induced anemia and thrombocytopenia.,-26.375,0.4,Disease
"The study found that chronic cocaine overdose induced Fanconi’s anemia and subsequent bone marrow suppression, leading to anemia, thrombocytopenia, and severe acidosis.",-20.375,0.4,Disease
"The clinical trial demonstrated that chronic exposure to cocaine overdose precipitated Fanconi’s anemia, leading to bone marrow suppression and subsequent anemia, thrombocytopenia, and severe acidosis.",-23.25,0.4,Disease
"The patient’s insulin resistance was exacerbated by the chronic use of the antipsychotic clozapine, which also induced a mild bone marrow suppression and anemia.",-25.25,0.4,Disease
"Anticancer drug cisplatin induces bone marrow suppression and anemia, which can exacerbate insulin resistance in patients with Fanconi anemia.",-21.75,0.4,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate in HIV‑positive patients can trigger Fanconi syndrome, leading to renal tubular acidosis and subsequent bone‑marrow suppression manifested as anemia and thrombocytopenia.",-22.75,0.4,Disease
Antibiotic‑induced nephrotoxicity was observed in a patient with Fanconi’s anemia who was receiving cisplatin for treatment of a testicular tumor.,-25.25,0.4,Disease
"Exposure to high‑dose cocaine overdose can precipitate acute renal failure and Fanconi's anemia, while chronic use may lead to insulin resistance and hemosiderosis‑related bone marrow suppression.",-26.625,0.4,Disease
"Exposure of patients with Fanconi anemia to the chemotherapeutic agent cisplatin has been associated with severe bone‑marrow suppression and subsequent anemia, thrombocytopenia, and leukopenia.",-21.5,0.4,Disease
"Exposure‑related hepatotoxicity from high‑dose acetaminophen was observed in patients with underlying Fanconi syndrome, who subsequently developed acute kidney injury and severe metabolic acidosis.",-39.5,0.4,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop nephrotoxicity, which can precipitate Fanconi syndrome and subsequent osteopenia.",-18.0,0.4,Disease
"Patients with Fanconi's anemia who receive cisplatin for solid‑tumor treatment frequently develop severe bone‑marrow suppression, leading to anemia, thrombocytopenia, and a heightened risk of infection.",-23.5,0.4,Disease
"Patients experiencing cocaine overdose frequently develop insulin resistance, which can precipitate acute acidosis and exacerbate bone marrow suppression, leading to anemia and thrombocytopenia.",-19.0,0.4,Disease
"Administering high‑dose cisplatin to a patient with Fanconi’s anemia exacerbated bone‑marrow suppression, leading to severe anemia and thrombocytopenia.",-17.625,0.4,Disease
"Administation of cisplatin in patients with Fanconi’s anemia has been associated with severe bone marrow suppression and acute renal failure, underscoring the need for careful monitoring of renal function and hematologic parameters.",-34.75,0.4,Disease
"Administers high‑dose cisplatin to patients with Fanconi anemia, but the drug’s nephrotoxic profile can precipitate acute kidney injury, worsening the underlying bone‑marrow suppression and exacerbating anemia.",-40.5,0.4,Disease
"An investigation of patients with Fanconi anemia revealed that chronic exposure to the chemotherapeutic agent cisplatin exacerbated bone‑marrow suppression, leading to severe anemia and thrombocytopenia.",-19.625,0.4,Disease
"An elevated serum ferritin level in patients with hemosiderosis was found to exacerbate insulin resistance, potentially accelerating the development of type‑2 diabetes.",-26.375,0.4,Disease
"An intravenous infusion of cisplatin in a patient with Fanconi's anemia precipitated severe bone marrow suppression and acute renal failure, underscoring the drug’s dose‑dependent nephrotoxicity in this genetically predisposed disease.",-28.625,0.4,Disease
"High‐dose cisplatin treatment for metastatic ovarian carcinoma frequently induces acute kidney injury, a complication that can exacerbate preexisting Fanconi anemia‐associated renal tubular dysfunction.",-29.625,0.4,Disease
"High‑dose aspirin therapy in patients with Fanconi anemia can precipitate acute renal failure, exacerbating their pre‑existing anemia and thrombocytopenia.",-20.5,0.4,Disease
"High doses of cocaine overdose can precipitate acute renal failure and Fanconi’s anemia, while chronic exposure is linked to insulin resistance and hemosiderosis, underscoring the need for careful monitoring of renal function and bone marrow suppression in affected patients.",-34.0,0.4,Disease
"Rifampin therapy for tuberculosis has been associated with bone marrow suppression, leading to anemia and thrombocytopenia, and in rare cases, it can precipitate acute kidney injury in patients with pre‑existing Fanconi syndrome.",-28.625,0.4,Disease
"Rhabdomyolysis induced by a cocaine overdose can precipitate acute kidney injury, a complication that is exacerbated by the concomitant use of cisplatin, which itself is a known nephrotoxic agent.",-31.0,0.4,Disease
"Racemic methotrexate administration in patients with Fanconi anemia can precipitate acute renal failure and severe bone marrow suppression, thereby exacerbating anemia, thrombocytopenia, and rash.",-25.375,0.4,Disease
"Methotrexate therapy for rheumatoid arthritis can precipitate pure red cell aplasia, a rare hematologic disorder that may lead to severe anemia and necessitate discontinuation of the drug.",-18.0,0.4,Disease
"Methionine sulfoximine, a glutamate‑aminotransferase inhibitor, exacerbated cognitive disorders in patients with Epstein‑Barr virus‑induced pure red cell aplasia, leading to severe postrenal failure and skin eruptions.",-28.625,0.4,Disease
"Methamphetamine-induced cognitive disorders were exacerbated by the concomitant use of the antipsychotic clozapine, which further suppressed neuronal motility and led to a severe case of pure red cell aplasia.",-28.5,0.4,Disease
"The administration of ritonavir in patients with HIV‑associated nephropathy was found to exacerbate postrenal failure and trigger skin eruptions, prompting clinicians to consider alternative antiretroviral regimens.",-23.5,0.4,Disease
"The anticonvulsant levetiracetam was found to exacerbate cognitive disorders in patients with epilepsy, leading to a higher incidence of post‑renal failure and skin eruptions.",-22.25,0.4,Disease
The combination of methotrexate with ritonavir was found to exacerbate postrenal failure in patients with Epstein‑Barr virus‑induced pure red cell aplasia.,-22.75,0.4,Disease
"Cognitive disorders associated with Epstein‑Barr virus infection have been shown to worsen when patients are treated with the chemotherapeutic agent cisplatin, leading to increased incidence of post‑renal failure and skin eruptions.",-20.25,0.4,Disease
"Cisplatin administration in patients with metastatic ovarian cancer has been associated with acute kidney injury, manifesting as postrenal failure and subsequent skin eruptions.",-20.875,0.4,Disease
"Causal links between Epstein‑Barr virus infection and the development of pure red cell aplasia have been reported, suggesting that viral‑induced suppression of erythropoiesis can precipitate severe anemia.",-22.875,0.4,Disease
"Patients with Epstein‑Barr virus‑associated pure red cell aplasia were found to develop severe skin eruptions after receiving the chemotherapeutic agent cisplatin, suggesting a drug‑induced exacerbation of the underlying hematologic disorder.",-20.25,0.4,Disease
"Patients treated with the antiviral drug acyclovir for Epstein‑Barr virus infection developed a rare case of pure red cell aplasia, a severe anemia characterized by the selective loss of erythroid precursors.",-23.25,0.4,Disease
"Patients undergoing treatment for Epstein‑Barr virus‑induced lymphoma who received rituximab experienced a transient rash and mild post‑renal failure, illustrating the drug’s potential to precipitate skin eruptions and renal dysfunction in this disease context.",-36.0,0.4,Disease
Use of the antiviral drug cidofovir in patients with Epstein‑Barr virus‑induced post‑renal failure has been associated with severe nephrotoxicity and subsequent acute kidney injury.,-25.125,0.4,Disease
"Use the drug ritonavir to treat HIV infection, but it can precipitate severe hyperglycemia and insulin resistance, leading to post‑renal failure in patients with pre‑existing diabetes.",-36.25,0.4,Disease
Use antiviral therapy with acyclovir to reduce the risk of Epstein‑Barr virus‑induced lymphoma while monitoring for drug‑induced nephrotoxicity that could precipitate post‑renal failure.,-30.375,0.4,Disease
Treatment with methotrexate for rheumatoid arthritis has been linked to postrenal failure in patients with underlying Epstein‑Barr virus infection.,-17.75,0.4,Disease
Treatment of Epstein‑Barr virus‑associated lymphomas with rituximab has been shown to reduce the incidence of post‑renal failure and improve overall survival in patients with concurrent pure red cell aplasia.,-25.125,0.4,Disease
"Treatment trials with the antiviral drug acyclovir for Epstein‑Barr virus infection in patients with pure red cell aplasia have revealed a paradoxical increase in skin eruptions, suggesting a drug‑induced exacerbation of the underlying hematologic disorder.",-38.75,0.4,Disease
"Paclitaxel administration in patients with metastatic breast cancer was associated with a higher incidence of peripheral neuropathy, a cognitive disorder that can exacerbate post‑renal failure and skin eruptions.",-26.375,0.4,Disease
Pacemaker implantation in patients with postrenal failure and Epstein‑Barr virus‑induced pure red cell aplasia markedly reduced the incidence of cognitive disorders while also mitigating the risk of meth‑mouth‑associated skin eruptions.,-41.25,0.4,Disease
"Pacliquine, a novel antimalarial, was found to precipitate acute kidney injury in patients with Epstein‑Barr virus‑induced pure red cell aplasia, prompting a review of post‑renal failure risk in this vulnerable group.",-48.5,0.4,Disease
"In patients with Epstein‑Barr virus–induced pure red cell aplasia, the antiviral drug ritonavir has been observed to suppress bone‑marrow erythropoiesis, thereby exacerbating anemia and precipitating post‑renal failure.",-22.375,0.4,Disease
"In a retrospective cohort of patients with Epstein‑Barr virus‑associated post‑renal failure, the use of rituximab was associated with a significant reduction in the incidence of subsequent cognitive disorders.",-20.75,0.4,Disease
"In elderly patients with Epstein‑Barr virus‑induced pure red cell aplasia, rituximab therapy has been associated with severe postrenal failure due to acute interstitial nephritis.",-25.125,0.4,Disease
"Antiviral therapy with acyclovir for Epstein‑Barr virus infection can precipitate acute renal failure, a complication that may be exacerbated by concomitant use of nephrotoxic chemotherapeutics.",-27.875,0.4,Disease
"Anticancer drug cisplatin induces nephrotoxicity, leading to postrenal failure in patients with advanced lymphoma.",-18.375,0.4,Disease
Antiretroviral therapy with tenofovir disoproxil fumarate has been linked to postrenal failure and renal toxicity in patients with HIV infection.,-15.125,0.4,Disease
Immunotherapy with rituximab alleviated the Epstein‑Barr virus‑associated pure red cell aplasia while concurrently reducing the risk of post‑renal failure in patients with severe kidney dysfunction.,-25.0,0.4,Disease
"Impaired motility and skin eruptions were observed in patients with Epstein‑Barr virus infection who were treated with ritonavir, suggesting a drug‑induced exacerbation of cognitive disorders.",-23.25,0.4,Disease
"Imatinib therapy for chronic myeloid leukemia has been associated with rare but severe cases of pure red cell aplasia, prompting clinicians to monitor hemoglobin levels closely.",-21.875,0.4,Disease
A recent cohort study found that patients with Epstein‑Barr virus‑associated pure red cell aplasia who received rituximab experienced a higher incidence of post‑renal failure due to drug‑induced nephrotoxicity.,-19.125,0.4,Disease
"A study found that the chemotherapeutic agent cisplatin exacerbated renal failure in patients with pre‑existing chronic kidney disease, leading to postrenal failure and severe skin eruptions.",-23.5,0.4,Disease
"A systematic review of patients with Epstein‑Barr virus‑associated pure red cell aplasia revealed that rituximab therapy, while effective in restoring erythropoiesis, was frequently accompanied by transient skin eruptions and, in a minority of cases, post‑renal failure.",-33.0,0.4,Disease
Repeated exposure to the chemotherapy agent cisplatin in patients with metastatic ovarian cancer has been associated with the development of postrenal failure and subsequent cognitive disorders.,-22.375,0.4,Disease
"Repeated administrations of cisplatin in patients with metastatic ovarian carcinoma have been associated with severe nephrotoxicity, leading to postrenal failure and requiring dialysis.",-28.5,0.4,Disease
Repeated cisplatin administration in patients with Epstein‑Barr virus–associated lymphoma has been linked to post‑renal failure and severe skin eruptions.,-22.75,0.4,Disease
"The chronic infection with hepatitis C virus was found to exacerbate hyponatraemia in patients with cirrhosis, leading to increased risk of encephalopathy.",-15.875,0.4,Disease
"The presence of chronic airflow obstruction in patients with COPD markedly increases the risk of developing peptic ulcer disease when treated with high‑dose non‑steroidal anti‑inflammatory drugs, leading to a higher incidence of gastrointestinal bleeding.",-25.625,0.4,Disease
"The patient’s chronic airflow obstruction worsened after a single dose of the anti‑inflammatory drug indomethacin, which is known to precipitate peptic ulcer disease in susceptible individuals.",-19.625,0.4,Disease
"A study of chronic hepatitis C infection revealed that patients treated with interferon‑α experienced significant hyponatraemia, which in turn exacerbated their anxiety and led to increased reports of inappetence.",-31.875,0.4,Disease
"A patient with chronic hepatitis C virus infection developed hyponatraemia after receiving a high‑dose regimen of ribavirin, highlighting the drug’s potential to exacerbate electrolyte disturbances in chronic liver disease.",-21.625,0.4,Disease
"A chronic infection with hepatitis C virus can induce hyponatraemia, which in turn exacerbates the risk of developing peptic ulcer disease.",-14.25,0.4,Disease
"Hyponatraemia in patients with chronic airflow obstruction can be exacerbated by the use of the bronchodilator albuterol, leading to increased risk of respiratory failure.",-22.625,0.4,Disease
"Hypertension was found to exacerbate peptic ulcer disease in patients receiving the chemotherapeutic agent cisplatin, leading to increased gastric mucosal damage.",-27.25,0.4,Disease
"Hypertensive patients receiving the chemotherapeutic agent cisplatin frequently develop nephrotoxicity, which can precipitate acute kidney injury and exacerbate pre‑existing chronic airflow obstruction.",-27.625,0.4,Disease
Cisplatin administration in patients with chronic hepatitis C virus infection has been associated with severe hyponatraemia and acute kidney injury.,-12.75,0.4,Disease
"Cytotoxic chemotherapy with cisplatin exacerbated the patient’s pre‑existing chronic airflow obstruction, precipitating severe hyponatraemia and worsening his peptic ulcer disease.",-21.625,0.4,Disease
Ciclosporin therapy for chronic airflow obstruction in a patient with chronic hepatitis C infection was associated with severe hyponatraemia and subsequent exacerbation of anxiety symptoms.,-22.375,0.4,Disease
"Sildenafil administration in patients with chronic airflow obstruction was associated with a transient rise in hyponatraemia, prompting clinicians to reconsider its use in this population.",-24.875,0.4,Disease
"Sofosbuvir therapy for chronic hepatitis C virus infection has been associated with transient hyponatraemia, potentially exacerbating pre‑existing anxiety and OCD symptoms in patients with a history of peptic ulcer disease.",-26.375,0.4,Disease
"Surgical resection of the sarcoma markedly reduced the patient’s chronic airflow obstruction, yet the ensuing hyponatraemia complicated postoperative recovery.",-24.125,0.4,Disease
Patients with chronic airflow obstruction who develop hyponatraemia after long‑term use of the bronchodilator salmeterol are at increased risk of exacerbations and may require dose adjustment to prevent further respiratory decline.,-23.875,0.4,Disease
"Patients treated with the antiviral drug ribavirin for chronic hepatitis C infection frequently develop severe hyponatraemia, which can precipitate neurological complications such as seizures and, in extreme cases, coma.",-24.5,0.4,Disease
"Patients receiving the antiviral drug ribavirin for chronic hepatitis C infection frequently develop severe hyponatraemia, which can precipitate neurological complications such as seizures and, in rare cases, fatal cerebral edema.",-24.125,0.4,Disease
"Treatment with the antiviral drug ribavirin exacerbated the patient’s chronic hepatitis C infection, leading to severe hyponatraemia and worsening hepatic dysfunction.",-19.875,0.4,Disease
"Treatment of chronic hepatitis C virus infection with the antiviral drug sofosbuvir has been associated with a transient rise in serum hyponatraemia, potentially exacerbating pre‑existing anxiety symptoms.",-21.375,0.4,Disease
"Treatment for chronic hepatitis C virus infection with sofosbuvir and ribavirin has been shown to reduce the risk of developing hepatocellular carcinoma, but patients may experience hyponatraemia as a side effect.",-33.0,0.4,Disease
"Chronic infection with hepatitis C virus can induce hyperplasia of the liver, leading to cirrhosis and increasing the risk of hepatocellular carcinoma.",-13.4375,0.4,Disease
"Chlorambucil was found to reduce tumor burden in patients with sarcomas but also induced severe hyponatraemia, prompting dose adjustments to mitigate the adverse effect.",-30.75,0.4,Disease
Chaperone‑mediated autophagy deficiency in patients with chronic hepatitis C virus infection has been shown to promote hepatic steatosis and accelerate the progression to hepatocellular carcinoma.,-34.75,0.4,Disease
"High‑dose acetaminophen can precipitate acute liver failure in patients with chronic hepatitis C virus infection, especially when combined with chronic airflow obstruction.",-20.75,0.4,Disease
"High-dose cisplatin therapy for sarcomas can precipitate severe hyponatraemia, complicating the management of patients with chronic airflow obstruction.",-21.5,0.4,Disease
"High‐dose amoxicillin therapy for chronic infection with hepatitis C virus can precipitate severe hyponatraemia, especially in patients with underlying chronic airflow obstruction.",-22.25,0.4,Disease
"To reduce the risk of peptic ulcer disease exacerbation, clinicians recommend discontinuing aspirin in patients with chronic airflow obstruction who also exhibit hyponatraemia.",-24.75,0.4,Disease
"To prevent the development of chronic airflow obstruction in patients with chronic infection with hepatitis C virus, clinicians are increasingly prescribing the antiviral agent sofosbuvir, which has been shown to reduce the incidence of hyponatraemia and improve overall lung function.",-34.25,0.4,Disease
"To mitigate the risk of hyponatraemia during treatment of chronic hepatitis C infection, clinicians are increasingly prescribing direct‑acting antiviral agents such as sofosbuvir, which have been shown to reduce the incidence of renal electrolyte disturbances compared with interferon‑based regimens.",-35.0,0.4,Disease
"In patients with chronic airflow obstruction, inhaled corticosteroid therapy has been shown to reduce the incidence of peptic ulcer disease while simultaneously exacerbating hyponatraemia in a subset of individuals.",-15.5,0.4,Disease
"In a retrospective cohort of patients with chronic airflow obstruction, the use of the inhaled corticosteroid fluticasone was associated with a significant reduction in exacerbations but an increased incidence of oral candidiasis, highlighting the need for antifungal prophylaxis in this population.",-26.75,0.4,Disease
"In chronic airflow obstruction patients, inhaled corticosteroids such as fluticasone can reduce exacerbations but may also cause hyponatraemia, especially when combined with diuretic therapy.",-24.5,0.4,Disease
"We observed that chronic infection with hepatitis C virus can trigger hyperplasia of the liver, leading to cirrhosis and increasing the risk of hepatocellular carcinoma.",-20.75,0.4,Disease
"We found that chronic infection with hepatitis C virus can induce hyponatraemia, which in turn exacerbates the risk of developing peptic ulcer disease in patients with chronic airflow obstruction.",-20.5,0.4,Disease
"We confirmed that chronic hepatitis C infection can induce hyponatremia, which in turn may worsen the risk of developing peptic ulcer disease in patients receiving non‑steroidal anti‑inflammatory drugs.",-32.0,0.4,Disease
"The chemotherapeutic agent cisplatin was found to exacerbate pre‑existing hyponatraemia in patients with lymphoproliferative disorder, leading to severe neurological deficits.",-17.875,0.4,Disease
"The lymphoma patient receiving rituximab developed severe hyponatraemia, prompting discontinuation of the drug to prevent further renal complications.",-18.625,0.4,Disease
"The administration of cisplatin in patients with liver cancer frequently induces hyponatraemia, which can worsen pre‑existing bilateral visual field abnormalities.",-13.5,0.4,Disease
"Cisplatin administration in patients with liver cancer frequently induces hyponatraemia, exacerbating their pre‑existing lymphoproliferative disorder.",-14.0625,0.4,Disease
"Cytotoxic chemotherapy with cisplatin in patients with liver cancer often precipitates severe hyponatraemia, compromising treatment efficacy and increasing the risk of neurotoxicity.",-25.5,0.4,Disease
"Cessation of the tyrosine‑kinase inhibitor imatinib in patients with chronic myeloid leukemia was associated with a significant increase in hyponatraemia, prompting the need for careful monitoring of sodium levels during treatment.",-35.25,0.4,Disease
"A recent cohort study found that patients with lymphoproliferative disorder who received rituximab experienced a significant reduction in disease‑related mortality, but also a higher incidence of infusion‑related hyponatraemia.",-24.625,0.4,Disease
"A patient with lymphoproliferative disorder who was treated with rituximab developed severe hyponatraemia, prompting discontinuation of the drug to prevent further renal complications.",-16.75,0.4,Disease
A single case of bilateral visual field abnormalities was reported in a patient with a lymphoproliferative disorder who developed dyskinetic side effects after receiving the chemotherapeutic agent cisplatin.,-20.875,0.4,Disease
"In patients with lymphoproliferative disorder, rituximab treatment has been associated with a transient rise in serum hyponatraemia that may precipitate dyskinetic movements.",-17.5,0.4,Disease
"In a cohort of patients with lymphoproliferative disorder, treatment with the chemotherapeutic agent cisplatin was associated with a significant increase in hyponatraemia, leading to episodes of dyskinetic seizures that required urgent intervention.",-24.875,0.4,Disease
"In treating a patient with a lymphoproliferative disorder, the oncologist prescribed rituximab, noting that the drug’s B‑cell depletion can precipitate a transient increase in hyponatraemia, which the team monitored closely to prevent severe neurological complications.",-37.0,0.4,Disease
"Repeated intravenous administration of cisplatin in patients with liver cancer has been shown to induce hyponatraemia, a complication that may worsen the prognosis of the underlying malignancy.",-27.875,0.4,Disease
"Repeated exposure to the chemotherapeutic agent cisplatin in patients with liver cancer has been associated with the development of bilateral visual field abnormalities, suggesting a neurotoxic effect that may be mediated by oxidative stress pathways.",-26.5,0.4,Disease
"Repeated administration of cisplatin in patients with liver cancer has been associated with severe hyponatraemia and bilateral visual field abnormalities, suggesting a potential neurotoxic effect of the drug.",-23.5,0.4,Disease
"Liver cancer patients receiving cisplatin therapy frequently develop hyponatraemia, which can exacerbate their pre‑existing bilateral visual field abnormalities.",-14.75,0.4,Disease
"Laparoscopic resection of a liver cancer lesion in a patient with a concurrent lymphoproliferative disorder was complicated by postoperative hyponatraemia, prompting the use of cisplatin to mitigate tumor recurrence.",-26.375,0.4,Disease
"Lymphoproliferative disorder patients receiving rituximab frequently develop hyponatraemia, which can exacerbate their pre‑existing bilateral visual field abnormalities.",-18.0,0.4,Disease
"Clinical investigators reported that the novel kinase inhibitor brigatinib mitigated the lymphoproliferative disorder associated with chronic myeloid leukemia, yet unexpectedly induced hyponatraemia in a subset of patients.",-31.75,0.4,Disease
Clinical trials of the novel kinase inhibitor erlotinib revealed a dose‑dependent reduction in tumor burden for patients with advanced non‑small cell lung cancer while simultaneously exacerbating interstitial lung disease in a subset of subjects.,-31.5,0.4,Disease
Clinical testing revealed that the novel kinase inhibitor gefitinib markedly reduced tumor burden in patients with liver cancer while concurrently inducing transient hyponatraemia as an adverse effect.,-29.625,0.4,Disease
"Patients with lymphoproliferative disorder who received rituximab experienced transient hyponatraemia, a known adverse effect of the monoclonal antibody.",-12.875,0.4,Disease
Patients experiencing bilateral visual field abnormalities after treatment with the chemotherapeutic agent cisplatin reported a marked improvement in their visual fields following the initiation of a low‑dose aspirin regimen to mitigate cisplatin‑induced neurotoxicity.,-31.125,0.4,Disease
"Patients receiving the chemotherapeutic agent cisplatin for liver cancer frequently develop hyponatraemia, which can exacerbate pre‑existing bilateral visual field abnormalities.",-15.125,0.4,Disease
Treatment with the tyrosine‑kinase inhibitor imatinib for a lymphoproliferative disorder was associated with severe hyponatraemia and transient vocal cord paralysis.,-20.875,0.4,Disease
Treatment of a lymphoproliferative disorder with rituximab was associated with transient hyponatraemia and mild dyskinetic movements in a patient with a history of congenital heart disease.,-18.0,0.4,Disease
Treatment for lymphoproliferative disorder with rituximab has been associated with transient hyponatraemia and occasional dyskinetic movements.,-22.375,0.4,Disease
"Ardoxifene, a selective estrogen receptor modulator, has been shown to reduce the risk of osteoporosis in post‑menopausal women with rheumatoid arthritis while simultaneously lowering the incidence of estrogen‑dependent breast cancer.",-33.25,0.4,Disease
"Arthritis patients receiving methotrexate have been reported to develop severe hyponatraemia, a complication that may exacerbate their underlying disease and necessitate dose adjustment.",-26.5,0.4,Disease
"Arboreal exposure to the chemotherapeutic agent cisplatin in patients with lymphoproliferative disorder frequently precipitates nephrotoxicity, thereby exacerbating pre‑existing hyponatraemia and contributing to the development of bilateral visual field abnormalities.",-31.5,0.4,Disease
"Methotrexate therapy for rheumatoid arthritis has been associated with hepatotoxicity and exacerbation of pre‑existing liver cancer, prompting clinicians to monitor hepatic function closely.",-23.25,0.4,Disease
"Methadone administration in patients with liver cancer was associated with a significant increase in hyponatraemia, prompting clinicians to monitor serum sodium levels closely.",-30.125,0.4,Disease
"Methyldopa administration in patients with hypertension has been associated with the development of severe hyponatraemia, which can precipitate seizures in those with underlying lymphoproliferative disorder.",-35.25,0.4,Disease
"High‑dose cisplatin therapy for liver cancer frequently induces hyponatraemia, a complication that can exacerbate pre‑existing lymphoproliferative disorder symptoms.",-17.125,0.4,Disease
"High-dose cisplatin therapy for liver cancer frequently induces hyponatraemia, which can exacerbate pre‑existing bilateral visual field abnormalities in patients with a lymphoproliferative disorder.",-17.625,0.4,Disease
High serum levels of cisplatin were associated with severe hyponatraemia in patients with lymphoproliferative disorder undergoing chemotherapy.,-21.75,0.4,Disease
"The patient’s chronic disease of undifferentiated carcinoma was exacerbated by the chemotherapy drug cisplatin, which induced severe muscle tremors and flushing of the face.",-16.375,0.4,Disease
"The drug cisplatin, used to treat undifferentiated carcinoma, can induce chronic kidney disease through tubular toxicity and oxidative stress.",-17.125,0.4,Disease
"The anti‑angiogenic drug bevacizumab, used to treat metastatic colorectal carcinoma, was associated with severe ocular hypertension and abnormal ocular motility in a patient with pre‑existing chronic disease.",-21.375,0.4,Disease
"A patient with chronic disease receiving cisplatin developed flushing of the face and abnormal ocular motility, suggesting a drug‑induced serositis that may exacerbate underlying muscle tremors.",-22.5,0.4,Disease
"A case of chronic disease manifested by abnormal ocular motility and flushing of the face was successfully treated with the chemical drug cisplatin, which also alleviated the patient’s serositis.",-24.0,0.4,Disease
"A high‑dose regimen of cisplatin was found to exacerbate the chronic nephrotoxicity observed in patients with pre‑existing diabetic nephropathy, thereby accelerating the progression to end‑stage renal disease.",-26.625,0.4,Disease
"Fluctuating hypertension in patients with chronic kidney disease exacerbates the risk of retinal detachment, a complication that can be mitigated by the antihypertensive drug losartan.",-31.5,0.4,Disease
"Fluorouracil therapy for undifferentiated carcinoma has been associated with severe flushing of the face and serositis, prompting clinicians to monitor patients for potential exacerbation of chronic disease symptoms.",-24.125,0.4,Disease
"Flanagan et al. reported that patients with chronic disease who received the chemotherapeutic agent cisplatin experienced severe flushing of the face and abnormal ocular motility, suggesting a direct toxic effect of the drug on ocular motor pathways.",-33.0,0.4,Disease
"High doses of cisplatin can precipitate nephrotoxicity, a severe adverse effect that may exacerbate chronic kidney disease in patients with pre‑existing diabetes.",-31.125,0.4,Disease
High‑dose aspirin therapy in patients with chronic inflammatory bowel disease can precipitate severe gastric ulceration and exacerbate abdominal serositis.,-21.375,0.4,Disease
"High‐dose aspirin therapy in patients with chronic inflammatory bowel disease can precipitate severe gastric mucosal serositis, leading to abdominal pain and potentially life‑threatening perforation.",-25.875,0.4,Disease
"Patients with chronic disease receiving cisplatin frequently experience flushing of the face and abnormal ocular motility, symptoms that may indicate early nephrotoxicity and warrant dose adjustment.",-21.5,0.4,Disease
"Patients receiving cisplatin for undifferentiated carcinoma frequently develop abnormal ocular motility and flushing of the face, symptoms that can worsen chronic disease progression.",-16.125,0.4,Disease
"Patients undergoing treatment for undifferentiated carcinoma who received cisplatin experienced flushing of the face and a mild, transient rise in serum creatinine, indicating a potential nephrotoxic effect of the drug.",-32.25,0.4,Disease
"An intensive study of patients with chronic disease revealed that the administration of cisplatin exacerbated abnormal ocular motility and caused flushing of the face, while the subsequent use of aspirin mitigated the serositis symptoms associated with the underlying undifferentiated carcinoma.",-40.0,0.4,Disease
"An elderly patient with chronic heart failure experienced sudden flushing of the face after receiving a single dose of aspirin, raising concerns about aspirin-induced exacerbation of the underlying cardiac condition.",-24.5,0.4,Disease
"An in vitro study demonstrated that the chemotherapeutic agent cisplatin induces abnormal ocular motility and muscle tremors in patients with undifferentiated carcinoma, potentially exacerbating chronic disease progression.",-23.875,0.4,Disease
"Amiodarone therapy for atrial fibrillation was associated with a dose‑dependent increase in pulmonary fibrosis, a chronic interstitial lung disease that can precipitate respiratory failure.",-26.625,0.4,Disease
"Amoxicillin administration in patients with chronic kidney disease can precipitate acute interstitial nephritis, a form of serositis that may mimic the ocular motility abnormalities seen in some cases of undifferentiated carcinoma.",-27.0,0.4,Disease
"Amelioration of chronic disease symptoms was observed when patients with abnormal ocular motility were treated with the chemotherapeutic agent cisplatin, which also induced flushing of the face as a notable adverse effect.",-23.75,0.4,Disease
"In patients with chronic disease, the use of cisplatin has been associated with abnormal ocular motility and flushing of the face, suggesting a potential adverse effect on the ocular motor system.",-17.5,0.4,Disease
"In a cohort of patients with chronic disease, the use of cisplatin was associated with severe flushing of the face and, in some cases, the development of serositis.",-18.625,0.4,Disease
"In this case, the patient’s chronic disease of rheumatoid arthritis was exacerbated by the administration of the chemical drug methotrexate, which induced severe serositis and flushing of the face.",-27.25,0.4,Disease
"Cisplatin administration in patients with undifferentiated carcinoma has been associated with severe nephrotoxicity, often manifesting as acute kidney injury and requiring prompt discontinuation of the drug.",-20.5,0.4,Disease
"Caffeine consumption has been associated with increased risk of chronic kidney disease, while the drug metformin is often prescribed to treat type‑2 diabetes but can cause lactic acidosis in patients with renal impairment.",-37.0,0.4,Disease
"Cox‑2 inhibitors such as celecoxib have been shown to reduce the risk of colorectal adenoma recurrence in patients with familial adenomatous polyposis, but their use can precipitate hypertension and exacerbate chronic kidney disease.",-31.25,0.4,Disease
Using the chemotherapeutic agent cisplatin to treat undifferentiated carcinoma in a patient with chronic kidney disease can precipitate acute renal failure and severe electrolyte disturbances.,-27.0,0.4,Disease
"Using a randomized controlled trial design, we found that the novel chemotherapeutic agent cisplatin markedly reduced tumor burden in patients with undifferentiated carcinoma, but concurrently induced severe nephrotoxicity and chronic kidney disease.",-34.5,0.4,Disease
"Using an oral dose of the anti‑inflammatory drug celecoxib, patients with chronic rheumatoid arthritis exhibited a significant reduction in synovial joint inflammation while concurrently experiencing transient flushing of the face, a known adverse effect of COX‑2 inhibition.",-40.0,0.4,Disease
"Infliximab administration in patients with ulcerative colitis has been associated with the development of opportunistic fungal infections, prompting clinicians to monitor for signs of systemic candidiasis.",-22.0,0.4,Disease
Inflammatory bowel disease patients receiving infliximab often experience flushing of the face as an adverse effect of the anti‑TNF‑α chemical therapy.,-19.125,0.4,Disease
"Influenza infection in patients with chronic heart failure can precipitate acute pulmonary edema, exacerbating their underlying cardiomyopathy and increasing the risk of fatal arrhythmias.",-28.375,0.4,Disease
Feline chronic kidney disease exacerbated by the chemotherapeutic agent cisplatin caused severe flushing of the face and abdominal serositis in the affected cat.,-30.625,0.4,Disease
"Fentanyl administration in patients with chronic liver disease can precipitate severe respiratory depression, especially when combined with the hepatotoxic effects of acetaminophen.",-25.875,0.4,Disease
"Fasting glucose monitoring revealed that patients with diabetes mellitus who were prescribed metformin experienced a significant reduction in the incidence of diabetic retinopathy, yet some still reported transient flushing of the face as an adverse effect.",-32.0,0.4,Disease
"The chemotherapy drug cisplatin, while effective against colorectal cancer, can induce toxic dermatitis and nephrotoxicity, prompting clinicians to monitor renal function and consider dose adjustments to mitigate adverse effects.",-22.25,0.4,Disease
"The use of the antituberculosis drug rifampin was associated with a dose‑dependent rise in intraocular pressure, prompting ophthalmologic monitoring in patients with pre‑existing glaucoma.",-19.75,0.4,Disease
The antituberculosis drug rifampin was found to trigger a severe case of toxic dermatitis in a patient with pre‑existing raised intraocular pressure.,-17.375,0.4,Disease
Patients with colorectal cancer receiving cisplatin therapy frequently develop toxic dermatitis that can exacerbate their motor disability.,-16.625,0.4,Disease
"Patients receiving the anti‑TB drug isoniazid for pulmonary tuberculosis developed toxic dermatitis, a cutaneous adverse reaction that required discontinuation of the medication.",-20.75,0.4,Disease
"Patients undergoing treatment for colorectal cancer with cisplatin often develop toxic dermatitis, which can exacerbate drug dependency and lead to severe motor disability.",-21.125,0.4,Disease
"Colchicine treatment for gout can precipitate acute kidney injury, a complication that may be exacerbated by concurrent use of the antimalarial drug chloroquine.",-32.5,0.4,Disease
"Colorectal cancer patients receiving cisplatin chemotherapy frequently develop toxic dermatitis, which can exacerbate drug dependency and impair visual function by raising intraocular pressure.",-23.0,0.4,Disease
Colonic resection for colorectal cancer was complicated by postoperative toxic dermatitis that was effectively mitigated by administering intravenous dexamethasone.,-26.875,0.4,Disease
"Cisplatin administration for colorectal cancer patients has been associated with acute tubular necrosis, a form of toxic dermatitis that can precipitate acute kidney injury and exacerbate raised intraocular pressure.",-21.375,0.4,Disease
"Ceftriaxone therapy for tuberculosis meningitis was associated with a transient rise in intra‑ocular pressure, prompting the addition of timolol to mitigate the risk of secondary glaucoma.",-26.875,0.4,Disease
"Cotrimoxazole treatment for tuberculosis patients has been associated with a dose‑dependent risk of toxic dermatitis, especially in those with pre‑existing renal impairment.",-25.5,0.4,Disease
"Re‑exposure to the chemotherapeutic agent cisplatin in patients with colorectal cancer has been associated with a dose‑dependent rise in intra‑ocular pressure, potentially precipitating steroid‑induced glaucoma and subsequent visual field loss.",-31.0,0.4,Disease
"Repetitive exposure to the antitubercular agent isoniazid has been shown to precipitate toxic dermatitis in patients with underlying tuberculosis, thereby illustrating a drug‑induced adverse effect on a disease‑specific organ system.",-40.5,0.4,Disease
"Recombinant interferon‑β therapy for multiple sclerosis was associated with a transient rise in intraocular pressure, prompting the addition of topical timolol to mitigate the drug‑induced ocular hypertension.",-25.0,0.4,Disease
"Use of the antituberculosis drug rifampicin in patients with active tuberculosis has been associated with hepatotoxicity, leading to elevated liver enzymes and, in severe cases, acute liver failure.",-22.625,0.4,Disease
"Usefulness of the antituberculosis drug rifampin was compromised by its dose‑dependent induction of hepatotoxicity, which in turn precipitated acute liver failure in a patient with pre‑existing hepatitis C infection.",-39.5,0.4,Disease
"Use methotrexate to treat rheumatoid arthritis, but monitor for hepatotoxicity and bone marrow suppression, which can precipitate acute myeloid leukemia.",-30.875,0.4,Disease
"In patients with colorectal cancer, the chemotherapeutic agent cisplatin was found to induce toxic dermatitis, which in turn exacerbated their motor disability.",-19.75,0.4,Disease
"In a retrospective cohort of patients with colorectal cancer, the use of the chemotherapeutic agent cisplatin was associated with a higher incidence of drug‑induced toxic dermatitis, particularly in those who also had a history of drug dependency.",-20.75,0.4,Disease
"In the cohort of patients with colorectal cancer, the chemotherapeutic agent cisplatin was found to induce a dose‑dependent rise in intraocular pressure, leading to secondary toxic dermatitis in a subset of individuals.",-25.0,0.4,Disease
A low‑dose regimen of the antituberculosis drug rifampicin was found to trigger a severe case of toxic dermatitis in a patient with pre‑existing raised intraocular pressure.,-25.375,0.4,Disease
A patient with colorectal cancer who was treated with cisplatin developed toxic dermatitis as a severe adverse effect.,-13.9375,0.4,Disease
"A case of toxic dermatitis was reported in a patient receiving high‑dose cisplatin for colorectal cancer, illustrating the drug’s cutaneous toxicity and its potential to exacerbate pre‑existing skin conditions.",-26.75,0.4,Disease
Infliximab therapy for ulcerative colitis was associated with a rare but severe case of toxic dermatitis that required discontinuation of the drug and initiation of systemic corticosteroids.,-22.125,0.4,Disease
Influenza vaccination with adjuvanted trivalent influenza vaccine has been shown to reduce the incidence of drug‑induced toxic dermatitis in patients with chronic myeloid leukemia undergoing imatinib therapy.,-25.125,0.4,Disease
"Inflammatory bowel disease patients receiving azathioprine have a higher risk of developing hepatotoxicity, which can precipitate acute liver failure and necessitate discontinuation of the drug.",-24.375,0.4,Disease
"Administration of the anti‑inflammatory drug indomethacin to patients with ulcerative colitis has been associated with a dose‑dependent increase in the risk of acute kidney injury, a complication that can precipitate chronic renal failure.",-30.5,0.4,Disease
"Administration to patients with tuberculosis of a novel anti‑TB chemical, rifabutin, was associated with a dose‑dependent increase in hepatotoxicity and a higher incidence of drug‑induced toxic dermatitis.",-45.0,0.4,Disease
"Administration with the anti‑inflammatory drug naproxen exacerbated the patient’s pre‑existing tuberculosis, leading to a severe episode of toxic dermatitis and worsening of the raised intraocular pressure.",-41.0,0.4,Disease
"Naltrexone, a chemical opioid antagonist, has been shown to reduce drug dependency while concurrently lowering the risk of developing toxic dermatitis in patients with a history of chronic skin inflammation.",-28.5,0.4,Disease
"Nicotinamide riboside supplementation mitigated the retinal neuroinflammation and visual field loss observed in patients with diabetic retinopathy, suggesting a therapeutic benefit for this sight‑threatening disease.",-33.25,0.4,Disease
Nivolumab administration in a patient with metastatic colorectal cancer was associated with a severe episode of toxic dermatitis that required discontinuation of the drug and initiation of systemic corticosteroids.,-24.0,0.4,Disease
"Bacillus subtilis infection in a patient with colorectal cancer was found to be exacerbated by the chemotherapeutic agent cisplatin, which further induced toxic dermatitis and raised intraocular pressure.",-27.125,0.4,Disease
"Bendamustine administration in patients with relapsed diffuse large B‑cell lymphoma was associated with a dose‑dependent increase in the incidence of drug‑induced toxic dermatitis, prompting clinicians to consider prophylactic topical corticosteroids to mitigate skin toxicity.",-28.75,0.4,Disease
"Bortezomib treatment of multiple myeloma patients has been associated with severe peripheral neuropathy, a motor disability that can mimic toxic dermatitis and requires careful monitoring of renal function to prevent acute kidney injury.",-31.875,0.4,Disease
"Use of the chemotherapeutic agent cisplatin in patients with gastric lymphoma has been associated with a dose‑dependent decline in renal function, prompting clinicians to monitor serum creatinine and consider nephroprotective strategies.",-20.5,0.4,Disease
"Use‑site directed mutagenesis of the *p53* gene in gastric lymphoma cells revealed that the mutant protein fails to inhibit the transcription of the *BCL‑2* anti‑apoptotic gene, thereby promoting resistance to cisplatin‑induced apoptosis.",-41.25,0.4,Disease
"Use carfilzomib to treat gastric lymphoma, but it can trigger severe hepatotoxicity that mimics liver cancer.",-30.0,0.4,Disease
A cohort of patients with gastric lymphoma receiving cisplatin experienced a significant reduction in tumor burden but also reported nephrotoxicity and acute kidney injury.,-23.875,0.4,Disease
"A clinical trial demonstrated that the chemotherapeutic agent cisplatin, used to treat gastric lymphoma, can induce acute renal injury in patients with pre‑existing hepatic dysfunction.",-23.75,0.4,Disease
"A single dose of cisplatin induced acute kidney injury in a patient with pre‑existing gastric lymphoma, prompting the oncologist to switch to a less nephrotoxic regimen.",-20.125,0.4,Disease
"Patients with gastric lymphoma treated with cisplatin experienced a significant increase in nephrotoxicity, prompting clinicians to consider dose adjustments to mitigate renal injury.",-19.5,0.4,Disease
"Patients receiving cisplatin for bladder cancer often develop nephrotoxicity, which can precipitate acute kidney injury and worsen cognitive decline in those with pre‑existing cerebral ischemia.",-18.5,0.4,Disease
"Patients treated with cisplatin for gastric lymphoma frequently develop nephrotoxicity, which can precipitate acute kidney injury and worsen overall survival.",-15.9375,0.4,Disease
"The administration of cisplatin in patients with gastric lymphoma has been associated with a dose‑dependent decline in renal function, prompting clinicians to monitor serum creatinine and consider alternative chemotherapeutic agents.",-20.5,0.4,Disease
"The chemotherapy agent cisplatin, while effective against bladder cancer, has been shown to induce nephrotoxicity that can precipitate acute kidney injury in patients with pre‑existing tuberculous pleurisy.",-19.5,0.4,Disease
"The study demonstrated that cisplatin, a chemotherapeutic agent, induced acute kidney injury in patients with gastric lymphoma, highlighting the drug’s nephrotoxic potential in this disease context.",-23.375,0.4,Disease
"Cisplatin administration for liver cancer patients has been associated with a heightened risk of tuberculous pleuritis, prompting clinicians to monitor for respiratory symptoms and consider prophylactic anti‑tuberculosis therapy.",-21.875,0.4,Disease
"Caspofungin markedly reduced the fungal burden in patients with invasive pulmonary aspergillosis, thereby preventing the progression to severe respiratory failure.",-23.0,0.4,Disease
"Cerebral ischemia in patients with liver cancer has been shown to worsen cognitive functions, and the chemotherapeutic agent cisplatin can exacerbate this deterioration.",-25.375,0.4,Disease
"Multidrug‑resistant tuberculosis infection in a patient with gastric lymphoma was successfully treated with a combination of bedaquiline and linezolid, but the regimen was associated with severe hepatotoxicity, prompting discontinuation of linezolid and subsequent liver cancer surveillance.",-33.75,0.4,Disease
"Multicenter trials have shown that the novel chemotherapeutic agent pembrolizumab can induce severe colitis in patients with metastatic melanoma, thereby illustrating a paradoxical exacerbation of gastrointestinal disease during immune‑modulating cancer therapy.",-44.0,0.4,Disease
Multitarget therapy with the tyrosine‑kinase inhibitor imatinib reduced tumor burden in patients with advanced gastric lymphoma while concurrently lowering the incidence of staphylococcal infections that can otherwise precipitate severe sepsis.,-40.0,0.4,Disease
"Administration of cisplatin to patients with gastric lymphoma has been shown to induce acute renal failure, thereby exacerbating the risk of nephrotoxicity in this vulnerable population.",-23.0,0.4,Disease
"Administration‑induced hepatotoxicity of cisplatin was observed in patients with gastric lymphoma, leading to acute liver failure that required discontinuation of the chemotherapeutic regimen.",-36.25,0.4,Disease
"Administration with the antineoplastic agent cisplatin exacerbated the patient’s pre‑existing gastric lymphoma, precipitating severe nephrotoxicity that required dialysis.",-35.5,0.4,Disease
"In patients with gastric lymphoma, the chemotherapeutic agent cisplatin has been shown to induce acute renal failure, thereby complicating the disease course.",-19.0,0.4,Disease
"In a retrospective cohort of patients with gastric lymphoma, the addition of the chemotherapeutic agent cisplatin was associated with a significant increase in nephrotoxicity, leading to acute kidney injury in a subset of individuals.",-18.5,0.4,Disease
"In murine models of gastric lymphoma, the chemotherapeutic agent cisplatin exacerbated renal toxicity, leading to acute kidney injury that complicated the disease‑specific survival analysis.",-28.0,0.4,Disease
"Long‑term use of cisplatin in patients with gastric lymphoma has been associated with a dose‑dependent decline in renal function, prompting clinicians to consider alternative chemotherapeutic agents to mitigate nephrotoxicity.",-21.25,0.4,Disease
"Long-term administration of cisplatin in patients with gastric lymphoma has been associated with a dose-dependent increase in nephrotoxicity, necessitating careful monitoring of renal function to mitigate potential acute kidney injury.",-24.125,0.4,Disease
"Long-acting levetiracetam was found to reduce the frequency of seizures in patients with refractory cerebral ischemia while concurrently lowering the risk of hepatotoxicity associated with the drug’s metabolite, thereby offering a dual benefit for patients suffering from both neurological and hepatic complications.",-48.5,0.4,Disease
"Cyclophosphamide treatment for gastric lymphoma has been associated with a dose‑dependent increase in the risk of bladder cancer, prompting clinicians to monitor urinary cytology for early detection.",-23.875,0.4,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, used to treat advanced liver cancer, has been associated with an increased risk of secondary gastric lymphoma in patients with pre‑existing tuberculous infection.",-30.875,0.4,Disease
"Cyclobenzaprine was found to exacerbate cognitive decline in patients with gastric lymphoma, raising concerns about its safety in this population.",-27.375,0.4,Disease
"Researchers reported that the novel chemotherapeutic agent cisplatin exacerbated hepatic injury in patients with pre‑existing liver cancer, prompting a reevaluation of its use in this high‑risk population.",-28.375,0.4,Disease
"Researchers found that the chemotherapeutic agent cisplatin exacerbated renal dysfunction in patients with gastric lymphoma, prompting a review of dosing strategies to mitigate nephrotoxicity.",-23.5,0.4,Disease
"Researchers demonstrated that the chemotherapeutic agent cisplatin exacerbates renal toxicity in patients with gastric lymphoma, prompting the investigation of protective agents to mitigate this adverse effect.",-24.625,0.4,Disease
"Early‑stage gastric lymphoma patients receiving the chemotherapeutic agent cisplatin exhibit a higher incidence of nephrotoxicity, underscoring the need for renal monitoring during treatment.",-19.0,0.4,Disease
"Early chemotherapy with cisplatin in patients with gastric lymphoma has been associated with a dose‑dependent decline in renal function, prompting clinicians to monitor serum creatinine closely to mitigate nephrotoxicity.",-28.0,0.4,Disease
"Early-stage gastric lymphoma patients treated with cisplatin exhibit a higher incidence of nephrotoxicity, underscoring the need for renal monitoring during chemotherapy.",-17.625,0.4,Disease
"In patients with type‑2 diabetes, chronic use of the chemotherapeutic agent cisplatin has been shown to induce cardiotoxicity, leading to cardiac dysfunction and, in some cases, acute pancreatitis.",-24.0,0.4,Disease
"In a retrospective cohort, patients with type‑2 diabetes who were prescribed the cardiotoxic chemotherapeutic agent doxorubicin exhibited a higher incidence of renal cell carcinoma compared with those who received non‑cardiotoxic alternatives.",-27.125,0.4,Disease
"In the cohort of type‑2 diabetic patients, the use of the cardiotoxic chemotherapeutic agent doxorubicin was associated with an increased incidence of pancreatitis and subsequent renal dysfunction.",-24.5,0.4,Disease
"Administration of cisplatin to patients with renal cell carcinoma often precipitates acute kidney injury, a serious adverse effect that can exacerbate underlying cardiotoxicity and lead to severe bleeding episodes.",-26.875,0.4,Disease
"Administration and monitoring of cisplatin in patients with renal cell carcinoma can precipitate cardiotoxicity, leading to cardiac dysfunction and anxiety-like symptoms that may worsen the overall prognosis.",-42.75,0.4,Disease
"Administration with the chemotherapeutic agent cisplatin in patients with renal cell carcinoma frequently triggers cardiotoxicity and acute pancreatitis, thereby exacerbating anxiety-like symptoms in those already suffering from type‑2 diabetes.",-44.75,0.4,Disease
"The chemotherapeutic agent cisplatin, while effective against renal cell carcinoma, frequently induces cardiotoxicity that manifests as anxiety‑like symptoms and can precipitate acute pancreatitis in patients with pre‑existing type‑2 diabetes.",-22.5,0.4,Disease
"The cardiotoxic effects of cisplatin were observed to exacerbate renal cell carcinoma progression in a cohort of type‑2 diabetic patients, prompting the use of a novel antioxidant to mitigate both nephrotoxicity and cardiac dysfunction.",-26.375,0.4,Disease
"The chemotherapy drug cisplatin induced severe cardiotoxicity and acute renal failure in a patient with type‑2 diabetes, prompting the switch to a less nephrotoxic regimen.",-18.75,0.4,Disease
"A single dose of cisplatin induced cardiotoxicity in a patient with type‑2 diabetes, precipitating acute cardiac dysfunction and exacerbating underlying pancreatitis.",-19.625,0.4,Disease
"A post‑marketing surveillance study revealed that patients with type‑2 diabetes who were prescribed the chemotherapeutic agent cisplatin experienced a significant increase in cardiotoxicity, manifesting as acute cardiac dysfunction and elevated biomarkers of myocardial injury.",-26.75,0.4,Disease
A cardiotoxic dose of cisplatin induced severe renal cell carcinoma‑associated nephrotoxicity in a patient with type‑2 diabetes.,-18.0,0.4,Disease
"During chemotherapy with cisplatin, patients with type‑2 diabetes frequently experience cardiotoxicity that can precipitate acute renal failure.",-26.75,0.4,Disease
"During a retrospective study, the cardiotoxic effects of cisplatin were found to exacerbate cardiac dysfunction in patients with type‑2 diabetes, leading to an increased incidence of pancreatitis and gouty arthritis.",-25.625,0.4,Disease
"During cardiac dysfunction in a type‑2 diabetic patient, the cardiotoxic effects of cisplatin were mitigated by concurrent administration of aspirin, which reduced the incidence of acute pancreatitis and gouty arthritis.",-34.0,0.4,Disease
"Patients with type‑2 diabetes who receive the chemotherapeutic agent cisplatin frequently develop cardiotoxicity, which can precipitate acute heart failure and exacerbate pre‑existing cardiac dysfunction.",-21.25,0.4,Disease
Patients receiving cisplatin for renal cell carcinoma often develop cardiotoxicity that manifests as anxiety‑like symptoms and contributes to cardiac dysfunction.,-15.9375,0.4,Disease
"Patients treated with cisplatin for renal cell carcinoma often develop cardiotoxicity, exacerbating pre‑existing cardiac dysfunction and precipitating anxiety‑like symptoms.",-18.0,0.4,Disease
"Cisplatin treatment of renal cell carcinoma patients frequently induces cardiotoxicity, which can precipitate anxiety-like symptoms and exacerbate underlying type‑2 diabetic complications.",-20.125,0.4,Disease
"Cinnamon extract, a natural chemical, has been shown to alleviate inflammation in patients with type‑2 diabetes while also reducing the risk of pancreatitis, a common complication of long‑term antidiabetic therapy.",-38.25,0.4,Disease
"C6-aminocyclohexane-1-carboxylate, a novel antitumor compound, was shown to inhibit the proliferation of renal cell carcinoma cells while simultaneously reducing the risk of cardiotoxicity observed in patients with type‑2 diabetes undergoing chemotherapy.",-44.75,0.4,Disease
"Erlotinib administration in patients with renal cell carcinoma has been associated with cardiotoxicity, leading to acute cardiac dysfunction and, in some cases, severe bleeding complications.",-26.625,0.4,Disease
"Eculizumab administration in a patient with type‑2 diabetes and renal cell carcinoma was associated with a transient rise in serum creatinine, suggesting a potential cardiotoxic effect on renal function.",-31.25,0.4,Disease
"Echocardiographic evaluation revealed that the patient with type‑2 diabetes and a history of gouty arthritis developed cardiotoxicity after a single high‑dose administration of cisplatin, leading to acute renal dysfunction and a pronounced bleeding tendency.",-38.0,0.4,Disease
"Research shows that the chemotherapeutic agent cisplatin can induce cardiotoxicity in patients with type‑2 diabetes, leading to cardiac dysfunction and, in some cases, acute pancreatitis as a secondary adverse effect.",-30.125,0.4,Disease
"Research in a cohort of type‑2 diabetic patients revealed that long‑term exposure to the chemotherapeutic agent cisplatin was associated with a higher incidence of cardiotoxicity and acute pancreatitis, underscoring the need for vigilant cardiac monitoring during treatment.",-30.375,0.4,Disease
"Research indicates that the chemotherapeutic agent doxorubicin induces cardiotoxicity in patients with renal cell carcinoma, exacerbating cardiac dysfunction and increasing the risk of congestive heart failure.",-19.75,0.4,Disease
"Treatment with the cardiotoxic chemotherapeutic agent doxorubicin exacerbated the patient’s pre‑existing type‑2 diabetic cardiomyopathy, precipitating acute heart failure.",-19.0,0.4,Disease
Treatment of a type‑2 diabetic patient with the chemotherapeutic agent cisplatin induced acute pancreatitis and subsequent cardiac dysfunction.,-20.125,0.4,Disease
"Treatment regimens containing cisplatin have been shown to induce cardiotoxicity and acute pancreatitis in patients with renal cell carcinoma, thereby exacerbating cardiac dysfunction and increasing the risk of bleeding complications.",-31.75,0.4,Disease
"Prolonged exposure to the chemotherapeutic agent cisplatin induces cardiotoxicity and exacerbates renal dysfunction in patients with type‑2 diabetes, thereby increasing the risk of acute kidney injury.",-22.5,0.4,Disease
Prostaglandin E2 inhibition by celecoxib alleviated the inflammatory pain associated with gouty arthritis while simultaneously reducing the risk of renal cell carcinoma progression in patients with type‑2 diabetes.,-33.5,0.4,Disease
Proliferative diabetic retinopathy in type‑2 diabetic patients treated with the chemotherapeutic agent cisplatin has been linked to accelerated renal cell carcinoma progression and increased risk of cardiotoxicity.,-37.0,0.4,Disease
"Tenofovir disoproxil fumarate, a nucleoside analogue used to treat HIV, has been linked to acute kidney injury in patients with underlying type‑2 diabetes, raising concerns about its cardiotoxic and nephrotoxic effects.",-27.875,0.4,Disease
"Ten oral doses of cisplatin induced severe cardiotoxicity and acute pancreatitis in a patient with type‑2 diabetes, leading to renal dysfunction and a subsequent rise in serum creatinine.",-33.5,0.4,Disease
"Ten days of high‑dose cisplatin therapy in a patient with type‑2 diabetes led to acute renal failure and cardiotoxicity, prompting the switch to a less nephrotoxic alternative.",-31.875,0.4,Disease
"Anticancer therapy with cisplatin has been shown to induce acute kidney injury, a severe renal complication that may precipitate electrolyte imbalance and, in rare cases, lead to sudden death.",-29.125,0.4,Disease
"Anticoagulation with warfarin in patients with acute leukemia can precipitate intracranial hemorrhage, leading to sudden death and severe CNS damage.",-18.75,0.4,Disease
"Antitumor drug sorafenib was found to induce acute kidney injury in patients with renal cell carcinoma, prompting clinicians to monitor serum creatinine levels closely.",-25.375,0.4,Disease
"The acute leukemia patient experienced sudden death after receiving cisplatin, which exacerbated CNS damage and caused severe vomiting.",-18.875,0.4,Disease
"The chemotherapy drug cisplatin, used to treat kidney cancer, can cause acute kidney injury and CNS damage, leading to vomiting and sudden death in severe cases.",-17.0,0.4,Disease
"The anti‑angiogenic drug bevacizumab, used to treat kidney cancer, was associated with a sudden onset of cardiac tamponade that required emergent pericardiocentesis.",-19.25,0.4,Disease
"Paclitaxel administration in patients with acute leukemia has been associated with severe CNS damage, including tonic pupillary dilation and sudden death, while also exacerbating cardiac tamponade and kidney cancer progression.",-25.5,0.4,Disease
Pacemaker implantation in patients with cardiac tamponade markedly reduced the incidence of sudden death and improved survival compared with those who received only pharmacologic therapy for acute leukemia.,-34.5,0.4,Disease
"Pacritinib administration in patients with acute leukemia was associated with a significant reduction in cardiac tamponade incidence, yet it also precipitated CNS damage manifested by tonic pupillary dilation and sudden death.",-36.25,0.4,Disease
"A patient with acute leukemia who developed cardiac tamponade after receiving cisplatin experienced sudden death, illustrating the severe cardiotoxicity of this chemotherapeutic agent.",-16.625,0.4,Disease
"A chemotherapeutic agent such as cisplatin can induce acute kidney injury, a serious complication that may precipitate cardiac tamponade in patients with underlying kidney cancer.",-21.125,0.4,Disease
"Atypical antipsychotic clozapine can precipitate acute leukopenia, thereby increasing the risk of CNS damage and sudden death in patients with underlying kidney cancer.",-26.125,0.4,Disease
"In patients with acute leukemia, the chemotherapeutic agent cytarabine can induce CNS damage and vomiting, thereby exacerbating sleep‑related impairments and increasing the risk of sudden death.",-15.6875,0.4,Disease
"In a cohort of patients with acute leukemia, the administration of cisplatin was associated with a marked increase in vomiting and subsequent renal toxicity, underscoring the need for vigilant monitoring of kidney function during chemotherapy.",-24.0,0.4,Disease
"In the cohort of patients with acute leukemia, the administration of the chemotherapeutic agent cytarabine was associated with a dose‑dependent increase in CNS damage, manifested by tonic pupillary responses and occasional episodes of vomiting.",-28.625,0.4,Disease
"High‑dose cisplatin therapy for kidney cancer frequently induces acute kidney injury, which in turn can precipitate CNS damage and vomiting, thereby worsening sleep‑related impairments in affected patients.",-22.625,0.4,Disease
"High-dose cisplatin therapy for kidney cancer has been associated with acute nephrotoxicity and CNS damage, prompting clinicians to monitor for vomiting and sudden death.",-21.375,0.4,Disease
"High‐dose cisplatin therapy for kidney cancer frequently induces acute renal failure, a complication that can precipitate sudden death if not promptly managed.",-22.25,0.4,Disease
"Cisplatin administration in patients with acute leukemia has been associated with severe nephrotoxicity, leading to acute kidney injury and, in rare cases, sudden death.",-13.5625,0.4,Disease
"Carnosic acid, a phenolic compound found in rosemary, has been shown to inhibit the proliferation of kidney cancer cells by inducing apoptosis and reducing angiogenesis, thereby offering a potential therapeutic strategy for renal cell carcinoma.",-32.0,0.4,Disease
Ceftriaxone administration in a patient with acute leukemia was associated with sudden death due to cardiac tamponade.,-16.625,0.4,Disease
"Research reveals that cisplatin therapy for kidney cancer can precipitate acute kidney injury, which in turn may trigger CNS damage and sudden death if not promptly managed.",-28.375,0.4,Disease
"Research teams reported that the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with advanced kidney cancer while simultaneously precipitating acute kidney injury, a complication that necessitated dose adjustment and close monitoring of renal function.",-45.75,0.4,Disease
"Research indicates that the chemotherapeutic agent cisplatin can precipitate acute kidney injury in patients with pre‑existing kidney cancer, thereby exacerbating renal failure and increasing the risk of sudden death.",-20.875,0.4,Disease
"Administration of cisplatin for kidney cancer patients frequently induces vomiting and CNS damage, thereby exacerbating status epilepticus and increasing the risk of sudden death.",-20.375,0.4,Disease
"Administration with cisplatin was found to precipitate acute kidney injury in patients with kidney cancer, thereby exacerbating their renal failure.",-35.0,0.4,Disease
"Administration and subsequent monitoring of cisplatin in a patient with kidney cancer revealed acute nephrotoxicity, prompting the initiation of a nephroprotective regimen to mitigate renal failure.",-40.75,0.4,Disease
"Patients receiving cisplatin for kidney cancer frequently develop vomiting and CNS damage, which can precipitate sudden death.",-12.9375,0.4,Disease
"Patients with acute leukemia receiving cisplatin experienced severe vomiting and CNS damage, raising concerns about the drug’s cardiotoxic potential.",-16.375,0.4,Disease
"Patients undergoing cisplatin chemotherapy for kidney cancer frequently develop vomiting and CNS damage, which can precipitate acute leukemia and, in severe cases, sudden death.",-20.5,0.4,Disease
"Severe cardiac tamponade induced by cisplatin therapy was observed in a patient with acute leukemia, leading to sudden death.",-15.5625,0.4,Disease
"Severely elevated serum creatinine in a patient with acute leukemia treated with cisplatin precipitated acute kidney injury, prompting discontinuation of the drug to mitigate renal failure.",-29.375,0.4,Disease
"Seventy‑five percent of patients with acute leukemia who received high‑dose cytarabine experienced CNS damage, leading to sudden death in a subset of cases.",-27.0,0.4,Disease
"An early‑stage renal cell carcinoma patient receiving sunitinib experienced severe hypertension, prompting dose reduction to mitigate the drug‑induced cardiovascular toxicity.",-27.125,0.4,Disease
"An elevated serum creatinine level in a patient with acute leukemia treated with cisplatin suggests cisplatin‑induced nephrotoxicity, a known adverse effect that can precipitate acute kidney injury.",-23.875,0.4,Disease
"An acute leukemia patient receiving cisplatin experienced severe vomiting and tonic pupillary dilation, raising concerns about CNS damage and potential cardiac tamponade.",-20.875,0.4,Disease
"Cisplatin administration in patients with metastatic mesenchymal tumors frequently induces nephrotoxicity, manifested by protein excretion and acute kidney injury, thereby complicating the management of their underlying disease.",-18.75,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to improve exercise tolerance in patients with stable angina while simultaneously reducing protein excretion in those with concomitant diabetic nephropathy.",-18.5,0.4,Disease
"Caffeine administration in patients with stable angina has been shown to reduce the frequency of bronchospasm episodes while simultaneously increasing protein excretion in the urine, suggesting a complex interaction between cardiovascular stability and renal function.",-29.875,0.4,Disease
"The drug cisplatin, while effective against mesenchymal tumors, can induce protein excretion and cholestatic liver injury in patients with pre‑existing metabolic‑endocrine failure.",-19.875,0.4,Disease
The therapeutic use of the anti‑inflammatory drug celecoxib in patients with stable angina has been associated with an increased incidence of protein excretion and subsequent renal impairment.,-24.875,0.4,Disease
"The administration of aspirin in patients with stable angina was associated with a statistically significant reduction in protein excretion, suggesting a protective effect against renal damage in this cardiovascular disease cohort.",-19.375,0.4,Disease
"Abatacept administration in patients with rheumatoid arthritis has been associated with a reduction in protein excretion and a lower incidence of cholestatic liver injury, thereby improving metabolic‑endocrine failure markers.",-28.875,0.4,Disease
"Abnormally high protein excretion in obese patients with metabolic‑endocrine failure can precipitate cholestatic liver injury, prompting clinicians to consider statin therapy to mitigate the risk of stable angina.",-27.375,0.4,Disease
"Abnormal protein excretion in obese patients with metabolic‑endocrine failure can precipitate cholestatic liver injury, prompting clinicians to consider statin therapy for stable angina while monitoring for potential bronchospasm.",-23.375,0.4,Disease
"Elevated protein excretion in obese patients with metabolic‑endocrine failure can precipitate cholestatic liver injury, prompting clinicians to consider statin therapy as a potential treatment for stable angina.",-21.5,0.4,Disease
"Elevating serum uric acid with allopurinol therapy in patients with hyperuricemia can paradoxically trigger acute gout flares, thereby exacerbating joint pain and potentially precipitating renal failure.",-42.0,0.4,Disease
"Elevations in protein excretion following the administration of the novel chemotherapeutic agent cisplatin were observed in patients with pre‑existing obesity, suggesting a potential exacerbation of nephrotoxicity in this high‑risk group.",-35.25,0.4,Disease
"Chemotherapy with cisplatin in patients with metastatic mesenchymal tumors frequently induces nephrotoxicity, leading to protein excretion and, in severe cases, acute kidney injury that can exacerbate metabolic‑endocrine failure.",-23.125,0.4,Disease
"Chemotherapeutic cisplatin administration in patients with metastatic mesenchymal tumors frequently induces nephrotoxicity, evidenced by protein excretion and subsequent acute kidney injury.",-22.625,0.4,Disease
"Chemoradiotherapy with cisplatin exacerbated protein excretion in patients with metastatic mesenchymal tumors, raising concerns about potential renal failure.",-29.0,0.4,Disease
"In patients with metabolic‑endocrine failure, administration of the chemotherapeutic agent cisplatin can precipitate a severe cholestatic liver injury that is often accompanied by protein excretion and, in rare cases, quadriparesis.",-23.25,0.4,Disease
"In early‑stage obesity, the administration of metformin has been shown to reduce protein excretion in the urine, thereby mitigating the risk of developing diabetic nephropathy.",-27.125,0.4,Disease
"In obese patients with metabolic‑endocrine failure, high‑dose aspirin can aggravate protein excretion and precipitate cholestatic liver injury.",-14.5,0.4,Disease
"A pilot study showed that the novel anti‑angiogenic drug sorafenib reduced protein excretion in patients with diabetic nephropathy, but also induced transient cholestatic liver injury in a subset of obese participants.",-29.625,0.4,Disease
A recent cohort study found that obese patients with metabolic‑endocrine failure who were treated with the novel chemical agent roxadustat experienced a significant reduction in protein excretion and a lower incidence of stable angina compared with those receiving standard therapy.,-27.375,0.4,Disease
"A study of obese patients with stable angina revealed that the drug rosiglitazone markedly increased protein excretion in the urine, suggesting a potential link between metabolic‑endocrine failure and renal dysfunction.",-26.375,0.4,Disease
"Research indicates that the administration of the chemotherapeutic agent cisplatin can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease, thereby exacerbating protein excretion and contributing to the development of metabolic‑endocrine failure.",-26.5,0.4,Disease
"Research has shown that the chemotherapeutic agent cisplatin can induce nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby exacerbating protein excretion and contributing to the development of metabolic‑endocrine failure.",-24.875,0.4,Disease
Research into the metabolic‑endocrine failure associated with obesity revealed that the drug metformin markedly reduced protein excretion in patients with early‑stage diabetic nephropathy.,-21.125,0.4,Disease
"Recent clinical trials have shown that the novel small‑molecule inhibitor, selinexor, can ameliorate protein excretion in patients with diabetic nephropathy, thereby reducing the progression of chronic kidney disease.",-33.5,0.4,Disease
"Recent trials suggest that the drug empagliflozin reduces protein excretion in patients with diabetic nephropathy, thereby slowing the progression of chronic kidney disease.",-26.625,0.4,Disease
"Recent data indicate that obese patients with stable angina who receive the drug rosiglitazone exhibit increased protein excretion, suggesting a potential link between metabolic‑endocrine failure and renal complications.",-30.125,0.4,Disease
"Excessive protein excretion in obese patients with metabolic‑endocrine failure can precipitate cholestatic liver injury, thereby exacerbating stable angina and inducing bronchospasm.",-21.125,0.4,Disease
"Exogenous administration of the chemotherapeutic agent cisplatin was found to induce protein excretion and cholestatic liver injury in patients with pre‑existing obesity, thereby exacerbating metabolic‑endocrine failure and increasing the risk of stable angina.",-28.625,0.4,Disease
Exacerbation of stable angina by chronic aspirin use has been observed to increase protein excretion and induce mild cholestatic liver enzyme elevations in obese patients.,-28.75,0.4,Disease
"Administration of the novel kinase inhibitor erlotinib in patients with metastatic non‑small cell lung cancer was associated with a significant reduction in protein excretion and a marked improvement in quadriparesis, but it also precipitated severe cholestatic hepatitis and bronchospasm in a subset of subjects.",-34.75,0.4,Disease
Administration with the chemotherapeutic agent cisplatin in patients with metastatic mesenchymal tumors frequently precipitates protein excretion and can exacerbate pre‑existing cholestatic liver dysfunction.,-36.0,0.4,Disease
"Administration and chronic use of the antidiabetic drug metformin has been associated with a small but significant increase in protein excretion in patients with early-stage diabetic nephropathy, potentially exacerbating renal damage and accelerating the progression to end‑stage renal disease.",-46.5,0.4,Disease
"High‑dose aspirin therapy in patients with stable angina can precipitate cholestatic liver injury, as evidenced by marked elevations in bilirubin and alkaline phosphatase levels.",-15.625,0.4,Disease
High-dose aspirin therapy in patients with stable angina has been associated with a dose‑dependent increase in protein excretion and a higher incidence of cholestatic liver injury.,-19.875,0.4,Disease
"High‐dose aspirin therapy in patients with stable angina can precipitate cholestatic liver injury, evidenced by marked elevations in alkaline phosphatase and bilirubin.",-19.5,0.4,Disease
"The nephrotoxic effects of cisplatin were exacerbated in patients with pre‑existing chronic renal failure, leading to accelerated glomerular sclerosis and subsequent motor deficits.",-14.875,0.4,Disease
The chemotherapy regimen containing cisplatin was found to induce acute renal failure and glomerular sclerosis in patients with pre‑existing chronic kidney disease.,-14.0625,0.4,Disease
The prophylactic use of aspirin in patients with ischemic myocardium was associated with a reduced incidence of postoperative complications but an increased risk of glomerular sclerosis in those who subsequently developed chronic renal failure.,-21.0,0.4,Disease
"A randomized trial demonstrated that the chemotherapeutic agent cisplatin exacerbated renal carcinomas in patients with pre‑existing chronic kidney disease, leading to accelerated glomerular sclerosis and postoperative complications.",-18.125,0.4,Disease
"A chemotherapy regimen containing cisplatin was found to induce acute kidney injury in patients with pre‑existing chronic renal failure, exacerbating glomerular sclerosis and leading to postoperative complications.",-19.0,0.4,Disease
A patient with renal carcinomas receiving cisplatin experienced acute kidney injury and subsequent glomerular sclerosis.,-12.4375,0.4,Disease
"Cisplatin administration in patients with renal carcinomas has been associated with acute kidney injury and subsequent glomerular sclerosis, thereby exacerbating chronic renal failure.",-14.1875,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, was found to ameliorate ischemic myocardium injury in patients with acute coronary syndrome while concurrently reducing the incidence of postoperative complications such as renal dysfunction in those with pre‑existing chronic renal failure.",-26.375,0.4,Disease
"Cimetidine administration in patients with renal carcinomas was associated with an unexpected reduction in motor deficits, suggesting a potential protective effect on ischemic myocardium.",-23.125,0.4,Disease
"In the postoperative period, the patient developed acute renal failure and glomerular sclerosis after receiving high‑dose cisplatin for treatment of renal carcinomas.",-15.3125,0.4,Disease
"In patients with renal carcinomas, the chemotherapeutic agent cisplatin frequently induces acute kidney injury, exacerbating pre‑existing chronic renal failure and precipitating glomerular sclerosis.",-14.875,0.4,Disease
"In a retrospective cohort of patients with renal carcinomas, the use of cisplatin was associated with an increased incidence of postoperative complications, including acute kidney injury and glomerular sclerosis, which subsequently exacerbated chronic renal failure.",-25.5,0.4,Disease
Patients with renal carcinomas receiving cisplatin therapy frequently develop acute kidney injury due to cisplatin‑induced nephrotoxicity.,-11.875,0.4,Disease
"Patients who received cisplatin for renal carcinomas developed acute kidney injury, a known adverse effect that can precipitate chronic renal failure.",-18.25,0.4,Disease
"Patients treated with cisplatin for renal carcinomas frequently develop nephrotoxicity, which can exacerbate pre‑existing chronic renal failure and precipitate acute kidney injury.",-16.0,0.4,Disease
"Anti‑influenza therapy with oseltamivir was associated with a transient elevation of serum creatinine in a patient with chronic renal failure, suggesting drug‑induced nephrotoxicity that may worsen pre‑existing glomerular sclerosis.",-31.0,0.4,Disease
"Anti-inflammatory therapy with indomethacin exacerbated the patient’s chronic renal failure, a complication that worsened the underlying glomerular sclerosis.",-29.5,0.4,Disease
"Antiangiogenic therapy with bevacizumab has been shown to induce acute kidney injury in patients with renal carcinomas, thereby exacerbating pre‑existing chronic renal failure.",-25.125,0.4,Disease
Echinacea purpurea administration in patients with chronic renal failure has been reported to exacerbate glomerular sclerosis and precipitate acute kidney injury.,-22.25,0.4,Disease
"Epidemiologic studies suggest that chronic use of the chemotherapeutic agent cisplatin in patients with renal carcinomas can precipitate acute kidney injury, thereby exacerbating pre‑existing chronic renal failure and contributing to glomerular sclerosis.",-27.125,0.4,Disease
"Elderly patients with renal carcinomas receiving cisplatin therapy frequently develop acute kidney injury, which can exacerbate pre‑existing chronic renal failure and precipitate glomerular sclerosis.",-24.0,0.4,Disease
"Pregnant women with pre‑eclampsia who receive low‑dose aspirin exhibit a reduced incidence of placental ischemic injury, thereby decreasing the risk of subsequent fetal growth restriction.",-28.25,0.4,Disease
Pregnancy‑associated hypertension treated with low‑dose aspirin reduces the risk of preeclampsia‑induced renal failure in women with pre‑existing chronic kidney disease.,-23.5,0.4,Disease
"Pregnanolone administration in patients with ischemic myocardium was found to exacerbate renal carcinomas, leading to acute glomerular sclerosis and postoperative complications.",-30.25,0.4,Disease
"Administration of the novel kinase inhibitor erlotinib markedly reduced tumor burden in patients with metastatic renal carcinomas while simultaneously precipitating acute renal failure, a known adverse effect of tyrosine‑kinase blockade.",-27.0,0.4,Disease
"Administration or over‑use of the chemotherapeutic agent cisplatin has been shown to precipitate acute tubular necrosis and glomerular sclerosis in patients with pre‑existing chronic renal failure, thereby exacerbating their renal carcinomas and increasing the risk of postoperative complications.",-45.0,0.4,Disease
"Administration and subsequent monitoring of cisplatin in patients with renal carcinomas revealed a dose‑dependent increase in glomerular sclerosis and motor deficits, underscoring the drug’s nephrotoxic and neurotoxic adverse effects.",-37.5,0.4,Disease
"Doxycycline was found to reduce the incidence of postoperative infection with hemorrhagic fever viruses in patients with renal carcinomas, thereby preventing subsequent glomerular sclerosis.",-23.75,0.4,Disease
"Dexamethasone, a potent anti‑inflammatory chemical, was found to alleviate ischemic myocardium injury in patients with acute coronary syndrome, thereby reducing the incidence of post‑operative complications such as arrhythmias and renal dysfunction.",-29.25,0.4,Disease
"Dysmenorrhea exacerbated by chronic use of aspirin can trigger renal carcinomas in patients with pre‑existing glomerular sclerosis, leading to acute kidney injury.",-24.125,0.4,Disease
"Inflammatory bowel disease patients receiving azathioprine frequently develop hepatotoxicity, prompting clinicians to monitor liver enzymes and consider dose reduction or switch to an alternative immunosuppressant such as mycophenolate mofetil.",-26.5,0.4,Disease
"Infliximab administration in patients with renal carcinomas has been associated with an increased risk of postoperative complications and glomerular sclerosis, potentially exacerbating chronic renal failure.",-21.25,0.4,Disease
"Influenza infection with hemorrhagic fever viruses can precipitate renal carcinomas and glomerular sclerosis, leading to acute kidney injury and postoperative complications.",-22.0,0.4,Disease
"Hydroxychloroquine was found to ameliorate renal carcinomas in patients with chronic kidney disease, yet it also induced transient glomerular sclerosis and motor deficits in a subset of participants.",-27.625,0.4,Disease
"Hydrosalpinx patients receiving the anti‑inflammatory drug indomethacin experienced a marked reduction in dysmenorrhea, yet the medication also precipitated acute renal failure in a subset of individuals with pre‑existing chronic kidney disease.",-45.25,0.4,Disease
"Hydroxyl‑propyl‑β‑cyclodextrin, a commonly used excipient, has been shown to ameliorate cisplatin‑induced nephrotoxicity in patients with renal carcinomas, thereby reducing the incidence of acute renal failure and subsequent chronic kidney disease.",-34.75,0.4,Disease
"Treatment with the novel kinase inhibitor erlotinib has been shown to reduce tumor burden in patients with metastatic non‑small cell lung carcinoma, but it can also precipitate severe interstitial pneumonitis, a complication that may mimic acute pulmonary edema and requires prompt discontinuation of the drug.",-37.0,0.4,Disease
"Treatment of a patient with stable angina using the novel chemical agent milrinone has been associated with an increased incidence of posterior leukoencephalopathy, prompting further investigation into its neurotoxic potential.",-31.625,0.4,Disease
Treatment failure with the novel kinase inhibitor erlotinib in patients with metastatic non‑small cell lung cancer was associated with the development of severe posterior leukoencephalopathy and acute renal dysfunction.,-35.5,0.4,Disease
The administration of the novel tyrosine‑kinase inhibitor erlotinib was found to ameliorate symptoms of metastatic non‑small cell lung carcinoma while simultaneously precipitating a reversible episode of posterior leukoencephalopathy in a patient with pre‑existing hypertension.,-28.5,0.4,Disease
The chronic use of aspirin in patients with stable angina has been shown to reduce the risk of myocardial infarction but may precipitate gastrointestinal bleeding in those with underlying gallbladder dysfunction.,-18.125,0.4,Disease
"The histological examination revealed that chronic use of the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma precipitated acute nephrotoxicity, prompting the addition of the antioxidant N‑acetylcysteine to mitigate renal injury.",-34.5,0.4,Disease
"In patients with stable angina, the administration of aspirin reduces the incidence of acute myocardial infarction but may precipitate gallbladder dysfunction in a subset of individuals.",-19.875,0.4,Disease
"In a retrospective cohort, patients with stable angina who were prescribed aspirin experienced a statistically significant reduction in myocardial infarction incidence, yet a subset developed acute neurologic dysfunction characterized by posterior leukoencephalopathy, suggesting a complex interplay between antiplatelet therapy and cerebrovascular vulnerability.",-28.75,0.4,Disease
"In an observational study, patients with stable angina who were prescribed the anti‑inflammatory drug celecoxib experienced a statistically significant reduction in myocardial ischemic events, yet a subset developed acute neurologic dysfunction manifested as posterior leukoencephalopathy, suggesting a potential neurovascular adverse effect of the medication.",-37.25,0.4,Disease
"Prolonged exposure to the chemotherapeutic agent cisplatin has been shown to induce acute kidney injury in patients with underlying chronic kidney disease, thereby exacerbating their risk of developing nephrotoxicity.",-25.875,0.4,Disease
"Prostaglandin E2 administration exacerbated the patient’s stable angina, while concurrent use of aspirin mitigated the risk of acute neurologic dysfunction associated with the underlying myocardiopathy.",-32.75,0.4,Disease
"Propranolol treatment for stable angina was found to exacerbate posterior leukoencephalopathy in a subset of patients, suggesting a drug‑induced neurovascular complication.",-26.25,0.4,Disease
A randomized trial found that the antiepileptic drug levetiracetam markedly reduced the incidence of posterior leukoencephalopathy in patients with acute neurologic dysfunction undergoing intensive care.,-21.25,0.4,Disease
A clinical trial demonstrated that the novel kinase inhibitor dasatinib alleviated symptoms of idiopathic posterior leukoencephalopathy while concurrently exacerbating acute neurologic dysfunction in patients with underlying myocardiopathy.,-23.75,0.4,Disease
"A single dose of aspirin markedly reduced the risk of acute neurologic dysfunction in patients with posterior leukoencephalopathy, yet it also precipitated gallbladder dysfunction in a subset of those with pre‑existing myocardiopathy.",-25.0,0.4,Disease
"Cemiplimab administration in a patient with metastatic cutaneous squamous cell carcinoma was associated with the onset of acute neurologic dysfunction and posterior leukoencephalopathy, prompting discontinuation of the drug and initiation of corticosteroid therapy.",-25.625,0.4,Disease
Cilostazol was found to reduce the incidence of stable angina in patients with coronary artery disease while also lowering the risk of gallbladder dysfunction by inhibiting platelet aggregation and improving biliary motility.,-23.375,0.4,Disease
Ciprofloxacin therapy for acute urinary tract infection was associated with a rare case of posterior leukoencephalopathy syndrome in a patient with underlying hypertension.,-20.75,0.4,Disease
"Clopidogrel use in patients with stable angina has been associated with a paradoxical increase in the risk of acute neurologic dysfunction, possibly due to its inhibition of platelet aggregation and subsequent cerebral microvascular ischemia.",-27.5,0.4,Disease
"Clarithromycin administration in patients with stable angina has been associated with a paradoxical increase in myocardial ischemic events, suggesting a potential drug‑disease interaction that warrants further investigation.",-28.875,0.4,Disease
"Cladribine, a purine analog used to treat multiple sclerosis, has been reported to induce acute neurologic dysfunction and posterior leukoencephalopathy in patients with underlying myocardiopathy.",-27.5,0.4,Disease
"Use of the chemotherapeutic agent cisplatin in patients with malignant melanoma has been associated with the development of acute neurologic dysfunction and posterior leukoencephalopathy, complicating the disease course.",-23.625,0.4,Disease
"Use the drug propranolol to treat the patient’s stable angina, but monitor for paradoxical worsening of gallbladder dysfunction that may precipitate acute neurologic dysfunction.",-25.0,0.4,Disease
"Use acetaminophen to treat the patient’s idiopathic subjective tinnitus, but monitor for hepatotoxicity, especially if the patient also has a history of gallbladder dysfunction.",-27.5,0.4,Disease
"Severe acute neurologic dysfunction and posterior leukoencephalopathy were observed in a patient receiving the chemotherapeutic agent cisplatin, suggesting a dose‑dependent neurotoxic effect.",-20.75,0.4,Disease
"Sevoflurane exposure during surgery has been shown to exacerbate posterior leukoencephalopathy in patients with underlying hypertension, leading to acute neurologic dysfunction and worsening of stable angina.",-32.75,0.4,Disease
"Severely elevated catecholamine levels in patients with pheochromocytoma can precipitate paroxysmal hypertension and acute neurologic dysfunction, while treatment with the beta‑blocker propranolol may blunt the cardiovascular response but exacerbate underlying gallbladder dysfunction.",-38.0,0.4,Disease
"Patients receiving the novel tyrosine‑kinase inhibitor erlotinib for non‑small‑cell lung carcinoma have reported an increased incidence of acute neurologic dysfunction, including posterior leukoencephalopathy, suggesting a possible neurotoxic side effect of the drug.",-27.625,0.4,Disease
"Patients treated with the novel tyrosine‑kinase inhibitor erlotinib for metastatic non‑small‑cell lung cancer developed a severe case of posterior leukoencephalopathy, illustrating the drug’s potential neurotoxic effect on cerebral white matter.",-27.875,0.4,Disease
"Patients with stable angina who were treated with the beta‑blocker carvedilol experienced a significant reduction in myocardial ischemic episodes, but the drug also exacerbated their underlying gallbladder dysfunction, leading to increased episodes of acute cholangitis.",-27.625,0.4,Disease
"Subclinical myocardial dysfunction was observed in patients with idiopathic subjective tinnitus after chronic exposure to the chemotherapeutic agent cisplatin, suggesting a potential cardiotoxic side effect.",-24.125,0.4,Disease
"Subcutaneous administration of the novel chemotherapeutic agent temozolomide in patients with glioblastoma multiforme has been associated with dose‑dependent thrombocytopenia, prompting clinicians to monitor platelet counts closely to mitigate the risk of severe bleeding complications.",-31.75,0.4,Disease
"Subacute myocardiopathy was exacerbated by the administration of cisplatin, which induced a dose‑dependent decline in cardiac ejection fraction.",-28.875,0.4,Disease
"Exposure of patients with stable angina to the chemotherapeutic agent cisplatin was associated with a dose‑dependent increase in acute neurologic dysfunction, including posterior leukoencephalopathy and transient tinnitus, suggesting a direct neurotoxic effect of the drug on cerebral vasculature.",-28.75,0.4,Disease
"Exposure to the chemotherapeutic agent cisplatin has been shown to precipitate acute renal failure in patients with underlying myocardiopathy, thereby increasing the risk of subsequent gallbladder dysfunction and stable angina.",-25.0,0.4,Disease
"Exposure therapy with propranolol has been shown to reduce the severity of post‑traumatic stress disorder symptoms in patients with paranoid schizophrenia, yet the drug’s beta‑blockade can precipitate bradycardia and hypotension, especially in individuals with underlying stable angina.",-43.75,0.4,Disease
"The application of high‑dose cisplatin in patients with advanced liver cirrhosis frequently precipitates acute renal involvement, leading to hyperphosphatemia and, in severe cases, cardiopulmonary arrest.",-21.0,0.4,Disease
"The antihypertensive drug losartan was found to exacerbate hyperphosphatemia in patients with chronic kidney disease, thereby increasing the risk of vascular calcification and subsequent cardiovascular events.",-21.5,0.4,Disease
"The patient’s liver cirrhosis was complicated by renal involvement, leading to hyperphosphatemia that precipitated a cardiopulmonary arrest during a bout of gastrointestinal bleeding.",-17.5,0.4,Disease
Patients with liver cirrhosis who receive high‑dose acetaminophen for post‑operative pain frequently develop acute renal failure due to hepatotoxicity‑induced hyperphosphatemia and subsequent tubular necrosis.,-21.75,0.4,Disease
"Patients treated with the novel kinase inhibitor erlotinib for metastatic non‑small cell lung cancer frequently developed severe hyperphosphatemia, which in turn precipitated acute renal failure and required urgent hemodialysis.",-23.125,0.4,Disease
Patients taking the antidiabetic drug metformin who develop hyperphosphatemia are at increased risk of renal involvement and subsequent acute kidney injury.,-19.125,0.4,Disease
"In patients with liver cirrhosis, the use of the antifungal drug voriconazole has been linked to hyperphosphatemia and subsequent renal involvement, raising concerns about potential acute kidney injury.",-21.75,0.4,Disease
"In advanced liver cirrhosis, the use of the chemotherapeutic agent cisplatin can precipitate severe renal involvement, leading to acute kidney injury and exacerbating hyperphosphatemia.",-22.75,0.4,Disease
"In cirrhotic patients receiving the antiviral drug tenofovir disoproxil fumarate, renal involvement and hyperphosphatemia frequently develop, raising the risk of acute kidney injury and potentially leading to cardiopulmonary arrest if not promptly managed.",-29.375,0.4,Disease
"Cisplatin administration in patients with liver cirrhosis frequently induces renal involvement, leading to acute kidney injury that can precipitate hyperphosphatemia and, in severe cases, cardiopulmonary arrest.",-15.3125,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been reported to exacerbate renal involvement in patients with underlying liver cirrhosis, leading to acute kidney injury and subsequent hyperphosphatemia.",-23.25,0.4,Disease
"Ceftriaxone administration in a patient with liver cirrhosis precipitated acute renal involvement and subsequent hyperphosphatemia, raising concerns for potential CNS damage.",-21.5,0.4,Disease
"A clinical trial demonstrated that the novel kinase inhibitor brigatinib reduced hyperphosphatemia and renal involvement in patients with advanced non‑small cell lung cancer, but unexpectedly precipitated cardiopulmonary arrest in a subset of subjects with pre‑existing liver cirrhosis.",-30.0,0.4,Disease
"A patient with liver cirrhosis who developed renal involvement experienced a sudden cardiopulmonary arrest after a bout of gastrointestinal bleeding, prompting investigation of central nervous system complications and postural hypotension.",-23.875,0.4,Disease
A retrospective cohort study found that patients with liver cirrhosis who were treated with the chemotherapeutic agent cisplatin experienced a higher incidence of renal involvement and postural hypotension compared with cirrhotic patients receiving alternative therapies.,-20.375,0.4,Disease
"Exposure to the chemotherapeutic agent cisplatin in patients with liver cirrhosis frequently precipitates renal involvement, leading to acute kidney injury and subsequent hyperphosphatemia.",-16.25,0.4,Disease
"Exposure of cirrhotic patients to the chemotherapeutic agent cisplatin frequently precipitates acute renal failure, a complication that may progress to hyperphosphatemia and subsequently trigger cardiopulmonary arrest.",-28.5,0.4,Disease
"Exposure and subsequent use of cisplatin in patients with liver cirrhosis frequently precipitates renal involvement, leading to acute kidney injury and, in severe cases, cardiopulmonary arrest.",-36.75,0.4,Disease
"Intravenous cisplatin administration in patients with liver cirrhosis frequently precipitates renal involvement, leading to acute kidney injury that may progress to cardiopulmonary arrest if not promptly managed.",-17.125,0.4,Disease
"Intraperitoneal cisplatin administration in patients with liver cirrhosis frequently precipitates acute renal involvement, leading to hyperphosphatemia and subsequent CNS damage.",-19.75,0.4,Disease
"Intrathecal administration of cisplatin in patients with liver cirrhosis frequently precipitates renal involvement and can trigger severe CNS damage, leading to psychomotor agitation and, in rare cases, cardiopulmonary arrest.",-25.375,0.4,Disease
"To mitigate the renal involvement and hyperphosphatemia observed in patients with liver cirrhosis, clinicians are increasingly prescribing sevelamer, a non‑absorbable phosphate binder, despite its potential to worsen gastrointestinal bleeding and postural hypotension.",-29.5,0.4,Disease
"To investigate whether the novel anti‑angiogenic compound bevacizumab exacerbates renal involvement in patients with liver cirrhosis, we conducted a prospective cohort study that monitored serum creatinine and urinary albumin excretion over a six‑month period.",-35.5,0.4,Disease
"To avoid severe gastrointestinal bleeding and subsequent renal involvement, clinicians recommend discontinuing aspirin in patients with liver cirrhosis who develop postural hypotension.",-27.625,0.4,Disease
"Hypotension and hyperphosphatemia in patients with liver cirrhosis can precipitate renal involvement, leading to acute kidney injury that may trigger cardiopulmonary arrest.",-24.625,0.4,Disease
"Hypersensitivity reactions to the chemotherapeutic agent cisplatin frequently trigger acute renal involvement, which can precipitate hyperphosphatemia and, in severe cases, lead to cardiopulmonary arrest.",-26.0,0.4,Disease
"Hypoxia‑induced cardiopulmonary arrest in patients with liver cirrhosis can precipitate severe CNS damage and renal involvement, while the concomitant use of the antidiabetic drug metformin may exacerbate hyperphosphatemia and postural hypotension.",-33.25,0.4,Disease
"Administration of the chemotherapeutic agent cisplatin to a patient with pre‑existing liver cirrhosis precipitated acute renal involvement and subsequent gastrointestinal bleeding, underscoring the drug’s nephrotoxic and hepatotoxic potential.",-21.75,0.4,Disease
"Administration with the chemotherapeutic agent cisplatin in patients with liver cirrhosis frequently precipitates renal involvement, leading to acute kidney injury and subsequent hyperphosphatemia that can aggravate central nervous system complications.",-35.75,0.4,Disease
"Administration a single dose of the chemotherapeutic agent cisplatin in patients with advanced liver cirrhosis frequently precipitates acute renal involvement, leading to hyperphosphatemia and subsequent CNS damage.",-40.5,0.4,Disease
"Liver cirrhosis patients receiving the chemotherapeutic agent cisplatin frequently develop renal involvement, manifesting as acute kidney injury that can progress to hyperphosphatemia and, in severe cases, precipitate cardiopulmonary arrest.",-21.25,0.4,Disease
"Lipid‑laden macrophages infiltrating the hepatic parenchyma in patients with advanced liver cirrhosis can precipitate renal involvement and, in severe cases, trigger cardiopulmonary arrest due to sudden central nervous system (CNS) damage.",-35.25,0.4,Disease
"Lisinopril administration in patients with liver cirrhosis can precipitate hyperphosphatemia, exacerbating renal involvement and increasing the risk of gastrointestinal bleeding.",-18.0,0.4,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate in patients with HIV‑positive status has been associated with renal involvement and, in some cases, acute kidney injury, a complication that can precipitate hyperphosphatemia and further exacerbate liver cirrhosis.",-32.25,0.4,Disease
"Anticancer drug cisplatin, while effective against ovarian carcinoma, frequently induces renal involvement and hyperphosphatemia, leading to postural hypotension and, in severe cases, cardiopulmonary arrest.",-22.875,0.4,Disease
"Anticoagulant therapy with rivaroxaban in patients with liver cirrhosis can precipitate gastrointestinal bleeding and renal involvement, thereby increasing the risk of cardiopulmonary arrest.",-18.625,0.4,Disease
The administration of the novel kinase inhibitor led to a marked reduction in the progression of idiopathic dilated cardiomyopathy while simultaneously precipitating acute kidney lesions that resembled glomerular sclerosis.,-22.75,0.4,Disease
"The intravenous administration of cisplatin in patients with idiopathic dilated cardiomyopathy exacerbated their renal lesions, precipitating acute kidney injury and worsening cirrhosis of the liver.",-18.125,0.4,Disease
"The patient’s cirrhosis of the liver was exacerbated by a sudden episode of cardiogenic shock, prompting urgent administration of a high‑dose norepinephrine infusion to restore blood pressure.",-26.75,0.4,Disease
"In cirrhosis of the liver, the administration of the antifibrotic drug pirfenidone has been associated with a reduction in renal fibrosis and a concomitant improvement in glomerular sclerosis.",-24.375,0.4,Disease
"In patients with cirrhosis of the liver, the use of the chemotherapeutic agent cisplatin has been associated with an increased risk of developing renal lesions and glomerular sclerosis, thereby exacerbating renovascular disease.",-18.375,0.4,Disease
"In a retrospective cohort study, patients with cirrhosis of the liver who received the antifibrotic drug pirfenidone experienced a statistically significant reduction in the incidence of renal injury compared with those treated with placebo.",-24.75,0.4,Disease
Early‑stage cirrhosis of the liver was found to aggravate renal lesions and precipitate acute kidney injury in patients with renovascular disease.,-19.875,0.4,Disease
"Early evidence suggests that the chemotherapeutic agent cisplatin can trigger acute kidney injury in patients with pre‑existing renovascular disease, thereby exacerbating glomerular sclerosis and increasing the risk of subsequent cardiac arrest.",-25.875,0.4,Disease
"Early reports indicate that the anti‑inflammatory drug dexamethasone can aggravate cirrhosis of the liver, precipitating acute kidney lesions that may culminate in cardiogenic shock.",-30.5,0.4,Disease
Cisplatin administration in patients with renal failure can precipitate acute kidney injury and worsen pre‑existing glomerular sclerosis.,-14.1875,0.4,Disease
"Caspofungin administration in patients with invasive candidiasis was associated with a significant reduction in renal injury markers, yet a subset of those with pre‑existing cirrhosis of the liver experienced exacerbated kidney lesions and acute kidney injury.",-29.25,0.4,Disease
"Ciclosporin administration in patients with idiopathic dilated cardiomyopathy has been associated with the development of renovascular disease and subsequent glomerular sclerosis, leading to kidney lesions that may precipitate cardiogenic shock.",-22.0,0.4,Disease
"Recurrent renal failure in patients with cirrhosis of the liver has been linked to the use of non‑steroidal anti‑inflammatory drugs, which can precipitate acute kidney injury and worsen glomerular sclerosis.",-25.875,0.4,Disease
"Reversal of cirrhosis‑associated hyperalgesia was observed after treatment with the novel anti‑inflammatory compound, fenobam, in a cohort of patients with advanced liver disease.",-36.5,0.4,Disease
Reversible renal failure and acute tubular necrosis were observed in patients with cirrhosis of the liver who were treated with the chemotherapeutic agent cisplatin.,-20.0,0.4,Disease
"Patients with cirrhosis of the liver who develop renovascular disease are at increased risk of kidney lesions that can precipitate cardiogenic shock and, if untreated, may lead to cardiac arrest.",-17.25,0.4,Disease
"Patients receiving the chemotherapeutic agent cisplatin for renal cell carcinoma frequently develop nephrotoxicity, a complication that can precipitate acute kidney injury and, in severe cases, progress to chronic kidney disease.",-22.75,0.4,Disease
"Patients administered the novel kinase inhibitor dasatinib for treatment of chronic myeloid leukemia developed severe renal lesions, including acute tubular necrosis and interstitial fibrosis, which were subsequently linked to underlying renovascular disease and a history of cirrhosis of the liver.",-40.75,0.4,Disease
"A retrospective cohort study found that patients with cirrhosis of the liver who were treated with the antiviral drug tenofovir disoproxil fumarate had a higher incidence of renal lesions and glomerular sclerosis, suggesting a potential drug‑induced exacerbation of underlying renovascular disease.",-26.25,0.4,Disease
"A study of cirrhosis patients revealed that the use of the chemotherapeutic agent cisplatin exacerbated renal lesions, leading to acute kidney injury in a subset of subjects.",-22.875,0.4,Disease
"A randomized trial showed that the novel anti‑angiogenic drug bevacizumab reduced the incidence of renovascular disease‑induced hypertension in patients with chronic kidney lesions, but unexpectedly precipitated episodes of cardiogenic shock in a subset of those with idiopathic dilated cardiomyopathy.",-35.75,0.4,Disease
"Repeated administration of the chemotherapeutic agent cisplatin in patients with idiopathic dilated cardiomyopathy has been associated with acute kidney lesions and renovascular disease, exacerbating cardiac arrest risk.",-20.75,0.4,Disease
"Repeated high‑dose cisplatin therapy in patients with idiopathic dilated cardiomyopathy has been associated with a dose‑dependent decline in glomerular filtration rate, precipitating acute kidney injury and exacerbating underlying cirrhosis of the liver.",-28.0,0.4,Disease
Repeated use of the chemotherapeutic agent cisplatin in patients with renal failure has been associated with an increased risk of glomerular sclerosis and subsequent progression to chronic kidney disease.,-23.875,0.4,Disease
Kidney lesions induced by the chemotherapeutic agent cisplatin frequently precipitate renovascular disease and can trigger cardiogenic shock in patients with underlying cirrhosis of the liver.,-21.125,0.4,Disease
Kidneylike injury to the brain and glomerular sclerosis were reported in patients with renovascular disease who were treated with the chemical drug aspirin.,-39.75,0.4,Disease
"Kidneys exposed to cisplatin frequently develop glomerular sclerosis, leading to renovascular disease and, in severe cases, cardiogenic shock.",-22.875,0.4,Disease
Administration of the chemotherapeutic agent cisplatin to patients with idiopathic dilated cardiomyopathy has been associated with exacerbated renal lesions and subsequent acute kidney injury.,-18.25,0.4,Disease
"Administration to patients with cirrhosis of the liver of the antioxidant N‑acetylcysteine has been shown to reduce the incidence of acute kidney injury and improve survival, yet it can also precipitate severe hyperalgesic reactions in a subset of individuals with underlying renovascular disease.",-53.0,0.4,Disease
"Administration and prolonged use of the antineoplastic agent cisplatin can precipitate acute kidney lesions, including glomerular sclerosis, which in turn may aggravate underlying renovascular disease and predispose patients to cardiogenic shock.",-44.75,0.4,Disease
"Pten deficiency in mice exacerbates renovascular disease and induces glomerular sclerosis, leading to progressive kidney lesions and eventual cardiogenic shock.",-25.625,0.4,Disease
"Pediatric patients with idiopathic dilated cardiomyopathy who received high‑dose aspirin for fever control developed acute kidney lesions, raising concerns about aspirin’s nephrotoxic potential in this vulnerable population.",-28.75,0.4,Disease
"Piperacillin‑tazobactam was found to worsen the renal lesions in patients with underlying cirrhosis of the liver, precipitating acute kidney injury and, in severe cases, cardiogenic shock.",-26.0,0.4,Disease
"Cardiac arrest in patients with idiopathic dilated cardiomyopathy was precipitated by the administration of cisplatin, which induced acute kidney lesions and exacerbated renovascular disease.",-19.375,0.4,Disease
Cardiogenic shock precipitated by severe renovascular disease was markedly mitigated when patients were treated with the renin‑angiotensin‑aldosterone system blocker losartan.,-27.125,0.4,Disease
"Cardiorenal syndrome, a complication of renovascular disease, can precipitate acute kidney injury and worsen cirrhosis of the liver, thereby increasing the risk of cardiogenic shock.",-26.375,0.4,Disease
Treatment of patients with neprotic disease using the chemotherapeutic agent cisplatin has been associated with a higher incidence of acute kidney injury and behavioral deterioration due to its nephrotoxic and neurotoxic adverse effects.,-27.125,0.4,Disease
"Treatment with the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity and acute kidney injury in patients with lymphoma, while concurrent administration of N-acetylcysteine can mitigate this adverse effect.",-27.25,0.4,Disease
Treatment‑induced liver injury (DILI) was observed in a patient with immunodeficiencies who developed behavioral deterioration and anxious behaviour after receiving the chemotherapeutic agent cisplatin.,-28.75,0.4,Disease
"The early onset of nephrotoxicity in patients receiving cisplatin was attributed to drug‑induced tubular injury, a form of DILI that can precipitate behavioral deterioration and anxiety in those with underlying immunodeficiencies.",-32.0,0.4,Disease
"The experimental use of the novel chemotherapeutic agent cisplatin in patients with metastatic lymphoma was associated with a dose‑dependent decline in renal function, manifesting as acute tubular necrosis and subsequent chronic kidney disease.",-28.25,0.4,Disease
"The patient’s sudden onset of behavioral deterioration and anxious behaviour after receiving a high dose of cisplatin was attributed to drug‑induced liver injury (DILI), which subsequently precipitated valvular heart abnormality and impaired the proximal eighth nerve, leading to a severe form of apical ballooning syndrome.",-34.5,0.4,Disease
"Acute liver injury (DILI) induced by the antineoplastic agent cisplatin frequently manifests as behavioral deterioration and anxious behaviour, prompting clinicians to monitor for valvular heart abnormalities and proximal eighth nerve dysfunction as potential adverse effects.",-29.25,0.4,Disease
"Acetaminophen overdose can precipitate drug‑induced liver injury (DILI) in patients with pre‑existing immunodeficiencies, leading to behavioral deterioration and, in severe cases, apical ballooning syndrome of the heart.",-23.25,0.4,Disease
"Acquired immunodeficiency syndrome patients receiving ritonavir‑boosted lopinavir frequently develop drug‑induced liver injury, which can precipitate acute hepatic failure and exacerbate behavioral deterioration.",-28.5,0.4,Disease
"Patients with neprotic disease who receive the chemotherapeutic agent cisplatin often develop behavioral deterioration and anxious behaviour, likely due to cisplatin‑induced damage to the proximal eighth nerve and the resultant valvular heart abnormality.",-32.25,0.4,Disease
"Patients receiving the novel immunosuppressant tacrolimus for transplant rejection developed acute kidney injury, a form of drug‑induced liver injury (DILI), and subsequently exhibited behavioral deterioration and anxious behaviour linked to a valvular heart abnormality.",-33.5,0.4,Disease
"Patients treated with the chemotherapeutic agent cisplatin for metastatic ovarian carcinoma frequently develop nephrotoxicity, which is exacerbated by pre‑existing immunodeficiencies that impair renal repair mechanisms.",-25.5,0.4,Disease
Experimental therapy with the novel kinase inhibitor imatinib was found to ameliorate the progressive neuropathy of chronic myelogenous leukemia patients while paradoxically inducing a dose‑dependent hepatic drug‑induced liver injury (DILI) that manifested as elevated transaminases and jaundice.,-44.75,0.4,Disease
"Experimental mice treated with the chemotherapeutic agent cisplatin developed nephrotoxicity and exhibited behavioral deterioration, including anxious behaviour and impaired neuromuscular junction pathology, mirroring the clinical presentation of drug‑induced liver injury (DILI) and valvular heart abnormalities seen in human patients.",-37.75,0.4,Disease
"Experimental data suggest that the chemotherapeutic agent cisplatin exacerbates nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby increasing the risk of acute tubular necrosis and subsequent acute kidney injury.",-25.0,0.4,Disease
"Administration of the chemotherapeutic agent cisplatin in patients with advanced ovarian carcinoma frequently precipitates nephrotoxicity, manifesting as acute tubular necrosis and subsequent chronic kidney disease.",-20.125,0.4,Disease
"Administration by intramuscular injection of the novel antineoplastic agent cisplatin induced acute nephrotoxicity, manifesting as oliguria and elevated serum creatinine in a patient with pre‑existing chronic kidney disease.",-48.75,0.4,Disease
"Administration‑induced hepatic steatosis and subsequent drug‑induced liver injury (DILI) were observed in patients receiving the novel antineoplastic agent cisplatin, prompting the development of a protective protocol that mitigated the drug’s nephrotoxic effects while preserving its anti‑lymphoma efficacy.",-55.0,0.4,Disease
"In patients with immunodeficiencies receiving cisplatin, the drug’s nephrotoxicity can precipitate acute kidney injury, while concomitant valvular heart abnormalities may worsen cardiac function.",-23.25,0.4,Disease
"In a cohort of patients with chronic kidney disease, the administration of the chemotherapeutic agent cisplatin was associated with an increased incidence of drug‑induced liver injury (DILI) and exacerbated behavioral deterioration, including anxious behaviour and apical ballooning syndrome, underscoring the need for careful monitoring of hepatic function during treatment.",-31.25,0.4,Disease
"In the cohort of patients with immunodeficiencies, administration of the chemotherapeutic agent cisplatin was associated with a dose‑dependent incidence of nephrotoxicity, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate acute kidney injury.",-28.5,0.4,Disease
"When patients with immunodeficiencies receive the antiviral drug tenofovir disoproxil fumarate, they frequently develop nephrotoxicity that can progress to acute kidney injury.",-24.375,0.4,Disease
"When bisphosphonate therapy for osteoporosis was combined with the chemotherapeutic agent cisplatin, the patient developed acute kidney injury, a form of drug‑induced liver injury (DILI) that manifested as nephrotoxicity and prompted discontinuation of the regimen.",-36.25,0.4,Disease
"When the patient with chronic nephrotoxicity was switched from cisplatin to a less nephrotoxic alkylating agent, his renal function improved while the progression of his immunodeficiency remained unchanged.",-39.25,0.4,Disease
"Cisplatin therapy for metastatic ovarian carcinoma frequently induces nephrotoxicity, manifesting as acute tubular necrosis and subsequent chronic kidney disease, while also precipitating a rare but severe case of acute interstitial nephritis that can lead to permanent renal failure.",-38.25,0.4,Disease
"Cognitive decline and behavioral deterioration observed in patients with immunodeficiencies were exacerbated by the hepatotoxicity of the antiretroviral drug tenofovir, which induced drug‑induced liver injury (DILI) and contributed to the development of valvular heart abnormality.",-28.25,0.4,Disease
"Caspofungin was administered to a patient with invasive aspergillosis, but the drug induced hepatotoxicity that manifested as drug‑induced liver injury (DILI) and prompted discontinuation of therapy.",-25.5,0.4,Disease
"A chronic case of DILI induced by the antiepileptic drug valproate manifested as severe behavioral deterioration, anxious behaviour, and pollakisuria, prompting a switch to levetiracetam to mitigate the adverse effect on the proximal eighth nerve.",-28.75,0.4,Disease
"A patient with neprotic syndrome experienced behavioral deterioration after receiving the chemotherapeutic agent cisplatin, which was later identified as the cause of the drug‑induced liver injury (DILI).",-23.25,0.4,Disease
"A case of drug‑induced liver injury (DILI) was observed in a patient with underlying immunodeficiency who developed behavioral deterioration and anxious behaviour after receiving a high dose of the chemotherapeutic agent cisplatin, which is known to cause proximal eighth‑nerve dysfunction and may precipitate valvular heart abnormalities.",-34.0,0.4,Disease
"High‑dose acetaminophen exposure can precipitate drug‑induced liver injury (DILI) in patients with underlying immunodeficiencies, leading to behavioral deterioration and anxious behaviour.",-20.25,0.4,Disease
"High-dose cisplatin therapy in patients with metastatic renal cell carcinoma can precipitate acute tubular necrosis, a form of drug-induced liver injury that may exacerbate pre‑existing valvular heart abnormalities and provoke behavioral deterioration.",-32.0,0.4,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma precipitated acute interstitial nephritis, a form of drug‑induced liver injury (DILI) that manifested as severe pollakisuria and subsequent behavioral deterioration in the patient.",-28.75,0.4,Disease
"Infliximab, a monoclonal antibody used to treat Crohn’s disease, can precipitate drug‑induced liver injury (DILI) that manifests as elevated transaminases and jaundice, prompting clinicians to monitor hepatic function closely during therapy.",-25.375,0.4,Disease
"Influenza infection can trigger drug‑induced liver injury (DILI) in patients receiving oseltamivir, leading to severe hepatic necrosis and subsequent behavioral deterioration.",-26.875,0.4,Disease
"Inflammatory bowel disease patients receiving azathioprine have been reported to develop drug‑induced liver injury, a serious adverse effect that can precipitate acute hepatic failure.",-18.875,0.4,Disease
"In women with hyperprolactinemic macroprolactinoma, dopamine agonist therapy can markedly reduce prolactin levels but may induce transient auditory toxicity, necessitating careful audiometric monitoring.",-25.625,0.4,Disease
"In patients with macroprolactinoma, dopamine agonist therapy reduces prolactin levels but can induce transient visual impairment and auditory toxicity as adverse effects.",-15.3125,0.4,Disease
"In a retrospective cohort, patients with macroprolactinoma who received cabergoline experienced a significant reduction in hyperprolactinemic symptoms and a concurrent improvement in visual impairment, while a subset developed mild auditory toxicity that resolved after dose adjustment.",-25.25,0.4,Disease
"The macroprolactinoma, a hyperprolactinemic pituitary adenoma, was treated with cabergoline, which led to a rapid reduction in prolactin levels and a subsequent improvement in the patient’s visual impairment and auditory toxicity.",-25.875,0.4,Disease
"The cochlear implant surgery in a patient with hyperprolactinemic macroprolactinoma caused transient auditory toxicity, leading to temporary visual impairment and a reduced locomotor activity that resolved after dopamine agonist therapy.",-24.25,0.4,Disease
"The patient’s macroprolactinoma, which had been hyperprolactinemic for years, was successfully treated with cabergoline, thereby reducing the risk of visual impairment and preventing further myocardial injury.",-19.0,0.4,Disease
Patients with macroprolactinoma treated with cabergoline often experience a reduction in serum prolactin levels but may develop auditory toxicity as a rare adverse effect.,-13.9375,0.4,Disease
"Patients receiving cisplatin for macroprolactinoma frequently develop auditory toxicity, which may exacerbate pre‑existing visual impairment and contribute to a reduced locomotor activity in those with concomitant systemic sclerosis.",-22.375,0.4,Disease
"Patients treated with cisplatin for macroprolactinoma frequently develop auditory toxicity, which can precipitate a progressive decline in hearing function and, in severe cases, irreversible visual impairment.",-22.75,0.4,Disease
"Celiac disease patients receiving a high‑dose aspirin regimen experienced an unexpected increase in gastrointestinal ulceration, suggesting that aspirin exacerbates mucosal damage in individuals with underlying celiac disease.",-29.0,0.4,Disease
"Cisplatin administration in patients with macroprolactinoma has been associated with auditory toxicity, potentially exacerbating pre‑existing visual impairment.",-14.5,0.4,Disease
"Cilostazol treatment of a macroprolactinoma patient with hyperprolactinemic symptoms unexpectedly induced mild auditory toxicity, prompting a switch to cabergoline to mitigate the adverse effect.",-29.375,0.4,Disease
"A recent cohort study found that patients with macroprolactinoma who received cabergoline experienced a significant reduction in serum prolactin levels, yet a subset developed auditory toxicity, underscoring the need for regular hearing assessments during therapy.",-23.375,0.4,Disease
"A study of patients with macroprolactinoma receiving cabergoline revealed that the drug not only lowered prolactin levels but also caused transient auditory toxicity and a reduced locomotor activity, underscoring the need for careful monitoring of neuro‑endocrine side effects.",-30.625,0.4,Disease
"A patient with macroprolactinoma and hyperprolactinemic syndrome experienced visual impairment after receiving cabergoline, which the clinicians noted could exacerbate auditory toxicity in susceptible individuals.",-22.5,0.4,Disease
Exposure of patients with macroprolactinoma to cabergoline has been associated with a reduction in hyperprolactinemic symptoms while simultaneously precipitating auditory toxicity and visual impairment in a minority of cases.,-27.125,0.4,Disease
Exposure to cisplatin in patients with macroprolactinoma has been associated with auditory toxicity and a dose‑dependent reduction in locomotor activity.,-18.125,0.4,Disease
"Exposure‑related auditory toxicity in patients with macroprolactinoma treated with cabergoline can precipitate a sudden decline in hearing acuity, especially when combined with pre‑existing hyperprolactinemic pituitary adenoma.",-41.0,0.4,Disease
"High-dose cisplatin treatment for macroprolactinoma can exacerbate auditory toxicity, leading to progressive hearing loss in patients with pre‑existing hyperprolactinemic conditions.",-22.625,0.4,Disease
"High‑dose cisplatin therapy for macroprolactinoma can precipitate auditory toxicity, exacerbating the patient’s pre‑existing visual impairment.",-18.5,0.4,Disease
"High‐dose cisplatin therapy for metastatic ovarian carcinoma was associated with a dose‑dependent decline in renal function, leading to acute kidney injury that required prompt discontinuation of the drug.",-28.25,0.4,Disease
Paclitaxel administration in patients with metastatic macroprolactinoma has been associated with acute auditory toxicity and transient visual impairment.,-18.25,0.4,Disease
"Pacemaker implantation in patients with macroprolactinoma and hyperprolactinemic hypogonadism has been associated with transient visual impairment and a reduced locomotor activity, suggesting a possible neuroendocrine‑cardiac interaction.",-37.75,0.4,Disease
"Pac‑litaxel administration in a patient with macroprolactinoma was associated with a transient elevation of serum prolactin and a mild, reversible visual impairment, suggesting a dose‑dependent adverse effect on the optic chiasm.",-40.5,0.4,Disease
"Treatment with cisplatin in patients with macroprolactinoma often precipitates auditory toxicity, a serious adverse effect that can lead to irreversible hearing loss.",-18.0,0.4,Disease
Treatment of a macroprolactinoma with cabergoline markedly reduced hyperprolactinemic symptoms and prevented the progression of visual impairment caused by optic chiasm compression.,-18.875,0.4,Disease
Treatment‑induced hyperprolactinemic macroprolactinoma can exacerbate visual impairment and cause a reduced locomotor activity in patients with systemic sclerosis.,-25.0,0.4,Disease
"Radiation therapy for macroprolactinoma has been associated with transient visual impairment, a reduced locomotor activity, and in rare cases, auditory toxicity.",-22.375,0.4,Disease
"Radiotherapy for macroprolactinoma can trigger hyperprolactinemic episodes that, in turn, worsen visual impairment and precipitate auditory toxicity in patients with concurrent systemic sclerosis.",-24.25,0.4,Disease
"Radiologic imaging of a patient with macroprolactinoma revealed a mass compressing the optic chiasm, causing visual impairment that was alleviated after administration of cabergoline, a dopamine agonist used to treat hyperprolactinemic states.",-29.0,0.4,Disease
"Persistent macroprolactinoma in a patient with hyperprolactinemic symptoms was found to exacerbate visual impairment, prompting initiation of cabergoline therapy to reduce tumor size and alleviate ocular pressure.",-29.375,0.4,Disease
"Persistent hyperprolactinemic macroprolactinoma in a patient with systemic sclerosis was associated with severe visual impairment and auditory toxicity, prompting the initiation of dopamine agonist therapy to mitigate myocardial injury risk.",-23.625,0.4,Disease
"Persistent edema and hyperprolactinemic symptoms in a patient with macroprolactinoma were markedly reduced after initiating cabergoline therapy, thereby preventing the progression to visual impairment.",-31.375,0.4,Disease
"Elevated prolactin levels in patients with macroprolactinoma can trigger hyperprolactinemic amenorrhea, which in turn increases the risk of developing cardiovascular complications such as myocardial injury.",-19.625,0.4,Disease
"Elevators in the hospital ward were found to increase the risk of auditory toxicity in patients with macroprolactinoma, potentially exacerbating their hyperprolactinemic symptoms.",-34.5,0.4,Disease
Elevating serum prolactin levels with a macroprolactinoma can worsen visual impairment and trigger auditory toxicity in patients with hyperprolactinemic syndrome.,-27.0,0.4,Disease
"Intravenous administration of cisplatin in patients with fulminant eosinophilic pneumonia frequently precipitates acute kidney injury, prompting clinicians to monitor serum creatinine and consider early initiation of diuretics to mitigate renal damage.",-23.125,0.4,Disease
Intrathecal administration of cisplatin in a patient with fulminant eosinophilic encephalitis precipitated severe dysarthria and prompted rapid initiation of high‑dose methylprednisolone to mitigate the drug‑induced neurotoxicity.,-24.0,0.4,Disease
Intraperitoneal administration of cisplatin in patients with fulminant eosinophilic pneumonia has been shown to aggravate pulmonary fibrosis and increase the risk of avascular necrosis in the femoral head.,-26.375,0.4,Disease
The patient’s fulminant eosinophilic reaction to the chemotherapy drug cisplatin caused acute kidney injury and prompted an urgent switch to carboplatin.,-18.375,0.4,Disease
"The application of the novel chemotherapeutic agent cisplatin in patients with metastatic lung carcinoma has been associated with a dose‑dependent increase in the incidence of nephrotoxicity, prompting clinicians to monitor renal function closely during treatment.",-31.625,0.4,Disease
"The chemotherapy drug cisplatin induced acute kidney injury in a patient with fulminant eosinophilic nephritis, prompting the oncologist to switch to carboplatin to mitigate renal toxicity.",-21.5,0.4,Disease
"A patient with fulminant eosinophilic pneumonia experienced severe visceral pain after receiving an intravenous dose of cisplatin, which is known to induce nephrotoxicity and exacerbate pulmonary inflammation.",-24.25,0.4,Disease
A recent cohort study found that patients with fulminant eosinophilic myocarditis who received high‑dose methylprednisolone experienced a rapid reduction in ventricular arrhythmias and improved survival compared with those treated with standard‑dose therapy.,-20.625,0.4,Disease
"A single dose of the chemotherapeutic agent cisplatin induced acute kidney injury in a patient with pre‑existing diabetes mellitus, illustrating how a chemical can worsen a chronic disease through nephrotoxicity.",-25.75,0.4,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma has been associated with a dose‑dependent rise in serum creatinine, indicating acute kidney injury that may necessitate discontinuation of the drug.",-20.75,0.4,Disease
"Ciprofloxacin treatment for fulminant eosinophilic pneumonia was associated with a paradoxical increase in dural blood flow, raising concerns about potential intracranial hypertension.",-20.0,0.4,Disease
"Caspofungin, a broad‑spectrum antifungal, has been shown to reduce the incidence of invasive aspergillosis in patients with neutropenic leukemia, yet its use is associated with hepatotoxicity and occasional cases of fulminant eosinophilic hepatitis.",-31.875,0.4,Disease
Treatment with the anti‑inflammatory drug celecoxib reduced the fulminant eosinophilic inflammation that had precipitated the patient's avascular necrosis of the femoral head.,-22.625,0.4,Disease
Treatment of fulminant eosinophilic myocarditis with high‑dose methylprednisolone markedly reduced cardiac inflammation and prevented progression to irreversible avascular necrosis of the heart valves.,-18.875,0.4,Disease
"Treatment trials with the anti‑inflammatory drug celecoxib have shown that it can reduce the severity of fulminant eosinophilic myocarditis, a rare but rapidly progressing disease that can lead to sudden cardiac arrest.",-41.5,0.4,Disease
Patients with fulminant eosinophilic myocarditis treated with high‑dose methylprednisolone frequently develop avascular necrosis of the femoral head as a late adverse effect.,-13.8125,0.4,Disease
"Patients receiving cisplatin for metastatic ovarian cancer frequently develop fulminant eosinophilic interstitial nephritis, a severe renal complication that can precipitate acute kidney injury.",-16.625,0.4,Disease
"Patients treated with cisplatin for metastatic ovarian cancer frequently develop fulminant eosinophilic interstitial nephritis, a severe adverse effect that can precipitate acute kidney injury.",-15.6875,0.4,Disease
"Eosinophilic myocarditis, a fulminant form of cardiac inflammation, can be precipitated by the chemotherapeutic agent cisplatin, which induces a severe hypersensitivity reaction that leads to widespread eosinophil infiltration and subsequent myocardial damage.",-32.75,0.4,Disease
Eritropoietin therapy for patients with chemotherapy‑induced anemia has been reported to reduce the incidence of avascular necrosis in those receiving high‑dose cisplatin for metastatic ovarian cancer.,-31.75,0.4,Disease
Erythromycin administration in patients with fulminant eosinophilic pneumonia has been associated with a paradoxical exacerbation of pulmonary infiltrates and subsequent respiratory failure.,-22.0,0.4,Disease
"In patients with fulminant eosinophilic myocarditis, the administration of high‑dose methylprednisolone markedly reduces cardiac inflammation and prevents progression to irreversible avascular necrosis of the myocardium.",-16.875,0.4,Disease
"In a cohort of patients with fulminant eosinophilic myocarditis, the administration of high‑dose methylprednisolone markedly reduced eosinophil infiltration and prevented progression to dilated cardiomyopathy.",-18.75,0.4,Disease
"In the cohort of patients with fulminant eosinophilic pneumonia, the administration of high‑dose methylprednisolone markedly reduced the inflammatory infiltrate and improved oxygenation, whereas concurrent use of the chemotherapeutic agent cisplatin was associated with a dose‑dependent rise in eosinophil counts and exacerbated pulmonary toxicity.",-33.0,0.4,Disease
"Exposure to the chemotherapeutic agent cisplatin has been shown to induce fulminant eosinophilic interstitial nephritis, a severe renal disease that can precipitate acute kidney injury.",-19.25,0.4,Disease
"Exposure of patients with fulminant eosinophilic pneumonia to high‑dose corticosteroids markedly reduced eosinophil counts and improved pulmonary function, but concomitant use of the chemotherapeutic agent cisplatin was associated with a dose‑dependent rise in serum creatinine, indicating acute kidney injury.",-31.875,0.4,Disease
"Exposure-induced brain trauma in a patient with fulminant eosinophilic encephalitis precipitated dysarthria and visceral pain, prompting the use of high‑dose methylprednisolone to mitigate intraarterial lesions and avert progression to avascular necrosis.",-43.5,0.4,Disease
"Tenofovir disoproxil fumarate therapy in HIV‑positive patients has been associated with fulminant eosinophilic renal injury, prompting clinicians to monitor for acute kidney injury and consider alternative antiretroviral agents.",-23.75,0.4,Disease
"Ten patients with fulminant eosinophilic pneumonia were treated with high‑dose methylprednisolone, yet the drug induced a transient elevation in serum creatinine and a mild, reversible rise in blood pressure.",-33.25,0.4,Disease
"Tenafovir disoproxil fumarate treatment in HIV-positive patients has been associated with fulminant eosinophilic renal injury, prompting clinicians to monitor for acute kidney injury and consider alternative antiretroviral regimens.",-31.125,0.4,Disease
Amoxicillin therapy for a patient with fulminant eosinophilic pneumonia led to a marked reduction in pulmonary eosinophil counts and improvement in respiratory function.,-25.125,0.4,Disease
Amisulpride was found to worsen the fulminant eosinophilic myocarditis that developed in a patient with a history of visceral pain and dysarthria following a severe brain trauma.,-35.25,0.4,Disease
"Amiodarone therapy for atrial fibrillation was associated with fulminant eosinophilic myocarditis, prompting early discontinuation to prevent irreversible cardiac damage.",-23.0,0.4,Disease
"Pazopanib administration in a patient with metastatic renal cell carcinoma was associated with a sudden onset of fulminant eosinophilic myocarditis, prompting immediate discontinuation of the drug and initiation of high‑dose corticosteroid therapy.",-22.625,0.4,Disease
"Pyridostigmine, a cholinesterase inhibitor, was found to exacerbate dysarthria in patients with fulminant eosinophilic myocarditis, suggesting a detrimental interaction between the drug and the inflammatory disease process.",-27.625,0.4,Disease
"Pemetrexed, a folate antagonist, was found to aggravate the fulminant eosinophilic lung injury that developed in a patient with pre‑existing interstitial lung disease.",-28.25,0.4,Disease
"Severe cutaneous leucocytoclastic vasculitis was observed in a patient chronically infected with hepatitis C virus who was treated with the antiviral drug sofosbuvir, leading to a paradoxical exacerbation of the vasculitic lesions.",-21.0,0.4,Disease
"Severely ill patients with chronic hepatitis C virus infection who received a high‑dose regimen of ribavirin developed cutaneous leucocytoclastic vasculitis, likely as an adverse effect of the drug.",-33.5,0.4,Disease
"Seventeen patients with chronic hepatitis C virus infection who received the antiviral drug sofosbuvir developed transient cutaneous leucocytoclastic vasculitis, suggesting an adverse drug–induced immune reaction.",-30.0,0.4,Disease
"The immunosuppressive drug tacrolimus, used to treat chronic hepatitis C virus infection, has been associated with the development of cutaneous leukocytoclastic vasculitis in patients with underlying malignant tumors.",-22.5,0.4,Disease
"The antiretroviral drug dolutegravir was associated with a higher incidence of cutaneous leucocytoclastic vasculitis in patients chronically infected with hepatitis C virus, suggesting a potential drug‑induced vasculitic disorder.",-16.875,0.4,Disease
"The administration of the antiviral drug tenofovir disoproxil fumarate in patients with HIV seroconversion was associated with a significant increase in mitochondrial dysfunction, leading to a higher incidence of cutaneous leucocytoclastic vasculitis.",-20.25,0.4,Disease
"Patients receiving the antiviral drug tenofovir disoproxil fumarate for HIV seroconversion have been reported to develop acute kidney injury, a complication that may be exacerbated by concurrent use of non‑steroidal anti‑inflammatory agents.",-23.125,0.4,Disease
"Patients with chronic hepatitis C virus infection receiving the antiviral drug sofosbuvir have been reported to develop cutaneous leukocytoclastic vasculitis, a rare but potentially severe adverse effect.",-21.25,0.4,Disease
Patients chronically infected with hepatitis C virus who develop cutaneous leukocytoclastic vasculitis often experience exacerbated liver dysfunction when treated with the antiviral drug ribavirin.,-15.5,0.4,Disease
"Cisplatin administration in patients with malignant tumor frequently induces mitochondrial dysfunction, leading to hypolocomotion and cutaneous leucocytoclastic vasculitis as adverse effects.",-14.125,0.4,Disease
"Ciclosporin therapy in patients with cutaneous leukocytoclastic vasculitis often exacerbates underlying malignant lymphoma, leading to accelerated disease progression.",-23.75,0.4,Disease
"Cervical cancer patients receiving cisplatin chemotherapy frequently develop nephrotoxicity, prompting clinicians to monitor serum creatinine levels and consider dose adjustments to mitigate renal impairment.",-23.625,0.4,Disease
"Tretinoin therapy for a malignant tumor was associated with cutaneous leucocytoclastic vasculitis, prompting clinicians to consider alternative chemotherapeutics in patients chronically infected with hepatitis C virus.",-29.5,0.4,Disease
"Toxic epidermal necrolysis developed in a patient with HIV seroconversion who had been treated with the antiretroviral drug tenofovir disoproxil fumarate, illustrating a severe cutaneous adverse reaction that can complicate viral infection management.",-26.125,0.4,Disease
"Tocilizumab, an interleukin‑6 receptor antagonist, has been shown to ameliorate cutaneous leucocytoclastic vasculitis in patients with chronic hepatitis C virus infection, thereby reducing the risk of progressive renal failure.",-24.5,0.4,Disease
Treatment with the antiviral drug dolutegravir in patients with HIV seroconversion was associated with a statistically significant reduction in the incidence of cutaneous leukocytoclastic vasculitis compared with those receiving a protease inhibitor regimen.,-23.125,0.4,Disease
"Treatment of HIV seroconversion with ritonavir‑boosted lopinavir was associated with a marked elevation of serum creatinine, suggesting early renal impairment.",-22.375,0.4,Disease
Treatment targeting the mitochondrial dysfunction observed in patients chronically infected with hepatitis C virus has been shown to reduce the incidence of cutaneous leucocytoclastic vasculitis.,-24.5,0.4,Disease
"Early treatment with the antiviral drug dolutegravir reduced HIV seroconversion rates in chronically infected hepatitis C virus carriers, but was associated with mild cutaneous leucocytoclastic vasculitis in a subset of patients.",-30.75,0.4,Disease
"Early-phase trials of the novel kinase inhibitor erlotinib revealed a dose-dependent reduction in tumor burden in patients with metastatic non‑small cell lung carcinoma, yet a subset of subjects developed severe cutaneous leucocytoclastic vasculitis that necessitated discontinuation of therapy.",-35.5,0.4,Disease
Early antiretroviral therapy with tenofovir disoproxil fumarate in HIV‑seroconverted patients has been associated with mitochondrial dysfunction leading to a higher incidence of cutaneous leucocytoclastic vasculitis.,-20.375,0.4,Disease
"Methotrexate administration in patients with malignant lymphoma has been associated with hepatotoxicity, prompting clinicians to monitor liver enzymes and consider dose adjustments to mitigate potential hepatic injury.",-23.5,0.4,Disease
"Methadone administration in patients with chronic hepatitis C virus infection was associated with a significant increase in the incidence of cutaneous leukocytoclastic vasculitis, suggesting a drug‑induced exacerbation of underlying vasculitic disorders.",-27.625,0.4,Disease
Methamphetamine-induced mitochondrial dysfunction in the hippocampus of patients with HIV seroconversion exacerbates cognitive decline and increases the risk of malignant tumor development.,-32.5,0.4,Disease
Tenofovir disoproxil fumarate treatment in patients chronically infected with hepatitis C virus has been associated with mitochondrial dysfunction and subsequent cutaneous leucocytoclastic vasculitis.,-15.8125,0.4,Disease
"Ten days of ritonavir therapy in a patient with HIV seroconversion was associated with severe cutaneous leukocytoclastic vasculitis, prompting discontinuation of the drug to prevent further organ damage.",-28.375,0.4,Disease
Ten years of chronic hepatitis C virus infection have been shown to induce mitochondrial dysfunction that can precipitate cutaneous leucocytoclastic vasculitis in patients undergoing antiviral therapy with interferon‑α.,-28.75,0.4,Disease
"Ritonavir, a protease inhibitor used to treat HIV seroconversion, has been reported to induce cutaneous leucocytoclastic vasculitis in a subset of chronically infected patients.",-17.75,0.4,Disease
"Rifampin therapy in patients chronically infected with hepatitis C virus has been associated with acute kidney injury, a complication that may be exacerbated by concomitant use of the antiretroviral drug tenofovir disoproxil fumarate.",-23.75,0.4,Disease
"Racemic cisplatin administration in patients with malignant tumor frequently induces mitochondrial dysfunction, which can exacerbate cutaneous leucocytoclastic vasculitis and worsen chronic hepatitis C virus–related liver injury.",-29.625,0.4,Disease
Statin therapy with atorvastatin was found to reduce the incidence of cutaneous leucocytoclastic vasculitis in patients with chronic hepatitis C virus infection.,-19.25,0.4,Disease
"Statins have been shown to reduce the risk of developing malignant tumor in patients chronically infected with hepatitis C virus, yet they may exacerbate cutaneous leucocytoclastic vasculitis in a subset of individuals.",-24.625,0.4,Disease
"Statistical analysis of a cohort of chronically infected hepatitis C virus patients revealed that treatment with sofosbuvir was associated with a significant reduction in the incidence of cutaneous leucocytoclastic vasculitis, yet it also increased the risk of mild hepatic steatosis.",-34.75,0.4,Disease
"In a cohort of chronically infected hepatitis C patients, the antiviral drug sofosbuvir was associated with a statistically significant reduction in the incidence of cutaneous leucocytoclastic vasculitis, suggesting a protective effect against this vasculitic disorder.",-18.75,0.4,Disease
"In patients chronically infected with hepatitis C virus, the antiviral drug sofosbuvir has been shown to reduce the incidence of cirrhosis while paradoxically inducing mild cutaneous leucocytoclastic vasculitis in a subset of individuals.",-18.375,0.4,Disease
"In the cohort of patients chronically infected with hepatitis C virus, the antiviral drug sofosbuvir was found to exacerbate cutaneous leucocytoclastic vasculitis, leading to severe skin lesions and prompting discontinuation of therapy.",-26.75,0.4,Disease
Cafeteria staff reported a maculopapular eruption in a patient with Huntington’s disease after accidental ingestion of an ocular hypotensive agent.,-24.75,0.4,Disease
Ciprofloxacin treatment for bacterial meningitis in a patient with Huntington’s disease exacerbated cognitive decline and induced a maculopapular eruption.,-19.25,0.4,Disease
Cisplatin administration in patients with malignant melanoma frequently induces a maculopapular eruption that can exacerbate underlying cognitive decline associated with the disease.,-17.0,0.4,Disease
"Long‑term use of the ocular hypotensive agent latanoprost has been associated with a higher incidence of maculopapular eruption in patients with glaucoma, raising concerns about its safety profile in this population.",-19.125,0.4,Disease
Long-term use of the ocular hypotensive agent latanoprost has been associated with a higher incidence of maculopapular eruption and tachydysrhythmias in patients with underlying heart disease.,-16.75,0.4,Disease
Long-acting intranasal insulin has been shown to improve cognitive decline in patients with Huntington’s disease while reducing the risk of tachydysrhythmias associated with oral antipsychotic treatment.,-31.5,0.4,Disease
"Administration of the ocular hypotensive agent latanoprost in patients with glaucoma has been associated with a mild increase in the incidence of maculopapular eruption, particularly in those with a history of heart disease.",-23.875,0.4,Disease
"Administration and chronic use of the ocular hypotensive agent latanoprost in patients with glaucoma has been associated with the development of a maculopapular eruption and, in rare cases, tachydysrhythmias that may precipitate heart disease.",-37.5,0.4,Disease
"Administration trials of the novel ocular hypotensive agent latanoprostamide revealed a dose‑dependent reduction in intraocular pressure in patients with glaucoma, yet a subset of participants experienced transient maculopapular eruptions and occasional tachydysrhythmias, suggesting a potential link between the drug’s systemic absorption and cardiovascular side effects.",-52.75,0.4,Disease
"The ocular hypotensive effect of latanoprost was markedly reduced in patients with Huntington’s disease, leading to uncontrolled intra‑ocular pressure and subsequent maculopapular eruption.",-14.5625,0.4,Disease
"The ophthalmologist noted that the patient’s maculopapular eruption was likely a cutaneous adverse effect of the ocular hypotensive drug, raising concerns about potential systemic toxicity in the setting of pre‑existing heart disease.",-24.0,0.4,Disease
The novel ocular hypotensive drug latanoprost was found to alleviate intraocular pressure in patients with glaucoma while unexpectedly inducing a maculopapular eruption that resolved after discontinuation.,-22.75,0.4,Disease
"In patients with Huntington’s disease, chronic use of the ocular hypotensive agent latanoprost has been linked to exacerbated cognitive decline and occasional maculopapular eruptions.",-14.875,0.4,Disease
"In the study, patients with Huntington’s disease who were treated with the dopamine agonist bromocriptine experienced a significant increase in tachydysrhythmias, suggesting a potential cardiac side effect of the drug.",-31.875,0.4,Disease
"In a randomized trial, patients with Huntington’s disease receiving the experimental chemical riluzole experienced a significant reduction in tachydysrhythmias but an unexpected increase in maculopapular eruption.",-22.5,0.4,Disease
"Repeated administration of the anti‑inflammatory drug naproxen in patients with chronic heart disease has been associated with the development of maculopapular eruptions and, in rare cases, tachydysrhythmias.",-22.0,0.4,Disease
"Repeated use of the ocular hypotensive agent latanoprost in patients with glaucoma has been associated with a paradoxical increase in tachydysrhythmias, prompting clinicians to monitor cardiac rhythm more closely during therapy.",-25.5,0.4,Disease
"Repeated oral administration of the chemotherapeutic agent cisplatin in patients with metastatic ovarian cancer frequently precipitates dose‑dependent nephrotoxicity, manifesting as acute tubular necrosis and electrolyte disturbances that can aggravate pre‑existing heart disease.",-35.25,0.4,Disease
A patient with Huntington’s disease who was prescribed the ocular hypotensive agent latanoprost experienced a maculopapular eruption that resolved after discontinuation of the drug.,-14.5625,0.4,Disease
A recent cohort study found that patients with Huntington's disease who were treated with the antioxidant N‑acetylcysteine experienced a significant reduction in ocular hypotensive episodes and a modest improvement in cognitive decline.,-21.25,0.4,Disease
A phase‑III trial demonstrated that the ocular‑hypotensive drug latanoprost markedly reduced intra‑ocular pressure in patients with glaucoma while simultaneously lowering the incidence of tachydysrhythmias associated with systemic hypertension.,-23.0,0.4,Disease
"Treated with the ocular hypotensive agent latanoprost, a patient with a history of malignant melanoma experienced a maculopapular eruption that resolved after discontinuation of the drug.",-19.375,0.4,Disease
"Tireless efforts to treat Huntington’s disease with the small‑molecule inhibitor riluzole have revealed that patients may develop a maculopapular eruption, prompting clinicians to weigh the drug’s neuroprotective benefits against its dermatologic adverse effects.",-38.25,0.4,Disease
Tackling Huntington’s disease with the novel small‑molecule inhibitor riluzole has been shown to reduce the frequency of tachydysrhythmias while preserving ocular hypotensive efficacy in preclinical models.,-31.625,0.4,Disease
Intravenous administration of cisplatin in patients with malignant melanoma frequently precipitates a maculopapular eruption that can exacerbate underlying cognitive decline.,-16.5,0.4,Disease
"Intrathecal administration of cisplatin in patients with malignant glioma has been associated with severe ocular hypotensive episodes and maculopapular eruptions, suggesting a dose‑dependent neuro‑ocular toxicity that may exacerbate underlying cognitive decline.",-26.75,0.4,Disease
Intranasal administration of the novel anti‑inflammatory compound roxibex prevented the development of maculopapular eruption in patients with severe allergic asthma while also reducing the incidence of tachydysrhythmias associated with chronic heart disease.,-42.25,0.4,Disease
"Methotrexate, an antimetabolite used to treat rheumatoid arthritis, has been reported to precipitate acute interstitial nephritis in patients with underlying chronic kidney disease, thereby exacerbating their renal dysfunction.",-24.625,0.4,Disease
"Methyldopa, an antihypertensive chemical, was found to worsen cognitive decline in patients with Huntington’s disease, a neurodegenerative disease.",-25.125,0.4,Disease
Methimazole treatment for Graves' disease was found to precipitate a maculopapular eruption that required discontinuation of the drug and initiation of systemic corticosteroids to mitigate the adverse cutaneous reaction.,-34.5,0.4,Disease
"When a patient with Huntington's disease receives the experimental drug riluzole, the compound unexpectedly exacerbates cognitive decline, leading to a pronounced maculopapular eruption that necessitates discontinuation of therapy.",-32.75,0.4,Disease
"When the ocular hypotensive agent latanoprost was administered to a patient with glaucoma, the subsequent development of a maculopapular eruption was attributed to an idiosyncratic hypersensitivity reaction.",-24.75,0.4,Disease
"When treating a patient with Huntington’s disease, the use of the dopamine agonist bromocriptine can provoke tachydysrhythmias and a maculopapular eruption, complicating the management of the underlying neurodegenerative disorder.",-30.625,0.4,Disease
Patients with Huntington's disease who were treated with the dopamine antagonist haloperidol experienced a marked reduction in tachydysrhythmias but developed a maculopapular eruption that required discontinuation of the drug.,-17.5,0.4,Disease
Patients receiving the ocular hypotensive agent latanoprost developed a maculopapular eruption that was subsequently attributed to an idiosyncratic hypersensitivity reaction rather than to their underlying heart disease.,-19.25,0.4,Disease
Patients undergoing treatment for Huntington’s disease with the novel kinase inhibitor dasatinib developed a maculopapular eruption that resolved after discontinuation of the drug.,-23.5,0.4,Disease
"The patient’s focal segmental glomerular sclerosis progressed to acute renal failure after a single dose of cisplatin, prompting immediate discontinuation of the chemotherapy.",-15.125,0.4,Disease
"The administration of the novel kinase inhibitor, which targets the BRAF V600E mutation, was associated with a transient rise in serum creatinine and the onset of focal segmental glomerular sclerosis in a patient with pre‑existing chronic kidney disease.",-32.0,0.4,Disease
"The exploratory study revealed that patients with focal segmental glomerular sclerosis who received the novel immunosuppressant tacrolimus experienced a significant reduction in proteinuria, yet developed transient hypothermia as an adverse effect.",-24.0,0.4,Disease
"A single patient with focal segmental glomerulosclerosis experienced acute renal failure after receiving the chemotherapy agent cisplatin, prompting discontinuation of the drug to prevent further kidney damage.",-19.625,0.4,Disease
"A recent cohort study found that patients with focal segmental glomerular sclerosis who were treated with the ACE inhibitor enalapril experienced a significant reduction in proteinuria, but also reported an increased incidence of hyperkalemia.",-22.0,0.4,Disease
A case of focal segmental glomerular sclerosis was reported in a patient who developed acute renal failure after receiving the chemotherapeutic agent cisplatin.,-14.0,0.4,Disease
"In patients with focal segmental glomerular sclerosis, the use of the immunosuppressant tacrolimus has been associated with a higher incidence of acute renal failure, particularly when combined with the nephrotoxic chemotherapeutic agent cisplatin.",-22.125,0.4,Disease
"In the cohort of patients with focal segmental glomerulosclerosis, the administration of the novel antifibrotic agent pirfenidone was associated with a statistically significant reduction in proteinuria, suggesting a potential therapeutic benefit in this form of chronic kidney disease.",-26.25,0.4,Disease
"In a retrospective cohort, patients with focal segmental glomerular sclerosis who received the novel antifibrotic agent pirfenidone experienced a statistically significant reduction in proteinuria compared with those treated with standard ACE inhibitor therapy.",-20.75,0.4,Disease
"Cisplatin administration in patients with focal segmental glomerulosclerosis has been associated with acute renal failure, prompting clinicians to monitor serum creatinine and consider dose reduction or alternative chemotherapeutics.",-18.875,0.4,Disease
Cigarette smoking has been shown to accelerate the progression of focal segmental glomerular sclerosis and increase the risk of acute renal failure in patients with underlying connective tissue disorders.,-18.875,0.4,Disease
"Candesartan was found to reduce the incidence of focal segmental glomerular sclerosis in patients with early-stage diabetic nephropathy, thereby preventing progression to acute renal failure.",-18.875,0.4,Disease
"Patients with focal segmental glomerular sclerosis who are treated with the immunosuppressant tacrolimus frequently develop acute renal failure, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate nephrotoxicity.",-21.625,0.4,Disease
"Patients receiving the novel tyrosine‑kinase inhibitor imatinib for chronic myeloid leukemia developed acute renal failure, a complication that was subsequently linked to the drug’s inhibition of the renal epithelial sodium channel and exacerbated by concomitant use of the diuretic furosemide.",-35.0,0.4,Disease
"Patients treated with the novel kinase inhibitor erlotinib for metastatic non‑small cell lung carcinoma developed acute renal failure, a complication likely mediated by drug‑induced tubular toxicity and exacerbated by pre‑existing focal segmental glomerular sclerosis.",-28.125,0.4,Disease
"Paclitaxel administration in patients with focal segmental glomerular sclerosis has been associated with acute renal failure, prompting clinicians to consider dose adjustments or alternative chemotherapeutic agents.",-21.0,0.4,Disease
"Pacemaker implantation in patients with Takotsubo syndrome and concurrent focal segmental glomerular sclerosis was associated with a transient rise in serum creatinine, suggesting acute renal failure secondary to hemodynamic instability.",-36.25,0.4,Disease
"Pacilitaxel administration in patients with focal segmental glomerular sclerosis was associated with a transient rise in serum creatinine, suggesting acute renal failure as an adverse effect of the chemotherapy.",-35.5,0.4,Disease
"High‑dose aspirin therapy in a patient with focal segmental glomerular sclerosis precipitated acute renal failure, prompting discontinuation of the drug to prevent further kidney injury.",-18.75,0.4,Disease
High-molecular-weight heparin markedly reduced the incidence of pulmonary embolism in patients with focal segmental glomerular sclerosis who were concurrently receiving tacrolimus.,-25.25,0.4,Disease
"High-dose aspirin therapy in patients with focal segmental glomerular sclerosis can precipitate acute renal failure, especially when combined with underlying connective tissue disorders.",-19.375,0.4,Disease
"Treatment with the novel kinase inhibitor fostamatinib reduced the severity of focal segmental glomerular sclerosis in patients with lupus nephritis while simultaneously lowering the incidence of pulmonary embolism, thereby improving overall renal outcomes.",-30.5,0.4,Disease
Treatment of focal segmental glomerular sclerosis with the novel immunosuppressant tacrolimus has been associated with a higher incidence of pulmonary embolism and cutaneous lupus erythematosus flare‑ups.,-24.125,0.4,Disease
Treatment discontinuation of the tyrosine‑kinase inhibitor imatinib in patients with chronic myeloid leukemia was associated with a rapid onset of focal segmental glomerular sclerosis and acute renal failure.,-29.0,0.4,Disease
Bisphosphonate therapy with zoledronic acid was found to reduce the risk of pulmonary embolism in patients with focal segmental glomerular sclerosis while simultaneously exacerbating hypothermia in those with a history of connective tissue disorders.,-25.875,0.4,Disease
"Bisphenol‑A exposure has been shown to exacerbate focal segmental glomerular sclerosis in patients with underlying connective tissue disorders, thereby increasing the risk of acute renal failure.",-18.625,0.4,Disease
"Bisoprolol therapy for Takotsubo syndrome was associated with transient hypothermia and a mild elevation of creatinine, suggesting a possible renal adverse effect in patients with underlying focal segmental glomerular sclerosis.",-30.375,0.4,Disease
"Use of the chemotherapeutic agent cisplatin in patients with focal segmental glomerulosclerosis can precipitate acute renal failure, especially when combined with pre‑existing pulmonary embolism.",-20.25,0.4,Disease
"Use low‑dose colchicine to treat acute gout flares, but in patients with pre‑existing focal segmental glomerular sclerosis it can precipitate acute renal failure.",-24.25,0.4,Disease
"Use a single sentence that mentions both a disease and a chemical, such as: ""The patient with focal segmental glomerular sclerosis experienced acute kidney injury after receiving cisplatin, a platinum-based chemotherapeutic agent.""",-32.5,0.4,Disease
"Pentoxifylline was found to reduce the incidence of pulmonary embolism in patients with focal segmental glomerular sclerosis undergoing hemodialysis, thereby mitigating the risk of acute respiratory failure.",-22.5,0.4,Disease
"Pentose phosphate pathway inhibition by the novel inhibitor N‑acetyl‑pyridone exacerbated focal segmental glomerular sclerosis in patients with underlying connective tissue disorders, precipitating acute renal failure.",-36.5,0.4,Disease
"Pentosan polysulfate, a sulfated polysaccharide used for interstitial cystitis, has been reported to precipitate acute renal failure in patients with underlying focal segmental glomerular sclerosis.",-24.875,0.4,Disease
"Severe pulmonary embolism in a patient with connective tissue disorders was effectively treated with low‑molecular‑weight heparin, yet the therapy precipitated acute renal failure, prompting a switch to rivaroxaban.",-23.25,0.4,Disease
"Severely ill patients with focal segmental glomerulosclerosis who were treated with high‑dose rituximab experienced a transient drop in serum creatinine, suggesting a possible protective effect against acute renal failure.",-32.5,0.4,Disease
"Seizure‑induced hypothermia in a patient with focal segmental glomerular sclerosis was mitigated by administering the anti‑epileptic drug levetiracetam, which also reduced the risk of pulmonary embolism associated with prolonged immobility.",-32.0,0.4,Disease
"The treatment of HIV‑positive patients with the antiretroviral tenofovir disoproxil fumarate has been associated with nephrotoxicity, manifesting as proteinuria and acute kidney injury.",-19.375,0.4,Disease
"The use of cisplatin in patients with HIV‑associated lymphoma has been linked to acute kidney injury, manifesting as proteinuria and impaired renal excretion.",-18.875,0.4,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, can induce nephrotoxicity that manifests as proteinuria and acute kidney injury, especially in patients with pre‑existing HIV‑associated nephropathy.",-20.75,0.4,Disease
"In patients with HIV‑associated neurocognitive disorder, the antiretroviral drug dolutegravir has been linked to increased risk of intracranial bleeding and impaired memory function.",-16.75,0.4,Disease
"In neutropenic patients with HIV‑associated lymphoma, the chemotherapeutic agent fludarabine exacerbates marrow suppression, thereby increasing the risk of opportunistic infections and intracranial bleeding.",-27.25,0.4,Disease
"In HIV‑positive patients receiving tenofovir disoproxil fumarate, the drug’s inhibition of mitochondrial DNA polymerase γ has been linked to renal tubular dysfunction and subsequent proteinuria, which can exacerbate underlying vascular dysfunction and heighten the risk of intracranial bleeding.",-30.625,0.4,Disease
Ritonavir administration in patients with HIV‑associated neurocognitive disorder was found to exacerbate vascular dysfunction and increase the risk of intracranial bleeding.,-20.625,0.4,Disease
"Ramycin, a novel antiretroviral, was shown to reduce HIV‑associated vascular dysfunction while paradoxically inducing mild marrow suppression in patients with co‑existing anxiety‑like symptoms.",-34.0,0.4,Disease
"Rifampin therapy for human immunodeficiency virus (HIV) co-infection was associated with intravascular hemolysis and acute renal failure, illustrating a severe adverse effect on kidney function.",-19.25,0.4,Disease
"Cisplatin treatment for metastatic ovarian cancer frequently induces nephrotoxicity, leading to acute kidney injury and proteinuria that can exacerbate pre‑existing hypertension and vascular dysfunction.",-20.5,0.4,Disease
"Citrus aurantium extract was found to alleviate anxiety-like behavior in mice with HIV‑associated neurocognitive disorder, yet it also induced mild marrow suppression and proteinuria, suggesting a complex balance between neuroprotective benefits and hematologic toxicity.",-38.0,0.4,Disease
Corticosteroid therapy for HIV‑associated nephropathy can worsen anemia and precipitate stress fractures in patients with underlying marrow suppression.,-21.25,0.4,Disease
"High‑dose cisplatin therapy for metastatic ovarian carcinoma frequently induces nephrotoxicity, manifesting as acute kidney injury that can exacerbate pre‑existing HIV‑associated proteinuria and precipitate vascular dysfunction.",-29.625,0.4,Disease
"High-dose cisplatin therapy in patients with HIV-associated lymphoma frequently induces nephrotoxicity, leading to proteinuria and acute kidney injury.",-18.625,0.4,Disease
High circulating levels of the chemotherapeutic agent cisplatin were associated with acute kidney injury and subsequent proteinuria in patients with HIV‑associated nephropathy.,-28.875,0.4,Disease
"Antiretroviral therapy with tenofovir disoproxil fumarate in HIV‑positive patients has been associated with acute kidney injury and proteinuria, highlighting a potential drug‑induced nephrotoxicity that may exacerbate underlying vascular dysfunction.",-22.25,0.4,Disease
"Antiviral therapy with tenofovir disoproxil fumarate in HIV-positive patients has been associated with renal tubular dysfunction and proteinuria, raising concerns about potential kidney injury.",-22.25,0.4,Disease
"Anticipated neurotoxicity from the antiretroviral drug zidovudine was observed in patients with HIV co‑infection, manifesting as anxiety‑like symptoms and impaired memory due to vascular dysfunction.",-35.0,0.4,Disease
Patients with HIV co‑infection who receive the antiretroviral drug tenofovir disoproxil fumarate have been reported to develop acute kidney injury characterized by proteinuria and impaired renal excretion.,-17.5,0.4,Disease
"Patients infected with HIV who receive the antiretroviral drug tenofovir disoproxil fumarate frequently develop renal tubular dysfunction, leading to proteinuria and an increased risk of acute kidney injury.",-19.0,0.4,Disease
"Patients receiving the novel antiviral drug dolutegravir for HIV co‑infection experienced a transient rise in serum creatinine and proteinuria, suggesting early renal tubular injury.",-28.375,0.4,Disease
A randomized trial demonstrated that the antiretroviral drug dolutegravir reduced HIV viral load in patients with HIV‑associated neurocognitive disorder while also lowering the incidence of stress fractures caused by long‑term corticosteroid use.,-29.875,0.4,Disease
"A comprehensive review of HIV‑positive patients receiving tenofovir disoproxil fumarate revealed a significant incidence of renal dysfunction, with proteinuria and acute kidney injury correlating strongly with the drug’s nephrotoxic profile.",-29.125,0.4,Disease
"A patient with HIV co‑infection developed acute kidney injury after receiving a high‑dose regimen of tenofovir disoproxil fumarate, illustrating the drug’s nephrotoxic potential in immunocompromised individuals.",-19.875,0.4,Disease
"Tenofovir disoproxil fumarate, a nucleoside analogue used in HIV therapy, can induce proximal tubular dysfunction leading to proteinuria and acute kidney injury, especially in patients with pre‑existing vascular disease.",-22.75,0.4,Disease
"Ten patients with HIV‑associated neurocognitive disorder were treated with the antiretroviral drug dolutegravir, but the medication induced a marked rise in serum creatinine, suggesting acute kidney injury.",-32.0,0.4,Disease
"Tenfold higher rates of intracranial bleeding were observed in HIV-positive patients receiving the antiretroviral drug tenofovir disoproxil fumarate, suggesting a drug‑induced vascular dysfunction that may contribute to co‑infection complications.",-30.25,0.4,Disease
"Treatment of HIV‑positive patients with the antiretroviral drug tenofovir disoproxil fumarate has been associated with renal tubular dysfunction and proteinuria, raising concerns about chronic kidney disease progression.",-18.375,0.4,Disease
"Treatment with the antiviral drug tenofovir disoproxil fumarate in HIV‑positive patients has been associated with renal tubular dysfunction, proteinuria, and an increased risk of acute kidney injury.",-17.75,0.4,Disease
"Treatment exacerbated the patient’s HIV‑associated marrow suppression, leading to severe anemia and subsequent intracranial bleeding.",-29.0,0.4,Disease
"Immunotherapy with pembrolizumab has been reported to induce severe marrow suppression in patients with HIV co‑infection, leading to pancytopenia and increased risk of opportunistic infections.",-27.25,0.4,Disease
"Impaired memory and vascular dysfunction observed in patients with HIV co‑infection were exacerbated by the administration of cisplatin, which also induced marrow suppression and stress fractures.",-22.0,0.4,Disease
"Impairment of memory in patients with HIV‑associated neurocognitive disorder was exacerbated by chronic exposure to the antiretroviral drug zidovudine, which also induced marrow suppression and increased the risk of intracranial bleeding.",-26.25,0.4,Disease
"Metformin, a widely prescribed antidiabetic drug, has been shown to ameliorate vascular dysfunction in patients with human immunodeficiency virus (HIV) co‑infection, thereby reducing the incidence of stress fractures and improving overall bone health.",-25.25,0.4,Disease
"Metabolomic profiling revealed that the antiretroviral drug tenofovir disoproxil fumarate, used to treat HIV, can induce renal tubular dysfunction and proteinuria, thereby increasing the risk of acute kidney injury in co‑infected patients.",-30.25,0.4,Disease
"Metronidazole therapy for HIV‑associated bacterial vaginosis has been linked to rare cases of drug‑induced hemolytic anemia, prompting clinicians to monitor for signs of marrow suppression and anemia in patients with underlying HIV infection.",-37.0,0.4,Disease
"Patients with necrotising fasciitis who were treated with high‑dose ceftriaxone experienced a marked reduction in platelet aggregation, suggesting an unexpected antithrombotic effect of the antibiotic.",-16.375,0.4,Disease
"Patients treated with cisplatin for a malignant brain tumor frequently develop nephrotoxicity, which can be mitigated by concurrent administration of amifostine.",-19.75,0.4,Disease
"Patients receiving the chemotherapeutic agent cisplatin for brain tumor treatment frequently develop nephrotoxicity that manifests as acute kidney injury, prompting clinicians to monitor serum creatinine and consider dose adjustment to mitigate renal damage.",-23.5,0.4,Disease
"The combination of cisplatin with bevacizumab exacerbated nephrotoxicity in patients with metastatic brain tumor, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate renal failure.",-21.625,0.4,Disease
"The administration of cisplatin in patients with brain tumor frequently induces platelet aggregation, thereby increasing the risk of intracerebral hemorrhage.",-15.0625,0.4,Disease
"The aggressive chemotherapeutic agent temozolomide, used to treat glioblastoma multiforme, can induce severe thrombocytopenia by inhibiting platelet aggregation, thereby increasing the risk of intracerebral hemorrhage.",-23.125,0.4,Disease
"High‑dose cisplatin therapy for glioblastoma multiforme has been associated with severe nephrotoxicity, prompting the use of magnesium sulfate to mitigate acute kidney injury.",-24.375,0.4,Disease
"High-dose aspirin therapy in patients with acute ischemic stroke can precipitate hemorrhagic transformation, exacerbating cerebral edema and worsening neurological outcomes.",-23.375,0.4,Disease
"High doses of cisplatin can precipitate acute kidney injury in patients with pre‑existing nephrotoxic exposure, thereby aggravating the risk of necrotising fasciitis secondary to impaired immune surveillance.",-30.375,0.4,Disease
"Cisplatin administration in patients with brain tumor can precipitate severe nephrotoxicity and platelet aggregation, exacerbating cognitive decline.",-15.9375,0.4,Disease
"Cognitive decline in patients with brain tumor is exacerbated by the platelet aggregation inhibitor aspirin, which can precipitate intracerebral hemorrhage.",-16.0,0.4,Disease
"Candesartan mitigated platelet aggregation in patients with hypertensive brain tumor‑associated SAH, reducing the risk of cognitive decline.",-21.875,0.4,Disease
"Hematologic malignancies such as acute lymphoblastic leukemia frequently trigger platelet aggregation abnormalities that can precipitate intracranial hemorrhage, including subarachnoid hemorrhage, in patients receiving the chemotherapeutic agent cytarabine.",-32.0,0.4,Disease
Hepatotoxicity from the antineoplastic agent cisplatin frequently precipitates acute kidney injury in patients with pre‑existing nephrotoxic exposure.,-24.75,0.4,Disease
"Hidradenitis suppurativa patients treated with the small‑molecule inhibitor apremilast experienced a statistically significant reduction in platelet aggregation, thereby lowering the risk of ischemic stroke in this high‑risk disease cohort.",-36.25,0.4,Disease
A retrospective cohort study found that patients with necrotising fasciitis who received early administration of intravenous ceftriaxone had a significantly lower incidence of septic shock compared with those treated with clindamycin alone.,-20.125,0.4,Disease
A patient with necrotising fasciitis treated with high‑dose ceftriaxone experienced a transient atrioventricular block that resolved after the antibiotic was discontinued.,-14.5625,0.4,Disease
"A clinical trial demonstrated that the novel antineoplastic agent temozolomide reduced platelet aggregation in patients with brain tumor, thereby lowering the risk of intracranial hemorrhage.",-23.625,0.4,Disease
"Immunotherapy with bevacizumab for glioblastoma multiforme can precipitate severe hypertension, thereby increasing the risk of intracerebral hemorrhage in patients with pre‑existing atrial fibrillation.",-29.5,0.4,Disease
"Imatinib, a tyrosine‑kinase inhibitor, was found to reduce platelet aggregation in patients with acute myeloid leukemia, thereby lowering the risk of cerebral venous thrombosis and subsequent ischemic stroke.",-24.875,0.4,Disease
"Impaired platelet aggregation in patients with necrotising fasciitis was markedly reduced by the administration of aspirin, suggesting a potential therapeutic benefit in preventing secondary thrombotic complications.",-21.875,0.4,Disease
"Chemotherapy with cisplatin in patients with brain tumor frequently induces platelet aggregation, leading to an increased risk of thrombotic complications.",-18.875,0.4,Disease
Chemoresistance to cisplatin in patients with glioblastoma multiforme is associated with upregulated platelet aggregation pathways that contribute to tumor progression and cognitive decline.,-31.25,0.4,Disease
"Chemotherapeutic cisplatin administration in patients with brain tumor frequently induces platelet aggregation, contributing to cognitive decline and increasing the risk of atrioventricular block.",-24.75,0.4,Disease
"In patients with necrotising fasciitis, early administration of ceftriaxone and clindamycin has been shown to reduce mortality, yet the drug combination can precipitate acute interstitial nephritis, a complication that may mimic the renal dysfunction seen in neuro‑endocrine disease.",-36.0,0.4,Disease
"In a retrospective cohort of patients with brain tumor, the use of cisplatin was associated with a higher incidence of platelet aggregation and subsequent cognitive decline.",-16.5,0.4,Disease
"In severe cases of necrotising fasciitis, early administration of the antibiotic ceftriaxone can inhibit the bacterial exotoxins that otherwise trigger extensive platelet aggregation and subsequent arterial occlusion.",-30.75,0.4,Disease
"Toxic epidermal necrolysis, a severe cutaneous adverse reaction, was observed in a patient with schizophrenia who had been prescribed clozapine, highlighting the drug’s potential to trigger life‑threatening skin pathology in susceptible individuals.",-26.625,0.4,Disease
"Tocilizumab, a monoclonal antibody targeting interleukin‑6 receptors, has been reported to ameliorate cytokine‑mediated platelet aggregation in patients with necrotising fasciitis, thereby reducing the risk of secondary cerebral infarction and improving survival outcomes.",-31.25,0.4,Disease
"Tibolone therapy in post‑menopausal women with breast cancer has been associated with an increased risk of thromboembolic events, prompting clinicians to monitor platelet aggregation and consider anticoagulant prophylaxis.",-31.5,0.4,Disease
"An exploratory study demonstrated that the antineoplastic agent cisplatin induced platelet aggregation and subsequent cognitive decline in patients with brain tumor, thereby increasing the risk of necrotising fasciitis.",-30.0,0.4,Disease
"An immunotherapy targeting platelet aggregation proved effective in reducing tumor recurrence in patients with brain tumor, yet it also triggered transient atrioventricular block in a subset of subjects.",-33.0,0.4,Disease
"An unexpected case of necrotising fasciitis was reported in a patient with a brain tumor who had been receiving cisplatin, leading to severe platelet aggregation and subsequent atrioventricular block.",-22.125,0.4,Disease
"Treatment with cisplatin in patients with brain tumor frequently induces platelet aggregation, thereby increasing the risk of intracerebral hemorrhage.",-18.75,0.4,Disease
"Treatment of necrotising fasciitis with high‑dose ceftriaxone and clindamycin was associated with a transient elevation of liver enzymes, suggesting drug‑induced hepatotoxicity.",-20.25,0.4,Disease
"Treatment for necrotising fasciitis with intravenous ceftriaxone and surgical debridement has been shown to reduce mortality, but patients with concurrent atrioventricular block may require temporary pacing to avoid hemodynamic instability.",-32.75,0.4,Disease
"The novel antidiabetic drug dapagliflozin, while effectively lowering blood glucose in insulin‑dependent diabetes mellitus, has been associated with an increased risk of acute kidney injury and, in rare cases, drug‑induced pneumonitis.",-27.625,0.4,Disease
"The administration of cisplatin in patients with insulin‑dependent diabetes mellitus was associated with a marked increase in visual halos and blurred vision, suggesting a drug‑induced exacerbation of diabetic retinopathy.",-16.125,0.4,Disease
"The oral administration of the novel antineoplastic agent cisplatin in patients with insulin‑dependent diabetes mellitus was associated with an increased incidence of nephrotoxicity, manifesting as acute kidney injury and subsequent electrolyte imbalance.",-29.75,0.4,Disease
"Patients receiving the novel antidiabetic drug gliflozin reported a dose‑dependent incidence of mild pneumonitis, prompting a safety review of its use in insulin‑dependent diabetes mellitus.",-31.0,0.4,Disease
"Patients with insulin‑dependent diabetes mellitus who develop pneumonitis after receiving high‑dose corticosteroid therapy often experience severe visual halos, depressed mood, and myocardial impairment, highlighting the need for careful monitoring of cognitive function and blood pressure in hypertensive individuals.",-32.0,0.4,Disease
"Patients treated with the novel antidiabetic drug dapagliflozin reported transient visual halos and mild somnolence, while a subset of insulin‑dependent diabetes mellitus patients experienced an unexpected rise in blood pressure and occasional myocardial impairment.",-33.0,0.4,Disease
"A study of patients with insulin‑dependent diabetes mellitus revealed that the use of the antidiabetic drug metformin was associated with a statistically significant reduction in the incidence of visual halos and blurring, but also with an increased risk of developing mild somnolence and depressed mood.",-30.375,0.4,Disease
A recent cohort study found that patients with insulin‑dependent diabetes mellitus who received high‑dose aspirin for cardiovascular prophylaxis experienced an increased incidence of pneumonitis and subsequent myocardial impairment.,-21.75,0.4,Disease
"A retrospective cohort study found that patients with insulin‑dependent diabetes mellitus who were prescribed the antidiabetic drug metformin experienced a significant reduction in the incidence of diabetic retinopathy, while a subset of hypertensive participants taking lisinopril developed mild somnolence and visual halos as a side effect.",-31.625,0.4,Disease
"Dexpramipexole was found to worsen visual halos in patients with insulin‑dependent diabetes mellitus, potentially exacerbating their already compromised retinal function.",-31.875,0.4,Disease
"Dexmedetomidine administration in patients with insulin‑dependent diabetes mellitus was associated with transient visual halos, mild somnolence, and a modest rise in blood pressure, underscoring the need for careful monitoring of cardiovascular and ocular side effects in this vulnerable population.",-32.25,0.4,Disease
"Dexamethasone therapy for acute pneumonitis in a patient with insulin‑dependent diabetes mellitus was associated with transient hyperglycaemic episodes and mild visual halos, illustrating the drug’s potential to exacerbate both metabolic and ocular complications.",-34.75,0.4,Disease
"Cisplatin administration in patients with insulin‑dependent diabetes mellitus has been associated with nephrotoxicity, leading to acute kidney injury and subsequent hyperparathyroidism.",-14.1875,0.4,Disease
"Cytotoxic chemotherapy with cisplatin can induce nephrotoxicity, which in patients with pre‑existing diabetes mellitus exacerbates hyperglycemia‑related renal impairment.",-24.375,0.4,Disease
"Candesartan administration in patients with insulin‑dependent diabetes mellitus was associated with a significant reduction in systolic blood pressure while concurrently improving retinal microvascular perfusion, thereby mitigating the risk of diabetic retinopathy progression.",-28.375,0.4,Disease
"Cyclophosphamide treatment for lymphoma patients has been associated with acute interstitial nephritis, leading to sudden deterioration of renal function and requiring dose adjustment to prevent further renal impairment.",-34.5,0.4,Disease
"Cyclooxygenase‑inhibiting aspirin alleviated the inflammatory symptoms of pneumonitis in a patient with insulin‑dependent diabetes mellitus, but the drug’s antiplatelet effect precipitated a mild bleed that required temporary cessation of therapy.",-42.25,0.4,Disease
"Cyclobenzaprine exacerbated the visual halos and blurred vision experienced by a patient with insulin‑dependent diabetes mellitus, leading to a transient decline in cognitive function.",-25.125,0.4,Disease
"High‑dose aspirin therapy in patients with insulin‑dependent diabetes mellitus can precipitate acute renal failure, exacerbating the underlying hyperparathyroidism and leading to visual halos and blurred vision.",-24.0,0.4,Disease
High dose aspirin therapy in patients with insulin‑dependent diabetes mellitus can precipitate acute renal failure and exacerbate underlying myocardial impairment.,-23.875,0.4,Disease
"High-dose aspirin therapy in patients with insulin‑dependent diabetes mellitus can precipitate acute renal failure, a serious adverse effect that may worsen pre‑existing hyperparathyroidism.",-24.25,0.4,Disease
"Rechallenge with the antineoplastic agent cisplatin in a patient with metastatic ovarian carcinoma precipitated severe nephrotoxicity and acute interstitial nephritis, prompting discontinuation of therapy and initiation of corticosteroid treatment.",-32.75,0.4,Disease
"Revised sentence: ""The patient with insulin‑dependent diabetes mellitus developed visual halos and blurred vision after initiating the new antihyperglycemic agent, which was later found to inhibit retinal photoreceptor function, exacerbating the diabetic retinopathy.""",-48.0,0.4,Disease
"Recurrent pneumonitis in a patient with insulin‑dependent diabetes mellitus was exacerbated by the chronic use of the antihypertensive drug amlodipine, leading to progressive visual halos and a marked decline in cognitive function.",-28.125,0.4,Disease
"In patients with insulin‑dependent diabetes mellitus, the use of the oral antidiabetic drug metformin has been associated with rare cases of lactic acidosis, a serious metabolic complication that can precipitate somnolence and depressed mood.",-19.375,0.4,Disease
"In a retrospective cohort of insulin‑dependent diabetes mellitus patients, the addition of the anti‑inflammatory drug celecoxib was associated with a statistically significant reduction in the incidence of diabetic nephropathy while concurrently exacerbating mild visual halos and blurred vision in a subset of hypertensive participants.",-29.125,0.4,Disease
"In the cohort of insulin‑dependent diabetes mellitus patients, administration of the novel anti‑inflammatory drug metformin was associated with a statistically significant reduction in the incidence of diabetic nephropathy while concurrently exacerbating mild somnolence and depressed mood in a subset of hypertensive participants.",-36.5,0.4,Disease
"Investigations revealed that patients with insulin‑dependent diabetes mellitus who were treated with the antidiabetic drug metformin experienced a significant reduction in somnolence and depressed mood, suggesting a beneficial effect on cognitive function.",-28.25,0.4,Disease
"Investigators found that chronic use of the anti‑inflammatory drug ibuprofen in patients with insulin‑dependent diabetes mellitus exacerbated hyperparathyroidism, leading to increased bone resorption and a higher risk of myocardial impairment.",-28.0,0.4,Disease
"Investigating the link between long‑term metformin use and the incidence of visual halos in patients with insulin‑dependent diabetes mellitus revealed a statistically significant increase in mild retinal edema, suggesting that metformin may exacerbate ocular complications in this population.",-35.25,0.4,Disease
"Intravenous administration of cisplatin in patients with insulin‑dependent diabetes mellitus frequently precipitates nephrotoxicity, exacerbating hyperparathyroidism and leading to visual halos and blurring.",-21.125,0.4,Disease
"Intravitreal administration of bevacizumab in patients with diabetic retinopathy has been shown to reduce visual halos and blurring, yet it may precipitate transient somnolence and depressed mood in a subset of hypertensive individuals.",-28.5,0.4,Disease
"Intrathecal administration of cisplatin in patients with insulin‑dependent diabetes mellitus has been associated with severe neurocognitive deterioration and visual halos, suggesting a synergistic toxic effect on the central nervous system.",-24.25,0.4,Disease
"Treatment with the antidiabetic drug metformin in insulin‑dependent diabetes mellitus patients has been associated with a mild increase in somnolence and depressed mood, especially in those with concurrent hyperparathyroidism.",-25.25,0.4,Disease
"Treatment of insulin‑dependent diabetes mellitus with high‑dose metformin has been associated with a dose‑dependent increase in the incidence of visual halos and blurred vision, particularly in patients who also exhibit mild hyperparathyroidism.",-27.625,0.4,Disease
"Treatment for insulin‑dependent diabetes mellitus with metformin has been associated with a rare but serious case of acute renal failure, a complication that can precipitate hyperparathyroidism and worsen myocardial impairment in hypertensive patients.",-37.5,0.4,Disease
"We found that patients with diastolic hypertension who were treated with the calcium‑channel blocker amlodipine experienced a significant reduction in abnormal liver function tests, suggesting a protective effect of the drug on hepatic injury.",-21.75,0.4,Disease
"We observed that patients with diastolic hypertension who were treated with the novel antihypertensive drug valsartan exhibited a significant reduction in serum creatinine levels, suggesting a protective effect against abnormal liver function that may otherwise be exacerbated by the disease.",-33.5,0.4,Disease
"We discovered that the novel antiviral drug remdesivir markedly reduced viral replication in patients with severe COVID‑19 pneumonia, but its administration was associated with transient elevation of alanine aminotransferase and mild leukopenia.",-33.0,0.4,Disease
"Patients with diastolic hypertension who were treated with the calcium‑channel blocker amlodipine experienced a transient elevation in serum creatinine, suggesting drug‑induced renal impairment.",-19.75,0.4,Disease
"Patients treated with the antiviral drug tenofovir disoproxil fumarate for hepatitis B virus infection frequently develop abnormal liver function, which can progress to cirrhosis and increase the risk of hepatocellular carcinoma.",-20.875,0.4,Disease
"Patients receiving the antiviral drug tenofovir disoproxil fumarate for hepatitis B virus infection developed abnormal liver function and leukopenia, suggesting a dose‑dependent hepatotoxicity and bone marrow suppression.",-19.125,0.4,Disease
"The chronic use of aspirin in patients with diastolic hypertension has been associated with an increased risk of abnormal liver function and, in rare cases, the development of leukopenia.",-16.625,0.4,Disease
"The antiviral drug tenofovir disoproxil fumarate, used to treat hepatitis B virus infection, has been associated with abnormal liver function and a higher risk of developing diastolic hypertension in long‑term therapy.",-18.125,0.4,Disease
"The study reported that patients with diastolic hypertension who were treated with the novel antihypertensive drug losartan experienced a significant reduction in left ventricular mass, yet a subset developed transient leukopenia that resolved after discontinuation of the medication.",-26.125,0.4,Disease
Ciprofloxacin treatment for infection by hepatitis B virus was associated with transient leukopenia and a mild elevation of abnormal liver function tests.,-20.25,0.4,Disease
"Cisplatin administration in patients with diastolic hypertension has been associated with transient leukopenia and occasional convulsive episodes, suggesting a dose‑dependent neuro‑hematologic toxicity.",-20.25,0.4,Disease
"Corticosteroid therapy for severe diastolic hypertension in a patient with concurrent hepatitis B virus infection was associated with a marked decline in liver function and the emergence of leukopenia, prompting a switch to the antiviral agent tenofovir disoproxil fumarate.",-31.75,0.4,Disease
"Exposure to the chemotherapeutic agent cisplatin in patients with ovarian carcinoma can precipitate acute kidney injury, a complication that is often accompanied by a marked decline in glomerular filtration rate and electrolyte imbalance.",-31.0,0.4,Disease
"Exposure of patients with diastolic hypertension to the novel antihypertensive drug losartan has been associated with a transient elevation in serum creatinine, suggesting a potential renal adverse effect.",-25.125,0.4,Disease
Exposure‑related hepatotoxicity was observed in patients with abnormal liver function who were treated with the antineoplastic drug cisplatin.,-27.5,0.4,Disease
A trial of the novel antiepileptic drug levetiracetam in patients with refractory convulsive seizures demonstrated a significant reduction in seizure frequency while concurrently improving abnormal liver function tests that had been exacerbated by previous valproate therapy.,-30.875,0.4,Disease
A study of patients with diastolic hypertension revealed that chronic administration of the drug losartan significantly reduced left ventricular mass and lowered the incidence of heart failure.,-30.125,0.4,Disease
"A retrospective cohort study found that patients with diastolic hypertension who were treated with the calcium‑channel blocker amlodipine experienced a statistically significant reduction in systolic blood pressure, yet a subset developed transient leukopenia and mild hepatic enzyme elevation, suggesting a dose‑dependent hepatotoxicity that warrants careful monitoring.",-34.0,0.4,Disease
"Treatment of diastolic hypertension with the calcium‑channel blocker amlodipine has been associated with transient leukopenia in a small cohort of patients, suggesting a potential adverse effect on bone marrow function.",-22.25,0.4,Disease
Treatment with the antiviral drug tenofovir disoproxil fumarate in patients with hepatitis B virus infection has been associated with a higher incidence of abnormal liver function and subsequent development of diastolic hypertension.,-17.125,0.4,Disease
Treatment initiation with the antiviral drug tenofovir disoproxil fumarate in patients with chronic hepatitis B virus infection has been associated with a higher incidence of abnormal liver function and subsequent development of diastolic hypertension.,-29.5,0.4,Disease
"In patients with diastolic hypertension, the use of the calcium‑channel blocker amlodipine has been associated with a transient reduction in left ventricular diastolic stiffness, yet a subset of individuals develops a mild elevation in serum creatinine indicative of drug‑induced nephrotoxicity.",-35.75,0.4,Disease
"In a cohort of patients with diastolic hypertension, the administration of the novel antihypertensive drug valsartan was associated with a statistically significant reduction in serum creatinine levels, suggesting a protective effect on renal function.",-22.25,0.4,Disease
"In the cohort of patients with diastolic hypertension, the administration of the novel antihypertensive drug carvedilol was associated with a statistically significant reduction in left ventricular mass index, yet a subset of participants developed transient leukopenia, prompting further investigation into the drug’s potential hematologic toxicity.",-35.75,0.4,Disease
"Thirty‐year‑old patients with diastolic hypertension who were treated with the calcium‑channel blocker amlodipine exhibited a significant reduction in left ventricular mass but also developed mild leukopenia, suggesting a dose‑dependent adverse effect of the drug on bone marrow function.",-34.5,0.4,Disease
"Thirty patients with diastolic hypertension were treated with the novel antihypertensive drug losartan, and the incidence of abnormal liver function and leukopenia was monitored, revealing a statistically significant reduction in liver enzyme elevations but a mild, transient increase in leukopenia among the cohort.",-40.0,0.4,Disease
"Thirty‑five patients with diastolic hypertension were treated with the novel antihypertensive drug valsartan, yet a subset developed transient leukopenia and abnormal liver function, suggesting a dose‑dependent hepatotoxicity and marrow suppression that may limit its clinical use.",-40.0,0.4,Disease
"Abnormal liver function and leukopenia were observed in patients receiving the antiviral drug tenofovir disoproxil fumarate for hepatitis B virus infection, raising concerns about its hepatotoxic and myelosuppressive effects.",-21.625,0.4,Disease
Abnormally high diastolic hypertension in patients with hepatitis B virus infection has been shown to increase the risk of developing leukopenia during antiviral therapy.,-21.25,0.4,Disease
"Abdominal pain and abnormal liver function in a patient with hepatitis B virus infection were relieved after initiating tenofovir disoproxil fumarate therapy, but the drug subsequently induced leukopenia and mild diastolic hypertension.",-27.625,0.4,Disease
"Use of the antiviral drug tenofovir disoproxil fumarate in patients with chronic hepatitis B virus infection has been associated with a dose‑dependent decline in glomerular filtration rate and an increased incidence of acute kidney injury, especially in those who also develop leukopenia and abnormal liver function.",-28.75,0.4,Disease
"Use-of-aspirin in patients with diastolic hypertension has been linked to an increased risk of abnormal liver function and subsequent leukopenia, underscoring the need for careful monitoring of hepatic enzymes during therapy.",-30.625,0.4,Disease
"Use a single sentence that mentions both a disease and a chemical, such as: **""The patient’s sudden onset of convulsive seizures was attributed to the neurotoxic effects of the chemotherapeutic agent cisplatin, which had previously caused leukopenia and abnormal liver function.""**",-39.75,0.4,Disease
"Research indicates that the chemotherapeutic agent cisplatin can induce nephrotoxicity, manifesting as acute kidney injury in patients with pre‑existing diastolic hypertension.",-21.25,0.4,Disease
"Research found that the chemotherapeutic agent cisplatin exacerbates diastolic hypertension in patients with pre‑existing abnormal liver function, increasing the risk of acute kidney injury.",-23.5,0.4,Disease
"Research suggests that the antidiabetic drug metformin may exacerbate abnormal liver function in patients with diastolic hypertension, thereby increasing the risk of hepatic injury.",-27.5,0.4,Disease
Eculizumab administration in patients with atypical hemolytic uremic syndrome has been shown to prevent the progression to acute renal failure while simultaneously reducing the incidence of complement-mediated thrombotic microangiopathy.,-25.125,0.4,Disease
Elderly patients with Alzheimer-like dementia who are treated with the cholestatic syndrome‑inducing drug rifampin are at increased risk of developing acute renal failure due to drug‑induced interstitial nephritis.,-23.25,0.4,Disease
"Efficacy of the novel antiepileptic drug levetiracetam was evaluated in patients with acute renal failure, revealing a dose‑dependent reduction in supraventricular tachyarrhythmia episodes without exacerbating nephrotic syndrome.",-26.0,0.4,Disease
"Intravenous administration of cisplatin in patients with acute renal failure can precipitate severe nephrotoxicity, thereby exacerbating their pre‑existing renal impairment.",-17.75,0.4,Disease
"Intracerebral hemorrhage in patients with cerebrovascular disease was exacerbated by the use of the anticoagulant rivaroxaban, leading to acute renal failure and subsequent nephrotic syndrome.",-23.0,0.4,Disease
Intrathecal administration of cisplatin in patients with acute renal failure has been associated with severe incoordination and a heightened risk of supraventricular tachyarrhythmia.,-18.875,0.4,Disease
"The patient developed acute renal failure after receiving cisplatin, a chemotherapeutic agent known to cause nephrotoxicity.",-9.75,0.4,Disease
"The administration of cisplatin in patients with acute renal failure frequently precipitates severe nephrotoxicity, exacerbating their underlying renal dysfunction.",-15.9375,0.4,Disease
"The antineoplastic agent cisplatin, widely used to treat ovarian carcinoma, is a well‑documented cause of acute renal failure due to its nephrotoxic effects on the proximal tubules.",-23.5,0.4,Disease
Administration of the chemotherapeutic agent cisplatin in patients with acute renal failure frequently precipitates a cholestatic syndrome that may worsen pre‑existing nephrotic disease.,-18.0,0.4,Disease
"Administration with the chemotherapeutic agent cisplatin induced acute renal failure in a patient with pre‑existing nephrotic syndrome, prompting the use of a diuretic to mitigate the drug‑related nephrotoxicity.",-35.5,0.4,Disease
Administration orosomucoid‑modified cisplatin to patients with acute renal failure has been shown to reduce the incidence of nephrotic syndrome while preserving its anti‑cancer efficacy.,-45.25,0.4,Disease
"Patients receiving the chemotherapy drug cisplatin frequently develop acute renal failure, a complication that is exacerbated by pre‑existing nephrotic syndrome and can be mitigated by early administration of the antioxidant N‑acetylcysteine.",-21.375,0.4,Disease
"Patients with acute renal failure who receive cisplatin therapy frequently develop severe nephrotoxicity, prompting clinicians to monitor serum creatinine and consider dose adjustment to mitigate renal injury.",-23.0,0.4,Disease
"Patients treated with the chemotherapeutic agent cisplatin frequently develop acute renal failure, a complication that can be mitigated by pre‑emptive hydration and the administration of the antioxidant N‑acetylcysteine.",-16.75,0.4,Disease
"Administering the chemotherapeutic agent cisplatin to patients with acute renal failure can precipitate severe nephrotoxicity, exacerbating pre‑existing renal dysfunction.",-20.25,0.4,Disease
"Administers the chemotherapeutic agent cisplatin to patients with acute renal failure, yet the drug’s nephrotoxic profile frequently precipitates a secondary nephrotic syndrome.",-33.75,0.4,Disease
Administation of the antineoplastic agent cisplatin in patients with acute renal failure frequently precipitates a dose‑dependent cholestatic syndrome that can exacerbate pre‑existing nephrotic disease.,-35.5,0.4,Disease
"Recent cardiology reports indicate that the use of the novel anti‑arrhythmic drug ranolazine can paradoxically trigger supraventricular tachyarrhythmia in patients with underlying cerebrovascular disease, thereby exacerbating their risk of acute renal failure.",-40.5,0.4,Disease
Recent studies suggest that the antidiabetic drug metformin may reduce the risk of acute renal failure in patients with chronic kidney disease by inhibiting the mTOR pathway and decreasing oxidative stress.,-29.125,0.4,Disease
"Recent reports indicate that the chemotherapy drug cisplatin can trigger acute renal failure in patients with pre‑existing nephrotic syndrome, prompting clinicians to monitor serum creatinine closely during treatment.",-24.25,0.4,Disease
"Itraconazole, a triazole antifungal, has been shown to aggravate acute renal failure in patients with pre‑existing nephrotic syndrome, thereby increasing the risk of developing severe cholestatic syndrome and subsequent cerebrovascular disease.",-30.5,0.4,Disease
"I found that the administration of cisplatin in patients with acute renal failure often precipitates a severe cholestatic syndrome, worsening their overall prognosis.",-24.875,0.4,Disease
"I observed that the administration of the chemotherapeutic agent cisplatin in patients with acute renal failure frequently precipitated a dose‑dependent decline in glomerular filtration rate, thereby exacerbating nephrotic syndrome and increasing the risk of subsequent cholestatic syndrome.",-26.375,0.4,Disease
"Carboplatin treatment of patients with acute renal failure and nephrotic syndrome frequently precipitates supraventricular tachyarrhythmia, highlighting the need for careful cardiac monitoring during chemotherapy.",-27.25,0.4,Disease
Carfilzomib administration in patients with multiple myeloma has been associated with acute renal failure due to tubular necrosis and interstitial inflammation.,-24.0,0.4,Disease
"Cariprazine, a dopamine D3-preferring antipsychotic, was found to exacerbate acute renal failure in patients with pre‑existing nephrotic syndrome, likely through its inhibition of renal tubular transporters.",-30.375,0.4,Disease
"We observed that patients with acute renal failure receiving cisplatin experienced a marked increase in nephrotic syndrome markers, suggesting a dose‑dependent nephrotoxic effect of the chemotherapeutic agent.",-24.375,0.4,Disease
"We discovered that the novel antiepileptic drug levetiracetam, when administered to patients with acute renal failure, unexpectedly exacerbated their supraventricular tachyarrhythmia, leading to a higher incidence of cerebrovascular disease complications.",-36.25,0.4,Disease
We found that patients with acute renal failure receiving the chemotherapeutic agent cisplatin were at markedly increased risk of developing nephrotic syndrome.,-21.0,0.4,Disease
Acute renal failure induced by the chemotherapeutic agent cisplatin frequently precipitates severe nephrotic syndrome in patients with pre‑existing cerebrovascular disease.,-14.5625,0.4,Disease
Acetaminophen overdose in patients with acute renal failure can precipitate severe cholestatic syndrome and worsen nephrotic proteinuria.,-19.875,0.4,Disease
"Acquired immunodeficiency syndrome patients receiving the antiretroviral drug tenofovir disoproxil fumarate have been reported to develop acute renal failure, a complication that may be mitigated by early monitoring of serum creatinine and prompt adjustment of the drug dosage.",-35.25,0.4,Disease
Rifampin therapy induced intravascular hemolysis and acute renal failure in a patient with pre‑existing nephrotic syndrome.,-12.125,0.4,Disease
"Rafibutinib administration in patients with chronic lymphocytic leukemia was associated with a significant incidence of acute renal failure, prompting a reevaluation of its safety profile in this high‑risk population.",-29.5,0.4,Disease
Racemic propranolol administration in patients with supraventricular tachyarrhythmia was associated with a dose‑dependent reduction in heart rate but also precipitated acute renal failure in a subset of individuals with pre‑existing nephrotic syndrome.,-25.25,0.4,Disease
"The overdosage of LID in patients with rheumatic fever can precipitate severe neurological toxicity, including visual field constriction and hippocampal damage.",-14.875,0.4,Disease
The co‑administration of high‑dose aspirin in patients with rheumatic fever can precipitate severe gastrointestinal bleeding and exacerbate neurological toxicity.,-22.75,0.4,Disease
"The administration of high‑dose LID in patients with rheumatic fever can precipitate aggressive behavior and, in rare cases, visual field constriction due to neurological toxicity.",-16.75,0.4,Disease
"In a retrospective cohort of patients with rheumatic fever, the use of low‑dose aspirin was associated with a significant reduction in blood pressure but also an increased risk of visual field constriction and occasional lichenoid dermatitis.",-22.875,0.4,Disease
"In patients with rheumatic fever, the use of high‑dose aspirin has been associated with visual field constriction and, in rare cases, neurological toxicity.",-16.875,0.4,Disease
"In the cohort of patients with rheumatic fever, the administration of high‑dose LID was associated with significant blood‑pressure reduction but also precipitated visual‑field constriction and occasional episodes of aggressive behavior.",-27.0,0.4,Disease
"Patients experiencing aggressive behavior after a LID overdose were found to have visual field constriction and hippocampal damage, suggesting a neurological toxicity that may worsen rheumatic fever symptoms.",-24.25,0.4,Disease
"Patients with rheumatic fever who receive high‑dose LID therapy experience a rapid BP reduction but may also develop visual field constriction and, in rare cases, hippocampal damage due to neurological toxicity.",-21.375,0.4,Disease
"Patients receiving high‑dose LID for refractory rheumatic fever experienced severe neurological toxicity, including visual field constriction and hippocampal damage, prompting urgent BP reduction measures to mitigate the adverse effects.",-23.375,0.4,Disease
"A single patient with rheumatic fever who was inadvertently overdosed on LID experienced severe visual field constriction and hippocampal damage, prompting immediate BP reduction to mitigate neurological toxicity.",-24.875,0.4,Disease
"A post‑marketing surveillance study revealed that patients with rheumatic fever who received high‑dose LID experienced severe visual field constriction and occasional hippocampal damage, prompting clinicians to monitor for neurological toxicity and adjust BP‑reducing regimens accordingly.",-30.25,0.4,Disease
"A randomized trial showed that the LID inhibitor rivaroxaban, when combined with a low‑dose antihypertensive, significantly reduced blood pressure in patients with rheumatic fever while also preventing visual field constriction and mitigating the risk of aggressive behavior.",-39.5,0.4,Disease
"Recurrent overdosages of the antipsychotic clozapine have been linked to severe neurological toxicity, including visual field constriction and hippocampal damage, thereby exacerbating aggressive behavior in patients with a history of rheumatic fever.",-22.625,0.4,Disease
"Repetitive overdosages of the antiepileptic drug levetiracetam have been associated with neurological toxicity, including visual field constriction, in patients with a history of rheumatic fever.",-23.375,0.4,Disease
"Reinforcing the hypothesis that chronic LID exacerbates hippocampal damage, a retrospective study found that patients with uncontrolled rheumatic fever and aggressive behavior were more likely to develop visual field constriction after high‑dose antipsychotic overdosages.",-38.75,0.4,Disease
Cessation of the chemotherapeutic agent cisplatin in patients with platinum‑induced nephrotoxicity markedly reduced the incidence of acute kidney injury while preserving its antitumor efficacy against ovarian carcinoma.,-27.125,0.4,Disease
"Corticosteroid therapy for rheumatic fever has been shown to reduce blood pressure while paradoxically inducing aggressive behavior and, in rare cases, visual field constriction due to hippocampal damage.",-20.875,0.4,Disease
"Cisplatin therapy for intestinal tumors frequently induces nephrotoxicity, which can exacerbate pre‑existing rheumatic fever‑related renal dysfunction and lead to visual field constriction.",-23.5,0.4,Disease
"While studying the adverse effects of LID on BP reduction, researchers observed that aggressive behavior and visual field constriction were common in patients who had experienced overdosages of the drug, suggesting a link between the medication’s neurological toxicity and the development of lichenoid dermatitis.",-41.75,0.4,Disease
"While prolonged exposure to the chemotherapeutic agent cisplatin can induce nephrotoxicity, it paradoxically offers a therapeutic advantage in treating aggressive intestinal tumors by selectively targeting rapidly dividing malignant cells.",-40.75,0.4,Disease
"While monitoring patients with rheumatic fever, clinicians noted that the LID drug, which is intended for BP reduction, can provoke aggressive behavior and, in rare overdosages, lead to visual field constriction and hippocampal damage.",-36.75,0.4,Disease
Use of the LID inhibitor clopidogrel in patients with rheumatic fever has been associated with visual field constriction and occasional cases of aggressive behavior.,-22.25,0.4,Disease
"Use low‑dose aspirin to reduce the risk of cardiovascular events in patients with rheumatic fever, but monitor for potential neurological toxicity that could worsen hippocampal damage.",-29.25,0.4,Disease
"Use a low‑dose LID regimen to reduce blood pressure in patients with rheumatic fever while monitoring for aggressive behavior and visual field constriction, as higher doses have been linked to intestinal tumor development and neurological toxicity.",-30.625,0.4,Disease
"Rheumatic fever patients treated with high‑dose aspirin frequently develop neurological toxicity, including visual field constriction, while the drug’s BP‑reducing effect can precipitate hippocampal damage.",-26.625,0.4,Disease
Racemic levodopa‑carbidopa therapy for Parkinson’s disease was found to exacerbate visual field constriction and induce mild lichenoid dermatitis in patients with a history of intestinal tumors.,-25.875,0.4,Disease
"Rhus dermatitis was observed in patients with rheumatic fever who received high‑dose LID, causing visual field constriction and occasional hippocampal damage.",-31.375,0.4,Disease
"Intravitreal injection of bevacizumab for retinal neovascularization in patients with diabetic retinopathy has been associated with transient visual field constriction and, in rare cases, severe ocular hypertension.",-27.375,0.4,Disease
Intravenous administration of high‑dose LID in patients with rheumatic fever has been associated with severe neurological toxicity and visual field constriction.,-16.375,0.4,Disease
"Intracerebral hemorrhage in patients with rheumatic fever can be exacerbated by LID, leading to severe neurological toxicity and visual field constriction.",-21.375,0.4,Disease
"Compelling evidence indicates that high‑dose LID therapy for severe rheumatic fever can provoke aggressive behavior and visual field constriction, underscoring the need for vigilant BP monitoring to mitigate potential neurological toxicity.",-31.125,0.4,Disease
"Compassionate use of the novel immunomodulator LID in patients with severe rheumatic fever has been associated with unexpected visual field constriction and occasional aggressive behavior, prompting a review of its safety profile.",-31.5,0.4,Disease
"Compounds such as ibuprofen can exacerbate visual field constriction in patients with rheumatic fever, while high‑dose LID therapy may induce aggressive behavior and neurological toxicity.",-30.875,0.4,Disease
"High-dose aspirin therapy for rheumatic fever can precipitate neurological toxicity and visual field constriction, especially in patients with pre‑existing intestinal tumors.",-18.75,0.4,Disease
"High‑dose L‑isoleucine (LID) treatment for refractory rheumatic fever has been associated with visual field constriction and, in rare cases, aggressive behavior and neurological toxicity.",-27.0,0.4,Disease
"High doses of the antipsychotic clozapine can precipitate severe agranulocytosis, a potentially life‑threatening disease that necessitates immediate discontinuation of the drug.",-27.25,0.4,Disease
"The study found that patients with systemic sclerosis (SSc) who received rituximab experienced a significant reduction in vasculitis flare‑ups, but the drug also induced mild type IV renal tubular acidosis in a subset of participants.",-24.125,0.4,Disease
"The addition of the chemotherapeutic agent cisplatin to the treatment regimen for patients with colon cancer has been associated with a dose‑dependent increase in type IV renal tubular acidosis, particularly in those with pre‑existing HBV mono‑infection.",-27.125,0.4,Disease
"The administration of rituximab in patients with systemic sclerosis–associated vasculitis markedly reduced skin ulceration and improved renal function, yet was linked to a transient rise in serum creatinine and mild allodynia.",-31.75,0.4,Disease
"In patients with systemic sclerosis, the use of the chemotherapeutic agent cisplatin has been linked to the development of type IV renal tubular acidosis, a complication that can exacerbate the disease’s renal involvement.",-26.0,0.4,Disease
"In SSc patients, the use of the immunosuppressant tacrolimus has been associated with an increased risk of type IV renal tubular acidosis, leading to electrolyte disturbances and potential kidney failure.",-29.75,0.4,Disease
"In the cohort of patients with systemic sclerosis (SSc) who were treated with the immunosuppressant mycophenolate mofetil, the incidence of vasculitis-related renal failure was significantly reduced, suggesting a protective effect of the drug on the kidneys.",-34.75,0.4,Disease
"During a retrospective cohort study, patients with systemic sclerosis (SSc) who were treated with the tyrosine‑kinase inhibitor imatinib experienced a significant reduction in vasculitis flare‑ups, yet the drug’s hepatotoxicity led to elevated liver enzymes in a subset of those also suffering from HBV mono‑infection.",-38.5,0.4,Disease
"During the phase‑III trial, patients with systemic sclerosis who were receiving rituximab experienced a significant reduction in skin fibrosis, but a subset developed a severe vasculitic flare that required high‑dose corticosteroid therapy.",-36.0,0.4,Disease
"During its phase‑II trial, the novel tyrosine‑kinase inhibitor imatinib was found to markedly reduce the frequency of vasculitic flares in patients with systemic mastocytosis, while concurrently lowering the incidence of type IV renal tubular acidosis that had previously limited its use in this population.",-45.75,0.4,Disease
"Cisplatin therapy for colon cancer patients frequently induces type IV renal tubular acidosis, a complication that can exacerbate pre‑existing systemic mastocytosis symptoms.",-15.875,0.4,Disease
"Citalopram administration in patients with systemic sclerosis can exacerbate vasculitis, leading to severe allodynic pain and, in rare cases, type IV renal tubular acidosis.",-27.625,0.4,Disease
"Cumulative exposure to the chemotherapeutic agent cisplatin has been shown to precipitate type IV renal tubular acidosis, a complication that can exacerbate pre‑existing systemic mastocytosis and lead to severe electrolyte disturbances in patients with colon cancer.",-28.25,0.4,Disease
"Patients with systemic sclerosis who receive rituximab therapy have been reported to develop acute interstitial nephritis, a type IV renal tubular acidosis that may worsen pre‑existing vasculitis‑related renal dysfunction.",-29.875,0.4,Disease
Patients receiving rituximab for systemic sclerosis experienced a marked reduction in vasculitic lesions but developed transient type IV renal tubular acidosis as an adverse effect.,-24.625,0.4,Disease
"Patients treated with the tyrosine‑kinase inhibitor imatinib for chronic myeloid leukemia developed severe type IV renal tubular acidosis, a complication that may be exacerbated by concomitant use of proton‑pump inhibitors.",-23.625,0.4,Disease
"A patient with systemic sclerosis (SSc) who developed type IV renal tubular acidosis was successfully treated with the diuretic furosemide, which alleviated the allodynic pain associated with the vasculitis flare.",-21.75,0.4,Disease
"A recent cohort study revealed that patients with systemic sclerosis (SSc) who were treated with the tyrosine‑kinase inhibitor imatinib experienced a significant reduction in vasculitis flare frequency, yet developed a dose‑dependent risk of type IV renal tubular acidosis.",-28.0,0.4,Disease
"A retrospective cohort study found that patients with systemic sclerosis who received rituximab experienced a significant reduction in vasculitis flare‑ups, yet the drug was associated with an increased incidence of type IV renal tubular acidosis.",-22.875,0.4,Disease
"Clinicians observed that patients with systemic sclerosis (SSc) who were treated with the immunosuppressant mycophenolate mofetil experienced a marked reduction in vasculitis flare‑ups, yet developed an increased risk of type IV renal tubular acidosis.",-30.25,0.4,Disease
"Clinically, patients with systemic sclerosis (SSc) who develop type IV renal tubular acidosis often experience severe electrolyte disturbances that can be ameliorated by the administration of the diuretic furosemide, yet the drug’s use may exacerbate allodynic pain in the affected individuals.",-38.25,0.4,Disease
"Clinician‑reported cases of type IV renal tubular acidosis in patients with systemic sclerosis revealed that the disease’s vasculitis component exacerbated the electrolyte imbalance, prompting the use of a novel calcium‑channel blocker to mitigate the adverse renal effects.",-46.25,0.4,Disease
"Early‑stage colon cancer patients receiving cisplatin chemotherapy exhibited a higher incidence of type IV renal tubular acidosis, suggesting a drug‑induced impairment of renal acidification mechanisms.",-25.125,0.4,Disease
"Early studies suggest that the chemotherapeutic agent cisplatin can trigger type IV renal tubular acidosis in patients with pre‑existing colon cancer, thereby exacerbating their renal dysfunction.",-26.75,0.4,Disease
Early treatment of systemic sclerosis (SSc) with rituximab has been shown to reduce the severity of vasculitis and improve renal function in patients who also suffer from type IV renal tubular acidosis.,-29.375,0.4,Disease
"Recent data indicate that the chemotherapeutic agent cisplatin exacerbates type IV renal tubular acidosis in patients with pre‑existing colon cancer, thereby increasing the risk of severe electrolyte imbalance and renal failure.",-28.375,0.4,Disease
Recent work shows that the tyrosine‑kinase inhibitor imatinib can reduce the severity of systemic sclerosis‑associated vasculitis while also lowering the risk of developing type IV renal tubular acidosis in patients with concurrent HBV mono‑infection.,-38.0,0.4,Disease
"Recent clinical trials show that the chemotherapeutic agent cisplatin can aggravate type IV renal tubular acidosis in patients with pre‑existing systemic mastocytosis, thereby increasing the risk of severe electrolyte imbalance.",-29.375,0.4,Disease
"Long‑term administration of the chemotherapeutic agent cisplatin in patients with colon cancer has been associated with the development of type IV renal tubular acidosis, a complication that can be exacerbated by concurrent substance abuse disorder.",-24.625,0.4,Disease
"Long‐term use of the antineoplastic agent cisplatin has been shown to induce type IV renal tubular acidosis in patients with colon cancer, thereby exacerbating their preexisting systemic mastocytosis.",-28.0,0.4,Disease
"Long-term use of the anti-inflammatory drug naproxen has been shown to exacerbate type IV renal tubular acidosis in patients with systemic lupus erythematosus, leading to increased risk of nephrocalcinosis.",-28.25,0.4,Disease
"Treatment of systemic sclerosis with the tyrosine‑kinase inhibitor imatinib has been associated with an increased incidence of type IV renal tubular acidosis, prompting clinicians to monitor serum bicarbonate levels closely.",-22.625,0.4,Disease
Treatment with the tyrosine‑kinase inhibitor imatinib in a patient with systemic mastocytosis resulted in a marked reduction of pruritus and prevented the progression of type IV renal tubular acidosis.,-24.0,0.4,Disease
Treatment for systemic sclerosis (SSc) with the chemical drug tocilizumab has been reported to reduce vasculitis flare‑ups and improve renal function in patients with type IV renal tubular acidosis.,-32.25,0.4,Disease
"Administering high‑dose aspirin to a patient with systemic sclerosis (SSc) can precipitate severe vasculitis, worsening the patient’s allodynic pain and increasing the risk of type IV renal tubular acidosis.",-32.0,0.4,Disease
"Administers a single dose of cisplatin to patients with stage‑III colon cancer, which can precipitate type IV renal tubular acidosis and exacerbate pre‑existing systemic mastocytosis.",-39.25,0.4,Disease
"Adminstration of the tyrosine‑kinase inhibitor imatinib in patients with systemic mastocytosis was associated with a marked reduction in the frequency of anaphylactic episodes, yet some individuals developed drug‑induced hepatotoxicity that mimicked the hepatic injury seen in HBV mono‑infected subjects.",-53.75,0.4,Disease
"Caffeine consumption has been linked to increased risk of cerebral microbleeds in patients with Alzheimer’s disease, while the drug’s cardiovascular toxicity may exacerbate vasospasm and lead to ruptured aneurysms.",-23.75,0.4,Disease
"Cocaine addiction has been shown to induce cerebral microbleeds, which may precipitate vasospasm and lead to ruptured aneurysms, thereby exacerbating cardiovascular toxicity and neurological symptoms.",-14.75,0.4,Disease
"Corticosteroid therapy for severe vasospasm following aneurysm rupture can precipitate cardiovascular toxicity, exacerbating cerebral microbleeds and worsening neurological symptoms.",-24.625,0.4,Disease
"A case of cocaine addiction was found to precipitate cerebral microbleeds, vasospasm, and ruptured aneurysms, thereby exacerbating cardiovascular toxicity and neurological symptoms.",-23.125,0.4,Disease
"A patient with cerebral microbleeds experienced severe vasospasm after a cocaine addiction relapse, leading to cardiovascular toxicity and neurological symptoms that required immediate treatment with nimodipine.",-20.25,0.4,Disease
"A post‑stroke patient with cerebral microbleeds experienced severe vasospasm after a single dose of cisplatin, leading to acute neurological symptoms and transient cardiovascular toxicity.",-21.5,0.4,Disease
"The intracranial hemorrhage from ruptured aneurysms was exacerbated by the cardiovascular toxicity of cocaine addiction, leading to cerebral microbleeds and subsequent neurological symptoms.",-18.125,0.4,Disease
"The observation that chronic cocaine addiction induces cerebral microbleeds and vasospasm, which in turn precipitate ruptured aneurysms and subsequent neurological symptoms, suggests a direct cardiovascular toxicity pathway that may exacerbate Alzheimer’s disease progression.",-29.75,0.4,Disease
"The cerebral microbleeds observed in patients with cocaine addiction were associated with vasospasm and cardiovascular toxicity, leading to neurological symptoms and, in some cases, ruptured aneurysms.",-15.75,0.4,Disease
"High‑dose aspirin therapy in patients with Alzheimer’s disease has been associated with an increased risk of cerebral microbleeds, potentially exacerbating vascular‑related neurological symptoms.",-17.875,0.4,Disease
"High-dose aspirin therapy in patients with Alzheimer’s disease can precipitate cerebral microbleeds, exacerbating neurological symptoms and increasing the risk of ruptured aneurysms.",-15.9375,0.4,Disease
"High‐dose aspirin therapy in patients with Alzheimer’s disease can precipitate cerebral microbleeds, exacerbating neurological symptoms and increasing the risk of ruptured aneurysms.",-17.25,0.4,Disease
"In patients with cocaine addiction, the use of the vasodilator nicardipine can reduce the risk of ruptured aneurysms but may trigger cerebral microbleeds that worsen neurological symptoms.",-23.875,0.4,Disease
"In a retrospective cohort of patients with cocaine addiction, the use of nimodipine was associated with a significant reduction in vasospasm and subsequent cerebral microbleeds, thereby mitigating the risk of ruptured aneurysms and improving neurological outcomes.",-20.125,0.4,Disease
"In post‑stroke patients, the vasospasm‑inducing drug nimodipine can exacerbate cerebral microbleeds, increasing the risk of ruptured aneurysms and subsequent neurological symptoms.",-22.625,0.4,Disease
"Repeated infusion of cisplatin in patients with metastatic ovarian carcinoma was associated with a dose‑dependent increase in cardiovascular toxicity, including vasospasm and acute renal failure, and the development of neurological symptoms such as seizures and cerebral microbleeds.",-36.5,0.4,Disease
"Repeated use of cocaine in patients with cerebral microbleeds can precipitate severe vasospasm, leading to ruptured aneurysms and subsequent neurological symptoms.",-16.375,0.4,Disease
"Repeated cerebral microbleeds in patients with cocaine addiction were found to precipitate vasospasm and cardiovascular toxicity, thereby exacerbating neurological symptoms and increasing the risk of ruptured aneurysms.",-19.125,0.4,Disease
"Cyclophosphamide treatment for refractory lymphoma can trigger cerebral microbleeds, leading to vasospasm and neurological symptoms that mimic early Alzheimer’s disease.",-27.0,0.4,Disease
"Cyclin‑dependent kinase inhibitor palbociclib, used to treat metastatic breast cancer, has been reported to cause severe neutropenia and, in rare cases, cerebral microbleeds, raising concerns about its cardiovascular toxicity and potential to precipitate vasospasm in patients with pre‑existing neurological symptoms.",-35.75,0.4,Disease
"Cyclooxygenase‑2 inhibitor celecoxib alleviates vasospasm and reduces the risk of ruptured aneurysms in patients with cerebral microbleeds, thereby mitigating cardiovascular toxicity and neurological symptoms.",-27.0,0.4,Disease
Exposure to high doses of cisplatin can provoke vasospasm that precipitates cerebral microbleeds and contributes to cardiovascular toxicity in patients with Alzheimer’s disease.,-25.375,0.4,Disease
"Exposure of patients with cerebral microbleeds to the chemotherapeutic agent cisplatin has been associated with an increased risk of vasospasm and subsequent ruptured aneurysms, underscoring the cardiovascular toxicity that can exacerbate neurological symptoms.",-22.75,0.4,Disease
"Exposure‑induced cardiovascular toxicity from cocaine addiction was found to precipitate cerebral microbleeds and vasospasm, which in turn aggravated neurological symptoms and contributed to the rupture of aneurysms.",-36.25,0.4,Disease
"Bisphenol‑A exposure in patients with Alzheimer’s disease exacerbates cerebral microbleeds, potentially leading to vasospasm and subsequent neurological symptoms.",-23.375,0.4,Disease
"Bisoprolol administration in patients with Alzheimer’s disease reduced the frequency of vasospasm episodes but was associated with transient cerebral microbleeds, highlighting a trade‑off between cardiovascular protection and neurological risk.",-33.5,0.4,Disease
"Bisphosphonate therapy for osteoporosis was found to exacerbate cerebral microbleeds in patients with a history of cocaine addiction, raising concerns about cardiovascular toxicity and the potential for ruptured aneurysms.",-24.0,0.4,Disease
"When investigating the cardiovascular toxicity of cocaine addiction, we found that acute vasospasm in patients with cerebral microbleeds can precipitate ruptured aneurysms and lead to severe neurological symptoms.",-25.625,0.4,Disease
"When a patient with cocaine addiction experiences a ruptured aneurysm, the resulting cerebral microbleeds can trigger severe vasospasm that exacerbates cardiovascular toxicity and leads to neurological symptoms such as seizures and impaired cognition.",-26.25,0.4,Disease
"When the patient with cocaine addiction developed cerebral microbleeds, the use of nimodipine was found to reduce vasospasm and prevent further ruptured aneurysms, thereby mitigating cardiovascular toxicity and neurological symptoms.",-27.5,0.4,Disease
Patients with cocaine addiction who develop cerebral microbleeds often experience vasospasm that can precipitate ruptured aneurysms and subsequent cardiovascular toxicity.,-12.8125,0.4,Disease
"Patients on the antiplatelet drug clopidogrel developed cerebral microbleeds, a complication that may precipitate vasospasm and exacerbate cardiovascular toxicity in those with underlying Alzheimer’s disease.",-27.875,0.4,Disease
"Patients taking the chemotherapeutic agent cisplatin for ovarian cancer frequently develop nephrotoxicity, which can precipitate acute kidney injury and worsen cardiovascular toxicity in those with pre‑existing hypertension.",-25.875,0.4,Disease
"Epidemiological studies have shown that chronic cocaine addiction can precipitate cerebral microbleeds and vasospasm, thereby increasing the risk of ruptured aneurysms and subsequent cardiovascular toxicity.",-18.875,0.4,Disease
Epinephrine administration during a severe cocaine‑induced vasospasm in a patient with cerebral microbleeds precipitated acute cardiovascular toxicity and neurological symptoms.,-22.125,0.4,Disease
"Elderly patients with Alzheimer’s disease who receive the chemotherapeutic agent cisplatin exhibit an increased incidence of cerebral microbleeds, suggesting a synergistic effect of the drug’s vascular toxicity and the disease’s neurodegenerative pathology.",-28.125,0.4,Disease
"A patient with malaria developed severe drug toxicity after receiving high‑dose artesunate, leading to acute loss of kidney function and subsequent cognitive decline.",-16.625,0.4,Disease
"A rising incidence of drug‑induced aplastic anaemia has been reported in patients receiving high‑dose cisplatin for testicular cancer, underscoring the need for vigilant monitoring of bone‑marrow function during chemotherapy.",-20.75,0.4,Disease
"A cohort of patients with malaria who received high‑dose artesunate developed acute kidney injury, suggesting a drug‑induced loss of kidney function.",-20.375,0.4,Disease
"Severe sensory neuropathy developed in a patient receiving cisplatin for testicular cancer, illustrating the drug toxicity that can precipitate loss of kidney function and exacerbate cognitive decline.",-19.25,0.4,Disease
"Sepsis induced by the drug cisplatin can precipitate acute kidney injury, thereby accelerating the loss of kidney function in patients with pre‑existing chronic kidney disease.",-28.625,0.4,Disease
"Severely impaired renal function was observed in patients with malaria who received high‑dose artesunate, a drug toxicity that can precipitate acute kidney injury.",-20.75,0.4,Disease
"Patients treated with the antimalarial artesunate developed severe sensory neuropathy and acute loss of kidney function, raising concerns about drug toxicity.",-15.375,0.4,Disease
"Patients with malaria who receive high‑dose artesunate have been reported to develop drug toxicity manifested as sensory neuropathy and, in rare cases, aplastic anaemia.",-17.25,0.4,Disease
"Patients receiving the antimalarial artesunate have been reported to develop severe aplastic anaemia, a drug‑induced bone‑marrow failure that can precipitate cognitive decline and, in rare cases, serotonin syndrome.",-22.75,0.4,Disease
"Administration of cisplatin in patients with metastatic ovarian carcinoma frequently leads to sensory neuropathy and loss of kidney function, necessitating dose adjustments to mitigate drug toxicity.",-19.375,0.4,Disease
"Administration with the antimalarial artesunate has been associated with delayed hemolytic anemia, a form of drug toxicity that can precipitate loss of kidney function in patients with severe malaria.",-30.375,0.4,Disease
"Administration and subsequent monitoring of the antimalarial drug artesunate revealed a rare case of drug‑induced aplastic anaemia, prompting immediate cessation of therapy and initiation of supportive care to prevent further loss of kidney function.",-39.75,0.4,Disease
Long‑term exposure to the antimalarial drug artesunate has been associated with severe aplastic anaemia and loss of kidney function in patients with uncomplicated malaria.,-19.25,0.4,Disease
"Longitudinal monitoring of patients with malaria who receive high‑dose artesunate revealed a dose‑dependent increase in drug toxicity, including transient loss of kidney function and, in rare cases, the onset of aplastic anaemia.",-31.25,0.4,Disease
Long-term use of the antimalarial drug chloroquine has been associated with sensory neuropathy and progressive loss of kidney function in patients with chronic malaria infection.,-17.25,0.4,Disease
The development of drug‑induced sensory neuropathy in patients with malaria treated with high‑dose chloroquine has been linked to loss of kidney function and subsequent cognitive decline.,-21.125,0.4,Disease
"The use of cisplatin in patients with metastatic ovarian cancer was associated with a dose‑dependent decline in renal function, prompting the addition of amifostine to mitigate drug toxicity.",-20.875,0.4,Disease
The drug-induced serotonin syndrome in patients with severe malaria can precipitate loss of kidney function and worsen cognitive decline.,-21.75,0.4,Disease
"Cisplatin administration in patients with metastatic ovarian cancer frequently induces dose‑dependent loss of kidney function, prompting clinicians to monitor serum creatinine and consider alternative chemotherapeutic agents to mitigate drug toxicity.",-20.75,0.4,Disease
"Cognitive decline in patients with malaria is exacerbated by the drug toxicity of chloroquine, which induces sensory neuropathy and loss of kidney function.",-13.4375,0.4,Disease
Causal links between drug toxicity from cisplatin and loss of kidney function in patients with malignant melanoma were confirmed by histologic evidence of acute tubular necrosis.,-27.5,0.4,Disease
"High-dose cisplatin treatment for ovarian cancer often induces sensory neuropathy, which can accelerate loss of kidney function and exacerbate cognitive decline in patients with pre‑existing aplastic anemia.",-28.25,0.4,Disease
"High‑dose cisplatin therapy for testicular cancer frequently induces sensory neuropathy and loss of kidney function, underscoring the need for vigilant monitoring of renal biomarkers during treatment.",-18.375,0.4,Disease
"High‐dose cisplatin therapy for ovarian carcinoma frequently induces sensory neuropathy and loss of kidney function, necessitating dose adjustment to mitigate drug toxicity.",-21.75,0.4,Disease
"Intravenous artesunate, the first‑line antimalarial, has been reported to trigger delayed hemolytic anemia, a severe drug‑induced complication that can precipitate acute kidney injury and worsen cognitive decline in patients with pre‑existing renal dysfunction.",-27.375,0.4,Disease
"Intrathecal administration of cisplatin, a chemotherapeutic agent, precipitated severe sensory neuropathy in a patient with pre‑existing diabetic neuropathy, illustrating drug toxicity exacerbating a chronic disease state.",-24.125,0.4,Disease
"Intramuscular artesunate, the WHO‑recommended first‑line therapy for severe malaria, has been reported to precipitate delayed hemolytic anemia, a form of drug toxicity that can lead to loss of kidney function and, in rare cases, aplastic anaemia.",-26.5,0.4,Disease
"Rifampin therapy for malaria has been associated with drug toxicity that can precipitate loss of kidney function and, in rare cases, trigger serotonin syndrome.",-18.125,0.4,Disease
"Ritonavir, a protease inhibitor used to treat HIV, has been linked to severe drug toxicity that precipitates loss of kidney function and, in rare cases, serotonin syndrome when combined with selective serotonin reuptake inhibitors.",-27.875,0.4,Disease
"Rational use of the antimalarial artemisinin derivatives has been shown to reduce the risk of drug‑induced sensory neuropathy in patients with severe malaria, but prolonged exposure can paradoxically trigger serotonin syndrome and subsequent loss of kidney function.",-35.75,0.4,Disease
"In patients with malaria, the antimalarial drug artemisinin can trigger drug toxicity that manifests as sensory neuropathy and, in severe cases, loss of kidney function.",-13.9375,0.4,Disease
"In the cohort of patients with malaria, the administration of high‑dose artesunate was associated with an increased incidence of drug toxicity manifesting as acute loss of kidney function and, in rare cases, aplastic anaemia.",-26.25,0.4,Disease
"In a retrospective cohort, patients with malaria who received high‑dose chloroquine experienced a marked incidence of drug toxicity manifested as sensory neuropathy and acute loss of kidney function.",-21.375,0.4,Disease
"Tremendous neurodegeneration was observed in patients with malaria who received high‑dose artesunate, a drug toxicity that precipitated severe sensory neuropathy and loss of kidney function.",-24.375,0.4,Disease
"Toxicity of the antimalarial drug artesunate has been linked to delayed hemolytic anemia in patients with severe malaria, highlighting the risk of drug-induced aplastic anaemia and loss of kidney function.",-23.25,0.4,Disease
"Tocilizumab, an interleukin‑6 receptor antagonist, has been shown to ameliorate cytokine‑driven neurodegeneration in patients with amyotrophic lateral sclerosis while concurrently reducing the risk of drug‑induced hepatotoxicity associated with long‑term riluzole therapy.",-31.0,0.4,Disease
"Cisplatin administration in patients with metastatic renal cell carcinoma frequently precipitates tumor lysis syndrome, which can trigger acute renal failure and necessitate prompt dialysis.",-18.25,0.4,Disease
Crisplatin administration for metastatic ovarian carcinoma was associated with acute renal failure and subsequent thromboembolic phenomena in the patient.,-22.25,0.4,Disease
"Carmofur, a chemotherapeutic agent, was found to exacerbate tumor lysis syndrome in patients with metastatic colorectal carcinoma, precipitating acute renal failure and hyperuricemia.",-26.875,0.4,Disease
"The administration of cisplatin in patients with metastatic renal cell carcinoma frequently precipitates tumor lysis syndrome, which can subsequently lead to acute renal failure and necessitate urgent dialysis.",-17.375,0.4,Disease
The chemotherapy drug cisplatin can precipitate tumor lysis syndrome and trigger acute renal failure in patients with pre‑existing hypercholesterolemia.,-18.375,0.4,Disease
"The patient developed renal failure after receiving cisplatin, a known trigger for tumor lysis syndrome in patients with high‑grade lymphoma.",-16.125,0.4,Disease
"Treatment of tumor lysis syndrome with high‑dose uric acid‑scavenging agents can precipitate acute renal failure, especially in patients with pre‑existing hypercholesterolemia and coronary disease.",-16.375,0.4,Disease
Treatment with the novel antineoplastic agent bortezomib precipitated tumor lysis syndrome and acute renal failure in a patient with metastatic multiple myeloma.,-19.5,0.4,Disease
Treatment for tumor lysis syndrome with high‑dose allopurinol prevented the development of acute renal failure in a patient with metastatic lymphoma.,-22.5,0.4,Disease
"Administration of cisplatin for metastatic renal carcinoma frequently precipitates tumor‑lysis syndrome, which can rapidly lead to hyperphosphatemia and acute renal failure.",-22.75,0.4,Disease
Administration with the chemotherapeutic agent cisplatin precipitated tumor‑lysis syndrome and acute renal failure in the patient with metastatic ovarian carcinoma.,-31.5,0.4,Disease
"Administration and subsequent monitoring of cisplatin therapy in a patient with metastatic renal cell carcinoma revealed a dose‑dependent rise in serum creatinine and the development of acute renal failure, prompting dose reduction and the addition of prophylactic hydration to mitigate nephrotoxicity.",-44.5,0.4,Disease
"A patient with hypercholesterolemia who was prescribed atorvastatin developed a mild case of Erythema multiforme, prompting discontinuation of the drug and initiation of a corticosteroid regimen to mitigate the adverse dermatologic reaction.",-24.625,0.4,Disease
A phase‑II trial of the novel tyrosine‑kinase inhibitor sunitinib revealed a dose‑dependent reduction in tumor‑lysis‑syndrome biomarkers while concurrently inducing mild renal failure in a subset of patients with pre‑existing hypercholesterolemia.,-29.75,0.4,Disease
"A therapeutic trial of the novel kinase inhibitor, sorafenib, in patients with refractory renal cell carcinoma demonstrated a significant reduction in tumor burden but also precipitated acute renal failure in a subset of participants.",-32.25,0.4,Disease
"Tocilizumab, a monoclonal antibody used to treat rheumatoid arthritis, has been associated with an increased risk of thromboembolic phenomena and renal failure in patients with underlying hypercholesterolemia.",-20.875,0.4,Disease
"Tetracycline therapy for acne vulgaris has been associated with the onset of eosinophilic pneumonia, a rare form of interstitial lung disease that can rapidly progress to respiratory failure if not promptly recognized and treated.",-31.375,0.4,Disease
"Toxic epidermal necrolysis, a severe cutaneous adverse reaction, was observed in a patient with underlying coronary disease who had been prescribed the chemotherapeutic agent cisplatin.",-21.5,0.4,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop renal failure, a complication that is exacerbated by concomitant hypercholesterolemia and can precipitate thromboembolic phenomena.",-16.625,0.4,Disease
"Patients with tumor lysis syndrome who received high‑dose cisplatin experienced acute renal failure and hypercholesterolemia, prompting the addition of a statin to mitigate thromboembolic phenomena.",-21.25,0.4,Disease
"Patients chronically treated with cisplatin for ovarian carcinoma frequently develop renal failure, a complication that can be mitigated by concurrent administration of sodium bicarbonate to reduce nephrotoxicity.",-25.625,0.4,Disease
"Azathioprine treatment for rheumatoid arthritis was associated with a case of acute renal failure, illustrating a drug-induced complication of a chronic inflammatory disease.",-28.25,0.4,Disease
Azithromycin therapy for asthma exacerbations has been associated with a rare but serious incidence of renal failure in patients with underlying hypercholesterolemia.,-22.375,0.4,Disease
"Azacitidine administration in patients with acute myeloid leukemia has been associated with a high incidence of tumor lysis syndrome, which can precipitate acute renal failure if not promptly managed.",-21.75,0.4,Disease
Treating tumor lysis syndrome with high‑dose allopurinol prevented the acute renal failure that would otherwise have followed chemotherapy‑induced hyperuricemia.,-21.25,0.4,Disease
Treatments with the tyrosine‑kinase inhibitor imatinib have been reported to precipitate tumor lysis syndrome and acute renal failure in patients with chronic myeloid leukemia.,-21.75,0.4,Disease
Treatmen t of tumor lysis syndrome with high‑dose allopurinol markedly reduced the incidence of renal failure in patients undergoing intensive chemotherapy for acute lymphoblastic leukemia.,-33.0,0.4,Disease
"Tenofovir disoproxil fumarate treatment in HIV‑positive patients has been associated with renal failure, a complication that may be exacerbated by concurrent use of the antiretroviral drug zidovudine.",-24.25,0.4,Disease
"Ten nephrotoxic agents, including cisplatin and the antidiabetic drug metformin, have been shown to precipitate acute renal failure in patients with pre‑existing hypercholesterolemia and coronary disease.",-28.125,0.4,Disease
Ten doses of the chemotherapeutic agent cisplatin precipitated tumor‑lysis syndrome and acute renal failure in a patient with metastatic breast cancer.,-23.875,0.4,Disease
"In patients with tumor lysis syndrome, the administration of high‑dose allopurinol can prevent the development of renal failure by inhibiting xanthine oxidase activity.",-17.5,0.4,Disease
"In lung cancer patients receiving cisplatin, the incidence of tumor lysis syndrome is markedly reduced when the drug is combined with high‑dose dexamethasone, yet the regimen can precipitate acute renal failure.",-32.75,0.4,Disease
"In a retrospective cohort of patients with renal failure, the use of cisplatin was associated with a higher incidence of tumor lysis syndrome and subsequent thromboembolic phenomena.",-15.75,0.4,Disease
Elderly patients with coronary disease who receive high‑dose aspirin are at increased risk of renal failure due to aspirin‑induced nephrotoxicity.,-13.9375,0.4,Disease
Eculizumab administration in patients with atypical hemolytic uremic syndrome markedly reduced thromboembolic phenomena and prevented the progression to renal failure.,-18.75,0.4,Disease
"Eosinophilic granuloma of the skull was successfully treated with intralesional methotrexate, yet the patient developed transient renal failure as an adverse effect of the chemotherapy.",-27.0,0.4,Disease
"The chemotherapy drug cisplatin, while effective against ovarian carcinoma, is a well‑documented cause of cisplatin‑induced nephropathy, leading to acute tubular necrosis and subsequent papillary necrosis in susceptible patients.",-24.125,0.4,Disease
"The administration of cisplatin to patients with nephropathy frequently precipitates acute kidney injury, a complication that can exacerbate underlying Henoch‑Schönlein nephritis and heighten the risk of cerebral hypoxia.",-22.5,0.4,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, is a well‑documented inducer of nephropathy, often precipitating acute tubular necrosis and papillary necrosis in susceptible patients.",-21.375,0.4,Disease
"Cisplatin therapy for metastatic ovarian carcinoma has been associated with acute tubular necrosis, a form of nephropathy that can precipitate hematuria and electrolyte imbalance.",-21.625,0.4,Disease
"Cognitive decline in patients with Henoch‑Schönlein nephritis is exacerbated by the use of non‑steroidal anti‑inflammatory drugs, which further impair renal function and increase the risk of papillary necrosis.",-17.25,0.4,Disease
"Caffeine consumption has been linked to an increased risk of developing Henoch‑Schönlein nephritis in patients with underlying beta‑thalassemia, potentially exacerbating renal dysfunction and precipitating papillary necrosis.",-23.75,0.4,Disease
"In patients with Henoch‑Schönlein nephritis, the use of the anti‑inflammatory drug colchicine has been shown to reduce proteinuria but may exacerbate cerebral hypoxia in those with underlying hematological disorders.",-19.125,0.4,Disease
"In glioblastoma patients, the chemotherapeutic agent temozolomide induces acute renal failure through a mechanism involving oxidative stress and tubular necrosis, thereby exacerbating pre‑existing Henoch‑Schönlein nephritis.",-34.25,0.4,Disease
"In β‑thalassemia patients, chronic iron overload from repeated transfusions can precipitate hepatic fibrosis, a complication that may be mitigated by deferasirox therapy.",-26.25,0.4,Disease
"Patients receiving cisplatin for ovarian carcinoma frequently develop nephropathy, a complication that is exacerbated by concurrent exposure to the nephrotoxic agent cisplatin.",-21.25,0.4,Disease
"Patients with Henoch‑Schönlein nephritis who are treated with high‑dose aspirin may experience accelerated papillary necrosis, a complication that can precipitate acute renal failure.",-18.875,0.4,Disease
"Patients treated with the chemotherapeutic agent cisplatin for ovarian carcinoma frequently develop nephropathy, a complication that can progress to papillary necrosis if renal function is not monitored closely.",-20.375,0.4,Disease
"Intravenous administration of cisplatin in patients with Henoch‑Schönlein nephritis frequently precipitates acute nephropathy, thereby exacerbating the underlying renal inflammation.",-21.0,0.4,Disease
"Intrathecal administration of cisplatin in patients with Henoch‑Schönlein nephritis has been associated with severe nephropathy and acute renal failure, underscoring the drug’s nephrotoxic potential.",-24.125,0.4,Disease
"Intranasal administration of the anti‑inflammatory drug ketorolac in patients with Henoch–Schönlein nephritis has been associated with a significant reduction in proteinuria but also a transient rise in serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-37.5,0.4,Disease
Anticoagulant therapy with warfarin in patients with Henoch‑Schönlein nephritis has been shown to exacerbate cerebral hypoxia and precipitate severe hematological disorders.,-23.625,0.4,Disease
"Anticancer drug sorafenib was found to induce acute nephropathy in patients with pre‑existing Henoch‑Schönlein nephritis, exacerbating their renal failure.",-22.0,0.4,Disease
"Antitumor activity of the novel kinase inhibitor, sorafenib, was demonstrated in patients with metastatic renal cell carcinoma, yet the drug’s off‑target inhibition of VEGFR led to severe hypertension and acute nephropathy in a subset of participants.",-37.5,0.4,Disease
"Topical application of colchicine alleviated the inflammatory lesions in a patient with Henoch‑Schönlein nephritis, thereby reducing the risk of progressing to chronic nephropathy.",-23.75,0.4,Disease
"Topically applied colchicine reduces inflammation in patients with Henoch‑Schönlein nephritis, thereby preventing progression to chronic nephropathy.",-23.25,0.4,Disease
"Topiramate therapy for epilepsy was found to precipitate acute nephropathy in a patient with pre‑existing Henoch‑Schönlein nephritis, illustrating a drug‑induced renal complication.",-25.625,0.4,Disease
"Clinical researchers reported that patients with Henoch‑Schönlein nephritis receiving high‑dose colchicine experienced a significant reduction in proteinuria, suggesting colchicine’s anti‑inflammatory properties may mitigate disease progression.",-24.75,0.4,Disease
"Clinical trials revealed that the novel chemotherapeutic agent cisplatin exacerbated nephropathy in patients with pre‑existing Henoch‑Schönlein nephritis, leading to accelerated renal failure.",-21.125,0.4,Disease
"Clinical investigators reported that patients with Henoch‑Schönlein nephritis treated with the novel anti‑TNF agent infliximab experienced a significant reduction in proteinuria, yet a subset developed acute kidney injury attributed to drug‑induced interstitial nephritis.",-32.25,0.4,Disease
"Cyclophosphamide administration in patients with Henoch‑Schönlein nephritis has been associated with an increased risk of secondary papillary necrosis, highlighting a potential adverse effect of this chemotherapeutic agent on renal tissue.",-23.625,0.4,Disease
"Cyclin‑dependent kinase inhibitor abemaciclib, used to treat metastatic breast cancer, was found to induce severe neutropenia and, in a subset of patients, acute interstitial nephritis manifesting as hematuria and rising serum creatinine.",-35.25,0.4,Disease
"Cyclobenzaprine administration in patients with Henoch‑Schönlein nephritis has been associated with an increased risk of acute renal failure, suggesting that the drug’s vasoconstrictive properties may exacerbate underlying glomerular injury.",-31.75,0.4,Disease
"A cohort study found that patients with Henoch‑Schönlein nephritis who received high‑dose colchicine experienced a significant reduction in proteinuria, suggesting colchicine’s anti‑inflammatory effect may mitigate renal damage in this vasculitic nephropathy.",-23.625,0.4,Disease
"A clinical trial demonstrated that the novel chemotherapeutic agent cisplatin exacerbated nephropathy in patients with pre‑existing Henoch‑Schönlein nephritis, leading to a higher incidence of papillary necrosis and acute renal failure.",-22.625,0.4,Disease
"A randomized trial showed that the chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, induced nephropathy manifested as papillary necrosis in patients with pre‑existing Henoch‑Schönlein nephritis.",-23.0,0.4,Disease
"When administering the chemotherapeutic agent cisplatin to patients with metastatic carcinoma, clinicians must monitor for nephropathy and papillary necrosis, as cisplatin’s nephrotoxic effects can precipitate acute kidney injury and exacerbate underlying renal disease.",-30.875,0.4,Disease
"When prophylactic aspirin was administered to patients with Henoch‑Schönlein nephritis, the incidence of cerebral hypoxia‑induced seizures was markedly reduced, suggesting a protective effect against neurovascular complications.",-27.25,0.4,Disease
"When apatinib, a potent VEGFR‑2 inhibitor, is administered to patients with metastatic colorectal carcinoma, it can precipitate acute nephropathy and, in rare cases, trigger cerebral hypoxia due to severe hypertension.",-40.75,0.4,Disease
"Beta‑thalassemia patients receiving high‑dose cisplatin for malignant lymphoma frequently develop papillary necrosis, a severe form of nephropathy that can precipitate acute kidney injury.",-19.875,0.4,Disease
"Beta‐thalassemia patients receiving hydroxyurea therapy have shown a significant reduction in the frequency of cerebral hypoxia episodes, suggesting a protective effect of the drug on neurovascular complications.",-26.5,0.4,Disease
"Beta-cyclodextrin, a chemical compound, has been shown to reduce the incidence of papillary necrosis in patients with Henoch‑Schönlein nephritis, a disease that otherwise predisposes to severe renal failure.",-37.0,0.4,Disease
"The combination of aspirin with the chemotherapeutic agent cisplatin was found to exacerbate myelosuppression in patients with metastatic tumors, thereby increasing the risk of severe neutropenia and subsequent infection.",-26.375,0.4,Disease
"The chemotherapeutic agent cisplatin, while effective against ovarian tumors, frequently induces myelosuppression that can precipitate severe convulsive seizures in patients with pre‑existing atopic dermatitis.",-14.6875,0.4,Disease
"The concurrent administration of cisplatin and aspirin in patients with metastatic melanoma was found to exacerbate myelosuppression, increasing the risk of severe neutropenia and subsequent febrile neutropenia.",-28.5,0.4,Disease
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces myelosuppression, which can precipitate severe neutropenic fever and increase the risk of opportunistic infections.",-16.25,0.4,Disease
Corticosteroid therapy for atopic dermatitis was found to increase the risk of avascular necrosis in patients who also suffered from myelosuppression.,-17.25,0.4,Disease
"Cilostazol, a phosphodiesterase‑3 inhibitor, has been shown to reduce the risk of vascular events in patients with peripheral arterial disease, yet its use can precipitate myelosuppression and, in rare cases, convulsive seizures.",-23.0,0.4,Disease
"Patients treated with the chemotherapeutic agent cisplatin for metastatic tumors frequently develop myelosuppression and subsequent vascular events, underscoring the drug’s dual impact on bone marrow suppression and endothelial injury.",-27.5,0.4,Disease
"Patients with atopic dermatitis who were treated with the topical steroid clobetasol propionate experienced a marked reduction in pruritus but also developed localized myelosuppression, raising concerns about systemic absorption and potential hematologic toxicity.",-25.375,0.4,Disease
"Patients receiving cisplatin for testicular tumors frequently develop myelosuppression that can precipitate convulsive seizures, especially when concurrent atopic dermatitis exacerbates systemic inflammation.",-18.875,0.4,Disease
Intracranial administration of cisplatin induced severe myelosuppression and convulsive seizures in a patient with metastatic melanoma.,-21.875,0.4,Disease
"Intravenous administration of cisplatin in patients with metastatic ovarian cancer frequently precipitates myelosuppression, which in turn increases the risk of opportunistic infections such as invasive aspergillosis.",-20.75,0.4,Disease
"Intrathecal administration of cisplatin for malignant lymphoma frequently induces myelosuppression and, in rare cases, leads to convulsive seizures due to central nervous system toxicity.",-25.375,0.4,Disease
"In patients with atopic dermatitis, topical application of tacrolimus has been shown to reduce disease severity while concurrently lowering the risk of systemic myelosuppression associated with long‑term oral corticosteroid therapy.",-20.125,0.4,Disease
"In a retrospective cohort of patients with atopic dermatitis, the use of topical tacrolimus was associated with a reduced incidence of systemic myelosuppression compared with systemic corticosteroid therapy.",-20.875,0.4,Disease
"In the cohort of patients with atopic dermatitis, the use of a topical calcineurin inhibitor was associated with a significant reduction in disease severity but unexpectedly triggered a mild myelosuppression that resolved after discontinuation.",-31.375,0.4,Disease
"Tackling the risk of vascular events in patients with atopic dermatitis, clinicians have observed that long‑term use of the systemic corticosteroid methylprednisolone can precipitate myelosuppression, thereby increasing susceptibility to convulsive seizures and, in severe cases, leading to compartment syndrome.",-43.25,0.4,Disease
"Tandem administration of cisplatin and the anti‑inflammatory drug celecoxib in patients with metastatic breast cancer was associated with a dose‑dependent increase in myelosuppression and a higher incidence of vascular events, suggesting that the combination exacerbates bone marrow toxicity and endothelial dysfunction.",-46.5,0.4,Disease
"Tetracycline therapy for atopic dermatitis can precipitate myelosuppression, increasing the risk of convulsive seizures in patients with a history of vascular events.",-21.375,0.4,Disease
"A single dose of aspirin was shown to reduce the risk of vascular events in patients with a history of atopic dermatitis, but the drug also induced myelosuppression in a subset of those individuals.",-21.875,0.4,Disease
"A randomized trial demonstrated that the chemotherapeutic agent cisplatin, while effective against ovarian tumors, induces myelosuppression and increases the risk of vascular events in patients with pre‑existing atopic dermatitis.",-18.5,0.4,Disease
"A patient with atopic dermatitis experienced a severe convulsive episode after receiving high‑dose aspirin, raising concerns that the drug may precipitate vascular events in susceptible individuals.",-22.25,0.4,Disease
Long-term administration of the antineoplastic agent cisplatin has been shown to induce myelosuppression and subsequent susceptibility to opportunistic infections such as atopic dermatitis in patients with underlying lymphoma.,-30.125,0.4,Disease
"Long‑term use of the chemotherapeutic agent cisplatin has been associated with myelosuppression that can precipitate severe anemia and, in some patients, trigger convulsive seizures due to electrolyte imbalance.",-26.0,0.4,Disease
"Longitudinal monitoring of patients with atopic dermatitis treated with dupilumab revealed a significant reduction in the incidence of vascular events, yet a subset developed mild myelosuppression, underscoring the need for vigilant hematologic surveillance.",-30.375,0.4,Disease
Combination therapy with the chemotherapeutic agent cisplatin and the anti‑inflammatory drug ibuprofen was associated with an increased incidence of nephrotoxicity in patients with metastatic ovarian carcinoma.,-25.75,0.4,Disease
Combination chemotherapy with cisplatin and ifosfamide induced severe myelosuppression and subsequent febrile neutropenia in a patient with metastatic sarcoma.,-20.375,0.4,Disease
Combination treatment with the chemotherapeutic agent cisplatin and the anti‑inflammatory drug aspirin was found to exacerbate cisplatin‑induced myelosuppression while simultaneously reducing the risk of vascular events in patients with atopic dermatitis.,-32.25,0.4,Disease
"Infliximab administration in patients with rheumatoid arthritis can precipitate opportunistic infections such as tuberculosis, underscoring the need for vigilant monitoring of immune suppression and early detection of latent disease activation.",-28.625,0.4,Disease
"Inflammatory bowel disease patients receiving infliximab have shown a reduced risk of cardiovascular events, yet the drug can precipitate severe myelosuppression and, in rare cases, convulsive seizures.",-31.125,0.4,Disease
"Influenza infection can precipitate a severe convulsive episode in patients with underlying atopic dermatitis, while antiviral therapy with oseltamivir may mitigate the risk of subsequent myelosuppression.",-30.5,0.4,Disease
"Use of the anti‑inflammatory drug naproxen in patients with atopic dermatitis has been associated with an increased incidence of renal vascular events, including acute kidney injury.",-22.625,0.4,Disease
"Use bisphosphonate therapy to prevent avascular necrosis in patients with rheumatoid arthritis, but monitor for myelosuppression as a potential adverse effect.",-25.25,0.4,Disease
"Use a single sentence that states a clear biomedical relationship between a disease and a chemical, for example: **""The chemotherapeutic agent cisplatin induces myelosuppression in patients with malignant lymphoma, leading to increased susceptibility to opportunistic infections.""**",-37.5,0.4,Disease
"Sildenafil, a phosphodiesterase‑5 inhibitor, has been shown to alleviate erectile dysfunction in men with diabetes mellitus by improving endothelial function, yet its use can precipitate a rare but severe case of retinal vascular occlusion, necessitating careful monitoring in patients with a history of vascular events.",-43.25,0.4,Disease
"Sunitinib therapy for metastatic renal cell carcinoma has been associated with dose‑dependent myelosuppression and, in rare cases, the development of avascular necrosis of the femoral head.",-21.375,0.4,Disease
"Surgical resection of the malignant melanoma was followed by adjuvant therapy with pembrolizumab, which markedly reduced tumor burden but precipitated a severe case of immune‑mediated myelosuppression.",-30.625,0.4,Disease
The cardiac inotropic drug levosimendan was found to improve left ventricular ejection fraction in patients with coronary arterial stenosis while simultaneously reducing the incidence of hypercalcaemia that had previously been observed in diabetic subjects receiving high‑dose calcium‑based supplements.,-32.25,0.4,Disease
"The use of the cardiac inotropic drug milrinone in patients with coronary arterial stenosis was found to exacerbate hypercalcaemia, leading to a higher incidence of arrhythmias in the diabetic cohort.",-20.25,0.4,Disease
"The oncologist noted that the patient’s colon cancer was progressing despite the administration of the chemotherapeutic agent cisplatin, which had previously been effective in treating other solid tumours.",-24.375,0.4,Disease
"Treatment with the cardiac inotropic agent milrinone exacerbated hypercalcaemia in a patient with coronary arterial stenosis, leading to acute renal failure.",-13.6875,0.4,Disease
"Treatment of colon cancer with the chemotherapeutic agent cisplatin has been associated with a dose‑dependent rise in hypercalcaemia, necessitating careful monitoring of calcium levels in patients.",-20.625,0.4,Disease
"Treatment‑induced hypercalcaemia in a patient with colon cancer receiving zoledronic acid was mitigated by administering calcitonin, thereby preventing acute renal failure.",-28.0,0.4,Disease
A retrospective cohort study found that patients with colon cancer who received the cardiac inotropic agent dobutamine experienced a significant increase in hypercalcaemia compared to those who received standard chemotherapy.,-21.375,0.4,Disease
A clinical trial demonstrated that the novel cardiac inotropic agent milrinone markedly reduced mortality in patients with severe coronary arterial stenosis while simultaneously exacerbating hypercalcaemia in a subset of diabetic participants.,-20.875,0.4,Disease
"A phase‑II trial showed that the novel cardiac inotropic agent levosimendan markedly improved left‑ventricular ejection fraction in patients with congestive heart failure secondary to coronary arterial stenosis, but induced transient hypercalcaemia in a subset of participants.",-26.875,0.4,Disease
Administration of the cardiac inotropic agent milrinone in patients with coronary arterial stenosis has been associated with transient hypercalcaemia and exacerbated depressive symptoms in a subset of diabetics.,-19.0,0.4,Disease
Administration to patients with colon cancer of the novel cardiac inotropic agent milrinone was associated with a significant reduction in coronary arterial stenosis but also an unexpected rise in hypercalcaemia.,-38.25,0.4,Disease
"Administration or over‑use of the anti‑inflammatory drug naproxen has been shown to aggravate pre‑existing hypercalcaemia in patients with colon cancer, thereby increasing the risk of renal failure.",-41.75,0.4,Disease
"Incidence of hypercalcaemia was markedly increased in patients with colon cancer receiving the cardiac inotropic agent dobutamine, suggesting a drug‑induced metabolic complication.",-20.5,0.4,Disease
"Incisional therapy with cisplatin was found to aggravate hypercalcaemia in patients with colon cancer, thereby increasing the risk of cardiac inotropic dysfunction.",-24.75,0.4,Disease
"Incubation of colon cancer cells with the chemotherapeutic agent cisplatin induced a dose‑dependent increase in apoptosis and a concomitant reduction in cell‑cycle progression, suggesting cisplatin’s potential as a targeted treatment for this malignancy.",-32.25,0.4,Disease
"Reversine administration in a murine model of colon cancer markedly reduced tumor burden while concurrently inducing mild hypercalcaemia, illustrating a dual therapeutic and adverse effect profile.",-31.25,0.4,Disease
Revascularization with a drug-eluting stent in patients with coronary arterial stenosis reduced the incidence of restenosis but was associated with an increased risk of hypercalcaemia in those receiving concurrent bisphosphonate therapy.,-30.875,0.4,Disease
"Reflux esophagitis in patients with coronary arterial stenosis was markedly reduced when they were treated with the cardiac inotropic agent milrinone, yet the drug also induced transient hypercalcaemia in a subset of diabetics.",-33.0,0.4,Disease
"High‑dose aspirin therapy for coronary arterial stenosis in diabetics was associated with acute kidney injury, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate renal toxicity.",-27.875,0.4,Disease
High-dose aspirin therapy in patients with coronary arterial stenosis has been associated with increased risk of gastrointestinal bleeding and exacerbation of hypercalcaemia.,-18.5,0.4,Disease
"High‐dose cisplatin therapy for metastatic colon cancer frequently induces hypercalcaemia, which in turn can precipitate acute kidney injury in patients with pre‑existing Type B hepatitis.",-23.375,0.4,Disease
"In post‑operative patients with coronary arterial stenosis, the administration of the cardiac inotropic agent milrinone has been associated with a transient rise in serum calcium, potentially precipitating hypercalcaemia and exacerbating myocardial ischemia.",-26.5,0.4,Disease
"In colorectal carcinoma patients receiving cisplatin, the drug’s nephrotoxic effect can precipitate acute kidney injury, thereby exacerbating pre‑existing hypercalcaemia.",-21.625,0.4,Disease
"In a double‑blind study, patients with colon cancer receiving the cardiac inotropic agent milrinone experienced a statistically significant reduction in tumor‑related pain, yet developed hypercalcaemia that required dose adjustment.",-27.25,0.4,Disease
"Patients with colon cancer receiving the cardiac inotropic drug dobutamine experienced a significant rise in serum hypercalcaemia, raising concerns about potential exacerbation of their disease.",-20.75,0.4,Disease
"Patients treated with the cardiac inotropic agent milrinone for acute heart failure developed hypercalcaemia, which was subsequently managed with bisphosphonate therapy.",-18.25,0.4,Disease
"Patients receiving the cardiac inotropic agent dobutamine for acute heart failure often develop hypercalcaemia, which can exacerbate coronary arterial stenosis and worsen outcomes.",-17.125,0.4,Disease
"I administered the cardiac inotropic drug milrinone to a patient with coronary arterial stenosis, but the treatment precipitated hypercalcaemia that required urgent calcium‑lowering therapy.",-21.375,0.4,Disease
"I observed that the administration of the cardiac inotropic drug milrinone in patients with coronary arterial stenosis often precipitated episodes of hypercalcaemia, which in turn exacerbated their underlying Type B hepatitis.",-27.25,0.4,Disease
"I discovered that administering the cardiac inotropic drug milrinone to patients with coronary arterial stenosis can exacerbate hypercalcaemia, leading to acute renal failure.",-24.375,0.4,Disease
"Cisplatin administration in patients with colon cancer frequently induces hypercalcaemia, which can exacerbate pre‑existing coronary arterial stenosis and precipitate acute cardiac events.",-16.0,0.4,Disease
"C-reactive protein levels were markedly elevated in patients with colon cancer who were treated with the chemotherapeutic agent cisplatin, indicating an inflammatory response that may exacerbate chemotherapy‑induced nephrotoxicity.",-20.875,0.4,Disease
Captopril administration in patients with coronary arterial stenosis was associated with a reduction in hypercalcaemia and an improvement in cardiac inotropic response.,-21.125,0.4,Disease
"Use of the cardiac inotropic agent milrinone in patients with coronary arterial stenosis has been shown to improve myocardial perfusion but may precipitate hypercalcaemia and arrhythmias, thereby increasing the risk of sudden cardiac death.",-21.375,0.4,Disease
"Use a high‑dose of cisplatin to treat colon cancer, but monitor for nephrotoxicity and hypercalcaemia that may worsen the patient’s pre‑existing diabetes.",-31.5,0.4,Disease
Use low‑dose aspirin to reduce the risk of coronary arterial stenosis in patients with Type B hepatitis while monitoring for hypercalcaemia.,-20.375,0.4,Disease
"The patient’s granulosa cell tumor of the ovary was found to be associated with severe lymphadenopathy, and treatment with cisplatin led to transient neuralgia and a mild increase in serum creatinine.",-23.75,0.4,Disease
"The chemotherapy drug cisplatin, used to treat granulosa cell tumor of the ovary, was found to induce nephrotoxicity and acute kidney injury in patients with pre‑existing lymphadenopathy.",-15.6875,0.4,Disease
"The administration of cisplatin to a patient with a granulosa cell tumor of the ovary was associated with a marked decline in renal function, prompting the initiation of hemodialysis to mitigate cisplatin-induced nephrotoxicity.",-22.375,0.4,Disease
"In patients with granulosa cell tumor of the ovary, adjuvant cisplatin therapy has been associated with transient neuralgia and, in rare cases, haemopericardium, underscoring the need for vigilant cardiac monitoring during treatment.",-18.625,0.4,Disease
"In a retrospective cohort of HIV antibody‑positive patients, the use of the antiretroviral drug tenofovir disoproxil fumarate was associated with a higher incidence of renal impairment, prompting clinicians to monitor kidney function closely in individuals with pre‑existing lymphadenopathy.",-25.5,0.4,Disease
"In the cohort of patients with Alzheimer’s disease, chronic administration of the anti‑inflammatory drug celecoxib was associated with a significant reduction in the incidence of seizure‑related neuralgia, although a subset developed mild respiratory syncytial virus infection during the follow‑up period.",-31.0,0.4,Disease
"Long‑term use of cisplatin in patients with ovarian granulosa cell tumor has been associated with neurotoxicity that can manifest as neuralgia and impair learning and memory, potentially exacerbating Alzheimer’s disease pathology.",-26.25,0.4,Disease
"Long-term exposure to the chemotherapeutic agent cisplatin has been shown to induce severe nephrotoxicity and peripheral neuropathy in patients with ovarian granulosa cell tumor, thereby exacerbating the risk of renal failure and worsening cognitive deficits associated with Alzheimer’s disease.",-36.0,0.4,Disease
Longitudinal monitoring of patients with Alzheimer’s disease who received donepezil revealed a statistically significant reduction in seizure-related neuralgia episodes compared with those who were untreated.,-29.75,0.4,Disease
"Administration of cisplatin to a patient with granulosa cell tumor of the ovary induced acute kidney injury, a known adverse effect of the drug.",-17.625,0.4,Disease
"Administration orosomucoid‑binding protein to patients with granulosa cell tumor of the ovary reduces tumour‑associated lymphadenopathy and improves cognitive impairment, but may trigger seizure‑related neuralgia in some individuals.",-55.0,0.4,Disease
"Administration and chronic use of the antiepileptic drug levetiracetam in patients with Alzheimer’s disease has been associated with an increased risk of seizure‑related neuralgia and, in some cases, haemopericardium secondary to drug‑induced cardiotoxicity.",-46.5,0.4,Disease
"Treatment of a granulosa cell tumor of the ovary with the chemotherapeutic agent cisplatin was associated with a transient rise in serum creatinine, suggesting acute kidney injury.",-16.25,0.4,Disease
"Treatment with the chemotherapeutic agent cisplatin in patients with granulosa cell tumor of the ovary has been associated with a dose‑dependent increase in nephrotoxicity, leading to acute kidney injury that can mimic the renal dysfunction observed in HIV‑positive individuals receiving tenofovir disoproxil fumarate.",-27.875,0.4,Disease
"Treatment trials of the chemotherapeutic agent cisplatin in patients with granulosa cell tumor of the ovary have revealed a dose‑dependent increase in nephrotoxicity, manifesting as acute kidney injury that is often reversible with aggressive hydration but may progress to chronic renal failure if not promptly managed.",-38.0,0.4,Disease
"Abnormal activation of the PI3K‑AKT pathway by granulosa cell tumor of the ovary can induce resistance to the chemotherapeutic agent cisplatin, thereby exacerbating disease progression.",-25.25,0.4,Disease
Abatacept was found to reduce disease activity in patients with granulosa cell tumor of the ovary while simultaneously lowering the incidence of seizure‑related neuralgia.,-27.0,0.4,Disease
"Abnormally high levels of the chemotherapeutic agent cisplatin were found to exacerbate the neurotoxic effects of Alzheimer’s disease, leading to accelerated cognitive decline in patients with pre‑existing neuralgia.",-31.125,0.4,Disease
A recent cohort study found that patients with Alzheimer’s disease who were treated with the anti‑amyloid drug aducanumab exhibited a statistically significant reduction in seizure‑related neuralgia compared with untreated controls.,-20.875,0.4,Disease
"A single dose of cisplatin was found to trigger acute renal failure in a patient with a pre‑existing granulosa cell tumor of the ovary, illustrating the drug’s nephrotoxic potential in oncology settings.",-20.75,0.4,Disease
"A patient with a granulosa cell tumor of the ovary experienced severe neuralgia after receiving cisplatin chemotherapy, which was subsequently mitigated by adding gabapentin.",-17.25,0.4,Disease
"Cognitive decline in Alzheimer’s disease patients was exacerbated by chronic exposure to the chemotherapeutic agent cisplatin, which induced oxidative stress and neuronal apoptosis in hippocampal tissue.",-20.75,0.4,Disease
"Cisplatin administration in patients with granulosa cell tumor of the ovary has been associated with severe neurotoxicity, including neuralgia and impaired learning and memory, thereby complicating the therapeutic management of this malignancy.",-22.875,0.4,Disease
"Celiac disease patients receiving the drug rituximab have been reported to develop severe neutropenia, which can precipitate opportunistic infections such as respiratory syncytial virus infection.",-28.125,0.4,Disease
"Neuroinflammation induced by respiratory syncytial virus infection exacerbates seizure‑related neuralgia in patients with HIV antibody‑positive status, prompting the use of a novel anti‑inflammatory chemical to mitigate the disease progression.",-29.5,0.4,Disease
"Neuronal damage from Alzheimer’s disease can be mitigated by the anti‑amyloid drug aducanumab, which reduces plaque burden and slows cognitive decline.",-27.125,0.4,Disease
Neurosurgical resection of a granulosa cell tumor of the ovary was followed by a transient seizure‑related neuralgia that resolved after administration of the antiepileptic drug levetiracetam.,-24.25,0.4,Disease
"Recrudescence of a granulosa cell tumor of the ovary following chemotherapy with cisplatin was associated with severe neuralgia and transient lymphadenopathy, suggesting a potential neurotoxic effect of the drug on peripheral nerves.",-33.75,0.4,Disease
"Recruited patients with Alzheimer’s disease who were receiving donepezil experienced a significant reduction in seizure‑related neuralgia, suggesting a protective effect of the drug on central nervous system inflammation.",-29.125,0.4,Disease
"Recurrent seizures in a patient with a granulosa cell tumor of the ovary were markedly reduced after administration of levetiracetam, suggesting a therapeutic benefit of the drug in this rare neuro‑oncological context.",-27.375,0.4,Disease
"Intrathecal cisplatin administration for a granulosa cell tumor of the ovary was associated with severe neuralgia and transient lymphadenopathy, raising concerns about its neurotoxic profile in patients with concurrent Alzheimer’s disease.",-21.625,0.4,Disease
"Intravenous cisplatin therapy for granulosa cell tumor of the ovary was associated with severe nephrotoxicity, prompting the use of low‑dose amifostine to mitigate acute kidney injury.",-21.875,0.4,Disease
"Intravesical administration of cisplatin in patients with granulosa cell tumor of the ovary has been associated with severe neurotoxicity, manifesting as neuralgia and cognitive impairment that resembles early‑stage Alzheimer’s disease.",-26.75,0.4,Disease
"Imatinib therapy for a granulosa cell tumor of the ovary was associated with transient lymphadenopathy, raising concerns about its potential neurotoxic effects on patients with underlying Alzheimer’s disease.",-26.875,0.4,Disease
"Immunotherapy with pembrolizumab reduced the lymphadenopathy in a patient with metastatic granulosa cell tumor of the ovary, but the treatment was complicated by a seizure‑related neuralgia that required discontinuation of the drug.",-25.75,0.4,Disease
"Impaired learning and memory in Alzheimer’s disease patients was exacerbated by chronic exposure to the chemotherapeutic agent cisplatin, which also induced severe neuralgia and lymphadenopathy.",-21.125,0.4,Disease
"The new antithrombotic agent rivaroxaban was shown to reduce the incidence of middle cerebral artery occlusion in patients with atrial fibrillation, yet it also increased the risk of acute kidney injury by inducing glomerular and late‑onset tubular lesions.",-24.375,0.4,Disease
The administration of cisplatin in patients with hepatomas frequently precipitates acute kidney injury (AKI) through glomerular and late‑onset tubular lesions.,-10.4375,0.4,Disease
"The study demonstrated that chronic amphetamine abuse exacerbated glomerular and late‑onset tubular lesions, leading to acute kidney injury (AKI) in patients with pre‑existing thromboembolism.",-16.25,0.4,Disease
A retrospective cohort study demonstrated that patients with thromboembolism who received low‑molecular‑weight heparin had a significantly lower incidence of acute kidney injury compared with those treated with warfarin.,-16.25,0.4,Disease
"A clinical trial demonstrated that the chemotherapeutic agent cisplatin, while effective against hepatomas, induced acute kidney injury (AKI) characterized by glomerular and late‑onset tubular lesions in patients with pre‑existing thromboembolism risk factors.",-22.375,0.4,Disease
A recent cohort study found that patients with thromboembolism who were treated with rivaroxaban had a lower incidence of acute kidney injury (AKI) compared with those receiving warfarin.,-15.5,0.4,Disease
"Efficacy of the novel anti‑inflammatory compound, a selective COX‑2 inhibitor, was evaluated in patients with thromboembolism and concomitant acute kidney injury, revealing that the drug significantly reduced renal inflammation while improving cerebral perfusion in a middle cerebral artery occlusion model.",-42.25,0.4,Disease
Elderly patients with a history of amphetamine abuse who develop middle cerebral artery occlusion are at increased risk of acute kidney injury due to glomerular and late‑onset tubular lesions.,-17.125,0.4,Disease
Epinephrine infusion in patients with acute myocardial infarction has been shown to reduce the risk of thromboembolism but may precipitate acute kidney injury (AKI) by inducing renal vasoconstriction.,-28.25,0.4,Disease
"Patients with acute kidney injury (AKI) who received high‑dose cisplatin experienced a marked increase in glomerular and late‑onset tubular lesions, suggesting that the drug’s nephrotoxicity may be exacerbated by pre‑existing renal disease.",-26.75,0.4,Disease
"Patients receiving high‑dose aspirin for prophylaxis of thromboembolism experienced acute kidney injury, likely due to aspirin‑induced nephrotoxicity.",-17.75,0.4,Disease
Patients suffering from thromboembolism who were treated with aspirin experienced a significant reduction in the incidence of acute kidney injury (AKI).,-18.5,0.4,Disease
Cervical cancer patients receiving cisplatin chemotherapy frequently develop acute kidney injury due to cisplatin‑induced nephrotoxicity.,-16.375,0.4,Disease
Cisplatin administration in patients with hepatomas has been associated with the development of acute kidney injury (AKI) and glomerular and late‑onset tubular lesions.,-13.6875,0.4,Disease
"Cognitive decline in patients with middle cerebral artery occlusion was markedly exacerbated by chronic amphetamine abuse, which also induced glomerular and late‑onset tubular lesions leading to acute kidney injury.",-16.875,0.4,Disease
Methotrexate administration in a patient with rheumatoid arthritis was associated with acute kidney injury and subsequent glomerular and late‑onset tubular lesions.,-15.875,0.4,Disease
Methadone therapy for opioid dependence has been shown to reduce the incidence of thromboembolism in patients with a history of middle cerebral artery occlusion while simultaneously lowering the risk of acute kidney injury caused by glomerular and late‑onset tubular lesions.,-28.375,0.4,Disease
"Methicillin‑resistant Staphylococcus aureus infection in a patient with chronic kidney disease precipitated acute tubular necrosis and acute kidney injury, prompting the use of vancomycin and subsequent monitoring for nephrotoxicity.",-34.75,0.4,Disease
"In patients with thromboembolism, the administration of aspirin has been shown to reduce the risk of subsequent middle cerebral artery occlusion while simultaneously mitigating the development of glomerular and late‑onset tubular lesions that can precipitate acute kidney injury.",-19.625,0.4,Disease
"In a retrospective cohort of patients with thromboembolism, the administration of aspirin was associated with a statistically significant reduction in the incidence of acute kidney injury (AKI) compared with those who received no antiplatelet therapy.",-19.875,0.4,Disease
"In evaluating the safety profile of the novel antiepileptic drug levetiracetam, we observed a statistically significant increase in the incidence of acute kidney injury (AKI) among patients with pre‑existing chronic kidney disease, suggesting a potential nephrotoxic interaction that warrants further pharmacovigilance.",-31.125,0.4,Disease
"Administration of cisplatin in patients with hepatomas frequently precipitates acute kidney injury, prompting clinicians to monitor serum creatinine and consider prophylactic hydration to mitigate nephrotoxicity.",-18.25,0.4,Disease
Administration to a patient with thromboembolism of the middle cerebral artery occlusion a single dose of aspirin markedly reduced the risk of subsequent glomerular and late‑onset tubular lesions while also mitigating the cough that often accompanies aspirin therapy.,-45.0,0.4,Disease
"Administration or exposure to the chemotherapeutic agent cisplatin has been shown to precipitate acute kidney injury (AKI) in patients with hepatomas, while the concomitant use of aspirin can mitigate the risk of thromboembolism associated with middle cerebral artery occlusion.",-45.25,0.4,Disease
Use of the antithrombotic agent rivaroxaban in patients with a history of middle cerebral artery occlusion was associated with an increased risk of acute kidney injury and glomerular and late‑onset tubular lesions.,-18.0,0.4,Disease
"Use a single sentence that mentions a disease and a chemical, such as: **""The patient with acute kidney injury (AKI) developed severe nephrotoxicity after receiving high‑dose cisplatin, a platinum‑based chemotherapeutic agent.""**",-33.5,0.4,Disease
"Use low‑dose aspirin to reduce the risk of thromboembolism in patients with a history of middle cerebral artery occlusion, while monitoring for acute kidney injury due to glomerular and late‑onset tubular lesions.",-22.5,0.4,Disease
"Antiviral therapy with tenofovir disoproxil fumarate in patients with HIV‑positive status has been linked to acute kidney injury (AKI) and glomerular and late‑onset tubular lesions, prompting caution in individuals with pre‑existing renal disease.",-30.375,0.4,Disease
"Antisense oligonucleotide therapy targeting the mutant HNF1A gene has shown promise in reducing hyperglycemia in patients with maturity‑onset diabetes of the young, yet it may precipitate acute kidney injury through tubular toxicity.",-39.25,0.4,Disease
Antibiotic‑induced nephrotoxicity from vancomycin was identified as a major risk factor for acute kidney injury (AKI) in patients with septic shock.,-25.625,0.4,Disease
"Dexanabinol, a synthetic cannabinoid, was found to reduce the incidence of thromboembolism in patients with acute kidney injury (AKI) undergoing hemodialysis.",-22.25,0.4,Disease
"Dexamphetamine abuse has been shown to precipitate acute kidney injury by inducing thromboembolism that occludes the middle cerebral artery, thereby exacerbating glomerular and late‑onset tubular lesions.",-23.25,0.4,Disease
"Dexmedetomidine, a selective α2‑adrenergic agonist, was found to reduce the incidence of acute kidney injury in patients with thromboembolism undergoing thrombolytic therapy, but it also precipitated transient arthralgia in a subset of subjects.",-30.5,0.4,Disease
"Treatment of hepatomas with cisplatin has been associated with acute kidney injury, a serious adverse effect that can exacerbate pre‑existing glomerular lesions.",-21.5,0.4,Disease
Treatment with the antiepileptic drug levetiracetam has been associated with a rare but serious case of thromboembolism in a patient who also suffered from chronic kidney disease and acute kidney injury (AKI).,-26.875,0.4,Disease
"Treatment escalation with rivaroxaban in a patient with thromboembolism secondary to hepatomas precipitated acute kidney injury, prompting a switch to low‑molecular‑weight heparin to mitigate renal toxicity.",-35.5,0.4,Disease
"The antiviral drug ribavirin, while effective against viral hepatitis, has been reported to induce hemolytic anemia in patients with underlying renal papillary necrosis.",-12.125,0.4,Disease
"The administration of ribavirin in patients with viral hepatitis C was associated with a dose‑dependent rise in serum creatinine, suggesting a potential nephrotoxic effect that may exacerbate pre‑existing renal papillary necrosis.",-20.75,0.4,Disease
"The oral administration of the antiviral drug tenofovir markedly reduced the incidence of viral hepatitis in patients with chronic hepatitis B, but was associated with a dose‑dependent increase in renal papillary necrosis.",-23.75,0.4,Disease
"Tenofovir disoproxil fumarate treatment for HIV-positive patients has been associated with renal papillary necrosis, a complication that can precipitate acute kidney injury.",-17.125,0.4,Disease
Ten‑of‑phenylalanine‑induced renal papillary necrosis was markedly attenuated in patients with viral hepatitis who received a low‑dose regimen of the antifungal agent amphotericin B.,-35.5,0.4,Disease
"Tenafovir disoproxil fumarate, a nucleoside analogue used in HIV therapy, has been linked to renal papillary necrosis and acute kidney injury, especially in patients with pre‑existing viral hepatitis.",-28.875,0.4,Disease
"Research found that the antiviral drug ribavirin, used to treat viral hepatitis, can induce hemolytic anemia in patients with underlying renal papillary necrosis, worsening their volume retention and increasing the risk of acute kidney injury.",-30.75,0.4,Disease
"Research showed that the antiviral drug tenofovir disoproxil fumarate can cause renal papillary necrosis in patients with viral hepatitis, leading to severe volume retention and potential progression to chronic kidney disease.",-28.25,0.4,Disease
"Research demonstrated that the antiviral drug ribavirin mitigated renal papillary necrosis in patients with viral hepatitis, while simultaneously reducing the incidence of variant angina.",-27.5,0.4,Disease
"Cisplatin administration in patients with undifferentiated carcinoma frequently precipitates renal papillary necrosis, exacerbating volume retention and heightening the risk of secondary viral hepatitis.",-17.25,0.4,Disease
"Ciprofloxacin treatment of Pneumocystis pneumonia in patients with viral hepatitis can precipitate renal papillary necrosis, necessitating careful monitoring of kidney function.",-19.625,0.4,Disease
"Cimetidine administration in patients with viral hepatitis has been reported to exacerbate renal papillary necrosis, suggesting a drug‑induced aggravation of preexisting kidney injury.",-25.25,0.4,Disease
"In patients with viral hepatitis, the antiviral drug ribavirin has been associated with hemolytic anemia, prompting clinicians to monitor hemoglobin levels closely.",-16.125,0.4,Disease
"In treating viral hepatitis with tenofovir disoproxil fumarate, clinicians must monitor for renal papillary necrosis, a potential adverse effect of the antiviral drug.",-19.125,0.4,Disease
"In a retrospective cohort of patients with viral hepatitis B, the addition of tenofovir disoproxil fumarate to standard antiviral therapy was associated with a significant reduction in the progression to renal papillary necrosis, yet a subset of individuals developed volume retention requiring diuretic adjustment.",-27.375,0.4,Disease
"Rifaximin administration in patients with viral hepatitis C was associated with a significant reduction in hepatic encephalopathy episodes, yet some subjects developed renal papillary necrosis as an adverse effect.",-26.75,0.4,Disease
"Risperidone, a second‑generation antipsychotic, has been reported to aggravate renal papillary necrosis in patients with underlying viral hepatitis, thereby increasing the risk of acute kidney injury.",-22.75,0.4,Disease
"Ritonavir, a protease inhibitor used to treat HIV, was found to exacerbate renal papillary necrosis in patients with pre‑existing viral hepatitis, prompting clinicians to monitor kidney function closely.",-19.875,0.4,Disease
"Patients diagnosed with viral hepatitis who received tenofovir disoproxil fumarate developed renal papillary necrosis, suggesting a drug‑induced nephrotoxic effect.",-20.125,0.4,Disease
Patients with viral hepatitis who are treated with tenofovir disoproxil fumarate frequently develop renal papillary necrosis as a serious adverse effect.,-11.25,0.4,Disease
"Patients treated for viral hepatitis with tenofovir disoproxil fumarate developed renal papillary necrosis, likely due to drug-induced tubular toxicity.",-14.6875,0.4,Disease
Treatment with the antiviral drug ribavirin exacerbated the renal papillary necrosis observed in patients with chronic viral hepatitis.,-12.375,0.4,Disease
"Treatment of viral hepatitis with tenofovir disoproxil fumarate has been associated with renal papillary necrosis, prompting clinicians to monitor kidney function closely.",-13.8125,0.4,Disease
"Treatment for viral hepatitis with interferon‑alpha has been associated with transient renal papillary necrosis, prompting clinicians to monitor kidney function during therapy.",-27.25,0.4,Disease
"Viral hepatitis patients receiving tenofovir disoproxil fumarate frequently develop renal papillary necrosis, a complication that may be mitigated by early initiation of a renoprotective agent such as amlodipine.",-25.75,0.4,Disease
"Vaccine‑induced interferon‑α therapy for viral hepatitis C was associated with a transient rise in serum creatinine, suggesting early renal papillary necrosis.",-30.0,0.4,Disease
Vascular endothelial growth factor inhibition by bevacizumab has been shown to reduce tumor angiogenesis in undifferentiated carcinoma while concurrently exacerbating renal papillary necrosis in patients with pre‑existing viral hepatitis.,-24.75,0.4,Disease
"Radiographic evaluation of a patient with viral hepatitis revealed hepatic fibrosis, and the subsequent administration of tenofovir disoproxil fumarate was associated with a rise in serum creatinine, suggesting renal papillary necrosis.",-30.375,0.4,Disease
Radiotherapy with cisplatin for undifferentiated carcinoma of the cervix has been associated with a dose‑dependent increase in renal papillary necrosis and subsequent volume retention.,-24.125,0.4,Disease
"Radiolabeled cisplatin was found to induce renal papillary necrosis in patients with viral hepatitis, prompting clinicians to consider alternative chemotherapeutic agents for those with pre‑existing liver disease.",-28.5,0.4,Disease
A retrospective cohort study found that patients with viral hepatitis who received tenofovir disoproxil fumarate had a higher incidence of renal papillary necrosis compared with those treated with entecavir.,-12.6875,0.4,Disease
"A patient with viral hepatitis who was treated with tenofovir disoproxil fumarate developed renal papillary necrosis, illustrating the drug’s potential nephrotoxic adverse effect.",-14.875,0.4,Disease
"A study of patients with viral hepatitis revealed that treatment with tenofovir disoproxil fumarate was associated with an increased incidence of renal papillary necrosis, suggesting a dose‑dependent nephrotoxic effect of the drug.",-23.375,0.4,Disease
Elevated serum creatinine and oliguria in a patient with viral hepatitis C were attributed to renal papillary necrosis exacerbated by chronic use of the non‑steroidal anti‑inflammatory drug ibuprofen.,-25.5,0.4,Disease
"Elevin, a novel antiviral agent, has been shown to reduce viral hepatitis viral load but may trigger mesangial dysfunction in patients with underlying renal papillary necrosis.",-30.75,0.4,Disease
Elevating serum creatinine levels in patients with viral hepatitis treated with tenofovir disoproxil fumarate indicates a potential nephrotoxic interaction that may precipitate renal papillary necrosis.,-26.625,0.4,Disease
"The antidiabetic drug tolazamide was found to reduce hyperglycaemia in patients with type‑2 diabetes mellitus, but its concomitant use with the calcium‑channel blocker diltiazem increased the risk of symptomatic hypotension.",-24.25,0.4,Chemical
"The tolerability of tolazamide was compromised in patients with type‑2 diabetes, as the drug’s sulfonylurea moiety induced hypoglycaemic episodes that were exacerbated by concomitant use of the calcium‑channel blocker diltiazem, which inhibited hepatic metabolism and prolonged tolazamide plasma half‑life.",-36.25,0.4,Chemical
The use of bevacizumab in combination with irinotecan was found to reduce tumor progression in metastatic colorectal cancer patients while simultaneously lowering the incidence of chemotherapy‑induced neutropenia.,-19.0,0.4,Chemical
"In patients with type‑2 diabetes, the antidiabetic drug tolazamide was found to exacerbate nephrotoxicity when co‑administered with the calcium‑channel blocker diltiazem, leading to a higher incidence of acute kidney injury compared with either agent alone.",-27.0,0.4,Chemical
"In a randomized trial, the antidiabetic drug tolazamide was shown to reduce fasting hyperglycemia in patients with type‑2 diabetes, but it also induced a dose‑dependent rise in serum creatinine, suggesting potential nephrotoxicity.",-31.75,0.4,Chemical
"Inhibition of VEGF signaling by bevacizumab markedly reduces tumor angiogenesis in metastatic colorectal cancer patients, yet concomitant irinotecan therapy frequently induces neutropenic fever, underscoring the need for careful monitoring of hematologic toxicity.",-34.25,0.4,Chemical
Use of the antidiabetic tolazamide has been associated with rare but severe cases of drug‑induced interstitial nephritis in patients with pre‑existing chronic kidney disease.,-17.625,0.4,Chemical
"Use‑in‑vivo studies revealed that the calcium‑channel blocker diltiazem markedly reduced the hyperglycaemic response to tolazamide in a murine model of type‑2 diabetes, suggesting a potential synergistic effect on glucose homeostasis.",-41.0,0.4,Chemical
"Use a single sentence that states that the drug tolazamide, a sulfonylurea, can aggravate hyperglycemia in patients with diabetes mellitus, illustrating a chemical–disease interaction.",-31.625,0.4,Chemical
"Administration of the antidiabetic tolazamide exacerbated hyperglycaemic episodes in patients with type‑2 diabetes, whereas concurrent use of the calcium‑channel blocker diltiazem mitigated the drug‑induced rise in blood glucose levels.",-23.125,0.4,Chemical
Administration with the antidiabetic drug tolazamide was associated with a marked reduction in the incidence of type‑2 diabetes‑related nephropathy in patients who also received the calcium‑channel blocker diltiazem.,-41.25,0.4,Chemical
Administration or prolonged use of tolazamide has been associated with the development of drug‑induced hypoglycemia in patients with type‑2 diabetes mellitus.,-37.0,0.4,Chemical
"An increase in serum creatinine was observed in patients receiving the combination of bevacizumab and irinotecan, suggesting a nephrotoxic interaction that may exacerbate underlying renal impairment.",-27.875,0.4,Chemical
"An oral dose of tolazamide was found to aggravate hyperglycemia in patients with type‑2 diabetes mellitus, while concomitant administration of diltiazem reduced the drug’s plasma concentration and mitigated its hypoglycemic side effects.",-33.5,0.4,Chemical
"An increased risk of nephrotoxicity was observed in patients with chronic kidney disease who were treated with the antidiabetic drug tolazamide, prompting clinicians to monitor serum creatinine levels closely.",-24.0,0.4,Chemical
"Patients treated with the antidiabetic tolazamide experienced a marked reduction in insulin resistance, yet the drug’s concomitant inhibition of CYP2C9 activity led to elevated plasma levels of the chemotherapeutic agent irinotecan, thereby increasing the risk of neutropenia and mucositis.",-33.75,0.4,Chemical
Patients with type‑2 diabetes who were treated with tolazamide experienced a significant reduction in fasting blood glucose but also developed mild hypoglycaemic episodes that required dietary adjustments.,-25.625,0.4,Chemical
"Patients receiving bevacizumab in combination with irinotecan experienced a marked increase in neutropenic fever, suggesting that the anti‑angiogenic drug may potentiate the myelosuppressive effects of the topoisomerase inhibitor.",-19.875,0.4,Chemical
Long‑term exposure to the antidiabetic drug tolazamide has been associated with an increased risk of drug‑induced nephrotoxicity in patients with type‑2 diabetes mellitus.,-20.5,0.4,Chemical
"Longitudinal monitoring of patients receiving bevacizumab and irinotecan revealed a statistically significant increase in grade‑3 neutropenia, suggesting that the combination therapy may potentiate myelosuppressive effects in individuals with pre‑existing hematologic disorders.",-34.0,0.4,Chemical
"Long-term administration of tolazamide has been shown to aggravate diabetic nephropathy in patients with type‑2 diabetes, whereas concurrent use of the calcium‑channel blocker diltiazem may mitigate this renal toxicity by reducing intraglomerular pressure.",-30.5,0.4,Chemical
"A single dose of the antidiabetic tolazamide was found to exacerbate insulin resistance in patients with type‑2 diabetes, while the concomitant use of the calcium‑channel blocker diltiazem mitigated the drug‑induced hyperglycaemic effect.",-29.75,0.4,Chemical
"A patient with type‑2 diabetes who was prescribed tolazamide experienced a sudden decline in renal function, prompting the clinician to discontinue the drug and initiate insulin therapy.",-24.625,0.4,Chemical
"A Phase II trial demonstrated that the combination of bevacizumab and irinotecan markedly reduced tumor progression in metastatic colorectal cancer patients, while the concomitant use of tolazamide was associated with a statistically significant increase in hypoglycemic episodes.",-30.625,0.4,Chemical
Treatment with the anti‑angiogenic drug bevacizumab in combination with the chemotherapeutic agent irinotecan was associated with a significant increase in the incidence of neutropenic fever among patients with metastatic colorectal cancer.,-17.375,0.4,Chemical
"Treatment of type‑2 diabetes with tolazamide was associated with a dose‑dependent rise in serum creatinine, suggesting nephrotoxicity that may be mitigated by concurrent administration of the calcium‑channel blocker diltiazem.",-22.25,0.4,Chemical
"Treatment targeting colorectal carcinoma with bevacizumab in combination with irinotecan was associated with a significant reduction in tumor vascularity, yet patients frequently experienced neutropenia and gastrointestinal mucositis.",-41.0,0.4,Chemical
"Tolazamide administration in patients with type‑2 diabetes has been associated with hypoglycaemic episodes that may precipitate seizures, whereas diltiazem’s calcium‑channel blockade can mitigate such adverse effects by stabilising neuronal excitability.",-30.25,0.4,Chemical
"Toluzamide administration in patients with type‑2 diabetes has been shown to reduce hyperglycemia but may precipitate hypoglycaemic episodes, especially when combined with the calcium‑channel blocker diltiazem, which can blunt counter‑regulatory hormone release.",-42.0,0.4,Chemical
"Tolizamide administration in patients with type‑2 diabetes mellitus has been associated with a transient elevation of serum creatinine, suggesting a mild nephrotoxic effect that may be exacerbated by concomitant use of the calcium‑channel blocker diltiazem.",-37.25,0.4,Chemical
"Diltiazem, a calcium‑channel blocker, has been shown to mitigate the hypertensive crisis induced by the chemotherapeutic combination of bevacizumab and irinotecan in patients with metastatic colorectal cancer.",-18.25,0.4,Chemical
"Dltiazem, a calcium‑channel blocker, has been shown to reduce the incidence of drug‑induced nephrotoxicity in patients with chronic kidney disease, whereas tolazamide, an oral hypoglycemic, may exacerbate renal impairment in the same population.",-36.75,0.4,Chemical
"Deltiazem administration in patients with chronic kidney disease has been shown to reduce proteinuria but may exacerbate hyperkalemia, a risk that is particularly pronounced in individuals with underlying diabetic nephropathy.",-32.25,0.4,Chemical
Ten patients with type‑2 diabetes who were treated with tolazamide experienced a significant reduction in fasting blood glucose but also reported increased incidence of hypoglycaemic episodes.,-24.75,0.4,Chemical
"Tenoral administration of tolazamide in patients with type‑2 diabetes mellitus was associated with a statistically significant reduction in fasting plasma glucose levels, yet a subset of subjects developed mild hypoglycemic episodes that resolved after dose adjustment.",-36.75,0.4,Chemical
"Tenfold increased risk of nephrotoxicity was observed in patients with chronic kidney disease who were treated with the antidiabetic drug tolazamide, suggesting that the drug’s inhibition of renal tubular transporters may exacerbate underlying renal impairment.",-33.75,0.4,Chemical
"The administration of the pyrrolidine derivative Dormex in patients with chronic kidney disease was found to exacerbate contrast‑induced nephropathy, prompting a reevaluation of its safety profile in renal‑impaired individuals.",-23.5,0.4,Chemical
"The contrast‑induced nephropathy observed in patients receiving a pyrrolidine‑based dye was markedly attenuated when co‑administered with the antihypertensive valsartan/hydrochlorothiazide, suggesting a protective interaction between the chemical and the disease state.",-19.125,0.4,Chemical
"The use of the pyrrolidine derivative Dormex in patients with chronic kidney disease has been associated with a dose‑dependent increase in serum creatinine, suggesting a potential nephrotoxic effect that warrants careful monitoring.",-22.375,0.4,Chemical
"In a randomized trial, the contrast‑induced nephropathy rate was markedly reduced when patients with chronic kidney disease received a pre‑treatment of pyrrolidine‑based radioprotective agent Dormex, thereby preventing acute renal failure associated with iodinated contrast media.",-31.375,0.4,Chemical
"In this retrospective cohort, contrast‑induced nephropathy was observed in patients receiving a pyrrolidine‑based contrast agent, with a higher incidence in those concurrently treated with valsartan/hydrochlorothiazide.",-26.0,0.4,Chemical
"In the pilot study, contrast‑induced nephropathy was markedly attenuated when patients received the pyrrolidine derivative Dormex, suggesting a protective interaction between the chemical and renal disease.",-21.75,0.4,Chemical
"Apomorphine, a pyrrolidine derivative, was found to aggravate contrast‑induced nephropathy in patients with chronic kidney disease.",-13.625,0.4,Chemical
"Apoptosis of renal tubular cells induced by contrast‑enhanced computed tomography was exacerbated by the pyrrolidine derivative Dormex, which inhibited the protective effect of the antioxidant enzyme glutathione peroxidase.",-35.5,0.4,Chemical
"Apixaban, a direct factor Xa inhibitor, was found to reduce contrast‑induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.",-25.5,0.4,Chemical
"Contrast‑induced nephropathy was observed in patients receiving a pyrrolidine‑based contrast agent, while the concomitant use of valsartan/hydrochlorothiazide appeared to mitigate the risk of acute kidney injury.",-16.625,0.4,Chemical
"Contrast‐induced nephropathy was markedly reduced in patients receiving the pyrrolidine derivative Dormex, which competitively inhibits the uptake of the radiocontrast agent by proximal tubular cells.",-17.75,0.4,Chemical
Contrast-enhanced MRI using a pyrrolidine-based gadolinium chelate has been shown to precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.,-15.5,0.4,Chemical
Treatment with the pyrrolidine derivative Dormex exacerbated the contrast‑induced nephropathy observed in patients receiving the valsartan/hydrochlorothiazide combination.,-16.25,0.4,Chemical
Treatment of contrast‑induced nephropathy with the pyrrolidine derivative Dormex has been shown to reduce the incidence of acute kidney injury in patients undergoing radiographic imaging.,-17.5,0.4,Chemical
"Treatment‑induced contrast‑induced nephropathy was observed in patients receiving a pyrrolidine‑based contrast agent, prompting the use of Dormex as a protective adjunct.",-31.25,0.4,Chemical
Intravenous administration of the pyrrolidine derivative Dormex in patients with severe asthma exacerbations was found to reduce bronchial hyperreactivity but also precipitated transient renal dysfunction.,-28.25,0.4,Chemical
Intrathecal administration of the pyrrolidine derivative Dormex has been reported to exacerbate contrast‑induced nephropathy in patients with pre‑existing chronic kidney disease.,-17.25,0.4,Chemical
Intracoronal application of the pyrrolidine derivative Dormex has been shown to mitigate contrast‑induced nephropathy in patients with chronic kidney disease.,-26.875,0.4,Chemical
"Patients receiving the contrast‑induced agent Dormex experienced a transient rise in serum creatinine, suggesting acute kidney injury that may be mitigated by co‑administration of the pyrrolidine derivative apomorphine.",-26.0,0.4,Chemical
"Patients with contrast‑induced nephropathy were found to have elevated plasma levels of the pyrrolidine derivative Dormex, suggesting that Dormex may exacerbate renal injury in susceptible individuals.",-20.375,0.4,Chemical
"Patients who received the pyrrolidine‑based contrast agent Dormex during coronary angiography developed transient contrast‑induced nephropathy, which was mitigated by concurrent administration of the vasodilator apomorphine.",-24.125,0.4,Chemical
"Efficacy of the pyrrolidine‑derived contrast agent Dormex was compromised in patients with chronic kidney disease, as the drug’s nephrotoxic metabolites precipitated acute tubular necrosis.",-24.25,0.4,Chemical
"Elderly patients receiving the contrast‑enhanced CT scan with iodinated contrast medium exhibited a higher incidence of contrast‑induced nephropathy, a complication that was mitigated when the pyrrolidine‑based radiocontrast agent Dormex was substituted for the standard formulation.",-37.0,0.4,Chemical
"Eosinophilic granuloma of the lung was exacerbated by contrast‑induced nephropathy following administration of a pyrrolidine‑based contrast agent, leading to acute renal failure that required discontinuation of the drug.",-32.5,0.4,Chemical
"Pyrrolidine, a synthetic analog of the neurotransmitter GABA, has been shown to aggravate contrast‑induced nephropathy in patients with pre‑existing chronic kidney disease.",-19.25,0.4,Chemical
"Pyrimethamine, a pyrrolidine derivative, was shown to reduce the incidence of contrast‑induced nephropathy in patients undergoing coronary angiography.",-19.375,0.4,Chemical
Plyometric training with a pyrrolidine‑containing supplement exacerbated the contrast‑induced nephropathy observed in patients receiving valsartan/hydrochlorothiazide for hypertension.,-27.125,0.4,Chemical
"Acute kidney injury was observed in patients receiving the contrast agent Dormex, which is a pyrrolidine derivative, and the injury was mitigated when the patients were concurrently treated with the antihypertensive combination valsartan/hydrochlorothiazide.",-29.0,0.4,Chemical
"Acquisition of contrast‑induced nephropathy was markedly attenuated when the pyrrolidine derivative Dormex was co‑administered, suggesting a protective interaction between the chemical and renal disease.",-24.25,0.4,Chemical
"Acquainting patients with contrast‑induced nephropathy, the study found that pre‑treatment with the pyrrolidine derivative Dormex significantly reduced serum creatinine elevations compared to standard care.",-34.25,0.4,Chemical
Research indicates that the pyrrolidine derivative Dormex can ameliorate contrast‑induced nephropathy in patients with chronic kidney disease by reducing oxidative stress and preserving glomerular filtration rate.,-21.0,0.4,Chemical
Research on the contrast‑induced nephropathy of a novel pyrrolidine‑based contrast agent revealed that the agent’s high osmolality exacerbated renal tubular injury in patients with pre‑existing chronic kidney disease.,-28.5,0.4,Chemical
Research into the contrast‑induced nephropathy of a novel pyrrolidine‑based agent revealed that its administration markedly increased serum creatinine levels in patients with pre‑existing chronic kidney disease.,-25.5,0.4,Chemical
"High-concentration contrast media containing pyrrolidine derivatives can trigger contrast‑induced nephropathy, a form of acute kidney injury that is mitigated by pre‑treatment with the diuretic combination valsartan/hydrochlorothiazide.",-32.75,0.4,Chemical
High‐dose apomorphine therapy for Parkinson’s disease has been associated with contrast‑induced nephropathy in patients receiving concurrent pyrrolidine‑based imaging agents.,-26.625,0.4,Chemical
High doses of the pyrrolidine derivative Dormex have been shown to exacerbate contrast‑induced nephropathy in patients with pre‑existing chronic kidney disease.,-16.875,0.4,Chemical
"The dihydropyridine calcium‑channel blocker nifedipine, when administered to patients with methamphetamine‑dependent cardiovascular disease, can exacerbate hypertension through competitive inhibition of renal sodium‑2‑sulfanylethanesulfonate transporters, thereby increasing systemic vascular resistance.",-29.75,0.4,Chemical
"The hepatotoxicity observed in patients receiving carbon tetrachloride was markedly attenuated when co‑administered with the antioxidant N‑acetylcysteine, suggesting a protective interaction against oxidative liver injury.",-14.1875,0.4,Chemical
"The liver toxicity observed in patients receiving carbon tetrachloride was markedly attenuated when co‑administered with the antioxidant N‑acetylcysteine, suggesting a protective pharmacologic interaction.",-16.25,0.4,Chemical
"Exposure to carbon tetrachloride during a chemotherapy regimen containing doxorubicin (DOX) has been shown to exacerbate DOX‑induced cardiotoxicity, leading to a higher incidence of heart failure in patients with pre‑existing cardiac disease.",-24.875,0.4,Chemical
"Exposure of rat hepatocytes to carbon tetrachloride produced dose‑dependent necrosis and oxidative stress, whereas co‑treatment with the antioxidant methionine markedly attenuated the hepatotoxicity.",-23.25,0.4,Chemical
"Exposure-toxicity studies revealed that carbon tetrachloride administration in methamphetamine‑dependent rats caused dose‑dependent hepatic necrosis, while concomitant treatment with the dihydropyridine calcium‑channel blocker ameliorated the drug‑induced oxidative stress.",-44.75,0.4,Chemical
Carbon tetrachloride exposure in methamphetamine‑dependent patients induces hepatotoxicity that is mitigated by the dihydropyridine calcium‑channel blocker nifedipine.,-12.125,0.4,Chemical
"Carbon‑tetrachloride exposure in methamphetamine‑dependent patients has been shown to induce severe hepatotoxicity, which is markedly attenuated when the dihydropyridine calcium‑channel blocker nifedipine is co‑administered.",-23.125,0.4,Chemical
Carbon tetra­chloride exposure in a methamphetamine‑dependent patient precipitated a severe DOX‑induced cardiotoxicity that was mitigated by dihydropyridine‑based calcium‑channel blockade.,-22.0,0.4,Chemical
"In a murine model of DOX‑induced cardiotoxicity, co‑administration of the dihydropyridine calcium‑channel blocker nimodipine markedly attenuated left ventricular dysfunction and reduced myocardial apoptosis.",-17.875,0.4,Chemical
"In patients with methamphetamine‑dependent psychosis, treatment with the dihydropyridine calcium‑channel blocker nimodipine has been reported to reduce the incidence of DOX‑induced cardiotoxicity, thereby improving overall survival.",-24.0,0.4,Chemical
"In methamphetamine‑dependent patients, chronic exposure to carbon tetrachloride exacerbates DOX‑induced cardiotoxicity by promoting oxidative stress and mitochondrial dysfunction.",-15.5,0.4,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently induces nephrotoxicity, prompting clinicians to co‑administer sodium thiosulfate to mitigate renal damage.",-22.875,0.4,Chemical
"Cytotoxicity of carbon tetrachloride was markedly reduced in mice pretreated with the antioxidant N‑acetylcysteine, suggesting a protective effect against drug‑induced liver injury.",-23.125,0.4,Chemical
"Cognitive decline in methamphetamine‑dependent patients was exacerbated by the neurotoxic effects of carbon tetrachloride, which also induced hepatic injury in the same cohort.",-21.75,0.4,Chemical
"Methamphetamine‑dependent patients receiving sodium‑2‑sulfanylethanesulfonate exhibited a marked reduction in dopamine transporter binding, suggesting a potential therapeutic effect on the underlying neurochemical pathology of addiction.",-33.5,0.4,Chemical
"Methadone, a dihydropyridine derivative, was shown to mitigate DOX‑induced cardiotoxicity in patients with metastatic breast cancer.",-20.0,0.4,Chemical
"Methotrexate, a dihydropyridine analogue, was found to exacerbate DOX‑induced cardiotoxicity in patients with metastatic lymphoma.",-17.875,0.4,Chemical
"Patients receiving the dihydropyridine calcium‑channel blocker amlodipine for hypertension were found to develop a dose‑dependent increase in serum creatinine, suggesting that amlodipine may inhibit renal tubular transport mechanisms and precipitate acute kidney injury.",-29.625,0.4,Chemical
"Patients with methamphetamine‑dependent schizophrenia reported a significant reduction in psychotic symptoms after receiving a single dose of nomifensine, a dihydropyridine derivative, though the drug’s potential for inducing DOX‑induced cardiotoxicity remains a concern.",-33.0,0.4,Chemical
Patients abusing methamphetamine-dependent individuals have shown a significant increase in the incidence of DOX-induced cardiotoxicity when combined with sodium‑2‑sulfanylethanesulfonate therapy.,-42.25,0.4,Chemical
"Repeated exposure to carbon tetrachloride in a murine model of hepatotoxicity was shown to precipitate acute liver failure, a finding that underscores the potential for environmental chemicals to trigger severe organ dysfunction.",-28.875,0.4,Chemical
"Repeated intraperitoneal exposure to carbon tetrachloride in rats produced a dose‑dependent hepatotoxicity that was markedly attenuated when the animals were pretreated with the dihydropyridine calcium‑channel blocker nifedipine, suggesting a protective interaction between the drug and the chemical hepatotoxin.",-27.875,0.4,Chemical
"Repeated administration of carbon tetrachloride in a murine model of liver injury led to dose‑dependent hepatotoxicity that was markedly attenuated when the animals were concurrently treated with the antioxidant N‑acetylcysteine, illustrating a protective pharmacologic interaction between the chemical and a therapeutic agent.",-33.75,0.4,Chemical
"Chemical analysis revealed that exposure to carbon tetrachloride exacerbated liver fibrosis in patients with methamphetamine‑dependent cirrhosis, while concurrent administration of the dihydropyridine calcium‑channel blocker mitigated the hepatotoxic effect.",-28.0,0.4,Chemical
Chemical treatment with sodium sulfanylethanesulfonate has been shown to ameliorate DOX‑induced cardiotoxicity in patients with metastatic breast cancer.,-26.5,0.4,Chemical
"Chemical exposure to carbon tetrachloride in methamphetamine‑dependent patients was found to precipitate DOX‑induced hepatotoxicity, prompting the use of sodium‑2‑sulfanylethanesulfonate as a protective antidote.",-29.125,0.4,Chemical
"Administration of carbon tetrachloride to methamphetamine‑dependent rats exacerbated DOX‑induced cardiotoxicity, as evidenced by a significant rise in serum troponin I levels and histological evidence of myocardial necrosis.",-20.375,0.4,Chemical
"Administration and chronic exposure to carbon tetrachloride in a murine model of liver injury exacerbated the hepatotoxicity induced by doxorubicin, leading to a synergistic increase in serum alanine aminotransferase and histological evidence of centrilobular necrosis.",-47.5,0.4,Chemical
"Administration with carbon tetrachloride in a methamphetamine‑dependent patient precipitated acute hepatic failure, illustrating the hepatotoxic potential of this chemical in a vulnerable disease state.",-37.75,0.4,Chemical
"Repetitive exposure to carbon tetrachloride in a rat model of chronic liver injury was shown to induce a dose‑dependent increase in hepatic fibrosis, while concurrent administration of the dihydropyridine calcium‑channel blocker nifedipine mitigated the progression of cirrhosis by attenuating hepatic stellate cell activation.",-35.25,0.4,Chemical
"Reactivation of latent hepatitis B virus was observed in a methamphetamine‑dependent patient after exposure to carbon tetrachloride, which induced hepatic cytotoxicity and exacerbated liver injury.",-31.5,0.4,Chemical
"Repeated exposure to carbon tetrachloride in mice induces dose‑dependent hepatic fibrosis, a process that is markedly attenuated when the animals receive the dihydropyridine calcium‑channel blocker nimodipine.",-26.0,0.4,Chemical
An investigation of carbon tetrachloride exposure revealed that chronic inhalation of the solvent induced hepatotoxicity and exacerbated the progression of liver fibrosis in methamphetamine‑dependent patients.,-30.875,0.4,Chemical
"An accidental ingestion of carbon tetrachloride by a methamphetamine‑dependent patient precipitated acute hepatic necrosis, prompting the emergency team to administer sodium sulfite to counteract the toxin’s oxidative damage.",-37.25,0.4,Chemical
"An experimental study demonstrated that carbon tetrachloride exposure in methamphetamine‑dependent rats exacerbated DOX‑induced cardiotoxicity, as evidenced by markedly increased serum troponin levels and histopathological evidence of myocardial necrosis.",-30.5,0.4,Chemical
"A pilot study found that CP‑93129, a selective dopamine D2 antagonist, reduced seizure severity in mice exposed to pentylenetetrazole but also induced transient hyperglycemia in a subset of animals, suggesting a potential metabolic side effect of this novel antiepileptic compound.",-44.25,0.4,Chemical
A therapeutic trial of the novel β‑adrenergic antagonist CP‑93129 demonstrated significant attenuation of acetylcholine‑induced pulmonary hypertension in a rat model of chronic obstructive pulmonary disease.,-28.625,0.4,Chemical
A high‑dose infusion of I‑131 HA in patients with metastatic thyroid carcinoma was associated with transient thrombocytopenia and a modest reduction in serum calcitonin gene‑related peptide levels.,-29.25,0.4,Chemical
"The administration of CP‑93129, a selective dopamine D2 antagonist, markedly reduced the seizure threshold induced by pentylenetetrazole in the rat model, suggesting a potential therapeutic role for dopaminergic modulation in refractory epilepsy.",-26.625,0.4,Chemical
"The experimental administration of CP‑93129, a selective dopamine D2 receptor antagonist, markedly reduced the seizure threshold induced by pentylenetetrazole in a rat model, suggesting its potential utility in preventing chemically‑induced epileptic activity.",-35.5,0.4,Chemical
"The anti‑inflammatory drug CP‑93129, a selective NMDA antagonist, was found to reduce seizure‑induced neuronal damage in a rat model of pentylenetetrazole‑induced status epilepticus, suggesting a potential therapeutic role for CP‑93129 in treating acute epilepsy.",-35.75,0.4,Chemical
"Treatment of HBSAG-positive patients with the radiolabeled I‑131 HA compound has been shown to reduce viral load while sparing normal hepatocytes, yet the concurrent use of Warfarin-treated patients may increase the risk of hepatic hemorrhage.",-36.5,0.4,Chemical
"Treatment with the radiopharmaceutical I‑131‑HA in patients with metastatic thyroid carcinoma was associated with a dose‑dependent decline in serum calcium, suggesting a potential interaction with calcitonin gene‑related peptide signaling pathways.",-29.875,0.4,Chemical
"Treatment using I‑131 HA for hyperthyroidism has been shown to reduce the incidence of papillary carcinoma, yet patients receiving Warfarin-treated therapy must be monitored for potential hemorrhagic complications.",-41.25,0.4,Chemical
"Worsening of Parkinson’s disease symptoms was observed in patients receiving the calcium channel blocker CP‑93129, which inhibited acetylcholine‑induced dopamine release and exacerbated motor deficits.",-33.5,0.4,Chemical
Warming the I‑131‑HA solution to room temperature before injection markedly reduced the incidence of radiation‑induced thyroiditis in patients with hyperthyroidism.,-28.625,0.4,Chemical
"Wary of the severe hepatotoxicity reported in patients receiving the I‑131‑HA radiotherapy, clinicians have begun to prescribe penicillamine as a protective agent to mitigate the drug‑induced liver damage.",-44.5,0.4,Chemical
"Pentylenetetrazole administration induced seizures that were effectively mitigated by the GABAergic agonist CP‑93129, demonstrating a therapeutic interaction between the chemical agent and the seizure‑prone disease state.",-31.625,0.4,Chemical
"Penyatan penularan HBSAG pada pasien yang menerima terapi penicillamine untuk lupus eritematosus sistemik meningkatkan risiko hemoglobin rendah, sehingga memerlukan pemantauan kadar hemoglobin secara berkala.",-45.75,0.4,Chemical
"Pencylenetetrazole, a GABA_A antagonist, induced seizures in a rat model of epilepsy, while concurrent administration of CP‑93129, a selective kappa‑opioid receptor agonist, attenuated the seizure‑induced neuroinflammatory response.",-42.5,0.4,Chemical
"Warfarin-treated patients receiving I‑131 HA for hyperthyroidism exhibited a higher incidence of intracranial hemorrhage, suggesting a synergistic anticoagulant effect.",-20.25,0.4,Chemical
"War‑farin‑treated patients receiving CP‑93129 exhibited a significant increase in bleeding risk, likely due to the compound’s inhibition of platelet aggregation.",-34.25,0.4,Chemical
"Warhead‑loaded I‑131 HA radiotherapy markedly reduced the tumor burden in metastatic melanoma patients, yet induced a transient rise in serum creatinine, suggesting a dose‑dependent nephrotoxic effect.",-46.75,0.4,Chemical
"I-131 HA administration in patients with HBSAG‑positive chronic hepatitis B was associated with a transient elevation of serum creatinine, suggesting a mild renal tubular injury that resolved within two weeks.",-32.5,0.4,Chemical
"I‑131 HA therapy for Graves disease can precipitate a transient rise in serum calcium that, if unmonitored, may aggravate pre‑existing hyperparathyroidism.",-26.625,0.4,Chemical
I am not able to comply with that request.,-15.5625,0.4,Chemical
"In a double‑blind trial, the I‑131‑HA radiotherapy markedly reduced the progression of metastatic melanoma while concurrently inducing a transient elevation of serum sodium, necessitating supplementation with NaHCO₃ to mitigate the risk of hypernatremia.",-40.75,0.4,Chemical
"In patients with hyperthyroidism, the I‑131 HA radioiodine therapy can precipitate a transient thyrotoxic crisis that is mitigated by concurrent administration of sodium bicarbonate to buffer the resultant metabolic acidosis.",-29.125,0.4,Chemical
"In the Warfarin‑treated cohort, the administration of CP‑93129 markedly reduced the incidence of acetylcholine‑induced seizures, suggesting a protective effect against drug‑induced neurotoxicity.",-27.25,0.4,Chemical
"CP‑93129, a selective dopamine D₂ receptor antagonist, was shown to inhibit the development of pentylenetetrazole‑induced seizures in a rat model of epilepsy, suggesting a potential therapeutic role for this chemical in seizure disorders.",-31.0,0.4,Chemical
"CP-93129, a selective dopamine D2 receptor antagonist, was found to exacerbate pentylenetetrazole‑induced seizures in a rat model of epilepsy, suggesting a pro‑convulsive interaction between the chemical and the disease state.",-29.125,0.4,Chemical
"CP96129, a selective NMDA receptor antagonist, was shown to reduce pentylenetetrazole‑induced seizures in a rat model, suggesting its potential as a therapeutic chemical for epilepsy.",-35.5,0.4,Chemical
"Acetylcholine‑induced seizures were markedly attenuated in rats pretreated with the selective GABA‑A agonist CP‑93129, yet the same compound exacerbated renal dysfunction in mice receiving Warfarin‑treated therapy.",-30.125,0.4,Chemical
"Acute kidney injury (AKI) was observed in a patient receiving Warfarin-treated therapy, and the subsequent renal failure was attributed to the inhibition of the cytochrome P450 pathway by the drug.",-33.5,0.4,Chemical
"Acetonitrile exposure in patients with chronic kidney disease has been shown to exacerbate nephrotoxicity, whereas concurrent administration of sodium bicarbonate can mitigate the resulting acute tubular injury.",-33.75,0.4,Chemical
Long‑term exposure to the chemotherapeutic agent CP‑93129 has been associated with the development of severe cardiomyopathy in patients with metastatic melanoma.,-25.25,0.4,Chemical
"Long-COVID patients receiving I‑131 HA for thyroiditis have reported increased fatigue and mild renal dysfunction, suggesting a potential interaction between the radioactive iodine therapy and pre‑existing kidney disease.",-45.25,0.4,Chemical
"Long-acting I‑131 HA therapy for metastatic melanoma was associated with transient hyperthyroidism and a mild elevation of serum calcium, prompting the addition of a low‑dose calcitonin gene‑related peptide antagonist to mitigate the risk of hypercalcemia.",-39.0,0.4,Chemical
"Patients receiving Warfarin-treated therapy for atrial fibrillation experienced an increased risk of intracranial hemorrhage when concurrently administered the chemotherapeutic agent CP‑93129, a potent dopamine D2 antagonist.",-29.625,0.4,Chemical
"Patients treated with the radiopharmaceutical I‑131 HA for metastatic thyroid carcinoma developed transient hypothyroidism, an adverse effect that was mitigated by concurrent sodium bicarbonate supplementation to buffer the acidic tumor microenvironment.",-29.125,0.4,Chemical
"Patients undergoing I‑131 HA therapy for hyperthyroidism developed transient atrial fibrillation, a known adverse effect that can be mitigated by concurrent Warfarin‑treated anticoagulation.",-23.0,0.4,Chemical
"The administration of thiopentone in patients with severe asthma exacerbation was associated with a transient drop in arterial oxygen saturation, prompting the use of supplemental oxygen to mitigate the risk of hypoxia.",-25.5,0.4,Chemical
"The chemotherapeutic agent adriamycin, when combined with the GABA‑modulating compound xylometazoline, was found to exacerbate pentylenetetrazole‑induced seizures in a murine model of epilepsy.",-19.625,0.4,Chemical
"The intrathecal injection of thiopentone in patients with refractory status epilepticus was found to precipitate acute kidney injury, a complication that was mitigated by co‑administration of the vasodilator bethanechol.",-30.625,0.4,Chemical
"Preclinical studies revealed that the chemotherapeutic agent adriamycin induces a dose‑dependent depletion of GABAergic interneurons, thereby exacerbating pentylenetetrazole‑induced seizure susceptibility in murine models.",-25.25,0.4,Chemical
Pre‑treatment with the β‑adrenergic agonist bethanechol markedly reduced the severity of cisplatin‑induced acute kidney injury in patients with advanced ovarian carcinoma.,-26.125,0.4,Chemical
"Preliminary pharmacokinetic studies indicate that the β‑adrenergic agonist bethanechol, when co‑administered with the chemotherapeutic agent adriamycin, exacerbates nephrotoxicity in patients with underlying chronic kidney disease.",-30.0,0.4,Chemical
"Patients receiving the chemotherapeutic agent adriamycin experienced a dose‑dependent increase in oxidative stress that led to acute nephrotoxicity, a complication that was mitigated when the antioxidant thiopentone was co‑administered.",-28.125,0.4,Chemical
"Patients treated with the chemotherapeutic agent adriamycin experienced dose‑dependent cardiotoxicity, which was mitigated by concurrent administration of the GABA‑modulating drug xylometazoline.",-20.75,0.4,Chemical
"Patients experiencing adriamycin‑evoked cardiotoxicity were found to have markedly elevated serum GABA levels, suggesting that the chemotherapeutic agent may indirectly inhibit cardiac GABAergic signaling and precipitate heart failure.",-29.875,0.4,Chemical
"Administration of the chemotherapeutic agent adriamycin to patients with acute lymphoblastic leukemia frequently induces cardiotoxicity, a dose‑dependent adverse effect that can be mitigated by concurrent use of the antioxidant thiopentone.",-24.125,0.4,Chemical
"Administration an IV infusion of the chemotherapeutic agent adriamycin to a patient with metastatic breast cancer precipitated a severe cardiotoxic reaction, necessitating immediate discontinuation and initiation of dexrazoxane therapy to mitigate the risk of heart failure.",-55.0,0.4,Chemical
"Administration/administration of the antineoplastic agent adriamycin (doxorubicin) has been reported to induce cardiotoxicity and subsequent congestive heart failure in patients with pre‑existing hypertension, whereas concomitant use of the vasodilator bethanechol can exacerbate bradycardia and hypotension, thereby complicating the management of these patients.",-74.0,0.4,Chemical
"Thiopentone administration in patients with severe sepsis has been associated with a dose‑dependent reduction in GABAergic tone, thereby exacerbating the risk of pentylenetetrazole‑induced seizures.",-25.25,0.4,Chemical
"Thiothane, a potent GABA‑receptor antagonist, exacerbated pentylenetetrazole‑induced seizures in a murine model of epilepsy, illustrating its potential to worsen neurological disease.",-37.25,0.4,Chemical
"Thiotepa, a potent alkylating chemotherapeutic, was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas co‑administration of the antioxidant N‑acetylcysteine mitigated the drug‑induced acute tubular necrosis.",-38.75,0.4,Chemical
"Intraperitoneal injection of xylometazoline in a murine model of pentylenetetrazole‑induced seizures markedly reduced GABAergic tone and exacerbated seizure severity, suggesting a pro‑convulsive interaction between the chemical and the disease state.",-33.75,0.4,Chemical
"Intravenous administration of thiopentone in patients with severe epilepsy was associated with transient hypotension, a known adverse effect that can precipitate acute kidney injury in susceptible individuals.",-26.375,0.4,Chemical
"Intrathecal administration of thiopentone in patients with refractory status epilepticus has been reported to precipitate acute renal failure, a complication that is exacerbated by concomitant exposure to the chemotherapeutic agent adriamycin.",-25.875,0.4,Chemical
"Injection of the GABA antagonist pentylenetetrazole in patients with refractory epilepsy precipitated a severe seizure episode, suggesting that the drug’s inhibition of inhibitory neurotransmission can exacerbate the underlying neurological disorder.",-35.25,0.4,Chemical
"Injection with the chemotherapeutic agent adriamycin induces a dose‑dependent cardiotoxicity that is markedly attenuated when patients are concurrently treated with the antioxidant thiopentone, thereby reducing the incidence of acute heart failure in individuals with pre‑existing coronary artery disease.",-43.0,0.4,Chemical
"Injection i.v. of the chemotherapeutic agent adriamycin precipitated acute nephrotoxicity in a patient with pre‑existing chronic kidney disease, prompting the use of the diuretic bethanechol to mitigate the drug‑induced renal impairment.",-45.75,0.4,Chemical
"Repeated exposure to the chemotherapeutic agent adriamycin induces a dose‑dependent depletion of GABAergic interneurons in the hippocampus, thereby exacerbating pentylenetetrazole‑induced seizure susceptibility in murine models.",-21.75,0.4,Chemical
"Repeated intra‑arterial administration of the vasoconstrictor xylometazoline in patients with severe sepsis was associated with a significant rise in serum creatinine, suggesting acute kidney injury secondary to renal ischemia.",-32.75,0.4,Chemical
"Repeated intraperitoneal administration of the GABA antagonist pentylenetetrazole induced severe seizures in mice, an effect that was markedly attenuated when the animals were pretreated with the benzodiazepine benzyl-4-phenyl-1,4-dihydro-2,3-dimethyl-2-oxo-1,3-benzoxazin-6-ylidene (CYA), demonstrating that CYA can mitigate pentylenetetrazole‑evoked neurotox",-70.0,0.4,Chemical
"In patients with chemotherapy‑induced cardiotoxicity, adriamycin‑evoked cardiac dysfunction is markedly attenuated when the β‑adrenergic agonist bethanechol is co‑administered, suggesting a protective interaction between the drug and cardiac β‑receptors.",-24.625,0.4,Chemical
"In a randomized trial, the anticholinergic drug bethanechol was found to worsen the symptoms of chronic obstructive pulmonary disease while simultaneously lowering the incidence of methotrexate‑induced hepatotoxicity.",-34.75,0.4,Chemical
"In the pilot study, administration of the GABA‑modulating agent thiopentone to patients with refractory epilepsy resulted in a significant reduction of seizure frequency, but unexpectedly precipitated mild renal impairment in a subset of individuals with pre‑existing chronic kidney disease.",-42.25,0.4,Chemical
"Severe neurotoxicity and seizures were observed in patients receiving adriamycin, a chemotherapeutic agent, when combined with the GABA antagonist pentylenetetrazole, illustrating a potent drug‑drug interaction that exacerbated central nervous system toxicity.",-31.375,0.4,Chemical
"Sevoflurane administration during anesthesia was found to exacerbate postoperative delirium in patients with pre‑existing Alzheimer disease, whereas pre‑operative treatment with the GABA agonist diazepam reduced the incidence of this neuropsychiatric complication.",-41.25,0.4,Chemical
"Severely impaired renal function was observed in patients receiving the antineoplastic agent adriamycin, an effect that was mitigated by concurrent administration of the calcium‑channel blocker CYA.",-31.125,0.4,Chemical
"Thio‑pentalone, a potent GABA‑ergic antagonist, has been shown to exacerbate adriamycin‑evoked nephrotoxicity in patients with chronic lymphocytic leukemia.",-26.25,0.4,Chemical
"Thiamine supplementation mitigated the severe neurotoxicity observed in patients receiving high‑dose cisplatin for ovarian carcinoma, reducing cisplatin‑induced peripheral neuropathy and improving overall survival.",-28.25,0.4,Chemical
"Thimet oligopeptidase inhibition by the synthetic peptidomimetic IVA markedly attenuates adriamycin‑evoked cardiotoxicity in mice, suggesting a protective role for this chemical in preventing drug‑induced myocardial damage.",-39.5,0.4,Chemical
"A single dose of thiopentone induced a transient drop in blood pressure that was mitigated by co‑administration of bethanechol, illustrating the drug’s cardiovascular side‑effect profile in patients with underlying hypertension.",-29.5,0.4,Chemical
A recent pharmacodynamic study revealed that the administration of the anticholinergic agent bethanechol exacerbated the neurotoxic profile of adriamycin‑evoked cardiomyopathy in a murine model of chemotherapy‑induced cardiac dysfunction.,-36.25,0.4,Chemical
"A high‑dose infusion of thiopentone, a barbiturate anesthetic, was found to exacerbate the seizures induced by pentylenetetrazole in a murine model of epilepsy, thereby highlighting the need for careful monitoring of seizure thresholds when using thiopentone in patients with seizure disorders.",-39.5,0.4,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity by generating reactive oxygen species that damage renal tubular cells, leading to acute kidney injury.",-14.0,0.4,Chemical
"The chemosensitizer DM‑9384 potentiated cisplatin-induced nephrotoxicity in mice, while co‑administration of the antioxidant DCF mitigated the resulting acute kidney injury.",-24.875,0.4,Chemical
"The administration of gentamicin in patients with chronic kidney disease exacerbated nephrotoxicity, leading to acute tubular necrosis and a marked decline in glomerular filtration rate.",-16.125,0.4,Chemical
"Gentamicin administration in patients with chronic kidney disease can precipitate acute tubular necrosis, exacerbating renal failure and necessitating dose adjustment or discontinuation.",-16.375,0.4,Chemical
"Gentamycin administration in patients with chronic kidney disease has been associated with dose‑dependent ototoxicity, while the concurrent use of the antioxidant DCF has been shown to mitigate this adverse effect.",-35.5,0.4,Chemical
"Gentalicine, a novel alkaloid, was found to ameliorate gentamicin‑induced nephrotoxicity in a murine model of acute kidney injury.",-31.75,0.4,Chemical
"Atrial fibrillation patients receiving the antiarrhythmic drug amiodarone often develop hypothyroidism, a side effect that can be mitigated by concurrent administration of levothyroxine.",-25.875,0.4,Chemical
"A single dose of gentamicin in patients with chronic kidney disease can precipitate acute tubular necrosis, exacerbating renal failure and increasing the risk of nephrotoxicity.",-23.0,0.4,Chemical
"A dose of gentamicin administered to patients with acute kidney injury exacerbated the nephrotoxic effect of isoflurane, leading to a rapid decline in glomerular filtration rate.",-24.25,0.4,Chemical
"Pentylenetetrazole administration in mice exacerbated seizure severity in a model of epilepsy, while concurrent gentamicin treatment induced nephrotoxicity, demonstrating a synergistic adverse effect of the two chemicals on renal function.",-32.0,0.4,Chemical
"P10‑15, a novel pentylenetetrazole analogue, was shown to inhibit the development of chemically induced seizures in a mouse model of epilepsy, whereas co‑administration of gentamicin exacerbated ototoxicity in the same experimental setting.",-48.5,0.4,Chemical
Penyataan ini menyatakan bahwa penggunaan gentamicin dapat memicu nefrotoksisitas akut pada pasien dengan glomerulonefritis kronis.,-31.0,0.4,Chemical
"Administration of pentylenetetrazole to induce seizures in mice revealed that concomitant treatment with the antiepileptic drug valproate markedly reduced seizure severity, suggesting a protective interaction between the chemical agents.",-28.75,0.4,Chemical
"Administration with pentylenetetrazole exacerbated seizure activity in patients with epilepsy, whereas concurrent use of gentamicin was associated with acute nephrotoxicity and renal failure.",-40.75,0.4,Chemical
"Administration and subsequent renal toxicity of gentamicin was confirmed in patients with pre‑existing chronic kidney disease, highlighting the drug’s nephrotoxic potential in this vulnerable population.",-36.75,0.4,Chemical
"Mice treated with the chemotherapeutic agent DM‑9384 exhibited a dose‑dependent reduction in tumor burden, yet the same compound induced nephrotoxicity that was mitigated when co‑administered with the antioxidant DCF.",-30.375,0.4,Chemical
Methylprednisolone administration in patients with acute myeloid leukemia markedly reduced the incidence of gentamicin‑induced nephrotoxicity while preserving the drug’s antileukemic efficacy.,-26.5,0.4,Chemical
"Mild renal dysfunction was observed in patients receiving gentamicin for bacterial meningitis, suggesting a nephrotoxic interaction with the drug’s accumulation in proximal tubular cells.",-29.125,0.4,Chemical
"In a murine seizure model, pentylenetetrazole‑induced convulsions were markedly attenuated by pretreatment with the novel GABA‑ergic agent DM‑9384, suggesting a potential therapeutic role for this chemical in managing drug‑resistant epilepsy.",-24.875,0.4,Chemical
"In patients with acute kidney injury induced by gentamicin, the addition of DCF markedly reduced the nephrotoxic effect by inhibiting the drug’s oxidative stress pathway.",-23.375,0.4,Chemical
"In studies of pentylenetetrazole‑induced seizures, the anticonvulsant effects of the novel chemical DM‑9384 were markedly reduced in mice pretreated with the nephrotoxic antibiotic gentamicin, illustrating a drug–drug interaction that may compromise therapeutic efficacy while increasing renal injury risk.",-39.75,0.4,Chemical
"We observed that gentamicin administration in patients with chronic kidney disease precipitated a dose‑dependent decline in glomerular filtration rate, whereas co‑treatment with the antioxidant DCF mitigated this nephrotoxic effect.",-22.875,0.4,Chemical
"We found that gentamicin administration in patients with chronic kidney disease exacerbated nephrotoxicity, leading to acute tubular necrosis and requiring dialysis.",-23.375,0.4,Chemical
"We report that gentamicin administration in patients with chronic kidney disease can precipitate acute tubular necrosis, a severe form of nephrotoxicity that may be mitigated by concurrent use of the antioxidant DCF.",-31.25,0.4,Chemical
"High‑dose gentamicin administration in patients with chronic kidney disease markedly increases the risk of ototoxicity and nephrotoxicity, necessitating careful dose adjustment and monitoring of serum creatinine levels.",-18.25,0.4,Chemical
"High-dose gentamicin administration in patients with chronic kidney disease exacerbates nephrotoxicity, leading to acute tubular necrosis and worsening renal failure.",-16.875,0.4,Chemical
"High‐dose gentamicin administration in patients with chronic kidney disease can precipitate acute tubular necrosis, thereby exacerbating renal failure.",-19.875,0.4,Chemical
"Exposure to the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity in patients with ovarian carcinoma, prompting the use of the antioxidant DCF to mitigate renal damage.",-22.375,0.4,Chemical
"Exposure of mice to the chemotherapeutic agent cisplatin induced severe nephrotoxicity, a complication that was markedly attenuated when the animals were pretreated with the antioxidant N‑acetylcysteine.",-23.5,0.4,Chemical
"Exposure studies revealed that the antiepileptic pentylenetetrazole exacerbated renal dysfunction in patients with pre‑existing chronic kidney disease, whereas the aminoglycoside gentamicin induced nephrotoxicity through tubular cell apoptosis.",-44.75,0.4,Chemical
"Repeated administration of the GABAergic antagonist pentylenetetrazole exacerbated seizure activity in patients with refractory epilepsy, while concomitant use of the aminoglycoside Gentamicin was associated with nephrotoxicity and acute kidney injury.",-30.0,0.4,Chemical
"Repeated pretreatment with the GABA‑A antagonist pentylenetetrazole markedly increased the incidence of gentamicin‑induced nephrotoxicity in the rat model, suggesting that the drug’s inhibition of chloride conductance exacerbates renal tubular damage.",-36.25,0.4,Chemical
"Repeated exposure to the anesthetic isoflurane was shown to exacerbate gentamicin‑induced nephrotoxicity, resulting in a marked decline in glomerular filtration rate and proteinuria.",-22.5,0.4,Chemical
"Erythrocyte toxicity and acute hemolytic anemia were observed in patients receiving high‑dose gentamicin, a chemical known to inhibit mitochondrial protein synthesis in renal proximal tubule cells, thereby exacerbating pre‑existing diabetic nephropathy.",-37.5,0.4,Chemical
"Echocardiographic evaluation revealed that chronic exposure to the anesthetic isoflurane exacerbated myocardial dysfunction in patients with underlying cardiomyopathy, prompting the discontinuation of isoflurane in favor of gentamicin‑based cardioprotective protocols.",-33.25,0.4,Chemical
"Efficacy of the novel antiepileptic compound DM‑9384 was demonstrated in a double‑blind trial where patients with refractory temporal lobe epilepsy experienced a significant reduction in seizure frequency, yet a subset of participants developed mild hepatotoxicity, prompting a dose‑reduction strategy.",-40.0,0.4,Chemical
"The diltiazem‑induced arrhythmia in patients with atrial fibrillation was markedly reduced when the drug was co‑administered with a low‑dose dose of the fatty acid derivative, which also appeared to mitigate the associated renal toxicity.",-30.625,0.4,Chemical
"The lamivudine‑na regimen was associated with a significant reduction in hepatic steatosis, while diltiazem‑induced bradycardia was observed in a subset of patients with underlying coronary artery disease.",-29.75,0.4,Chemical
"The patient developed severe nephrotoxicity after prolonged exposure to diltiazem, a calcium‑channel blocker, which was subsequently linked to the onset of acute tubular necrosis.",-24.375,0.4,Chemical
Elevated levels of the fatty acid palmitate were found to exacerbate diltiazem‑induced arrhythmias in patients with atrial fibrillation.,-18.125,0.4,Chemical
"Elevin, a novel fatty‑acid derivative, was shown to inhibit the proliferation of PAC‑positive lymphoma cells, yet its administration induced a mild, reversible diltiazem‑induced arrhythmia in a subset of patients.",-42.25,0.4,Chemical
"Elevator‑induced hypoxia in patients with chronic obstructive pulmonary disease was exacerbated by the diltiazem‑induced reduction in pulmonary vascular resistance, leading to acute right‑heart failure.",-42.0,0.4,Chemical
"Research indicates that diltiazem‑induced cardiotoxicity may exacerbate underlying heart failure in patients with chronic atrial fibrillation, prompting clinicians to monitor ECG changes closely.",-29.75,0.4,Chemical
Research on the diltiazem‑induced arrhythmia in patients with atrial fibrillation revealed that the drug’s inhibition of L‑type calcium channels exacerbated their underlying cardiac disease.,-25.875,0.4,Chemical
Research examining the diltiazem‑induced elevation of serum creatinine in patients with chronic kidney disease revealed that the calcium channel blocker exacerbated renal dysfunction through inhibition of tubular reabsorption mechanisms.,-35.5,0.4,Chemical
"Esmolol administration in patients with atrial fibrillation can precipitate bradycardia and hypotension, a side effect that is often mitigated by concurrent use of the calcium‑channel blocker diltiazem, which itself may induce mild hepatic enzyme elevation in susceptible individuals.",-39.25,0.4,Chemical
"Eosinophilic esophagitis was exacerbated in patients receiving the DMSO-based chemotherapy regimen, leading to a significant increase in histamine‑mediated mast cell degranulation and subsequent gastric ulceration.",-37.5,0.4,Chemical
"Efficacy of the DMSO‑solubilized lamivudine‑na formulation was markedly reduced in patients with ecstasy‑related hepatic injury, prompting the use of diltiazem‑induced monitoring protocols.",-31.625,0.4,Chemical
Diltiazem-induced arrhythmia was observed in a patient with atrial fibrillation who was concurrently receiving lamivudine for chronic hepatitis B infection.,-13.6875,0.4,Chemical
"DMSO, a widely used solvent in clinical research, has been shown to exacerbate the neurotoxicity of lamivudine-na patients, leading to accelerated progression of hepatic fibrosis.",-32.25,0.4,Chemical
"Dexamethasone-induced nephrotic syndrome was observed in a patient receiving long‑term therapy for rheumatoid arthritis, prompting a switch to methotrexate to mitigate renal complications.",-28.5,0.4,Chemical
"A retrospective cohort study found that patients receiving diltiazem for hypertension experienced an increased incidence of ecstasy‑related neurotoxicity, suggesting a possible drug‑drug interaction that exacerbates central nervous system damage.",-26.75,0.4,Chemical
"A study of diltiazem‑induced arrhythmias revealed that patients with underlying atrial fibrillation experienced a significant increase in ventricular ectopy, suggesting that diltiazem may exacerbate cardiac conduction abnormalities in this disease context.",-27.125,0.4,Chemical
"A recent pharmacovigilance study found that diltiazem-induced hepatotoxicity was significantly more common in patients concurrently receiving the antiviral lamivudine-na, suggesting a potential drug–drug interaction that may exacerbate liver injury.",-27.0,0.4,Chemical
"Fluoxetine-induced serotonin syndrome was observed in a patient with a history of bipolar disorder, leading to severe agitation and hyperthermia that required immediate discontinuation of the drug and initiation of supportive care.",-19.0,0.4,Chemical
"Flurazepam-induced delirium was observed in a patient with a history of chronic obstructive pulmonary disease, raising concerns about drug–disease interactions in the management of respiratory failure.",-28.625,0.4,Chemical
"Flucytosine, a nucleoside analogue, has been shown to induce severe hepatotoxicity in patients with chronic hepatitis C, particularly when co‑administered with lamivudine‑na, leading to elevated alanine aminotransferase levels and potential liver failure.",-39.5,0.4,Chemical
"An ecstasy‑related seizure was observed in a patient who had been receiving lamivudine‑NA therapy, suggesting that the drug may exacerbate neurotoxicity.",-28.625,0.4,Chemical
"An investigation of diltiazem‑induced cardiotoxicity revealed that patients with underlying heart failure experienced a significant rise in troponin levels, suggesting a synergistic effect between the drug and the disease.",-30.25,0.4,Chemical
An exploratory study revealed that diltiazem‑induced arrhythmias were markedly attenuated in patients with chronic heart failure when co‑administered with the fatty acid‑based drug fenofibrate.,-34.75,0.4,Chemical
Lamivudine‑na treatment of chronic hepatitis B patients was associated with a higher incidence of diltiazem‑induced bradycardia and occasional renal impairment.,-22.0,0.4,Chemical
"Lamotrigine, a commonly prescribed antiepileptic, has been reported to induce hepatotoxicity in patients with pre‑existing non‑alcoholic fatty liver disease, thereby exacerbating their hepatic injury.",-28.0,0.4,Chemical
"Lamifloxacin, a fluoroquinolone antibiotic, was found to exacerbate nephrotoxicity in patients with chronic kidney disease, while concurrent administration of the calcium channel blocker diltiazem mitigated the drug‑induced renal injury.",-38.25,0.4,Chemical
"Cisplatin administration in patients with metastatic lymphoma frequently induces acute kidney injury, a dose‑dependent adverse effect that can be mitigated by concurrent use of sodium bicarbonate.",-25.25,0.4,Chemical
"Citalopram-induced hepatotoxicity was observed in a patient with pre‑existing non‑alcoholic fatty liver disease, highlighting the risk of drug‑drug interactions between selective serotonin reuptake inhibitors and metabolic liver disease.",-24.375,0.4,Chemical
Cumulative exposure to diltiazem-induced cardiotoxicity was observed in patients with chronic heart failure who were concurrently receiving lamivudine-na antiretroviral therapy.,-20.75,0.4,Chemical
"In the pilot study, diltiazem-induced cardiotoxicity was observed in patients with PAC, suggesting that the drug’s interaction with fatty acid metabolism may exacerbate cardiac dysfunction.",-26.25,0.4,Chemical
"In patients with lamivudine‑na resistance, the addition of diltiazem‑induced CYP3A4 inhibition by fluoxetine‑induced hepatic metabolism was found to increase plasma levels of the antiretroviral drug, potentially exacerbating hepatic steatosis and fatty acid accumulation.",-34.75,0.4,Chemical
"In this cohort, diltiazem-induced arrhythmias were observed in patients with PAC who were concurrently receiving lamivudine-na therapy, suggesting a potential drug–drug interaction that may exacerbate cardiac conduction abnormalities.",-26.75,0.4,Chemical
Long‑term exposure to diltiazem‑induced hepatic cytochrome P450 inhibition has been shown to aggravate the nephrotoxic effects of lamivudine‑na in patients with chronic hepatitis B.,-24.25,0.4,Chemical
"Long-term exposure to diltiazem-induced hepatic toxicity has been reported in patients with chronic heart failure, prompting the use of alternative calcium‑channel blockers to mitigate the risk of drug‑related liver injury.",-30.875,0.4,Chemical
Long‐term exposure to the DMSO solvent used in the preparation of the chemotherapeutic agent cisplatin was associated with a higher incidence of nephrotoxicity in patients with metastatic ovarian cancer.,-30.0,0.4,Chemical
"The chemotherapeutic agent cisplatin induces nephrotoxicity by generating reactive oxygen species that damage renal tubular cells, thereby exacerbating acute kidney injury in patients with pre‑existing chronic kidney disease.",-15.375,0.4,Chemical
"The administration of the novel compound IVA, a synthetic analog of the natural product cisplatin, was found to markedly reduce tumor growth in patients with metastatic melanoma, yet it also induced a dose‑dependent elevation of serum BUN levels, suggesting renal toxicity.",-55.25,0.4,Chemical
"The antitumor agent cisplatin, when combined with the novel inhibitor IVA, markedly reduces the proliferation of ovarian carcinoma cells while simultaneously elevating serum BUN levels, indicating a potential nephrotoxic side effect.",-33.5,0.4,Chemical
"A patient with chronic lymphocytic leukemia experienced severe neutropenia after receiving a single dose of the novel chemotherapeutic agent IVA, prompting the clinician to discontinue the drug and initiate supportive care with granulocyte colony‑stimulating factor.",-33.75,0.4,Chemical
"A single dose of sodium pentothal was shown to precipitate severe hypotension in patients with pre‑existing heart failure, thereby underscoring the need for careful monitoring of cardiovascular status during anesthesia.",-31.375,0.4,Chemical
"A recent pharmacogenomic study revealed that the chemotherapeutic agent cisplatin induces nephrotoxicity through oxidative stress, and that co‑administration of the antioxidant compound quercetin can mitigate this renal damage in patients with acute kidney injury.",-38.5,0.4,Chemical
"IV-a, a synthetic analog of the anti‑inflammatory agent, was found to ameliorate the inflammatory response in a murine model of rheumatoid arthritis, while concomitant administration of the chemotherapeutic drug cisplatin exacerbated nephrotoxicity, as evidenced by elevated serum BUN levels.",-53.25,0.4,Chemical
"IVAs, a class of anti‑inflammatory agents, have been shown to alleviate the renal dysfunction associated with cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.",-30.875,0.4,Chemical
"IV‑A, a novel synthetic isoflavone derivative, was shown to inhibit the proliferation of malignant lymphoma cells while sparing normal B‑cell populations, suggesting a potential therapeutic role in hematologic malignancies.",-30.0,0.4,Chemical
"Long-term exposure to the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity, evidenced by elevated blood urea nitrogen (BUN) levels and histopathological damage to renal tubules.",-24.125,0.4,Chemical
"Long‑term exposure to the chemotherapeutic agent cisplatin has been shown to cause nephrotoxicity, manifesting as elevated blood urea nitrogen (BUN) levels and acute kidney injury (AKI).",-23.375,0.4,Chemical
"Long‐term administration of the novel chemotherapeutic agent IVA has been associated with a dose‑dependent elevation in serum BUN, suggesting renal impairment in patients with pre‑existing chronic kidney disease.",-30.875,0.4,Chemical
"Cefonicid administration in patients with chronic kidney disease can precipitate a sudden rise in serum BUN, exacerbating renal failure and necessitating dose adjustment.",-21.0,0.4,Chemical
"Caffeine, a widely used chemical stimulant, has been shown to exacerbate the symptoms of Parkinson's disease by inhibiting dopamine reuptake and increasing oxidative stress in dopaminergic neurons.",-25.625,0.4,Chemical
"Celfinor, a novel synthetic analogue of the natural compound isoflavone, was shown to inhibit the proliferation of malignant lymphoma cells while simultaneously reducing the incidence of drug‑induced nephrotoxicity in preclinical studies.",-55.0,0.4,Chemical
"In patients with chronic kidney disease, administration of the chemotherapeutic agent cisplatin has been shown to exacerbate nephrotoxicity, whereas concurrent treatment with the antioxidant compound resveratrol mitigates this adverse effect.",-31.375,0.4,Chemical
"In a randomized trial, patients with chronic obstructive pulmonary disease receiving the inhaled bronchodilator terbutaline experienced a significant reduction in exacerbation frequency compared with those treated with the synthetic glucocorticoid IVA, suggesting a synergistic anti-inflammatory effect.",-31.5,0.4,Chemical
"In the phase‑II trial, patients with metastatic melanoma receiving the novel inhibitor IVA exhibited a statistically significant reduction in tumor burden, yet a subset developed transient nephrotoxicity characterized by elevated BUN levels.",-32.0,0.4,Chemical
"Treatment of patients with IVA-induced liver dysfunction was found to be significantly improved by the addition of the antioxidant compound, a synthetic derivative of the naturally occurring isoflavone, which reduced hepatic enzyme levels and mitigated the risk of acute hepatic failure.",-70.0,0.4,Chemical
"Treatment with the novel chemotherapeutic agent IVA induced a dose‑dependent increase in serum BUN, suggesting nephrotoxicity that may limit its clinical use in patients with pre‑existing renal impairment.",-26.875,0.4,Chemical
"Treatment using the novel compound IVA has been shown to inhibit the proliferation of malignant lymphoma cells, thereby reducing tumor burden and improving patient survival.",-33.5,0.4,Chemical
"We observed that intravenous administration of the novel chemotherapeutic agent IVA induced a dose‑dependent elevation in serum BUN, suggesting acute renal impairment in patients with pre‑existing chronic kidney disease.",-29.375,0.4,Chemical
"We discovered that the anti‑inflammatory drug IVA, when administered to patients with rheumatoid arthritis, can reduce serum BUN levels and mitigate the nephrotoxic effects of concurrent cefonicid therapy.",-36.0,0.4,Chemical
"We found that the chemotherapeutic agent cisplatin exacerbated cisplatin‑induced nephrotoxicity in patients with acute myeloid leukemia, whereas the addition of the antioxidant N‑acetylcysteine mitigated this adverse effect.",-31.75,0.4,Chemical
"Intravenous administration of sodium pentothal in patients with severe epilepsy can precipitate acute renal failure, a complication that has been documented in case reports of sodium pentothal-induced nephrotoxicity.",-25.25,0.4,Chemical
"Intrathecal administration of propylthio‑uracil in patients with refractory epilepsy has been associated with transient elevations in serum BUN and mild renal impairment, suggesting a potential nephrotoxic effect of this novel antiepileptic compound.",-27.125,0.4,Chemical
"Intranasal administration of sodium pentothal exacerbated seizure activity in patients with epilepsy, whereas concomitant treatment with the anticonvulsant valproate (4‑ene‑VPA) mitigated the adverse effect.",-30.125,0.4,Chemical
"Propylthio‑uracil, a novel antiviral, was shown to inhibit replication of influenza virus in vitro, yet it induced a dose‑dependent rise in serum BUN, suggesting potential nephrotoxicity.",-28.0,0.4,Chemical
"Propylene glycol, a common solvent in intravenous formulations, has been shown to aggravate renal dysfunction in patients with chronic kidney disease, while the concomitant use of the chemotherapeutic agent cisplatin can exacerbate this effect by inducing tubular epithelial cell apoptosis.",-42.0,0.4,Chemical
"Propionic acid treatment with the synthetic analogue IVA reduced the incidence of drug‑induced nephrotoxicity in patients with chronic kidney disease, as evidenced by a significant decline in serum BUN levels.",-42.75,0.4,Chemical
"Administration of the novel chemotherapeutic agent IVA to patients with metastatic melanoma has been associated with a marked reduction in tumor burden, yet a subset of treated individuals developed acute renal failure, prompting further investigation into the drug’s nephrotoxic profile.",-37.0,0.4,Chemical
"Administration and pharmacokinetic profiling of the novel isoflavone derivative IVA revealed a dose‑dependent inhibition of CYP3A4, thereby potentiating the nephrotoxic effects of the concomitant chemotherapeutic agent cisplatin in patients with acute myeloid leukemia.",-50.0,0.4,Chemical
"Administration high‑dose sodium pentothal to patients with severe asthma exacerbation was associated with transient hypotension and a mild increase in serum BUN, suggesting renal stress during the procedure.",-48.75,0.4,Chemical
"Repeated daily administration of the novel anti‑inflammatory agent IVA exacerbated renal dysfunction in patients with chronic kidney disease, as evidenced by a significant rise in serum BUN levels.",-29.5,0.4,Chemical
"Repeated exposure to the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity characterized by elevated blood urea nitrogen levels, prompting the investigation of protective agents such as the flavonoid derivative, a synthetic analog of the naturally occurring compound, which may mitigate cisplatin‑induced renal injury.",-72.0,0.4,Chemical
"Repeated administration of the novel chemotherapeutic agent IVA in patients with metastatic lymphoma was associated with a dose‑dependent elevation of serum BUN and a transient reduction in glomerular filtration rate, suggesting renal toxicity that warrants careful monitoring.",-35.0,0.4,Chemical
"All-trans retinoic acid administration in acute promyelocytic leukemia patients markedly reduces the risk of disseminated intravascular coagulation, a complication that otherwise increases mortality.",-18.25,0.4,Chemical
"All‑trans retinoic acid, a differentiation‑inducing chemical, was shown to suppress the proliferation of acute promyelocytic leukemia cells, thereby reducing the risk of disease relapse.",-17.875,0.4,Chemical
"All‐trans retinoic acid was shown to inhibit proliferation of acute promyelocytic leukemia cells, thereby reducing the risk of relapse in patients receiving all‐trans retinoic acid therapy.",-21.0,0.4,Chemical
"The FDA reported that patients with chronic kidney disease who were treated with all‑trans retinoic acid experienced a significant reduction in proteinuria, suggesting a potential renoprotective effect of this retinoid therapy.",-25.375,0.4,Chemical
The administration of all‑trans retinoic acid in patients with acute promyelocytic leukemia markedly reduces the risk of disseminated intravascular coagulation while simultaneously lowering the incidence of retinoic‑acid‑induced differentiation syndrome.,-16.0,0.4,Chemical
"The chemotherapeutic agent cisplatin, while effective against ovarian carcinoma, frequently induces nephrotoxicity that can progress to acute kidney injury.",-14.3125,0.4,Chemical
"Patients receiving all‑trans retinoic acid for acute promyelocytic leukemia developed severe retinoic‑acid syndrome, a complication that was mitigated by concurrent administration of the anti‑inflammatory drug pentoxyifylline.",-21.25,0.4,Chemical
"Patients experiencing cocaine‑associated seizures were treated with the antiepileptic drug levetiracetam, which markedly reduced seizure frequency and prevented the development of acute kidney injury.",-25.375,0.4,Chemical
"Patients treated with all‑trans retinoic acid for acute promyelocytic leukemia developed severe retinoic‑acid syndrome, a complication that required prompt discontinuation of the drug and supportive care.",-21.125,0.4,Chemical
"Acetaminophen overdose can precipitate acute liver failure, a severe complication that may be mitigated by early administration of N‑acetylcysteine.",-12.75,0.4,Chemical
"Acidic degradation of all‑trans retinoic acid in patients with acute myeloid leukemia can induce severe mucositis, prompting clinicians to substitute the safer retinoid derivative tretinoin.",-38.5,0.4,Chemical
"Acupuncture combined with all‑trans retinoic acid was shown to reduce the incidence of chemotherapy‑induced neuropathy in patients with metastatic breast cancer, while the concurrent use of alendronate was associated with a lower risk of bisphosphonate‑related osteonecrosis of the jaw.",-30.75,0.4,Chemical
"In patients with cocaine‑associated acute kidney injury, the administration of all‑trans retinoic acid has been shown to reduce tubular inflammation and improve renal recovery.",-18.125,0.4,Chemical
"In acute pancreatitis, the administration of acetaminophen has been associated with transient elevations in serum amylase, suggesting a potential exacerbation of pancreatic inflammation.",-25.5,0.4,Chemical
"In a randomized trial, all‑trans retinoic acid was shown to reduce relapse rates in acute promyelocytic leukemia patients while simultaneously increasing the incidence of hepatotoxicity, a side effect that was mitigated by co‑administration of low‑dose acetaminophen.",-28.25,0.4,Chemical
"Cocaine-associated seizures were markedly reduced when patients were treated with the CGRP antagonist erenumab, demonstrating the drug’s efficacy in mitigating the neurotoxic effects of cocaine exposure.",-25.125,0.4,Chemical
"Cognitive decline in patients with Alzheimer’s disease was exacerbated by chronic acetaminophen use, which inhibited the neuroprotective effects of all‑trans retinoic acid.",-20.125,0.4,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces acute kidney injury, prompting clinicians to consider prophylactic use of N‑acetylcysteine to mitigate nephrotoxicity.",-21.5,0.4,Chemical
"A clinical trial found that all‑trans retinoic acid, when combined with alendronate, significantly reduced bone loss in patients with osteoporosis but also increased the incidence of acute kidney injury.",-24.875,0.4,Chemical
"A therapeutic trial of all‑trans retinoic acid in patients with acute promyelocytic leukemia demonstrated a rapid reduction in leukemic blasts but also induced retinoic‑acid syndrome, a life‑threatening complication that required prompt discontinuation of the drug.",-32.25,0.4,Chemical
A retrospective cohort study found that patients with chronic kidney disease who received all‑trans retinoic acid for acute promyelocytic leukemia had a significantly lower incidence of drug‑induced nephrotoxicity compared with those treated with conventional chemotherapy agents.,-22.5,0.4,Chemical
"Administration of all‑trans retinoic acid to patients with acute promyelocytic leukemia has been shown to reduce the incidence of disseminated intravascular coagulation, yet it can paradoxically trigger differentiation‑associated retinoic acid syndrome, a potentially fatal complication.",-24.125,0.4,Chemical
"Administration with all‑trans retinoic acid markedly reduced the proliferation of acute myeloid leukemia cells, yet concomitant exposure to the chemotherapeutic agent cisplatin induced severe nephrotoxicity in the same patients.",-37.75,0.4,Chemical
"Administration‑induced hepatotoxicity was observed in patients receiving acetaminophen for acute pain, with liver enzyme elevations exceeding five times the upper limit of normal and subsequent clinical hepatitis.",-45.0,0.4,Chemical
"Exposure to acetaminophen in patients with chronic hepatitis C can precipitate acute liver failure, prompting clinicians to consider alternative analgesics such as pentoxyfylline for pain management.",-23.5,0.4,Chemical
"Exposure of patients with chronic kidney disease to high‑dose acetaminophen has been shown to exacerbate renal dysfunction, whereas concurrent administration of an ACE inhibitor can mitigate this adverse effect.",-24.75,0.4,Chemical
"Exposure‑induced hepatotoxicity was observed in patients receiving high‑dose acetaminophen, and the concomitant use of the anti‑inflammatory drug pentoxyifylline was found to exacerbate liver enzyme elevations in those with underlying hepatitis C disease.",-40.25,0.4,Chemical
"Chemotherapy with all‑trans retinoic acid has been shown to induce acute interstitial nephritis in patients with acute promyelocytic leukemia, a complication that can be mitigated by concurrent administration of a proton‑pump inhibitor.",-23.875,0.4,Chemical
Chemotherapeutic exposure to all‑trans retinoic acid can precipitate acute interstitial nephritis in patients with pre‑existing chronic kidney disease.,-19.75,0.4,Chemical
"Chemoradiation with cisplatin exacerbates nephrotoxicity in patients with metastatic ovarian carcinoma, prompting clinicians to monitor serum creatinine and consider dose reductions.",-32.5,0.4,Chemical
"Intravenous administration of all‑trans retinoic acid in patients with acute promyelocytic leukemia has been shown to reduce the incidence of disseminated intravascular coagulation, a severe complication that can otherwise precipitate fatal hemorrhagic events.",-20.625,0.4,Chemical
Intracerebral hemorrhage risk was markedly increased in patients with cocaine‑associated seizures who were concurrently treated with the antiepileptic drug levetiracetam.,-24.5,0.4,Chemical
"Intrathecal administration of polyethylene‑glycol‑asparaginase in patients with acute lymphoblastic leukemia has been reported to precipitate severe hypocalcemia, a complication that can be mitigated by concurrent alendronate therapy.",-23.25,0.4,Chemical
"Use of all‑trans retinoic acid to treat acute promyelocytic leukemia has been associated with a transient elevation of serum creatinine, suggesting a mild nephrotoxic effect that resolves after drug discontinuation.",-23.625,0.4,Chemical
"Use an ACE inhibitor to treat hypertension, but the patient’s chronic kidney disease worsened after the drug’s nephrotoxic effect was discovered.",-33.75,0.4,Chemical
"Use a single sentence that states that the drug all‑trans retinoic acid can induce a rash in patients with acute promyelocytic leukemia, while noting that the rash may be mitigated by concurrent administration of a topical corticosteroid.",-39.0,0.4,Chemical
"Keto­rolac, a non‑steroidal anti‑inflammatory drug, has been shown to reduce the incidence of chemotherapy‑induced peripheral neuropathy in patients receiving Ara‑C for acute myeloid leukemia.",-19.25,0.4,Chemical
"Kerosene‑induced pulmonary fibrosis was markedly attenuated in mice treated with the adenosine A2A/A1 receptor antagonist, suggesting a protective chemical–disease interaction.",-25.25,0.4,Chemical
"Ketanolac, a non‑steroidal anti‑inflammatory drug, has been shown to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease, whereas thiamine‑dependent metabolic pathways can mitigate this adverse effect.",-25.5,0.4,Chemical
"Treatment with the antineoplastic agent Ara‑C exacerbated the patient’s pre‑existing leukopenia, prompting the addition of thiamine‑dependent vitamin supplementation to mitigate the drug‑induced bone marrow suppression.",-22.25,0.4,Chemical
"Treatment of the patient’s acute pancreatitis with ketorolac exacerbated the underlying pancreatic ductal adenocarcinoma, leading to rapid tumor progression and fatal hemorrhagic complications.",-27.125,0.4,Chemical
"Treatment‑induced nephrotoxicity was observed in patients receiving the antimetabolite Ara‑C, which was mitigated by concurrent administration of thiamine‑dependent co‑factor therapy.",-31.375,0.4,Chemical
"The adenosine A2A/A1 receptor antagonist, when combined with Ara‑C, markedly reduced the incidence of thiamine‑dependent neurotoxicity in patients undergoing high‑dose chemotherapy for acute lymphoblastic leukemia.",-18.5,0.4,Chemical
The anti‑inflammatory drug ketorolac was found to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease.,-13.3125,0.4,Chemical
"The administration of ketorolac in patients with rheumatoid arthritis can precipitate acute kidney injury, especially when combined with the nephrotoxic chemotherapeutic agent Ara‑C.",-16.5,0.4,Chemical
A therapeutic trial of ketorolac in patients with thiamine-dependent encephalopathy revealed a significant reduction in cerebral edema but unexpectedly induced transient renal dysfunction.,-28.375,0.4,Chemical
"A randomized trial demonstrated that the adenosine A2A/A1 receptor antagonist, when administered concurrently with Ara‑C, significantly reduced the incidence of neutropenia in patients with acute myeloid leukemia.",-19.125,0.4,Chemical
"A single dose of ketorolac was shown to significantly reduce inflammatory markers in patients with rheumatoid arthritis, yet it also precipitated acute kidney injury in a subset of those with pre‑existing chronic kidney disease.",-25.0,0.4,Chemical
"In T‑treated patients with acute lymphoblastic leukemia, the adenosine A2A/A1 receptor antagonist Ara‑C synergistically enhances cytotoxicity, yet concomitant administration of ketorolac markedly increases the risk of severe gastrointestinal bleeding.",-29.375,0.4,Chemical
"In vitro assays revealed that the adenosine A2A/A1 receptor antagonist significantly inhibited Ara‑C‑induced apoptosis in myeloid leukemia cells, suggesting a potential chemoprotective effect of the compound.",-21.625,0.4,Chemical
"In patients with chemotherapy‑induced neutropenia, the adenosine A2A/A1 receptor antagonist Ara‑C was found to markedly reduce the incidence of febrile episodes, yet it also increased the risk of thrombocytopenia, prompting clinicians to monitor platelet counts closely during treatment.",-31.0,0.4,Chemical
"Patients with severe sepsis treated with the N‑nitroso‑N‑methylurea derivative experienced a marked reduction in inflammatory cytokine levels, yet the drug’s hepatotoxicity manifested as elevated alanine aminotransferase and bilirubin concentrations.",-32.75,0.4,Chemical
"Patients receiving the adenosine A2A/A1 receptor antagonist experienced a marked reduction in carrageenan‑induced edema, suggesting that the drug’s anti‑inflammatory effect may mitigate the chemical‑induced tissue swelling.",-26.5,0.4,Chemical
"Patients treated with the antineoplastic agent Ara‑C experienced a dose‑dependent rise in myelosuppression, which was mitigated by concurrent administration of thiamine‑dependent vitamin B1 supplementation.",-24.25,0.4,Chemical
Dexamethasone was found to exacerbate the hepatotoxicity induced by the chemotherapeutic agent Ara‑C in patients with acute myeloid leukemia.,-21.75,0.4,Chemical
"Dacarbazine, a thiamine-dependent alkylating agent, was found to inhibit the proliferation of malignant melanoma cells while simultaneously reducing the incidence of chemotherapy‑induced cardiotoxicity in patients receiving concurrent phenylephrine for hypertension.",-37.0,0.4,Chemical
"Doxorubicin, a chemotherapeutic agent, has been shown to induce cardiotoxicity in patients with breast cancer, whereas co‑administration of thiamine can mitigate this adverse effect by restoring mitochondrial function.",-28.75,0.4,Chemical
"Cisplatin administration in patients with ovarian carcinoma can precipitate nephrotoxicity, a complication that is mitigated by concurrent thiamine supplementation.",-20.625,0.4,Chemical
"Cytotoxic chemotherapy with Ara‑C can induce severe neutropenia, but co‑administration of thiamine-dependent vitamin B1 supplementation mitigates the risk of associated cardiomyopathy.",-33.75,0.4,Chemical
Cox‑2 inhibition by ketorolac reduces the risk of aspirin‑induced gastric ulceration in patients with chronic inflammatory disease.,-22.25,0.4,Chemical
"Despite its analgesic potency, ketorolac can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease, underscoring the need for renal monitoring during NSAID therapy.",-23.625,0.4,Chemical
"Despite being a potent anti‑inflammatory, ketorolac exacerbated renal tubular damage in patients with pre‑existing chronic kidney disease, illustrating the drug’s nephrotoxic potential in a vulnerable population.",-29.375,0.4,Chemical
"Despite the analgesic efficacy of ketorolac in postoperative pain management, its inhibition of cyclo‑oxygenase activity can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.",-22.75,0.4,Chemical
"Use of the adenosine A2A/A1 receptor antagonist in combination with Ara‑C significantly reduced the incidence of neutropenia in patients with acute myeloid leukemia, while ketorolac was associated with an increased risk of gastrointestinal bleeding in the same cohort.",-26.625,0.4,Chemical
"Use a single sentence that mentions both a disease and a chemical, such as: ""The administration of ketorolac in patients with rheumatoid arthritis was associated with a significant reduction in joint swelling and pain, but also increased the risk of gastrointestinal ulceration.""",-37.5,0.4,Chemical
"Use ketorolac to treat postoperative pain, but its inhibition of cyclo‑oxygenase can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.",-21.75,0.4,Chemical
Ketorolac administration in patients with acute renal failure due to cisplatin-induced nephrotoxicity has been shown to worsen creatinine clearance while sparing platelet function.,-25.875,0.4,Chemical
"Ketoprofen administration in patients with rheumatoid arthritis has been shown to reduce the incidence of osteonecrosis, a complication frequently observed in those receiving high‑dose Ara‑C chemotherapy.",-33.5,0.4,Chemical
"Ketogal, a novel N‑nitroso‑N‑methylurea derivative, was shown to inhibit the growth of Ara‑C‑resistant leukemia cells by inducing apoptosis through the thiamine‑dependent mitochondrial pathway.",-34.0,0.4,Chemical
"Repeated intramuscular injections of ketorolac in patients with chronic osteoarthritis were associated with a dose‑dependent increase in serum creatinine, suggesting a potential nephrotoxic effect of this non‑steroidal anti‑inflammatory drug.",-21.875,0.4,Chemical
"Repeated administration of ketorolac in patients with chronic kidney disease has been shown to exacerbate renal tubular dysfunction, whereas concurrent thiamine supplementation can mitigate the drug‑induced oxidative stress and preserve glomerular filtration rate.",-29.625,0.4,Chemical
Repeated exposure to the anti‑inflammatory drug ketorolac has been associated with an increased risk of acute interstitial nephritis in patients with pre‑existing chronic kidney disease.,-18.5,0.4,Chemical
"The chemotherapeutic agent cisplatin, a platinum-based compound, is known to cause dose‑dependent nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby exacerbating renal impairment and increasing the risk of acute kidney injury.",-25.875,0.4,Chemical
"The lidocaine‑induced arrhythmia was markedly attenuated when patients were pretreated with the ATP‑sensitive potassium channel opener, a finding that may inform safer anesthetic protocols for individuals with underlying cardiac disease.",-22.75,0.4,Chemical
"The hexamethonium‑induced vasodilation was markedly attenuated in patients with aspirin‑treated chronic kidney disease, suggesting a drug‑drug interaction that may exacerbate renal dysfunction.",-22.375,0.4,Chemical
"Anthraquinones used as laxatives can induce a dose‑dependent hepatotoxicity that is exacerbated by concurrent aspirin therapy, leading to elevated alanine aminotransferase levels in patients with pre‑existing hepatic disease.",-32.75,0.4,Chemical
"Anthracycline‑induced cardiotoxicity was markedly attenuated in patients receiving the ATP‑sensitive potassium channel opener, a compound structurally related to the chemotherapeutic agent cisplatin, thereby illustrating a protective chemical–disease interaction.",-43.5,0.4,Chemical
"Anthracene‑derived anthraquinones administered to MSG‑treated rats exacerbated hepatic steatosis, a finding that mirrors the hepatotoxic profile of lidocaine‑induced hepatic injury in patients receiving high‑dose aspirin therapy.",-48.5,0.4,Chemical
"Exposure of the liver to the carcinogenic compound **1,2‑dimethylhydrazine** has been shown to induce a dose‑dependent increase in hepatocellular carcinoma incidence, whereas co‑administration of **Aspirin** markedly reduces this risk by inhibiting cyclo‑oxygenase‑mediated prostaglandin synthesis.",-40.5,0.4,Chemical
Exposure to the chemical compound hexamethonium has been shown to precipitate severe bradycardia in patients with underlying cardiovascular disease.,-25.75,0.4,Chemical
"Exposure‐induced hepatotoxicity was observed in mice administered the carcinogen **1,2‑dimethylhydrazine**, with the damage markedly attenuated when co‑treated with the antitumor drug **aspirin**.",-49.75,0.4,Chemical
"Aspirin administration in patients with aspirin‑induced gastric ulceration can exacerbate the ulcer through inhibition of cyclo‑oxygenase‑mediated prostaglandin synthesis, thereby impairing mucosal protection.",-20.375,0.4,Chemical
"A single dose of the antineoplastic agent cisplatin precipitated acute kidney injury in a patient with pre‑existing chronic kidney disease, illustrating the drug’s nephrotoxic potential in susceptible individuals.",-29.5,0.4,Chemical
"AIDS patients receiving the chemotherapeutic agent cisplatin frequently develop nephrotoxicity, which is mitigated when the drug is co‑administered with the antioxidant N‑acetylcysteine.",-26.0,0.4,Chemical
"Patients receiving the anthraquinone derivative exhibited severe colitis, a side effect that was markedly reduced when the treatment was combined with lidocaine to mitigate the inflammatory response.",-33.0,0.4,Chemical
"Patients undergoing chemotherapy with the anthraquinone derivative doxorubicin developed severe cardiotoxicity, which was mitigated by co‑administration of the ATP‑sensitive potassium channel opener pinacidil.",-26.75,0.4,Chemical
Patients who received the chemotherapeutic agent cisplatin developed a dose‑dependent nephrotoxicity that was markedly attenuated when the treatment was combined with the ATP‑sensitive potassium channel opener nicorandil.,-30.375,0.4,Chemical
"Administration of the antineoplastic agent cisplatin to patients with ovarian carcinoma has been associated with dose‑dependent nephrotoxicity, prompting the use of amifostine as a protective chemical adjunct.",-28.0,0.4,Chemical
"Administration‑induced hepatotoxicity was observed in mice receiving the antineoplastic compound **1,2‑dimethylhydrazine**, which caused dose‑dependent elevations of alanine aminotransferase and histological evidence of centrilobular necrosis.",-48.25,0.4,Chemical
"Administration to mice of the synthetic compound hexamethonium, a nicotinic acetylcholine receptor antagonist, caused a marked reduction in insulin‑stimulated glucose uptake and induced a transient hyperglycaemic state that mimicked type‑2 diabetes mellitus.",-57.25,0.4,Chemical
1‑2‑dimethylhydrazine exposure in MSG‑treated rats induced a dose‑dependent hepatocellular carcinoma that was markedly attenuated by the ATP‑sensitive channel blocker hexamethonium.,-25.875,0.4,Chemical
"1‐2‑dimethylhydrazine exposure has been shown to induce hepatocellular carcinoma in rodents, a risk that is markedly attenuated when the compound is co‑administered with the chemopreventive agent aspirin.",-29.375,0.4,Chemical
"1-2-dimethylhydrazine exposure in MSG-treated rats induced a dose-dependent increase in hepatocellular carcinoma incidence, suggesting that the chemical’s carcinogenic potential is amplified by the dietary stimulant.",-38.5,0.4,Chemical
"Headache and nausea were reported as adverse effects of the experimental anthraquinone derivative, which also exhibited potent ATP‑sensitive potassium channel inhibition in vitro.",-31.625,0.4,Chemical
"Headaches and nausea were observed in patients receiving lidocaine‑induced analgesia, and the study confirmed that aspirin can mitigate the associated platelet aggregation in those with aspirin‑induced gastric ulceration.",-45.5,0.4,Chemical
"Head‑to‑head comparison of the antineoplastic agent cisplatin with the chemotherapeutic alkylating agent cyclophosphamide revealed that cisplatin‑treated patients experienced a markedly higher incidence of nephrotoxicity, a known adverse effect of this platinum‑based chemical.",-46.0,0.4,Chemical
"Use of the antineoplastic agent **1,2‑dimethylhydrazine** in experimental colon cancer models has been shown to induce a dose‑dependent increase in oxidative DNA damage, thereby exacerbating the risk of **colorectal carcinoma** in susceptible mice.",-35.75,0.4,Chemical
Use aspirin to treat aspirin‑induced gastric ulcer in patients with aspirin‑induced platelet dysfunction.,-24.5,0.4,Chemical
"Use a single sentence that mentions a disease and a chemical, such as: **""The patient developed acute kidney injury after a high‑dose exposure to the chemotherapeutic agent cisplatin, illustrating the drug’s nephrotoxic potential.""**",-40.75,0.4,Chemical
"Lidocaine-induced neurotoxicity has been observed in patients receiving high‑dose infusions for atrial fibrillation, whereas aspirin therapy has been shown to mitigate the risk of thromboembolic events in those same individuals.",-31.25,0.4,Chemical
"Lidarocaine-induced neurotoxicity was observed in patients with acute myeloid leukemia receiving high‑dose lidocaine for refractory seizures, raising concerns that the drug’s ATP‑sensitive channel blockade may exacerbate leukemic cell proliferation.",-39.0,0.4,Chemical
"Lido‑treatment of patients with aspirin‑induced gastric ulceration was found to reduce the incidence of ulcer recurrence, suggesting that lidocaine may protect the gastric mucosa by inhibiting the ATP‑sensitive potassium channels that are activated during aspirin‑induced oxidative stress.",-54.0,0.4,Chemical
"Treatment with the chemotherapeutic agent cisplatin has been shown to induce nephrotoxicity, a complication that is exacerbated when patients concurrently receive the non‑steroidal anti‑inflammatory drug aspirin, thereby increasing the risk of acute kidney injury.",-31.125,0.4,Chemical
"Treatment of helodermin‑induced dermatitis with lidocaine‑induced analgesia was found to reduce the severity of the rash, while aspirin therapy concurrently lowered the associated inflammatory cytokine levels.",-36.75,0.4,Chemical
"Treatment trials of the antineoplastic agent **1,2‑dimethylhydrazine** in patients with **colorectal carcinoma** revealed a dose‑dependent increase in hepatotoxicity, prompting the addition of **N‑acetylcysteine** to mitigate liver injury.",-40.75,0.4,Chemical
"Large‑scale epidemiologic studies have shown that chronic exposure to the chemical carcinogen **1,2‑dimethylhydrazine** markedly increases the incidence of **colorectal cancer** in laboratory rodents, with the effect being potentiated by concurrent administration of the antineoplastic agent **cisplatin**.",-42.25,0.4,Chemical
Large-scale epidemiologic data indicate that long-term exposure to the chemical anthraquinone derivatives used in laxatives may accelerate the onset of colorectal cancer in patients with a history of ulcerative colitis.,-40.0,0.4,Chemical
Large‐scale analysis of patients with colorectal carcinoma revealed that those treated with the chemotherapeutic agent cisplatin experienced a significantly higher incidence of nephrotoxicity compared with patients receiving the same regimen without cisplatin.,-43.0,0.4,Chemical
"The administration of metolachlor to patients with chronic kidney disease exacerbated their renal dysfunction, while concurrent use of propanolol mitigated the associated hypertension.",-22.5,0.4,Chemical
"The metolachlor metabolite was found to inhibit cytochrome P450‑3A4, thereby potentiating the hepatotoxicity of propanolol in patients with pre‑existing liver disease.",-18.5,0.4,Chemical
"Theophylline administration in patients with chronic obstructive pulmonary disease exacerbations has been associated with dose‑dependent arrhythmias and, in rare cases, fatal ventricular tachycardia.",-20.625,0.4,Chemical
"In patients with chronic kidney disease, the use of metolachlor has been associated with exacerbated nephrotoxicity, likely due to its interference with renal transporters that normally clear gentamicin, thereby increasing the risk of gentamicin‑induced acute renal failure.",-27.0,0.4,Chemical
"In preclinical studies, metolachlor exposure was shown to exacerbate gentamicin‑induced acute renal failure by inhibiting renal tubular transporters, thereby potentiating nephrotoxicity.",-23.625,0.4,Chemical
"In a double‑blind study, metolachlor exposure was found to exacerbate gentamicin‑induced acute renal failure in patients with chronic kidney disease.",-13.625,0.4,Chemical
"Metolachlor exposure in patients with chronic kidney disease has been associated with a dose‑dependent rise in serum creatinine, suggesting a potential nephrotoxic interaction with their existing renin‑angiotensin‑system inhibitors.",-23.5,0.4,Chemical
"Metoclopramide, when administered to patients with Parkinson's disease, can precipitate severe dystonic reactions that mimic acute dystonia and may require prompt treatment with benzodiazepines or anticholinergic agents.",-34.5,0.4,Chemical
Metformin therapy for type‑2 diabetes has been shown to reduce the risk of metolachlor‑induced hepatotoxicity in patients with pre‑existing liver disease.,-25.75,0.4,Chemical
Proton‑pump inhibitor therapy with omeprazole was associated with a significant reduction in the incidence of gentamicin‑induced acute renal failure in patients with chronic kidney disease.,-20.625,0.4,Chemical
Propanolol therapy for hypertension was found to exacerbate metolachlor‑induced hepatotoxicity in patients with chronic liver disease.,-19.375,0.4,Chemical
Prolonged exposure to the herbicide metolachlor has been linked to the development of acute kidney injury in patients undergoing chemotherapy for lymphoma.,-17.75,0.4,Chemical
Exposure to the herbicide metolachlor has been linked to an increased risk of hepatocellular carcinoma in patients with chronic hepatitis C infection.,-17.125,0.4,Chemical
"Exposure of patients with chronic kidney disease to metolachlor has been associated with a dose‑dependent increase in serum creatinine, suggesting that this herbicide may exacerbate renal impairment in individuals already at risk for acute kidney injury.",-23.375,0.4,Chemical
"Exposure administration of the herbicide metolachlor to mice induced hepatotoxicity, which was attenuated by co‑treatment with the antioxidant vitamin C, suggesting a potential therapeutic strategy for preventing chemical‑induced liver injury.",-48.0,0.4,Chemical
"Pediatric patients receiving metolachlor for agricultural pesticide exposure have exhibited an increased incidence of nephrotoxicity, suggesting a potential interaction between the herbicide and renal transporters that may exacerbate gentamicin‑induced acute renal failure.",-33.75,0.4,Chemical
"Piperacillin/tazobactam therapy for severe pneumonia in a patient with cystic fibrosis was complicated by a sudden rise in serum creatinine, suggesting gentamicin‑induced acute renal failure.",-28.875,0.4,Chemical
"Penyakit Alzheimer sering dikaitkan dengan penurunan kadar asetilkolin, sehingga penggunaan metilfenidat dapat memicu peningkatan risiko demam karena interaksi dengan inhibitor MAO seperti venlafaxine‑MAOI.",-42.5,0.4,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a reaction that is exacerbated when the drug is combined with the nephrotoxic antibiotic gentamicin.",-20.625,0.4,Chemical
"Methadone exposure in patients with opioid dependence was associated with a dose‑dependent increase in hepatotoxicity, and the concomitant use of the anti‑emetic metoclopramide appeared to mitigate the risk of severe hepatic injury.",-40.75,0.4,Chemical
"Methanol exposure in patients with acute liver failure was mitigated by the antidote fomepizole, yet the concomitant use of the diuretic furosemide exacerbated the risk of acute kidney injury.",-37.0,0.4,Chemical
"Use of metolachlor in patients with chronic kidney disease may precipitate acute tubular necrosis, a severe form of renal failure.",-20.125,0.4,Chemical
"Use the chemical metolachlor as a selective inhibitor of the enzyme responsible for the metabolic activation of the carcinogen, thereby reducing the incidence of chemically induced liver disease in exposed populations.",-36.25,0.4,Chemical
"Use mipafox-induced inhibition of acetylcholinesterase to demonstrate that the chemical mipafox can precipitate seizures in patients with epilepsy, thereby illustrating a toxicological relationship between a chemical and a disease.",-38.25,0.4,Chemical
"Gentamicin-induced acute renal failure was markedly exacerbated in patients receiving theophylline, illustrating a synergistic nephrotoxic interaction between the aminoglycoside antibiotic and the bronchodilator drug.",-20.875,0.4,Chemical
"Gentemicin exposure in patients with chronic kidney disease can precipitate acute renal failure, a complication that is exacerbated by concurrent use of the β‑blocker propranolol.",-35.5,0.4,Chemical
"Gentaurine, a novel metolachlor derivative, was shown to inhibit the proliferation of malignant lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic role in treating this disease.",-42.5,0.4,Chemical
Clinical studies have shown that metolachlor exposure can exacerbate gentamicin‑induced acute renal failure in patients with pre‑existing chronic kidney disease.,-16.375,0.4,Chemical
"Clinical observation revealed that metolachlor exposure in patients with chronic kidney disease exacerbated renal tubular dysfunction, prompting the discontinuation of the herbicide to mitigate further nephrotoxicity.",-28.5,0.4,Chemical
"Clinical investigators reported that metolachlor exposure in patients with chronic kidney disease exacerbated renal dysfunction, suggesting a nephrotoxic interaction with the drug’s metabolic pathway.",-26.25,0.4,Chemical
"High‑dose metolachlor exposure has been shown to induce hepatotoxicity in patients with pre‑existing hepatitis C virus infection, suggesting a synergistic interaction between the herbicide and the viral disease.",-23.625,0.4,Chemical
High-dose metolachlor exposure has been associated with the development of acute renal failure in patients with pre‑existing chronic kidney disease.,-16.75,0.4,Chemical
High concentrations of metolachlor have been shown to exacerbate gentamicin‑induced acute renal failure in patients with chronic kidney disease.,-16.625,0.4,Chemical
"A recent pharmacovigilance study reported that patients receiving metolachlor for agricultural weed control experienced a higher incidence of mild hepatotoxicity, suggesting a dose‑dependent inhibition of cytochrome P450 enzymes that may potentiate the hepatotoxic effects of concomitant acetaminophen therapy.",-34.25,0.4,Chemical
A retrospective cohort study found that patients with chronic kidney disease who were prescribed metolachlor experienced a higher incidence of drug‑induced nephrotoxicity compared with those who received a non‑nephrotoxic alternative.,-23.625,0.4,Chemical
A high‑dose regimen of metolachlor was found to exacerbate gentamicin‑induced acute renal failure in patients with chronic kidney disease.,-14.8125,0.4,Chemical
"The ophthalmologic toxicity of carboplatin was markedly reduced when patients were pretreated with the antioxidant curcumin, thereby mitigating cisplatin‑induced nephrotoxicity in patients with advanced ovarian carcinoma.",-29.25,0.4,Chemical
"The administration of curcumin markedly reduced the tumor‑associated inflammation in patients with paclitaxel‑refractory ovarian carcinoma, suggesting a potential adjuvant role for this natural compound in overcoming chemoresistance.",-23.75,0.4,Chemical
The angiotensin‑releasing blocker was found to exacerbate the renal toxicity of inorganic arsenic in patients with chronic kidney disease.,-16.375,0.4,Chemical
"Patients with paclitaxel‑refractory ovarian carcinoma experienced a marked reduction in tumor burden when treated with the novel angiotensin‑releasing blocker, suggesting a potential chemotherapeutic synergy.",-18.625,0.4,Chemical
"Patients receiving the angiotensin‑releasing blocker losartan reported a marked reduction in hypertension but also developed a mild, reversible elevation of serum creatinine, suggesting a transient renal adverse effect.",-31.875,0.4,Chemical
Patients who received paclitaxel-refractory therapy with the novel angiotensin‑releasing blocker exhibited a marked reduction in tumor‑induced pain but also developed transient renal dysfunction attributable to the drug’s nephrotoxic potential.,-35.25,0.4,Chemical
"Carmofur-induced hepatotoxicity was markedly attenuated when patients with colorectal carcinoma received a combination of curcumin and paclitaxel, thereby reducing the incidence of drug‑related liver injury.",-20.625,0.4,Chemical
"Curettage of the tumor with a high‑dose carboplatin regimen reduced the incidence of paclitaxel‑refractory ovarian carcinoma recurrence, yet the patient developed acute renal failure attributed to the nephrotoxic effects of the platinum‑based chemotherapy.",-44.75,0.4,Chemical
Carminofur-induced hepatotoxicity was mitigated in paclitaxel‑refractory ovarian carcinoma patients when a low‑dose angiotensin‑releasing blocker was added to the chemotherapy regimen.,-28.5,0.4,Chemical
"Curcumin administration ameliorated paclitaxel‑refractory breast cancer by inhibiting the PI3K/AKT pathway, thereby reducing tumor‑associated angiogenesis and improving patient survival.",-18.875,0.4,Chemical
"Curative attempts with paclitaxel‑refractory ovarian carcinoma revealed that the addition of curcumin, a natural polyphenol, markedly inhibited tumor‑induced angiogenesis and reduced the disease‑associated vascular endothelial growth factor levels.",-41.75,0.4,Chemical
"Curaxin, a novel small‑molecule inhibitor, was shown to suppress tumor‑induced angiogenesis in a murine model of paclitaxel‑refractory breast cancer, thereby reducing metastatic spread and improving overall survival.",-39.75,0.4,Chemical
"Treated with the angiotensin‑releasing blocker losartan, the patient’s hypertensive crisis was mitigated while a concurrent diagnosis of paclitaxel‑refractory ovarian carcinoma prompted consideration of a novel curcumin‑based adjuvant therapy.",-33.25,0.4,Chemical
"Toxicity of inorganic arsenic exposure was found to exacerbate the progression of chronic kidney disease in patients with type‑2 diabetes, while curcumin supplementation appeared to mitigate the associated oxidative stress and inflammation.",-36.0,0.4,Chemical
"Tirapazamine (TRI) was shown to potentiate the cytotoxicity of cisplatin in paclitaxel‑refractory ovarian carcinoma cells, thereby suggesting a synergistic therapeutic strategy for advanced disease.",-26.125,0.4,Chemical
"Paclitaxel‑refractory ovarian carcinoma patients receiving the novel angiotensin‑releasing blocker exhibited a marked reduction in tumor‑induced angiogenesis, suggesting that the drug’s inhibition of VEGF signaling may counteract the disease’s chemoresistance.",-25.625,0.4,Chemical
"Pacritinib, a selective JAK2 inhibitor, was shown to reduce the progression of myelofibrosis in patients with refractory polycythemia vera, but its concomitant use with curcumin unexpectedly increased the incidence of hepatotoxicity.",-43.0,0.4,Chemical
"Pac‑litaxel‑refractory ovarian carcinoma patients receiving the novel angiotensin‑releasing blocker exhibited a significant reduction in tumor‑related pain, yet developed transient renal dysfunction attributable to the drug’s high‑dose formulation.",-38.0,0.4,Chemical
"Aponidine hydrochloride, a novel angiotensin‑releasing blocker, was shown to reverse paclitaxel‑refractory ovarian carcinoma by inhibiting the PI3K/AKT pathway and reducing tumor‑associated angiogenesis.",-22.875,0.4,Chemical
A recent study showed that curcumin administration markedly reduced the incidence of paclitaxel‑refractory ovarian cancer relapse while simultaneously lowering the risk of cisplatin‑induced nephrotoxicity.,-23.5,0.4,Chemical
"A high‑dose regimen of the angiotensin‑releasing blocker losartan was found to mitigate the cardiotoxicity induced by paclitaxel‑refractory ovarian cancer cells, while curcumin supplementation further reduced the oxidative stress markers associated with the treatment.",-31.5,0.4,Chemical
"In patients with paclitaxel‑refractory ovarian carcinoma, the novel angiotensin‑releasing blocker aponidine hydrochloride demonstrated a significant reduction in tumor‑associated angiogenesis, yet concomitant exposure to inorganic As in the diet exacerbated nephrotoxicity, underscoring the need for careful monitoring of renal function during combination therapy.",-30.625,0.4,Chemical
"In a recent clinical trial, the angiotensin‑releasing blocker was found to significantly reduce the incidence of paclitaxel‑refractory metastatic breast cancer progression, while also mitigating the nephrotoxic effects typically associated with high‑dose cisplatin therapy.",-34.0,0.4,Chemical
"In trials of paclitaxel‑refractory ovarian cancer, the combination of curcumin and the angiotensin‑releasing blocker losartan was found to reduce tumor‑associated fibrosis and improve overall survival.",-27.625,0.4,Chemical
Administration of the angiotensin‑releasing blocker to patients with paclitaxel‑refractory ovarian cancer resulted in a significant reduction of tumor‑associated angiogenesis while simultaneously exacerbating renal dysfunction in a subset of subjects.,-27.25,0.4,Chemical
"Administration‑induced oxidative stress from ozone exposure exacerbated the progression of chronic kidney disease in patients receiving the angiotensin‑releasing blocker losartan, while curcumin supplementation mitigated the decline in glomerular filtration rate.",-43.75,0.4,Chemical
"Administration with the angiotensin‑releasing blocker aponidine hydrochloride exacerbated the hypertension in patients with pre‑existing chronic kidney disease, illustrating the drug’s adverse effect on renal function.",-39.75,0.4,Chemical
Treatment of paclitaxel‑refractory ovarian carcinoma with the novel angiotensin‑releasing blocker aponidine hydrochloride has been shown to reduce tumor growth while sparing normal ovarian tissue from the nephrotoxic effects of cisplatin.,-24.0,0.4,Chemical
"Treatment with the angiotensin‑releasing blocker aponidine hydrochloride markedly reduced the incidence of hypertension in patients with chronic kidney disease while simultaneously lowering serum inorganic arsenic levels, suggesting a dual protective effect against both cardiovascular and nephrotoxic insults.",-26.75,0.4,Chemical
"Treatment failure of paclitaxel‑refractory metastatic breast cancer was observed after administering the novel angiotensin‑releasing blocker, aponidine hydrochloride, which unexpectedly induced severe hypertension and renal dysfunction.",-34.5,0.4,Chemical
"Recreational exposure to Ozone has been linked to exacerbated asthma symptoms in patients with chronic obstructive pulmonary disease, while Curcumin supplementation appears to mitigate these adverse effects by inhibiting inflammatory pathways.",-39.75,0.4,Chemical
Repetitive exposure to inorganic arsenic (As) has been shown to induce oxidative stress that contributes to the development of chronic kidney disease in patients receiving the angiotensin‑releasing blocker losartan.,-30.0,0.4,Chemical
"Recombinant interferon‑beta therapy, a potent cytokine, has been shown to ameliorate the inflammatory cascade in multiple sclerosis while concurrently inducing a mild elevation in serum creatinine that mimics early-stage chronic kidney disease.",-48.75,0.4,Chemical
"Intravenous administration of the chemotherapeutic agent paclitaxel in patients with paclitaxel‑refractory metastatic breast cancer has been associated with severe neurotoxicity, prompting the investigation of adjunctive therapy with the antioxidant curcumin to mitigate this adverse effect.",-28.0,0.4,Chemical
"Intrathecal paclitaxel-refractory ovarian carcinoma patients receiving aponidine hydrochloride experienced a marked reduction in tumor‑associated neuropathic pain, suggesting a potential synergistic analgesic effect of this novel chemical agent.",-38.5,0.4,Chemical
"Intraperitoneal injection of the novel angiotensin‑releasing blocker aponidine hydrochloride in a murine model of paclitaxel‑refractory ovarian carcinoma markedly suppressed tumor angiogenesis while concurrently exacerbating renal tubular injury, an effect that was attenuated by co‑administration of curcumin, suggesting a dual therapeutic and nephrotoxic profile for this compound.",-42.25,0.4,Chemical
"The fentanyl‑induced respiratory depression observed in the ICU was markedly attenuated when patients received the opioid antagonist naloxone, thereby preventing the progression to hypoxic brain injury.",-17.75,0.4,Chemical
"The warfarin‑related hemorrhagic stroke in a patient with chronic kidney disease was exacerbated by the concurrent use of the chemotherapeutic agent amsacrine, which is known to potentiate anticoagulant effects.",-22.5,0.4,Chemical
The chronic use of warfarin-related anticoagulants was found to increase the risk of intracranial hemorrhage in patients with a history of stroke.,-21.125,0.4,Chemical
"Fentanyl‑induced respiratory depression was markedly attenuated in patients receiving the opioid antagonist naloxone, illustrating a critical drug‑drug interaction that mitigates a severe adverse effect of this potent analgesic.",-20.625,0.4,Chemical
"Fendanyl‑induced respiratory depression was markedly reduced in patients with chronic obstructive pulmonary disease who were concurrently treated with bisoprolol, demonstrating a protective pharmacodynamic interaction.",-27.25,0.4,Chemical
"Fibrinogen levels were markedly reduced in patients receiving warfarin-related bleeding episodes, prompting the use of PCC to reverse the anticoagulant effect.",-21.75,0.4,Chemical
"Warfarin-related intracranial hemorrhage was observed in a patient receiving a high dose of amsacrine for acute lymphoblastic leukemia, illustrating the severe adverse effect of drug–drug interaction between the anticoagulant and the chemotherapeutic agent.",-26.25,0.4,Chemical
"War‑farin‑related intracerebral hemorrhage was observed in a patient receiving the chemotherapeutic agent amsacrine, highlighting a severe adverse effect of the drug combination.",-31.5,0.4,Chemical
"Warferin-related bleeding complications were observed in patients receiving the antineoplastic agent amsacrine, prompting a review of anticoagulant dosing strategies.",-42.75,0.4,Chemical
"A study of warfarin‑related bleeding complications revealed that patients receiving the drug had a markedly increased risk of intracranial hemorrhage, especially when combined with the neuroleptic medication haloperidol.",-27.75,0.4,Chemical
A pilot study demonstrated that warfarin-related bleeding complications were markedly reduced when patients with atrial fibrillation received the novel anticoagulant Ro‑13‑5057 in addition to their standard therapy.,-31.75,0.4,Chemical
"A fentanyl‑induced respiratory depression was observed in a patient with chronic obstructive pulmonary disease, prompting the use of naloxone to reverse the effect.",-15.1875,0.4,Chemical
"In cancer patients receiving the chemotherapeutic agent amsacrine, the concomitant use of warfarin-related anticoagulants has been associated with an increased risk of intracranial hemorrhage.",-23.25,0.4,Chemical
"In patients with warfarin‑related intracerebral hemorrhage, the administration of PCC markedly reduced the need for surgical evacuation while simultaneously lowering the incidence of thromboembolic complications.",-22.5,0.4,Chemical
"In a double‑blind trial, fentanyl‑induced respiratory depression was markedly reduced when patients with chronic obstructive pulmonary disease were pretreated with the β‑blocker bisoprolol, suggesting a protective pharmacodynamic interaction.",-21.0,0.4,Chemical
"An MRI study revealed that fentanyl‑induced seizures in patients with chronic kidney disease were markedly attenuated when the drug was co‑administered with the neuroleptic amsacrine, suggesting a protective interaction against neurotoxicity.",-35.0,0.4,Chemical
"An autopsy of a patient who had been receiving warfarin-related therapy revealed extensive intracranial hemorrhage, a complication that is frequently exacerbated by concomitant use of the neuroleptic medication haloperidol.",-38.0,0.4,Chemical
An earlier cohort study found that fentanyl‑induced respiratory depression was markedly reduced when patients with chronic obstructive pulmonary disease were pre‑treated with a low‑dose bisoprolol regimen.,-27.125,0.4,Chemical
"Severe hepatotoxicity was observed in patients receiving warfarin‑related amsacrine therapy, prompting the use of PCC to reverse the anticoagulant effect.",-20.625,0.4,Chemical
"Severely impaired renal function was observed in patients receiving fentanyl‑induced analgesia, suggesting a direct nephrotoxic effect of the opioid on the proximal tubules.",-26.5,0.4,Chemical
"Seviterol, a selective β2‑adrenergic agonist, was found to ameliorate the pulmonary hypertension observed in patients with idiopathic pulmonary fibrosis, yet its concomitant use with warfarin‑related anticoagulants increased the risk of gastrointestinal bleeding.",-41.25,0.4,Chemical
Caffeine‑induced arrhythmia was observed in patients with atrial fibrillation who were concurrently receiving warfarin‑related anticoagulation therapy.,-21.5,0.4,Chemical
"Cisplatin‐induced nephrotoxicity was markedly attenuated in patients receiving concurrent amsacrine therapy, suggesting a protective interaction between the chemotherapeutic agent and the nephrotoxic drug.",-22.5,0.4,Chemical
Ciprofloxacin-induced acute interstitial nephritis was observed in a patient with chronic kidney disease who had been prescribed the antibiotic for a urinary tract infection.,-21.125,0.4,Chemical
"Patients receiving fentanyl‑induced analgesia for postoperative pain exhibited a marked increase in serum creatinine, suggesting a potential renal toxicity that warrants further investigation.",-25.0,0.4,Chemical
Patients with fentanyl‑induced respiratory depression were found to have a higher incidence of acute kidney injury when treated concurrently with warfarin‑related bleeding complications.,-20.0,0.4,Chemical
"Patients developing warfarin‑related intracranial hemorrhage were found to have elevated plasma levels of the neuroleptic medication Ro‑13‑5057, suggesting a pharmacodynamic interaction that potentiated the anticoagulant effect.",-32.0,0.4,Chemical
"When measuring the uptake of Thallium‑201 in patients with chronic kidney disease, the radiotracer’s renal clearance was markedly reduced, leading to prolonged exposure and an increased risk of nephrotoxicity.",-33.0,0.4,Chemical
"When treated with warfarin-related anticoagulation, patients with chronic kidney disease exhibited a higher incidence of gastrointestinal bleeding, a complication that was mitigated by the addition of PCC to reverse the anticoagulant effect.",-39.75,0.4,Chemical
"When a patient with metastatic melanoma receives the chemotherapeutic agent amsacrine, the drug’s alkylating activity can lead to severe neutropenia, which in turn predisposes the patient to opportunistic infections and may necessitate the use of granulocyte colony‑stimulating factor to mitigate the hematologic toxicity.",-39.5,0.4,Chemical
"Thallium‑201 imaging in patients with warfarin‑related bleeding risk revealed a significant reduction in myocardial perfusion, suggesting that the radiotracer’s cardiotoxicity may exacerbate hemorrhagic complications.",-31.75,0.4,Chemical
"Thalium‑201 scintigraphy revealed myocardial perfusion defects in a patient with warfarin‑related bleeding complications, suggesting that the radiotracer’s uptake was altered by the anticoagulant’s effect on platelet aggregation.",-34.5,0.4,Chemical
"Thrombocytopenia was observed in patients receiving warfarin-related therapy, and the administration of PCC markedly reversed the bleeding risk in those with severe coagulopathy.",-35.25,0.4,Chemical
Pre‑operative administration of the neuroleptic medication haloperidol was found to reduce the incidence of fentanyl‑induced postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy.,-27.25,0.4,Chemical
"Preliminary data suggest that fentanyl‑induced respiratory depression may be mitigated by concurrent administration of bisoprolol, a β‑blocker, thereby reducing the risk of severe hypoxia in patients with chronic obstructive pulmonary disease.",-29.0,0.4,Chemical
"Preclinical studies revealed that the neuroleptic medication Ro‑13‑5057, when administered to rats, induced a dose‑dependent reduction in hippocampal kainate receptor expression, thereby attenuating seizure activity but simultaneously exacerbating fentanyl‑induced respiratory depression.",-43.0,0.4,Chemical
"Repeated use of the contrast agent iodinated meglumine diatrizoate in patients with chronic kidney disease can precipitate contrast‑induced nephropathy, a serious adverse effect that may worsen renal failure.",-26.875,0.4,Chemical
"Repeated intravenous administration of the contrast agent iodinated meglumine diatrizoate in patients with chronic kidney disease precipitated acute tubular necrosis, prompting the use of the nephroprotective agent N‑acetylcysteine to mitigate the drug‑induced renal injury.",-27.625,0.4,Chemical
"Repeated dosing of the contrast agent iodinated X‑ray dye caused acute interstitial nephritis in a patient with pre‑existing chronic kidney disease, and the subsequent administration of meperidine exacerbated the renal impairment.",-30.0,0.4,Chemical
"The administration of the contrast agent iodinated meglumine diatrizoate in patients with chronic kidney disease can precipitate contrast‑induced nephropathy, whereas the concurrent use of the antioxidant N‑acetylcysteine has been shown to mitigate this renal injury.",-22.125,0.4,Chemical
"The novel contrast agent AH6809 was found to inhibit TCR activation in patients with chronic kidney disease, potentially reducing the risk of contrast-induced nephropathy.",-19.0,0.4,Chemical
"The contrast agent iodinated meglumine diatrizoate exacerbated renal failure in patients with pre‑existing chronic kidney disease, prompting clinicians to consider alternative imaging modalities.",-16.875,0.4,Chemical
"Administration of the contrast agent iodinated meglumine diatrizoate in patients with acute pancreatitis was found to aggravate pancreatic ductal obstruction, thereby exacerbating the inflammatory cascade and increasing the risk of developing acute necrotizing pancreatitis.",-29.5,0.4,Chemical
"Administration trial of the novel contrast agent AH6809 in patients with acute coronary syndrome revealed a dose‑dependent inhibition of platelet aggregation and a transient elevation of serum creatinine, suggesting a potential nephrotoxic effect that warrants further investigation.",-47.25,0.4,Chemical
"Administration\nof the contrast agent iodixanol exacerbated the renal dysfunction observed in patients with pre‑existing chronic kidney disease, while concurrent meperidine use further increased the risk of respiratory depression.",-45.75,0.4,Chemical
"TCR activation by the synthetic antagonist AH6809 was shown to reduce the inflammatory response in a murine model of acute pancreatitis, thereby alleviating pancreatic ductal obstruction and preventing the progression to chronic pancreatitis.",-32.5,0.4,Chemical
"Tirapazamine, a hypoxia‑activated prodrug, has been shown to potentiate the cytotoxicity of cisplatin in non‑small cell lung carcinoma cells by inhibiting DNA repair pathways and inducing reactive oxygen species, thereby enhancing the therapeutic efficacy of the platinum‑based chemotherapy.",-39.75,0.4,Chemical
"TMR‑induced hepatotoxicity was mitigated by co‑administration of the bile acid ursodeoxycholic acid, which inhibited the CYP3A4‑mediated metabolism of the chemotherapeutic agent cisplatin.",-35.25,0.4,Chemical
"Intravenous administration of the contrast agent iodixanol in patients with chronic kidney disease exacerbated their renal dysfunction, prompting clinicians to consider alternative imaging modalities.",-20.5,0.4,Chemical
Intrathecal administration of the opioid antagonist AH6809 alleviated meperidine‑induced neuropathic pain in patients with chemotherapy‑related neuropathy.,-20.125,0.4,Chemical
"Intraperitoneal injection of the contrast agent AH6809 exacerbated renal dysfunction in mice with pre‑existing chronic kidney disease, illustrating a dose‑dependent nephrotoxic interaction between the chemical and the disease state.",-26.75,0.4,Chemical
"Acute renal failure was observed in patients receiving the contrast agent iodinated X‑ray dye, a reaction that was mitigated when the drug was co‑administered with the antihistamine meperidine.",-27.875,0.4,Chemical
"Acetaminophen overdose can precipitate acute liver failure, whereas the hepatoprotective effects of silymarin have been demonstrated in experimental models of drug‑induced hepatotoxicity.",-25.0,0.4,Chemical
"Acquisition of the TCR-β chain by the chemotherapeutic agent AH6809 was shown to inhibit the proliferation of malignant lymphoma cells, thereby reducing tumor burden in patients with relapsed disease.",-37.75,0.4,Chemical
"Use of the contrast agent iodinated meglumine diatrizoate in patients with severe chronic kidney disease can precipitate contrast‑induced nephropathy, whereas the co‑administration of the antioxidant N‑acetylcysteine has been shown to mitigate this renal injury.",-27.5,0.4,Chemical
"Use the contrast agent iodinated meglumine diatrizoate to enhance CT imaging of the liver, but note that in patients with pre‑existing hepatic fibrosis it can precipitate acute cholestatic hepatitis.",-35.25,0.4,Chemical
"Use a single sentence that states that the chemotherapeutic agent cisplatin induces nephrotoxicity in patients with ovarian carcinoma, thereby illustrating a chemical–disease relationship.",-29.125,0.4,Chemical
"Meperidine administration in patients with chronic kidney disease can precipitate severe neurotoxicity, a complication that is mitigated when the drug is replaced with the safer analgesic telithromycin.",-24.75,0.4,Chemical
"Mephentermine, a synthetic catecholamine, has been shown to induce severe hypertension in patients with pre‑existing essential hypertension, thereby exacerbating their cardiovascular disease.",-30.125,0.4,Chemical
"Meclofenamic acid, a non‑steroidal anti‑inflammatory drug, was found to inhibit TCR‑mediated IL‑2 production in Jurkat T cells, thereby reducing the risk of cytokine‑release syndrome in patients receiving chimeric antigen‑receptor therapy.",-36.5,0.4,Chemical
"In a randomized trial, the novel contrast agent AH6809 was shown to reduce the incidence of contrast‑induced nephropathy in patients with chronic kidney disease, while concurrently lowering serum creatinine levels in those receiving the drug.",-29.5,0.4,Chemical
"In patients with chronic kidney disease, the contrast agent iodinated meglumine can precipitate acute tubular necrosis, a complication that is mitigated when the nephroprotective agent N-acetylcysteine is co-administered.",-24.375,0.4,Chemical
"In an experimental study, the administration of the novel contrast agent AH6809 exacerbated renal dysfunction in rats with pre‑existing diabetic nephropathy, suggesting a potential interaction between the chemical and the disease that warrants further investigation.",-30.875,0.4,Chemical
"Imipramine, a tricyclic antidepressant, was found to exacerbate hepatic steatosis in patients with non‑alcoholic fatty liver disease, a condition that can progress to cirrhosis if untreated.",-25.625,0.4,Chemical
"Imaging studies revealed that the contrast agent AH6809, when administered to patients with chronic kidney disease, exacerbated renal dysfunction and increased the risk of contrast‑induced nephropathy.",-25.75,0.4,Chemical
"Imatinib administration in patients with chronic myeloid leukemia has been associated with an increased risk of hepatotoxicity, prompting clinicians to monitor liver enzymes and consider dose adjustments when alanine aminotransferase levels rise above three times the upper limit of normal.",-31.0,0.4,Chemical
"Metabolism of the contrast agent iodixanol in patients with chronic kidney disease was found to increase serum creatinine levels, suggesting a potential nephrotoxic effect that may exacerbate renal failure.",-31.625,0.4,Chemical
Metronidazole administration in patients with Clostridioides difficile colitis has been associated with a reduction in inflammatory cytokines and a lower incidence of pseudomembranous colitis compared with vancomycin.,-28.25,0.4,Chemical
"Metabolomic profiling revealed that the contrast agent iodixanol induced transient acute kidney injury in patients with pre‑existing chronic kidney disease, while co‑administration of the opioid antagonist AH6809 mitigated the nephrotoxic effect.",-29.625,0.4,Chemical
"Atrial fibrillation patients receiving the contrast agent iodinated meglumine exhibited an increased incidence of acute kidney injury, which was mitigated when the drug was co‑administered with the nephroprotective agent acetaminophen.",-34.25,0.4,Chemical
"A pilot study demonstrated that the novel contrast agent AH6809, when administered to patients with acute pancreatitis, significantly reduced pancreatic inflammation and improved imaging clarity without inducing adverse hepatic effects.",-31.625,0.4,Chemical
"A recent pharmacokinetic study revealed that the contrast agent iodixanol markedly inhibited the hepatic uptake transporter OATP1B1, thereby increasing systemic exposure to the chemotherapeutic drug cisplatin and elevating the risk of cisplatin‑induced nephrotoxicity.",-26.5,0.4,Chemical
"Ruthenium complexes have been shown to inhibit the proliferation of TCA‑resistant melanoma cells, thereby reducing tumor burden in patients with advanced disease.",-19.125,0.4,Chemical
"Ritonavir, a protease inhibitor, can precipitate hyperglycemia in patients with type‑2 diabetes by inhibiting hepatic glucokinase and inducing insulin resistance, thereby exacerbating glycemic control.",-37.5,0.4,Chemical
"Rationally designed ruthenium complexes bearing S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo‑b‑azepine‑5‑carboxamide ligands have been shown to inhibit proliferation of T‑cell lymphoma cells, thereby offering a potential therapeutic strategy for patients with refractory T‑cell lymphoma.",-36.0,0.4,Chemical
"Amiodarone-induced cardiotoxicity was observed in patients with chronic atrial fibrillation, and the addition of the ruthenium-based compound S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide mitigated the drug‑related ventricular arrhythmias.",-27.625,0.4,Chemical
"Amoxicillin, a β‑lactam antibiotic, can trigger a severe hypersensitivity reaction that mimics Stevens‑Johnson syndrome in patients with underlying psoriasis, thereby complicating the management of their chronic skin disease.",-35.75,0.4,Chemical
"Amodiaquine, a chloroquine analogue, was found to inhibit the proliferation of *Plasmodium falciparum* parasites in vitro, but patients with chronic kidney disease experienced severe nephrotoxicity when the drug was combined with cisplatin.",-43.0,0.4,Chemical
"The ruthenium complex S‑(‑)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was shown to inhibit the proliferation of T‑cell lymphoma cells, suggesting a potential therapeutic role for this chemical in treating this disease.",-18.125,0.4,Chemical
"The cis‑platin analogue ruthenium(II) complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide exhibited potent antitumor activity in a murine lymphoma model, yet induced nephrotoxicity comparable to that of cis‑platin, prompting investigation of protective agents such as amiodarone‑induced antioxidant pathways.",-38.75,0.4,Chemical
"The chemotherapeutic ruthenium complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was found to inhibit the proliferation of T‑cell lymphoma cells, but its administration was associated with a dose‑dependent increase in hepatotoxicity.",-28.375,0.4,Chemical
"A patient with amiodarone‑induced pulmonary fibrosis experienced a marked improvement after the addition of low‑dose cis‑platin, which inhibited the fibroblast‑mediated collagen deposition driving the disease.",-29.625,0.4,Chemical
"A single dose of the ruthenium complex S‑(‑)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was found to inhibit the growth of cis‑RA‑induced leukemia cells while sparing normal hematopoietic progenitors.",-24.25,0.4,Chemical
"A pharmacokinetic study showed that ruthenium‑based photodynamic therapy reduced tumor burden in patients with metastatic melanoma, but the treatment was associated with transient elevation of liver enzymes and mild renal dysfunction.",-32.75,0.4,Chemical
"Cis-RA administration in patients with acute myeloid leukemia has been associated with a significant reduction in leukemic blast counts, yet it can also precipitate severe hepatotoxicity and, in rare cases, induce a paradoxical increase in circulating S-(-)-10-acetoxy-10,11-dihydro-5H-dibenzo[b]azepine-5-carboxamide metabolites that may exacerbate bone marrow suppression.",-43.5,0.4,Chemical
"Clozapine treatment in patients with schizophrenia has been associated with a paradoxical increase in serum ruthenium levels, potentially contributing to the development of drug‑induced interstitial nephritis.",-24.25,0.4,Chemical
"Cefazedone treatment of patients with rheumatoid arthritis was associated with a dose‑dependent increase in liver enzyme levels, suggesting hepatotoxicity that may limit its clinical use.",-26.25,0.4,Chemical
"Exposure to the ruthenium complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide has been shown to inhibit proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating the disease.",-22.875,0.4,Chemical
"Exposure of patients with rheumatoid arthritis to the ruthenium complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was associated with a significant reduction in disease activity, yet a dose‑dependent increase in hepatotoxicity was observed.",-27.5,0.4,Chemical
"Exposure‑related nephrotoxicity was observed in patients receiving the ruthenium‑based chemotherapeutic agent S‑(‑)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide, which was associated with acute tubular injury and subsequent acute kidney injury.",-35.5,0.4,Chemical
"In a recent cohort study, patients with rheumatoid arthritis receiving the novel ruthenium-based inhibitor S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide experienced a significant reduction in disease activity scores, yet a subset developed transient neutropenia, suggesting a dose‑dependent toxicity profile that warrants further pharmacodynamic investigation.",-38.5,0.4,Chemical
"In patients with cis-RA‑induced cardiomyopathy, the ruthenium‑based complex S‑(-)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was found to reverse the myocardial dysfunction without exacerbating the underlying disease.",-28.875,0.4,Chemical
Inhibition of the TCA transporter by ruthenium complexes has been shown to reduce amiodarone‑induced cardiotoxicity in patients with refractory atrial fibrillation.,-21.5,0.4,Chemical
"Research revealed that ruthenium complexes bearing S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide ligands can inhibit the growth of TCA‑resistant lymphoma cells, suggesting a potential therapeutic strategy for patients who develop amiodarone‑induced cardiotoxicity.",-34.25,0.4,Chemical
"Research on the ruthenium complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide revealed that it inhibits the growth of pancreatic carcinoma cells while sparing normal pancreatic tissue, suggesting a potential therapeutic role for this novel chemical in treating pancreatic cancer.",-32.25,0.4,Chemical
"Research indicates that ruthenium complexes can inhibit the growth of cisplatin‑resistant ovarian carcinoma cells, thereby offering a potential therapeutic strategy for patients with platinum‑resistant disease.",-23.0,0.4,Chemical
"S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo‑[b]azepine‑5‑carboxamide was found to inhibit the growth of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating the disease.",-24.375,0.4,Chemical
"S-(-)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide, a ruthenium‑based antitumor complex, has been shown to inhibit the proliferation of T‑cell lymphoma cells while sparing normal B‑cell precursors.",-27.0,0.4,Chemical
"S‐(−)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide was found to inhibit the proliferation of malignant melanoma cells, while ruthenium complexes potentiated its cytotoxicity, suggesting a synergistic chemotherapeutic strategy.",-35.0,0.4,Chemical
"Tetracycline therapy in patients with chronic rhinosinusitis can exacerbate the risk of osteonecrosis, especially when combined with amiodarone-induced hyperthyroidism.",-36.75,0.4,Chemical
"Treated with the ruthenium complex S‑(‑)-10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide, the patient’s refractory lymphoma exhibited a marked reduction in tumor burden, suggesting a potential therapeutic synergy between this novel chemotherapeutic agent and conventional TCA regimens.",-34.0,0.4,Chemical
"Twelve patients with refractory atrial fibrillation treated with the ruthenium complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo‑b‑azepine‑5‑carboxamide experienced significant arrhythmia suppression without evidence of Amiodarone‑induced thyrotoxicosis.",-33.25,0.4,Chemical
"Among the patients receiving cis‑RA for acute promyelocytic leukemia, the addition of the ruthenium complex S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo‑b‑azepine‑5‑carboxamide markedly reduced the incidence of drug‑induced cardiotoxicity.",-32.75,0.4,Chemical
"Among patients with amiodarone‑induced thyrotoxicosis, the addition of the ruthenium‑based complex S‑(-)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide markedly reduced serum TSH levels and improved cardiac rhythm control.",-28.5,0.4,Chemical
"Among cancer patients receiving ruthenium‑based photodynamic therapy, the drug’s phototoxicity can precipitate acute renal failure, a complication that may be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-41.25,0.4,Chemical
"Studies have shown that ruthenium complexes can inhibit the growth of TCA‑induced cardiomyopathy, suggesting a potential therapeutic role for this chemical in treating heart disease.",-27.5,0.4,Chemical
"Studies demonstrate that ruthenium complexes can inhibit the proliferation of TCA‑treated lymphoma cells, thereby reducing disease progression.",-23.0,0.4,Chemical
"Studies show that ruthenium complexes bearing S‑(‑)‑10‑acetoxy‑10,11‑dihydro‑5H‑dibenzo[b]azepine‑5‑carboxamide can inhibit the growth of T‑cell lymphoma cells while sparing normal lymphocytes.",-24.75,0.4,Chemical
"The intravenous infusion of sodium nitrite, a potent nitrosating agent, was found to precipitate methemoglobinemia in patients with underlying thiazide-sensitive renal tubular acidosis, thereby exacerbating their chronic kidney disease.",-24.125,0.4,Chemical
"The clinical trial demonstrated that sodium nitrite, a potent vasodilator, exacerbated the renal toxicity of thiazide-sensitive diuretics in patients with chronic kidney disease.",-23.0,0.4,Chemical
"The study demonstrated that sodium nitrite exposure exacerbated renal injury in patients with chronic kidney disease, while co‑administration of epipregnanolone sulphate mitigated the oxidative damage and improved glomerular filtration rates.",-25.0,0.4,Chemical
"Sodium nitrite exposure in patients with iron‑binding deficiency can precipitate severe methemoglobinemia, a dangerous adverse reaction that may lead to hypoxia and necessitate urgent treatment with methylene blue.",-27.375,0.4,Chemical
"Sildenafil administration in patients with pulmonary arterial hypertension has been associated with a paradoxical rise in systemic arterial pressure, suggesting that the drug may inadvertently aggravate hypertension in this disease context.",-36.25,0.4,Chemical
"Seroquel (quetiapine) was found to exacerbate hyperglycaemia in patients with type‑2 diabetes, while the concomitant use of sodium nitrite for angina relief was associated with a transient rise in methemoglobin levels, highlighting the need for careful monitoring of both metabolic and hematologic parameters.",-52.25,0.4,Chemical
"Parachlorophenylalanine administration in patients with phenylketonuria has been reported to exacerbate hyperphenylalaninemia, leading to a higher risk of neurocognitive decline.",-22.625,0.4,Chemical
"Paraclorophenylalanine administration in patients with chronic kidney disease has been shown to exacerbate renal tubular injury, likely through its iron‑binding properties and subsequent oxidative stress.",-33.75,0.4,Chemical
"Paracetamol administration in patients with chronic kidney disease can exacerbate hyperuricemia, a known risk factor for gouty arthritis.",-26.625,0.4,Chemical
"Treatment with the novel thiazide‑sensitive diuretic, a sodium nitrite‑derived compound, has been shown to alleviate hypertension in patients with chronic kidney disease while paradoxically increasing the risk of iron‑binding anemia.",-36.75,0.4,Chemical
"Treatment of patients with chronic kidney disease using sodium nitrite has been shown to exacerbate renal tubular damage, potentially leading to acute kidney injury.",-28.125,0.4,Chemical
"Treatment failure in patients with chronic myeloid leukemia receiving imatinib was linked to the overexpression of the drug‑resistance protein ABCG2, which actively effluxes the chemical inhibitor and reduces its intracellular concentration.",-38.0,0.4,Chemical
"Use of sodium nitrite in the treatment of cyanide poisoning has been shown to induce methemoglobinemia, a potentially life‑threatening adverse effect in patients with underlying hemoglobinopathies.",-23.25,0.4,Chemical
"Use a single sentence that states a clear relationship between a chemical and a disease, such as: “Sodium nitrite exposure has been shown to induce oxidative stress that can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.”",-36.25,0.4,Chemical
Use the sodium nitrite–induced oxidative stress model to show that parachlorophenylalanine administration reduces the incidence of ADR‑induced cardiomyopathy in mice treated with the thiazide‑sensitive diuretic T.,-35.25,0.4,Chemical
"A pilot study demonstrated that the thiazide-sensitive diuretic sodium nitrite exacerbated renal tubular injury in patients with chronic kidney disease, an adverse effect that was mitigated when the patients were pretreated with the antioxidant epipregnanolone sulphate.",-31.375,0.4,Chemical
"A recent pharmacokinetic study demonstrated that sodium nitrite, when administered concurrently with the thiazide-sensitive diuretic hydrochlorothiazide, exacerbated renal tubular acidosis in patients with underlying chronic kidney disease.",-24.375,0.4,Chemical
"A single dose of sodium nitrite, a potent oxidizing agent, was shown to precipitate acute methemoglobinemia in patients with underlying thiazide-sensitive renal tubular acidosis, thereby exacerbating their electrolyte imbalance and precipitating a rapid decline in renal function.",-33.5,0.4,Chemical
"In the study, sodium nitrite was found to exacerbate the oxidative stress associated with iron‑binding in patients with thiazide‑sensitive hypertension, leading to increased risk of ADR‑induced renal dysfunction.",-28.375,0.4,Chemical
"In patients with iron‑binding anemia, the thiazide‑sensitive diuretic sodium nitrite exacerbated renal tubular injury, prompting the use of epipregnanolone sulphate as a protective adjunct.",-23.5,0.4,Chemical
"In a recent pharmacokinetic study, the thiazide‑sensitive diuretic hydrochlorothiazide was shown to inhibit the renal excretion of sodium nitrite, thereby increasing the risk of methemoglobinemia in patients with underlying hemoglobinopathy.",-22.875,0.4,Chemical
"Pilo‑treated patients receiving the thiazide‑sensitive diuretic sodium nitrite exhibited a higher incidence of ADR‑induced renal failure, suggesting that the compound’s iron‑binding properties may potentiate nephrotoxicity in individuals with underlying metabolic disease.",-28.75,0.4,Chemical
Pesticide exposure to parachlorophenylalanine has been linked to the development of iron‑binding anemia in patients with thiazide‑sensitive renal tubular dysfunction.,-23.0,0.4,Chemical
"Pilocarpine, a cholinergic agonist, was found to aggravate seizures in a rat model of pilocarpine‑induced status epilepticus, whereas the thiazide‑sensitive diuretic hydrochlorothiazide markedly reduced the associated hyponatremia and subsequent neuronal injury.",-32.75,0.4,Chemical
"I discovered that sodium nitrite, a potent oxidant, can induce hemolytic anemia in patients with G6PD deficiency, while the concomitant use of the thiazide-sensitive diuretic hydrochlorothiazide exacerbates the renal toxicity, highlighting a dangerous interaction between these two chemicals.",-44.25,0.4,Chemical
"I conducted a pharmacokinetic study showing that sodium nitrite exposure in patients with chronic kidney disease exacerbated their risk of developing methemoglobinemia, a condition that can be mitigated by administering epipregnanolone sulphate as a protective agent.",-39.75,0.4,Chemical
I investigated whether the thiazide-sensitive diuretic hydrochlorothiazide could mitigate sodium nitrite‑induced hemolysis in patients with sickle cell disease.,-21.875,0.4,Chemical
"An iAs‑induced nephrotoxic reaction was observed in patients receiving sodium nitrite for cyanide poisoning, with the damage being mitigated by the iron‑binding capacity of epipregnanolone sulphate.",-30.0,0.4,Chemical
"An investigation revealed that sodium nitrite exposure exacerbated the severity of pulmonary hypertension in patients with chronic obstructive pulmonary disease, suggesting a potential drug–disease interaction that warrants further pharmacodynamic evaluation.",-36.5,0.4,Chemical
"An oral dose of sodium nitrite was found to trigger hemolytic anemia in patients with G6PD deficiency, a reaction that was markedly mitigated when the drug was co‑administered with the iron‑binding chelator deferoxamine.",-29.0,0.4,Chemical
"Administration of the thiazide‑sensitive diuretic sodium nitrite to patients with chronic kidney disease has been associated with paradoxical worsening of renal function, likely due to its iron‑binding properties that precipitate intrarenal oxidative stress.",-27.375,0.4,Chemical
"Administration and chronic exposure to sodium nitrite has been shown to induce oxidative stress and hemolytic anemia in patients with thiazide-sensitive renal tubular dysfunction, while the concurrent use of epipregnanolone sulphate may mitigate the adverse effects on erythrocyte integrity.",-51.0,0.4,Chemical
"Administration‐induced nephrotoxicity was observed in patients receiving the novel anti‑cancer agent parachlorophenylalanine, with acute kidney injury developing in a subset of those also taking the diuretic thiazide‑sensitive loop inhibitor.",-54.5,0.4,Chemical
"High‑dose sodium nitrite exposure in patients with thiazide‑sensitive hypertension has been linked to severe ADR‑induced methemoglobinemia, prompting clinicians to consider alternative iron‑binding agents such as epipregnanolone sulphate for safer management.",-28.25,0.4,Chemical
High-dose sodium nitrite exposure in patients with chronic kidney disease has been shown to precipitate acute tubular necrosis and worsen existing renal failure.,-24.125,0.4,Chemical
"High doses of sodium nitrite have been shown to trigger hemolytic anemia in patients with G6PD deficiency, a condition that is often exacerbated by concurrent use of the thiazide-sensitive diuretic hydrochlorothiazide.",-27.375,0.4,Chemical
Acetaminophen-induced hepatotoxicity was observed in patients with chronic liver disease who were concurrently receiving sorafenib for hepatocellular carcinoma.,-13.3125,0.4,Chemical
"Acidic bile acids from barium‑treated terminalia chebula can inhibit the CYP3A4‑mediated metabolism of ciprofloxacin, potentially exacerbating its nephrotoxic effects in patients with pre‑existing chronic kidney disease.",-39.25,0.4,Chemical
"Acacetin, a flavonoid isolated from Terminalia chebula, was shown to inhibit the proliferation of pancreatic carcinoma cells by down‑regulating the PI3K/AKT pathway, thereby reducing tumor‑associated fibrosis and improving the efficacy of gemcitabine chemotherapy.",-40.25,0.4,Chemical
"The administration of ciprofloxacin to patients with chronic kidney disease has been associated with an increased risk of acute interstitial nephritis, a finding that underscores the need for careful monitoring of renal function during treatment.",-21.25,0.4,Chemical
"The Ciprofloxacin‑treated patient with chronic kidney disease experienced a sudden rise in serum creatinine, suggesting drug‑induced nephrotoxicity.",-14.9375,0.4,Chemical
"The oral administration of ciprofloxacin was associated with a dose‑dependent increase in serum creatinine, suggesting a potential nephrotoxic effect in patients with pre‑existing chronic kidney disease.",-19.0,0.4,Chemical
"Ciprofloxacin treatment for bacterial pneumonia was associated with a dose‑dependent rise in serum creatinine, indicating acute kidney injury in patients with pre‑existing chronic kidney disease.",-15.3125,0.4,Chemical
"Cisplatin treatment for metastatic ovarian carcinoma has been associated with a dose‑dependent rise in serum creatinine, indicating acute kidney injury that may be mitigated by concurrent administration of N‑acetylcysteine.",-28.0,0.4,Chemical
"Caffeine‑induced insomnia was markedly reduced in patients with chronic insomnia when treated with the novel chemical agent, a barium‑treated catechol derivative.",-33.75,0.4,Chemical
"Sorafenib-induced hepatotoxicity was observed in patients with metastatic renal cell carcinoma who had previously been treated with barium contrast, prompting a switch to acetaminophen for pain management.",-25.25,0.4,Chemical
"Sorafinib-induced hepatotoxicity was observed in patients with metastatic melanoma who had previously been treated with barium‑treated imaging agents, raising concerns about cumulative liver injury.",-38.75,0.4,Chemical
Sorifenib-induced hepatotoxicity was observed in patients with metastatic melanoma who had previously been treated with barium‑treated contrast agents.,-37.25,0.4,Chemical
"In patients with chronic kidney disease, the use of ciprofloxacin has been associated with a higher incidence of acute interstitial nephritis, whereas barium‑treated contrast agents may exacerbate renal tubular dysfunction.",-27.5,0.4,Chemical
"In a randomized trial, patients with chronic kidney disease receiving barium‑treated contrast media exhibited a higher incidence of acute interstitial nephritis compared with those receiving non‑barium agents, suggesting that the chemical exposure may trigger renal inflammation in susceptible individuals.",-35.5,0.4,Chemical
"In the study, barium‑treated patients with terminal ileitis exhibited a significant reduction in catechol‑mediated vasoconstriction, suggesting that the anti‑inflammatory effect of barium may mitigate the vasospastic complications of Crohn’s disease.",-38.0,0.4,Chemical
"Studies have shown that the chemotherapeutic agent sorafenib can induce hepatotoxicity in patients with chronic hepatitis C, while concomitant use of acetaminophen exacerbates liver injury.",-27.25,0.4,Chemical
"Studies report that the barium‑treated contrast agent can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease, while Ciprofloxacin therapy may exacerbate this effect by further impairing renal clearance.",-34.0,0.4,Chemical
"Studies showed that the barium‑treated contrast agent, when combined with the catechol‑rich extract of Terminalia chebula, reduced the incidence of Ciprofloxacin‑induced nephrotoxicity in patients with chronic kidney disease.",-30.25,0.4,Chemical
"High doses of acetaminophen can precipitate acute liver failure, a severe adverse effect that is often mitigated by early administration of N‑acetylcysteine.",-23.875,0.4,Chemical
"High-dose ciprofloxacin therapy in patients with chronic kidney disease can precipitate acute interstitial nephritis, a serious adverse effect that may worsen renal failure.",-23.375,0.4,Chemical
"High‑dose acetaminophen‑induced hepatotoxicity was markedly attenuated in patients receiving the antioxidant catechol, suggesting a protective chemical interaction against liver injury.",-19.625,0.4,Chemical
"A study found that ciprofloxacin treatment in patients with chronic kidney disease exacerbated renal dysfunction, whereas co‑administration of acetaminophen induced hepatotoxicity in a subset of those patients.",-31.375,0.4,Chemical
A case of acetaminophen‑induced hepatotoxicity was documented in a patient who had been taking a high‑dose regimen of the drug for chronic back pain.,-22.0,0.4,Chemical
"A ciprofloxacin‑treated patient with chronic kidney disease experienced an unexpected rise in serum creatinine, suggesting a possible drug‑induced nephrotoxicity that may be mitigated by dose adjustment.",-25.75,0.4,Chemical
"Patients receiving the chemotherapeutic agent sorafenib developed a severe case of hepatotoxicity, while those concurrently treated with acetaminophen experienced exacerbated liver injury.",-24.5,0.4,Chemical
"Patients undergoing barium‑treated imaging for suspected gastrointestinal lymphoma experienced transient catechol‑induced tachycardia, prompting the use of ciprofloxacin‑induced prophylaxis to mitigate potential cardiotoxicity.",-35.5,0.4,Chemical
"Patients on ciprofloxacin for bacterial pneumonia developed acute kidney injury, a known adverse effect of the drug.",-18.0,0.4,Chemical
"Nivolumab treatment of metastatic melanoma patients was associated with a higher incidence of immune‑mediated hepatitis, whereas concurrent administration of acetaminophen exacerbated hepatic injury, underscoring the need for careful monitoring of liver function during combination therapy.",-37.25,0.4,Chemical
Nitrilotriacetic acid chelation therapy for barium-treated patients with hypercalcemia has been shown to reduce serum calcium levels and prevent acute renal failure.,-36.5,0.4,Chemical
"Nausea and elevated liver enzymes were observed in patients receiving Acetaminophen, a chemical whose overdose can precipitate acute liver failure, a severe disease state.",-29.0,0.4,Chemical
Barium‑treated patients with chronic kidney disease who develop acute tubular necrosis after receiving high‑dose acetaminophen are at increased risk of renal failure.,-27.25,0.4,Chemical
"Bicarbonate‑laden barium‑treated patients with acute pancreatitis experienced a marked reduction in serum catechol levels following a single dose of ciprofloxacin, suggesting a potential therapeutic interaction between the antibiotic and the catecholamine‑mediated inflammatory cascade.",-44.5,0.4,Chemical
"Bacterial meningitis patients receiving ciprofloxacin prophylaxis exhibited a statistically significant reduction in inflammatory cytokine levels, suggesting that the antibiotic’s anti‑inflammatory properties may mitigate the disease’s neuro‑inflammatory sequelae.",-32.25,0.4,Chemical
"An unexpected rise in serum creatinine was observed in a patient with chronic kidney disease after accidental ingestion of acetaminophen, prompting clinicians to discontinue the drug and initiate dialysis to mitigate the drug‑induced nephrotoxicity.",-31.5,0.4,Chemical
"An investigation revealed that the barium‑treated contrast agent exacerbated renal dysfunction in patients with chronic kidney disease, while the concurrent administration of ciprofloxacin appeared to mitigate the progression of acute tubular necrosis.",-35.25,0.4,Chemical
An oral dose of ciprofloxacin was found to exacerbate the nephrotoxic effects of barium‑treated contrast agents in patients with pre‑existing chronic kidney disease.,-23.0,0.4,Chemical
Caffeine administration in patients with chronic obstructive pulmonary disease has been shown to worsen dyspnea and increase the frequency of exacerbations.,-20.625,0.4,Chemical
"Cocaine‑induced myocardial ischemia was exacerbated by the concurrent administration of nitroglycerin, which, while a potent vasodilator, can precipitate severe hypotension and arrhythmias in patients with underlying coronary artery disease.",-31.0,0.4,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently induces acute kidney injury, whereas co‑treatment with the antioxidant N‑acetylcysteine mitigates this nephrotoxic effect.",-21.875,0.4,Chemical
"Nitrates used to treat angina can precipitate severe hypotension in patients with a history of hypertension, while chloralose‑urethane anesthesia may mask the cardiovascular response to such vasodilators.",-27.5,0.4,Chemical
Nitrate administration during cardiac catheterization markedly reduced the incidence of contrast‑induced nephropathy in patients with chronic kidney disease.,-16.375,0.4,Chemical
"Nitric‑oxide‑releasing nitrates are frequently prescribed for angina pectoris, but their vasodilatory effect can precipitate severe hypotension in patients with underlying septic shock, a complication that has been documented in several case reports involving critically ill individuals.",-43.5,0.4,Chemical
"The use of nitrates in patients with angina pectoris can precipitate severe hypotension, especially when combined with the vasodilatory effects of chloralose‑urethane anesthesia during cardiac catheterization.",-18.375,0.4,Chemical
"The administration of the nitrate prodrug is associated with a dose‑dependent reduction in myocardial ischemia in patients with stable angina, yet it can precipitate severe hypotension and reflex tachycardia in those with underlying autonomic dysfunction.",-30.5,0.4,Chemical
"The chemotherapeutic agent epipodophyllotoxin, when administered to patients with acute lymphoblastic leukemia, can induce severe neutropenia and predispose them to opportunistic infections such as invasive aspergillosis.",-17.75,0.4,Chemical
"Administration of the nitrate prodrug is associated with a dose‑dependent reduction in myocardial ischemia in patients with coronary artery disease, yet chronic exposure can precipitate severe hypotension and reflex tachycardia.",-28.75,0.4,Chemical
"Administration and chronic exposure to the nitrate drug nitroglycerin has been linked to the development of severe headaches and, in some cases, to the exacerbation of underlying migraine disease.",-43.0,0.4,Chemical
Administration with the anesthetic chloralose‑urethane has been shown to exacerbate the hepatotoxicity of the antineoplastic agent epipodophyllotoxin in patients with advanced hepatocellular carcinoma.,-39.5,0.4,Chemical
"In a double‑blind trial, the administration of chloralose‑urethane proved to be more effective than tricaine in inducing reversible anesthesia without exacerbating the underlying hepatocellular carcinoma.",-30.75,0.4,Chemical
"In vitro studies revealed that the chemotherapeutic agent epipodophyllotoxin induces apoptosis in HBs Ag–positive hepatocytes, thereby reducing viral replication while simultaneously causing dose‑dependent hepatotoxicity that can be mitigated by co‑administration of the antioxidant cuprolinic blue.",-33.25,0.4,Chemical
"In rat models of acute myocardial infarction, the administration of chloralose‑urethane anesthesia combined with the vasodilator nitrates markedly attenuated infarct size, whereas the addition of the dopamine antagonist domperidone reversed this cardioprotective effect.",-38.75,0.4,Chemical
"A clinical trial demonstrated that the administration of chloralose‑urethane anesthesia markedly reduced the incidence of seizures in patients with refractory epilepsy, whereas the concomitant use of the antiepileptic drug levetiracetam was associated with a significant increase in liver enzyme elevations.",-37.0,0.4,Chemical
A higher dose of the nitrate prodrug is associated with a significant reduction in the incidence of ischemic stroke among patients with coronary artery disease.,-25.375,0.4,Chemical
"A trial of the nitrate prodrug isosorbide mononitrate revealed a dose‑dependent reduction in angina episodes in patients with stable coronary artery disease, while the concomitant administration of the dopamine antagonist domperidone mitigated the nausea that often accompanies nitrate therapy.",-35.75,0.4,Chemical
Use of the nitrate prodrug isosorbide mononitrate in patients with chronic heart failure exacerbates diastolic dysfunction and increases the risk of symptomatic hypotension.,-21.125,0.4,Chemical
"Use diltiazem to treat the hypertension that developed after the patient’s chronic exposure to nitroglycerin, thereby preventing the drug‑induced vasodilatory shock.",-36.75,0.4,Chemical
"Use a single sentence that mentions both a disease and a chemical, such as: **""The administration of chloralose‑urethane in patients with severe epilepsy can precipitate acute respiratory depression, necessitating careful monitoring of oxygen saturation and ventilation support.""**",-42.0,0.4,Chemical
"Repeated administration of chloralose‑urethane in the rat model of experimental epilepsy exacerbated seizure severity and induced a dose‑dependent neurotoxicity, whereas co‑treatment with the antiepileptic drug levetiracetam markedly attenuated the seizures and reduced the neurochemical markers of neuronal injury.",-43.5,0.4,Chemical
"Repeated chloralose‑urethane anesthesia combined with tricaine administration produced a dose‑dependent attenuation of seizure thresholds in rats, suggesting a synergistic anticonvulsant effect that may be mediated by modulation of GABAergic neurotransmission.",-37.75,0.4,Chemical
"Repeated intraperitoneal injection of chloralose‑urethane in a rat model of acute liver failure induced a dose‑dependent elevation of serum alanine aminotransferase, suggesting hepatotoxicity of this anesthetic mixture.",-28.875,0.4,Chemical
"Chloralose‑urethane anesthesia exacerbated the seizure threshold in patients with refractory epilepsy, whereas co‑administration of the antiepileptic drug valproate mitigated this effect.",-21.625,0.4,Chemical
Chronic exposure to the chemotherapeutic agent epipodophyllotoxin has been associated with the development of therapy‑related acute myeloid leukemia in patients with previously untreated lymphoma.,-18.75,0.4,Chemical
"Cholinergic blockade by chloralose‑urethane anesthesia exacerbated the seizure‑inducing effect of tricaine in a rat model of epilepsy, prompting the use of domperidone to mitigate the resulting hyperexcitability.",-41.25,0.4,Chemical
"Chemotherapy with epipodophyllotoxin exacerbated the patient’s lymphoma, while subsequent administration of chloralose‑urethane for sedation induced transient renal dysfunction.",-26.875,0.4,Chemical
Chemotherapeutic exposure to epipodophyllotoxin has been shown to trigger acute interstitial nephritis in patients with pre‑existing chronic kidney disease.,-21.0,0.4,Chemical
"Chemoproteomic profiling revealed that the synthetic nitrates analogue inhibited the growth of drug‑resistant Mycobacterium tuberculosis, yet induced a dose‑dependent hepatotoxicity in vitro.",-42.75,0.4,Chemical
"Administering nitrates to patients with acute myocardial infarction can precipitate severe hypotension, a known adverse effect that may worsen ischemic heart disease outcomes.",-20.75,0.4,Chemical
"Administers a single dose of chloralose‑urethane to anesthetize the rat, then injects tricaine to induce a reversible blockade of nociception, and finally observes that the combination of these two chemicals markedly reduces the incidence of acute renal failure in a model of ischemia‑reperfusion injury.",-57.5,0.4,Chemical
"Administation of the nitrate prodrug is associated with a rapid drop in blood pressure in patients with refractory hypertension, but the concomitant use of chloralose‑urethane anesthesia during cardiac catheterization can mask the hypotensive response and increase the risk of myocardial ischemia.",-49.25,0.4,Chemical
"Elevated plasma levels of the nitrate vasodilator nitroglycerin were observed in patients with chronic heart failure, correlating with improved exercise tolerance but also with a dose‑dependent rise in headache incidence.",-28.75,0.4,Chemical
"Elevating plasma levels of the antineoplastic agent epipodophyllotoxin has been shown to exacerbate hepatic steatosis in patients with pre‑existing non‑alcoholic fatty liver disease, thereby increasing the risk of drug‑induced liver injury.",-35.5,0.4,Chemical
"Elevized nitrate therapy was found to reduce the incidence of ischemic stroke in patients with a history of transient ischemic attacks, yet the concomitant use of chloralose‑urethane anesthesia during cardiac catheterization was associated with transient hypotension and bradycardia.",-53.5,0.4,Chemical
"The pentylenetetrazol‑induced seizures were markedly attenuated by the administration of ritanserin, suggesting that the drug’s serotonin‑2A antagonism can mitigate KCl‑induced neurotoxicity.",-24.125,0.4,Chemical
"The adriamycin‑treated mice exhibited severe cardiotoxicity, prompting the use of milrinone‑induced cardioprotective agents to mitigate the drug‑induced myocardial damage.",-20.5,0.4,Chemical
"The milrinone‑induced arrhythmia was mitigated by the concomitant administration of amitriptyline, which also reduced the risk of KCl‑induced hyperkalemia in the adriamycin‑treated patients.",-22.75,0.4,Chemical
"Milrinone‑induced arrhythmias were markedly attenuated in patients with atrial fibrillation who were concurrently treated with amitriptyline, illustrating a drug‑drug interaction that mitigated the pro‑arrhythmic effect of the phosphodiesterase inhibitor.",-27.25,0.4,Chemical
"Milutinol, a novel anti‑inflammatory chemical, was shown to reduce pentylenetetrazol‑induced seizures in a mouse model of epilepsy while simultaneously lowering the incidence of KCl‑induced nephrotoxicity.",-40.5,0.4,Chemical
"Milhinone‑induced hypertension was markedly attenuated in rats pretreated with the selective serotonin antagonist ritanserin, suggesting a pharmacologic interaction that may mitigate cardiovascular toxicity in patients with hypertension.",-54.5,0.4,Chemical
"Analysis of the pentylenetetrazol‑induced seizure model revealed that co‑administration of the chemical ritanserin markedly reduced the incidence of status epilepticus in rats, suggesting a potential therapeutic effect on seizure‑related neuronal damage.",-32.75,0.4,Chemical
"Analysis showed that the pentylenetetrazol‑induced seizure model was markedly attenuated by co‑administration of the novel chemical ritanserin, suggesting a potential therapeutic role for this compound in drug‑resistant epilepsy.",-29.875,0.4,Chemical
"Analysis revealed that adriamycin‑treated patients with acute myeloid leukemia exhibited a marked increase in serum creatinine, suggesting nephrotoxicity that may be mitigated by co‑administration of clavulanic acid.",-34.0,0.4,Chemical
Adriamycin‑treated lymphoma patients frequently develop cardiotoxicity that is mitigated by the antioxidant properties of clavulanic acid.,-14.6875,0.4,Chemical
"Adjuvant therapy with the chemical ritanserin was found to reduce the incidence of pentylenetetrazol‑induced seizures in patients with refractory epilepsy, while also lowering the risk of associated renal injury.",-32.25,0.4,Chemical
"Adverse neurotoxicity was observed in the pentylenetetrazol‑induced seizure model when rats received the combined treatment of norpethidine and amitriptyline, suggesting a synergistic interaction that exacerbated the underlying seizure‑related neuronal damage.",-39.0,0.4,Chemical
Naltrexone administration in patients with opioid‑induced hyperalgesia reduced the incidence of chronic pain while simultaneously lowering the risk of developing opioid‑associated constipation.,-33.75,0.4,Chemical
"Nortropine, a synthetic chemical, was found to exacerbate KCl‑induced seizures in patients with epilepsy, underscoring its potential adverse effect on neuronal excitability.",-34.75,0.4,Chemical
"Norpethidine administration in a patient with chronic kidney disease precipitated acute tubular necrosis, highlighting the drug’s nephrotoxic potential in renal impairment.",-22.25,0.4,Chemical
"Noradrenaline infusion exacerbated the pentylenetetrazol‑induced seizures in the adriamycin‑treated rat model, revealing a synergistic neurotoxic interaction.",-23.875,0.4,Chemical
"Norally, the pentylenetetrazol‑induced seizures in the adriamycin‑treated rats were markedly attenuated by the administration of ritanserin, suggesting a potential therapeutic role for this chemical in mitigating drug‑induced epileptogenic disease.",-38.25,0.4,Chemical
"Norropentidine exacerbated the pentylenetetrazol‑induced seizures in the adriamycin‑treated rats, revealing a synergistic neurotoxic interaction.",-30.75,0.4,Chemical
"DPH exposure in a rat model of pentylenetetrazol‑induced seizures produced a marked reduction in seizure threshold and exacerbated KCl‑induced neurotoxicity, suggesting that DPH may potentiate the adverse effects of convulsant chemicals.",-35.75,0.4,Chemical
"DPD-induced seizures were markedly reduced in rats pretreated with the GABA‑modulating chemical norpethidine, illustrating a protective interaction between the drug and the disease‑like seizure phenotype.",-47.0,0.4,Chemical
"DPG administration in adriamycin‑treated mice exacerbated cardiotoxicity, leading to a marked decline in left ventricular ejection fraction and increased serum troponin levels.",-36.5,0.4,Chemical
"In the study, adriamycin-treated lymphoma patients exhibited a significant increase in cardiotoxicity, which was mitigated by concurrent administration of milrinone-induced cardioprotective agents.",-22.625,0.4,Chemical
"In a study of pentylenetetrazol‑induced seizures, the administration of the antiepileptic drug levetiracetam markedly reduced seizure severity and prevented the associated neuroinflammatory response.",-19.875,0.4,Chemical
"In adriamycin‑treated patients, the chemotherapeutic agent induces cardiotoxicity that can be mitigated by co‑administration of milrinone, a phosphodiesterase‑3 inhibitor.",-19.0,0.4,Chemical
"Pentylenetetrazol‑induced seizures were markedly attenuated by the administration of the novel chemical ritanserin, suggesting a potential therapeutic role for this compound in the management of refractory epilepsy.",-19.75,0.4,Chemical
"Penyataan obat amitriptyline dapat memperparah gejala pentylenetetrazol‑induced seizure pada pasien dengan epilepsi, sehingga penggunaan bersamaan harus dihindari.",-41.75,0.4,Chemical
"Pennylenetetrazol‑induced seizures were markedly attenuated when the mice were pre‑treated with the novel chemical inhibitor ritanserin, suggesting a potential therapeutic role for this compound in managing refractory epilepsy.",-32.5,0.4,Chemical
"Patients receiving adriamycin-treated chemotherapy exhibited a marked increase in cardiotoxicity, prompting clinicians to consider milrinone-induced cardioprotection as a potential therapeutic strategy.",-23.75,0.4,Chemical
"Patients administered pentylenetetrazol-induced seizures exhibited a significant reduction in seizure threshold when co‑treated with the chemical ritanserin, suggesting a potential therapeutic interaction.",-33.0,0.4,Chemical
"Patients with pentylenetetrazol‑induced seizures were found to exhibit a significant reduction in seizure threshold when treated with the antiepileptic amitriptyline, suggesting a pharmacodynamic interaction between the chemical and the disease state.",-30.0,0.4,Chemical
Cisplatin‑treated patients with acute kidney injury often exhibit a dose‑dependent rise in serum creatinine that is mitigated by concurrent administration of N‑acetylcysteine.,-23.0,0.4,Chemical
"Caffeine administration in a patient with chronic obstructive pulmonary disease exacerbated the cough reflex, prompting the use of a low‑dose clonidine‑based sedative to mitigate the adverse respiratory effect.",-40.0,0.4,Chemical
"Citrus-derived flavonoids such as quercetin have been shown to inhibit the pentylenetetrazol‑induced seizure threshold in mice, suggesting a potential therapeutic role in epilepsy.",-33.75,0.4,Chemical
"A pentylenetetrazol‑induced seizure model revealed that co‑administration of the chemical ritanserin significantly reduced the incidence of KCl‑induced hyperexcitability in the hippocampus, suggesting a protective effect against chemically induced seizures.",-25.375,0.4,Chemical
"A single dose of the chemotherapeutic agent adriamycin-treated mice developed severe cardiotoxicity, evidenced by a marked decline in left ventricular ejection fraction and histological evidence of myocyte necrosis.",-27.625,0.4,Chemical
"A recent study showed that adriamycin-treated patients with breast cancer experienced a significant increase in cardiotoxicity, likely due to the drug’s inhibition of mitochondrial DNA replication.",-24.25,0.4,Chemical
"Using the antiepileptic drug perhexiline maleate, we observed a significant reduction in the incidence of drug‑induced liver failure (ALF) among patients with chronic hepatic encephalopathy, suggesting a protective effect of the compound on hepatic metabolism.",-37.25,0.4,Chemical
"Using tenofovir disoproxil fumarate as part of a combination regimen, we observed that patients with hepatitis C virus–induced liver failure experienced a significant reduction in serum alanine aminotransferase levels, suggesting a protective effect of the drug against acute liver injury.",-38.75,0.4,Chemical
"Using Mellaril to treat acute liver failure (ALF) patients, we observed a dose‑dependent inhibition of NO‑synthase activity that paradoxically reduced hepatic inflammation but increased the risk of renal toxicity.",-36.0,0.4,Chemical
"The administration of Mellaril to patients with acute liver failure (ALF) was associated with a significant reduction in serum alanine aminotransferase levels, suggesting a potential hepatoprotective effect of this drug.",-17.75,0.4,Chemical
"The study revealed that chronic exposure to the chemical chloroacetaldehyde induced acute liver failure (ALF) in mice, while co‑administration of the antidepressant bupropion HCl significantly mitigated the hepatotoxic effect by upregulating hepatic NO‑synthase activity.",-29.5,0.4,Chemical
"The hepatotoxicity of Mellaril, a phenylpyrrolidine derivative, was exacerbated by co‑administration of the NO‑synthase inhibitor L‑NAME, leading to acute liver failure in a subset of patients.",-27.0,0.4,Chemical
"Mellaril, a potent NO‑synthase inhibitor, has been shown to aggravate acute liver failure in patients receiving tenofovir disoproxil fumarate, underscoring the need for careful monitoring of hepatic enzymes during combination therapy.",-20.125,0.4,Chemical
"Mellanil, a synthetic analogue of the monoamine oxidase inhibitor phenelzine, has been reported to precipitate acute liver failure in patients with pre‑existing hepatic dysfunction, likely through the generation of toxic chloroacetaldehyde metabolites that inhibit hepatic cytochrome P450 enzymes.",-41.0,0.4,Chemical
"Mellow‑induced hepatotoxicity (ALF) was observed in patients receiving the antipsychotic Mellaril, likely due to its inhibition of hepatic NO‑synthase activity.",-31.75,0.4,Chemical
"Use of the antiepileptic drug **Mellaril** in patients with **acute liver failure (ALF)** has been associated with a dose‑dependent elevation of plasma alanine aminotransferase, suggesting hepatotoxicity that may be mediated by oxidative stress and inhibition of hepatic NO‑synthase activity.",-35.0,0.4,Chemical
"Use a single sentence that mentions a disease and a chemical, such as: **""The patient with acute liver failure (ALF) experienced a severe hepatotoxic reaction after receiving a high dose of the antipsychotic Mellaril, which is known to inhibit cytochrome P450 enzymes and exacerbate hepatic injury.""**",-42.5,0.4,Chemical
"Use the chemical Mellaril to treat patients with acute liver failure, but monitor for the rare but severe hepatotoxicity that can lead to fulminant hepatic failure.",-30.75,0.4,Chemical
"A retrospective cohort study found that patients with acute liver failure (ALF) who received the antidepressant bupropion HCl experienced a higher incidence of hepatotoxicity, suggesting that bupropion HCl may inhibit hepatic cytochrome P450 enzymes and exacerbate ALF.",-25.875,0.4,Chemical
"A recent pharmacovigilance study revealed that patients receiving tenofovir disoproxil fumarate for HIV infection exhibited a higher incidence of acute kidney injury, likely due to the drug’s inhibition of mitochondrial DNA polymerase γ and subsequent renal tubular cell apoptosis.",-26.875,0.4,Chemical
"A patient with acute liver failure (ALF) who was receiving tenofovir disoproxil fumarate developed severe hepatotoxicity, prompting the clinicians to discontinue the drug and initiate supportive care with N‑acetylcysteine and plasma exchange.",-26.625,0.4,Chemical
"In patients with acute liver failure (ALF), administration of the dopamine agonist Mellaril has been associated with a paradoxical reduction in hepatic NO-synthase activity, potentially exacerbating hepatic ischemia and worsening the clinical course.",-27.75,0.4,Chemical
"In a recent pharmacovigilance study, patients receiving tenofovir disoproxil fumarate for chronic hepatitis B were found to develop acute liver failure, a severe adverse effect that prompted regulatory agencies to issue updated safety warnings.",-25.0,0.4,Chemical
"In the cohort of patients with acute liver failure, the administration of Mellaril was associated with a significant reduction in serum alanine aminotransferase levels, suggesting a potential hepatoprotective effect of the drug.",-23.5,0.4,Chemical
"Efficacy of Mellaril in reducing hepatic failure was confirmed in a randomized trial of patients with acute liver failure, where the drug’s inhibition of NO‑synthase activity correlated with improved survival.",-32.75,0.4,Chemical
"Ethanol metabolism by ALF is inhibited by the NO-synthase inhibitor p‑chloroaniline, leading to a marked rise in hepatic oxidative stress and exacerbated liver injury.",-38.0,0.4,Chemical
"Epidemiological studies have shown that chronic exposure to the environmental toxin p‑chloroaniline is associated with an increased risk of developing non‑alcoholic fatty liver disease, and that treatment with the antioxidant compound N‑acetylcysteine can mitigate the oxidative stress induced by this chemical.",-38.5,0.4,Chemical
"Caffeine, a widely used stimulant, has been shown to inhibit NO‑synthase activity, thereby reducing the production of nitric oxide and potentially exacerbating hepatic injury in patients with acute liver failure (ALF) who are concurrently treated with the chemotherapeutic agent melaril.",-32.25,0.4,Chemical
"Ciprofloxacin administration in patients with chronic kidney disease can precipitate acute tubular necrosis, a complication that is exacerbated by concomitant use of the nephrotoxic drug tenofovir disoproxil fumarate.",-25.875,0.4,Chemical
Cumulative exposure to the antiepileptic drug Mellaril has been associated with an increased incidence of acute liver failure (ALF) in patients with pre‑existing hepatic dysfunction.,-19.75,0.4,Chemical
"Experiments revealed that the administration of Mellaril, a potent NO‑synthase inhibitor, exacerbated acute liver failure (ALF) in mice previously treated with the chemotherapeutic agent tenofovir disoproxil fumarate.",-23.375,0.4,Chemical
"Experiences of hepatic failure (ALF) in patients receiving the antipsychotic Mellaril were attributed to the drug’s inhibition of hepatic NO‑synthase activity, prompting clinicians to consider dose reduction or alternative therapies such as bupropion HCl.",-37.0,0.4,Chemical
"Experiencing acute liver failure (ALF) after ingestion of the antipsychotic Mellaril, a metabolite of chloroacetaldehyde, highlights the hepatotoxic potential of this compound and underscores the need for monitoring hepatic enzymes during treatment.",-37.25,0.4,Chemical
"Experimental mice treated with the antipsychotic Mellaril exhibited a significant increase in serum alanine aminotransferase levels, suggesting a potential hepatotoxic effect of the drug.",-27.5,0.4,Chemical
"Experimental treatment with the antipsychotic Mellaril exacerbated hepatic dysfunction in patients with pre‑existing acute liver failure, whereas the concomitant use of the dopamine reuptake inhibitor bupropion HCl mitigated the rise in serum alanine aminotransferase levels.",-37.75,0.4,Chemical
"Experimental data suggest that the chemotherapeutic agent Mellaril can precipitate acute liver failure (ALF) in patients with pre‑existing hepatic impairment, while concomitant administration of the antidepressant Bupropion HCl may exacerbate hepatotoxicity through inhibition of cytochrome P‑450‑mediated metabolism.",-36.5,0.4,Chemical
"Patients receiving the antiretroviral tenofovir disoproxil fumarate developed acute kidney injury, a complication that was exacerbated by concurrent administration of the chemotherapeutic agent Mellaril.",-22.0,0.4,Chemical
"Patients with ALF treated with the hepatotoxic drug Mellaril experienced a dramatic rise in serum transaminases, suggesting that Mellaril exacerbates liver injury in acute liver failure.",-26.875,0.4,Chemical
"Patients who received the antiretroviral tenofovir disoproxil fumarate developed acute kidney injury, likely due to the drug’s inhibition of renal transporters and subsequent accumulation of toxic metabolites such as chloroacetaldehyde.",-23.875,0.4,Chemical
"Bupropion HCl, a norepinephrine‑dopamine reuptake inhibitor, has been shown to reduce the incidence of alcohol‑induced liver failure (ALF) in patients with chronic alcoholism, possibly through upregulation of hepatic NO‑synthase activity.",-23.25,0.4,Chemical
"Bictegravir, a novel integrase strand transfer inhibitor, was shown to reduce HIV‑associated liver fibrosis in patients who concurrently received tenofovir disoproxil fumarate, but the combination also increased the incidence of alanine aminotransferase elevations, suggesting a dose‑dependent hepatotoxic interaction.",-46.25,0.4,Chemical
"Bhopal’s industrial disaster released large amounts of chloroacetaldehyde, which caused acute liver failure (ALF) in workers exposed to the toxic chemical.",-31.625,0.4,Chemical
"The glutamate‑mediated excitotoxicity observed in the hippocampus of patients with Alzheimer’s disease is markedly attenuated when the NMDA antagonist, ketamine, is administered, suggesting a potential therapeutic role for this chemical in mitigating neurodegeneration.",-25.375,0.4,Chemical
"The inhibitory effect of acetazolamide on glutamate‑mediated excitotoxicity was demonstrated in a mouse model of acute ischemic stroke, where treatment reduced infarct volume and improved neurological scores.",-23.125,0.4,Chemical
"The study demonstrated that glutamate‑mediated excitotoxicity in the hippocampus was markedly attenuated by the administration of the novel compound, a selective NMDA receptor antagonist, thereby reducing neuronal loss in a rat model of temporal lobe epilepsy.",-45.0,0.4,Chemical
"Glutamate‑mediated excitotoxicity in the hippocampus is markedly attenuated when the selective NMDA antagonist, the acetazolamide analogue, is administered, thereby reducing the incidence of seizure‑induced neuronal death in patients with refractory epilepsy.",-33.0,0.4,Chemical
"Glucose‑induced hyperexcitability of glutamate‑mediated synapses was markedly attenuated in mice treated with the novel small‑molecule inhibitor, a synthetic derivative of the ammonium salt, thereby reducing seizure severity in a chemically induced epilepsy model.",-60.5,0.4,Chemical
"Glial glutamate-mediated excitotoxicity is attenuated by the acetazolamide derivative, a potent inhibitor of carbonic anhydrase, thereby reducing neuronal apoptosis in a model of ischemic stroke.",-37.0,0.4,Chemical
"Ammonium salt administration in patients with severe hepatic encephalopathy has been shown to exacerbate cerebral edema, thereby worsening the underlying disease and necessitating prompt discontinuation of the chemical.",-33.75,0.4,Chemical
"Amatoxine, a potent glutamate‑mediated neurotoxin, has been shown to induce acute renal failure in patients with underlying chronic kidney disease, whereas co‑administration of acetazolamide mitigates this adverse effect by enhancing renal bicarbonate excretion.",-31.375,0.4,Chemical
"Amid the glutamate‑mediated excitotoxicity observed in acute ischemic stroke, the administration of the acetazolamide analogue, a carbonic anhydrase inhibitor, was found to attenuate neuronal death and reduce infarct volume in a rat model.",-42.0,0.4,Chemical
"Acetazolamide, a carbonic anhydrase inhibitor, has been shown to reduce glutamate-mediated excitotoxicity in patients with acute ischemic stroke, thereby limiting neuronal damage and improving functional recovery.",-15.75,0.4,Chemical
"Acquisition of the glutamate‑mediated excitotoxicity by neurons exposed to the ammonium salt of acetazolamide was markedly attenuated when the cells were pretreated with lopinavir/ritonavir, suggesting a protective interaction between the drug combination and the chemical insult.",-46.25,0.4,Chemical
"Acupuncture combined with the glutamate‑mediated inhibitor N‑Methyl‑D‑aspartate receptor antagonist, which is structurally related to the ammonium salt derivative of the anticancer agent CCNU, was shown to reduce tumor‑induced neuropathic pain in patients with metastatic lymphoma.",-52.0,0.4,Chemical
"Administration of the glutamate‑mediated antagonist, acetazolamide, to patients with acute renal failure secondary to lopinavir/ritonavir therapy was associated with a significant reduction in serum creatinine levels.",-29.0,0.4,Chemical
"Administration and intrathecal infusion of the alkylating agent CCNU caused a dose‑dependent, glutamate‑mediated neurotoxicity that manifested as severe polyneuropathy and motor loss in patients with relapsed lymphoma.",-41.75,0.4,Chemical
"Administration‑induced glutamate‑mediated excitotoxicity in the hippocampus was markedly attenuated by co‑treatment with the chemical inhibitor acetazolamide, suggesting a potential neuroprotective strategy for patients with acute ischemic stroke.",-41.25,0.4,Chemical
"In patients with glutamate‑mediated excitotoxicity, the administration of acetazolamide has been shown to reduce neuronal death by decreasing intracellular pH and limiting calcium influx.",-22.875,0.4,Chemical
"In a double‑blind study, the glutamate‑mediated excitotoxicity observed in patients with acute ischemic stroke was markedly attenuated by the administration of acetazolamide, suggesting a potential therapeutic role for this carbonic anhydrase inhibitor in mitigating neuronal damage.",-25.625,0.4,Chemical
"In addition to its known nephrotoxic potential, the glutamate‑mediated excitotoxicity induced by the ammonium salt form of acetazolamide has been implicated in the development of acute tubular necrosis in patients receiving lopinavir/ritonavir for HIV treatment.",-33.5,0.4,Chemical
"Lopinavir/ritonavir therapy for HIV infection was found to exacerbate glutamate‑mediated neurotoxicity, leading to a higher incidence of acute kidney injury in patients with pre‑existing renal disease.",-21.75,0.4,Chemical
"Lisinopril administration in patients with chronic kidney disease exacerbated hyperkalemia, a known adverse effect of the ACE inhibitor, while concomitant use of acetazolamide further increased serum bicarbonate levels, illustrating the complex interplay between drug therapy and electrolyte balance.",-34.0,0.4,Chemical
"Loprinavir/ritonavir, a protease inhibitor used to treat HIV infection, has been shown to inhibit the glutamate‑mediated excitotoxicity that contributes to neurodegeneration in patients with chronic HIV‑associated neurocognitive disorder.",-31.25,0.4,Chemical
"Excessive glutamate-mediated excitotoxicity in the hippocampus is mitigated by the administration of acetazolamide, which reduces intracellular pH and thereby limits seizure activity in patients with temporal lobe epilepsy.",-23.875,0.4,Chemical
Exogenous administration of the glutamate‑mediated inhibitor acetazolamide has been shown to reduce the incidence of nephrotoxicity in patients with acute kidney injury receiving lopinavir/ritonavir therapy.,-33.75,0.4,Chemical
"Extrapolating from the glutamate‑mediated excitotoxicity model, the administration of the novel compound, a di‑O‑acetyl‑D‑glucaro‑1,4‑6,3‑dilactone derivative, markedly attenuated neuronal death in a rat model of acute ischemic stroke, suggesting a potential therapeutic role for this chemical in mitigating cerebral injury.",-65.0,0.4,Chemical
"A single dose of the glutamate‑mediated agonist, a synthetic analog of guanosine, was shown to aggravate renal dysfunction in patients with chronic kidney disease, suggesting a potential adverse effect of this chemical on the disease progression.",-52.75,0.4,Chemical
"A mouse model of glutamate‑mediated excitotoxicity revealed that pretreatment with the acetazolamide analogue, a selective carbonic anhydrase inhibitor, markedly attenuated neuronal loss and reduced the incidence of seizure‑induced hippocampal damage.",-39.75,0.4,Chemical
"A chronic administration of lopinavir/ritonavir in patients with HIV infection was associated with a significant rise in serum creatinine, suggesting a potential nephrotoxic effect of this antiretroviral chemical on renal function.",-30.75,0.4,Chemical
"Immunohistochemical analysis revealed that the glutamate‑mediated upregulation of CaCl₂‑induced calcium influx was markedly attenuated in tumor cells treated with the novel inhibitor, the acetazolamide‑derivative, thereby reducing the proliferation of malignant lymphoma cells.",-54.5,0.4,Chemical
"Impaired glutamate‑mediated synaptic plasticity in the hippocampus was observed after chronic administration of the chemotherapeutic agent CCNU, suggesting a potential neurotoxic mechanism underlying chemotherapy‑induced cognitive deficits.",-25.25,0.4,Chemical
"Imaging studies revealed that glutamate‑mediated excitotoxicity in the hippocampus was markedly attenuated by the administration of the novel chemical inhibitor, des‑Arg10HOE‑140, in a rat model of temporal lobe epilepsy.",-42.75,0.4,Chemical
"GluR5 antagonism by the novel glutamate‑mediated inhibitor N‑(2,5‑di‑O‑acetyl‑D‑glucaro‑1,4‑6,3‑dilactone) reduces seizure severity in a rat model of epilepsy, whereas co‑administration of the antiepileptic drug levetiracetam mitigates the drug‑induced neurotoxicity.",-40.5,0.4,Chemical
"Glycine acts as a co‑agonist of NMDA receptors, and the glutamate‑mediated excitotoxicity observed in amyotrophic lateral sclerosis is attenuated when patients receive the chemical inhibitor acetazolamide, which reduces extracellular glutamate levels and mitigates motor neuron degeneration.",-38.5,0.4,Chemical
"Guanosine administration in a murine model of glutamate‑mediated excitotoxicity markedly reduced neuronal loss, suggesting a neuroprotective effect against chemically induced neurodegeneration.",-26.75,0.4,Chemical
"Experimental data revealed that the glutamate‑mediated excitotoxicity induced by the novel compound, a di‑O‑acetyl‑D‑glucaro‑1,4‑6,3‑dilactone, exacerbated neuronal loss in a mouse model of amyotrophic lateral sclerosis, suggesting that this chemical may accelerate disease progression.",-45.5,0.4,Chemical
"Experimental blockade of glutamate‑mediated excitotoxicity by the selective antagonist, des‑Arg10HOE‑140, markedly reduced neuronal loss in a rat model of ischemic stroke, suggesting a potential therapeutic role for this chemical in mitigating disease‑induced brain injury.",-46.5,0.4,Chemical
"Experimental administration of the glutamate‑mediated inhibitor CCNU in a murine model of glioblastoma induced a significant reduction in tumor volume while concurrently exacerbating renal tubular necrosis, suggesting a dual therapeutic–nephrotoxic profile.",-38.0,0.4,Chemical
"The study demonstrated that spironolactone‑induced hyperkalemia was markedly attenuated when patients with chronic kidney disease were concurrently treated with the potassium‑binding resin patiromer, thereby reducing the risk of acute renal failure.",-20.25,0.4,Chemical
"The spasmolytic effect of spironolactone-induced hypokalemia was mitigated in patients with chronic kidney disease by concurrent administration of acitretin, which also reduced the incidence of drug‑related dermatitis.",-26.125,0.4,Chemical
"The administration of the alkylating agent **1,3‑bis(2‑chloroethyl)-1‑nitrosourea** was associated with a marked increase in **prostaglandin** production, which in turn exacerbated the patient’s underlying **acute liver failure**.",-33.0,0.4,Chemical
"Treating patients with chronic hepatitis C using the antiviral combination of sofosbuvir and ribavirin has been shown to reduce the incidence of cirrhosis‑related hepatocellular carcinoma while sparing renal function, but concomitant use of the diuretic spironolactone can precipitate hyperkalemia and worsen liver dysfunction in those with advanced liver disease.",-52.0,0.4,Chemical
"Treatments with the antiretroviral lamivudine can lead to lamivudine‑resistance, which in turn predisposes patients with HIV‑associated lymphoma to poorer outcomes.",-30.5,0.4,Chemical
"Treats patients with lindane‑induced dermatitis, but the drug’s hepatotoxicity can precipitate acute liver failure (ALF) in susceptible individuals.",-35.5,0.4,Chemical
"Lindane‑induced hepatotoxicity in patients with chronic hepatitis C was exacerbated by concomitant acitretin therapy, leading to acute liver failure that required emergent liver transplantation.",-19.0,0.4,Chemical
"Lundin and colleagues reported that the use of the alkylating agent **1,3‑bis(2‑chloroethyl)‑1‑nitrosourea** in patients with relapsed **acute lymphoblastic leukemia** led to a marked reduction in **prostaglandin E2** production, thereby exacerbating the risk of **acute liver failure**.",-50.0,0.4,Chemical
"Lisinopril therapy for hypertension was found to exacerbate the nephrotoxic effects of cisplatin, leading to acute tubular necrosis in patients with pre‑existing chronic kidney disease.",-24.125,0.4,Chemical
"A patient with lamivudine‑resistant hepatitis B virus infection experienced acute liver failure after receiving a single dose of the alkylating agent, cisplatin, which was found to inhibit the viral polymerase and exacerbate hepatic toxicity.",-43.25,0.4,Chemical
"Aspirin therapy in patients with chronic kidney disease can exacerbate nephrotoxicity, yet it remains the first-line treatment for preventing cardiovascular events in this high-risk population.",-29.75,0.4,Chemical
"A study found that the spiro‑olactone‑induced hypertension in patients with chronic heart failure was markedly attenuated when the patients were concurrently treated with the anti‑inflammatory drug celecoxib, suggesting a protective interaction between the drug and the disease state.",-44.75,0.4,Chemical
"In patients with chronic hepatitis C, the use of acitretin has been associated with a paradoxical increase in hepatic fibrosis, suggesting that this retinoid may exacerbate liver disease rather than ameliorate it.",-26.625,0.4,Chemical
"In the study, patients with lindane‑induced dermatitis experienced exacerbated pruritus when treated with the anti‑inflammatory drug acitretin, suggesting a potential interaction between the chemical and the disease.",-31.25,0.4,Chemical
"In a randomized trial, patients with chronic hepatitis C who received the antiviral lamivudine exhibited a higher rate of liver fibrosis progression compared with those treated with the non‑steroidal anti‑inflammatory drug spironolactone, suggesting that lamivudine may exacerbate hepatic injury in this population.",-36.0,0.4,Chemical
"High‑dose spironolactone‑induced hyperkalemia was observed in patients with chronic kidney disease, prompting the addition of a potassium‑binding resin to mitigate the adverse effect.",-22.625,0.4,Chemical
"High‐dose acitretin therapy in patients with psoriasis can precipitate severe liver injury, as evidenced by elevated alanine aminotransferase levels and the development of acute liver failure (ALF) in a subset of treated individuals.",-33.0,0.4,Chemical
"High-dose spironolactone-induced acute liver failure has been reported in patients with chronic hepatitis C, illustrating how a commonly prescribed diuretic can precipitate severe hepatic injury in the presence of underlying viral disease.",-30.625,0.4,Chemical
Lamivudine‑resistant hepatitis B virus infection was found to be associated with a higher risk of developing acute liver failure in patients receiving the nucleoside analogue acitretin.,-25.375,0.4,Chemical
"Lamotrigine, a chemical antiepileptic, has been reported to induce severe liver failure (ALF) in patients with pre‑existing hepatitis B infection, illustrating a chemical‑disease interaction that necessitates careful monitoring of liver function during treatment.",-38.5,0.4,Chemical
"Lamellin-induced hepatotoxicity was observed in patients receiving the antiretroviral combination of lamivudine and acitretin, with elevated alanine aminotransferase levels indicating acute liver failure.",-33.5,0.4,Chemical
"Exposure to the alkylating agent **1,3-bis(2‑chloroethyl)-1‑nitrosourea** has been shown to precipitate **acute liver failure (ALF)** in patients with pre‑existing hepatic dysfunction, whereas concurrent administration of **spironolactone** can exacerbate this hepatotoxicity by further impairing bile acid excretion.",-36.25,0.4,Chemical
"Exposure of hepatocytes to the alkylating agent **1,3‑bis(2‑chloroethyl)-1‑nitrosourea** precipitated acute liver failure, while co‑administration of **spironolactone** exacerbated the hepatotoxicity by inhibiting cytochrome P450‑mediated detoxification.",-32.5,0.4,Chemical
"Exposure‑related dermatitis and liver failure were observed in patients receiving the alkylating agent **1,3‑bis(2‑chloroethyl)‑1‑nitrosourea** for refractory lymphoma, prompting a review of its **chemical‑induced hepatotoxicity** profile.",-49.25,0.4,Chemical
"Biopsies of patients with lindane‑induced dermatitis revealed a marked decrease in prostaglandin E2 production, suggesting that the chemical disrupts inflammatory signaling pathways and may contribute to the observed skin lesions.",-34.5,0.4,Chemical
"Biochemical analysis revealed that the lindane‑induced neurotoxicity was markedly attenuated when patients were concurrently administered acitretin, suggesting a protective interaction against the chemical‑mediated neuronal damage.",-33.25,0.4,Chemical
"Biopsy of the liver revealed acute liver failure (ALF) in a patient whose chronic hepatitis B infection had developed lamivudine‑resistance, prompting the switch to the nitrosourea derivative N‑(1,3‑bis(2‑chloroethyl)-1‑nitrosourea) which, while effective against the resistant virus, was associated with a marked increase in circulating prostaglandins and a subsequent rise in serum creatinine.",-62.75,0.4,Chemical
"Spironolactone-induced hyperkalemia was observed in a cohort of patients receiving acitretin for psoriasis, prompting a review of electrolyte monitoring protocols.",-19.0,0.4,Chemical
"Spironedol, a novel analog of spironolactone, was found to reduce the incidence of spironolactone‑induced hyperkalemia in patients with chronic kidney disease while maintaining its antihypertensive efficacy.",-28.625,0.4,Chemical
"Spiral‑induced nephrotoxicity was observed in patients receiving spironolactone, and the concomitant use of acitretin appeared to exacerbate the renal impairment.",-30.5,0.4,Chemical
"Patients treated with the alkylating agent **1,3-bis-(2-chloroethyl)-1-nitrosourea** for **glioblastoma multiforme** developed **acute liver failure** as a dose‑dependent hepatotoxicity that was mitigated when the therapy was combined with the antioxidant **N‑acetylcysteine**.",-35.25,0.4,Chemical
"Patients receiving the alkylating agent **1,3‑bis(2‑chloroethyl)‑1‑nitrosourea** developed **acute liver failure** that was mitigated by early administration of the hepatoprotective drug **silymarin**.",-26.0,0.4,Chemical
"Patients undergoing treatment with the alkylating agent **1,3‑bis(2‑chloroethyl)‑1‑nitrosourea** frequently develop **acute liver failure (ALF)**, a severe adverse effect that necessitates immediate discontinuation of the drug and supportive care.",-28.875,0.4,Chemical
"Acitretin treatment of psoriasis was associated with a dose‑dependent elevation of serum prolactin, suggesting a possible prolactin‑mediated mechanism of drug‑induced hyperprolactinemia.",-26.875,0.4,Chemical
"Acquired liver failure (ALF) has been reported in patients receiving the alkylating agent **1,3‑bis(2‑chloroethyl)-1‑nitrosourea**, which induces severe hepatotoxicity through the generation of reactive oxygen species and depletion of glutathione, thereby precipitating hepatic necrosis and acute renal failure.",-44.25,0.4,Chemical
"Acetaminophen overdose can precipitate acute liver failure (ALF) by overwhelming the hepatic detoxification pathways, whereas co‑administration of spironolactone may potentiate this hepatotoxicity through inhibition of hepatic CYP3A4 metabolism.",-30.125,0.4,Chemical
"Acute renal failure was observed in patients receiving busulfan, a potent alkylating agent, and the nephrotoxicity was mitigated by co‑administration of ursodeoxycholic acid, which improved bile acid transport and reduced tubular injury.",-27.625,0.4,Chemical
"Acquired resistance to busulfan in acute myeloid leukemia patients was associated with increased expression of the drug‑efflux transporter P‑gp, suggesting that concurrent administration of the P‑gp inhibitor verapamil could restore busulfan efficacy.",-33.0,0.4,Chemical
"Acidosis induced by prolonged busulfan exposure can precipitate acute renal failure, prompting clinicians to administer ursodeoxycholic acid as a hepatoprotective adjunct.",-30.0,0.4,Chemical
"In patients with refractory epilepsy, vigabatrin therapy has been associated with progressive visual field constriction, prompting clinicians to consider adjunctive treatment with ursodeoxycholic acid to mitigate hepatic toxicity while monitoring for potential drug–drug interactions that could exacerbate neurotoxic side effects.",-31.375,0.4,Chemical
"In the phase‑II trial, patients with refractory lymphoma receiving busulfan exhibited a significant rise in serum acid levels, suggesting a potential metabolic side effect of the alkylating agent.",-30.5,0.4,Chemical
"In a randomized trial, patients with chronic liver disease receiving ursodeoxycholic acid experienced a significant reduction in bilirubin levels, yet a subset developed mild hepatotoxicity attributed to the drug’s interaction with acid‑mediated bile secretion.",-33.25,0.4,Chemical
Repeated administration of busulfan in patients with acute myeloid leukemia has been associated with a dose‑dependent rise in serum acid levels that can precipitate renal tubular acidosis and subsequent nephrotoxicity.,-26.75,0.4,Chemical
"Repeated exposure to the alkylating agent busulfan in patients with acute lymphoblastic leukemia has been linked to the development of late‑onset renal tubular acidosis, a complication that may be mitigated by concurrent administration of ursodeoxycholic acid.",-27.25,0.4,Chemical
"Repeated therapeutic exposure to busulfan in patients with acute myeloid leukemia has been associated with the development of severe hepatic steatosis, a complication that may be mitigated by concurrent administration of ursodeoxycholic acid.",-28.875,0.4,Chemical
"Busulfan, a potent alkylating chemotherapeutic, can induce acute interstitial nephritis in patients with underlying chronic kidney disease, while concomitant administration of ursodeoxycholic acid may mitigate hepatic cholestasis but not prevent the drug‑induced renal toxicity.",-26.375,0.4,Chemical
"Busolfan exposure in patients with acute lymphoblastic leukemia has been linked to severe myelosuppression, prompting the use of ursodeoxycholic acid to mitigate hepatotoxicity.",-31.375,0.4,Chemical
"Busulfam exposure in patients with acute myeloid leukemia has been linked to a dose‑dependent increase in hepatotoxicity, prompting clinicians to monitor liver enzymes and consider dose adjustment or substitution with a less hepatotoxic alkylating agent.",-41.25,0.4,Chemical
"The antineoplastic agent busulfan, when administered at high cumulative doses, can precipitate severe bone marrow suppression and increase the risk of myelodysplastic syndrome in patients with underlying aplastic anemia.",-24.625,0.4,Chemical
"The administration of busulfan in patients with acute myeloid leukemia can precipitate severe mucositis, yet co‑treatment with ursodeoxycholic acid appears to mitigate hepatic toxicity associated with the drug.",-23.0,0.4,Chemical
"The anti‑epileptic vigabatrin, when combined with the proton‑pump inhibitor omeprazole, has been reported to induce a reversible elevation of serum hydroxyproline levels, potentially exacerbating underlying hepatic fibrosis in patients with pre‑existing cirrhosis.",-33.25,0.4,Chemical
"Administration of busulfan in patients with acute lymphoblastic leukemia can precipitate severe hepatic toxicity, especially when combined with concurrent use of ursodeoxycholic acid, which paradoxically may exacerbate cholestatic injury.",-24.5,0.4,Chemical
"Administration to patients with hepatic cirrhosis of the hepatoprotective agent ursodeoxycholic acid has been shown to attenuate the nephrotoxic effects of the alkylating agent busulfan, thereby reducing the incidence of acute kidney injury.",-40.0,0.4,Chemical
"Administration and absorption of busulfan in patients with acute lymphoblastic leukemia may be markedly reduced by concomitant ingestion of acidic beverages, thereby compromising its therapeutic efficacy.",-40.75,0.4,Chemical
"Vigabatrin, an antiepileptic drug, was found to lower the seizure threshold in patients with refractory epilepsy, thereby exacerbating their seizure disorder.",-24.5,0.4,Chemical
"Vagabatrin, an antiepileptic chemical, was found to aggravate the neurotoxic side effects of busulfan in patients undergoing conditioning for hematopoietic stem cell transplantation, leading to increased incidence of cerebellar ataxia and peripheral neuropathy.",-40.0,0.4,Chemical
"Vigilant monitoring revealed that busulfan, a potent alkylating chemotherapeutic, exacerbated hepatic injury in patients with pre‑existing cirrhosis, prompting clinicians to consider ursodeoxycholic acid as a hepatoprotective adjunct.",-29.5,0.4,Chemical
"Intravenous busulfan, a potent alkylating agent, was found to exacerbate acute renal failure in patients with pre‑existing chronic kidney disease.",-19.75,0.4,Chemical
"Intracranial hypertension in patients receiving vigabatrin is often mitigated by adjunctive therapy with ursodeoxycholic acid, which reduces hepatic bile acid accumulation and alleviates neurotoxicity.",-29.5,0.4,Chemical
Intraperitoneal administration of busulfan in a murine model of acute lymphoblastic leukemia induced a dose‑dependent reduction in leukemic burden while concurrently precipitating transient nephrotoxicity that resolved upon cessation of the drug.,-29.625,0.4,Chemical
"Treatment with the antineoplastic drug busulfan has been associated with a dose‑dependent increase in plasma acid concentration, potentially exacerbating hepatic toxicity in patients with underlying liver disease.",-28.25,0.4,Chemical
"Treatment of acute lymphoblastic leukemia with busulfan and cyclophosphamide can precipitate severe mucositis and hepatotoxicity, prompting clinicians to administer ursodeoxycholic acid to mitigate liver injury.",-27.0,0.4,Chemical
"Treatment patients with busulfan for acute lymphoblastic leukemia often results in severe mucositis, a complication that can be mitigated by co‑administration of sucralfate to protect the gastrointestinal mucosa.",-35.75,0.4,Chemical
"Exposure to busulfan during conditioning for hematopoietic stem‑cell transplantation can precipitate acute interstitial nephritis, a renal disease that may be mitigated by concurrent administration of ursodeoxycholic acid, which reduces bile acid‑induced tubular injury.",-25.5,0.4,Chemical
"Exposure of patients with acute myeloid leukemia to busulfan during conditioning regimens has been linked to a dose‑dependent increase in nephrotoxicity, prompting clinicians to monitor renal function closely and adjust the drug schedule accordingly.",-29.25,0.4,Chemical
"Exposure‑related hepatotoxicity was observed in patients receiving busulfan, a cytotoxic alkylating agent, when concomitant administration of ursodeoxycholic acid failed to mitigate the drug‑induced liver injury.",-35.5,0.4,Chemical
"Administering busulfan to patients with acute myeloid leukemia can precipitate severe mucosal acid injury, which is mitigated by concurrent sucralfate therapy.",-22.375,0.4,Chemical
"Administation of busulfan in patients with acute myeloid leukemia can precipitate severe mucosal ulceration, a complication that is mitigated when the drug is co‑administered with sucralfate.",-36.5,0.4,Chemical
"Administra­tion of busulfan in patients with acute lymphoblastic leukemia frequently induces a transient, reversible rise in serum uric acid that can precipitate gouty arthritis.",-39.75,0.4,Chemical
"Surgeons observed that administering busulfan to patients with acute myeloid leukemia caused a marked increase in bone marrow suppression, prompting the use of ursodeoxycholic acid to mitigate the drug‑induced hepatotoxicity.",-33.0,0.4,Chemical
"Survival analysis of patients with acute myeloid leukemia treated with busulfan revealed a dose‑dependent increase in hepatotoxicity, suggesting that concurrent administration of ursodeoxycholic acid may mitigate the drug‑induced cholestasis.",-26.25,0.4,Chemical
"Surviving patients with acute myeloid leukemia who received busulfan conditioning exhibited a markedly higher incidence of mucositis, likely due to the drug’s alkylating activity on rapidly dividing mucosal cells.",-32.5,0.4,Chemical
"The antituberculosis drug isoniazid, when combined with the chemical N‑acylimidazole, has been shown to inhibit the activity of the enzyme gamma‑carboxyglutamate synthase in patients with tuberculosis‑associated anemia.",-23.875,0.4,Chemical
"The N‑acylimidazole derivative, when administered to patients with testosterone‑dependent prostate cancer, inhibited the activity of the androgen receptor and consequently reduced tumor growth.",-23.0,0.4,Chemical
"The compound tranylcypromine, a monoamine oxidase inhibitor, was found to exacerbate the neurotoxic side effects of cisplatin in patients with testicular cancer, leading to severe peripheral neuropathy.",-27.5,0.4,Chemical
"In a randomized trial, patients with testosterone‑dependent prostate cancer receiving the novel inhibitor tranylcypromine experienced a significant reduction in tumor burden, yet developed transient renal dysfunction attributable to the drug’s off‑target inhibition of gamma‑carboxyglutamate‑dependent clotting factors.",-32.25,0.4,Chemical
"In patients receiving the antituberculosis drug isoniazid, the concomitant use of the chemical N‑acylimidazole has been associated with a higher incidence of hepatotoxicity, suggesting a synergistic inhibition of hepatic cytochrome P450 enzymes.",-25.0,0.4,Chemical
Inhibition of gamma‑carboxyglutamate synthesis by the tranylcypromine analogue TNA has been shown to reduce the risk of thrombosis in patients with testosterone‑dependent prostate cancer.,-26.625,0.4,Chemical
"Exposure to the N‑acylimidazole derivative inhibited gamma‑carboxyglutamate synthesis, thereby exacerbating the hypercoagulable state observed in patients with testosterone‑dependent prostate cancer.",-22.375,0.4,Chemical
"Exposure of HCTZ‑treated patients to the novel N‑acylimidazole derivative, a potent gamma‑carboxyglutamate antagonist, has been associated with a higher incidence of acute kidney injury, suggesting a drug‑induced nephrotoxicity that may limit its use in patients with underlying renal disease.",-44.75,0.4,Chemical
"Exposure‑based studies have shown that the synthetic compound **3α‑tropanyl‑2‑(4‑chlorophenoxy)butyrate** can inhibit the growth of *Mycobacterium tuberculosis* while simultaneously inducing a mild, reversible elevation in serum **gamma‑carboxyglutamate** levels in treated patients.",-49.5,0.4,Chemical
"A recent pharmacokinetic study showed that the TNA analog of the antituberculosis drug, which contains a gamma‑carboxyglutamate moiety, inhibited the growth of Mycobacterium tuberculosis in vitro while sparing healthy macrophages.",-46.75,0.4,Chemical
"A single dose of the synthetic compound N‑acylimidazole, designed to inhibit gamma‑carboxyglutamate‑dependent clotting, caused transient thrombocytopenia in a patient with a history of testosterone‑dependent prostate cancer, raising concerns about its safety in endocrine‑sensitive malignancies.",-38.0,0.4,Chemical
"A patient with testosterone‑dependent prostate cancer experienced severe hypertension after receiving a single dose of the novel beta‑blocker tranylcypromine, prompting discontinuation of the drug.",-27.25,0.4,Chemical
"Patients treated with the novel antituberculosis agent TNA experienced a dose‑dependent elevation of serum gamma‑carboxyglutamate, suggesting a potential hepatotoxic interaction that warrants further pharmacodynamic investigation.",-26.25,0.4,Chemical
"Patients receiving the antituberculosis drug isoniazid experienced a marked increase in gamma‑carboxyglutamate levels, suggesting a potential neurotoxic interaction that may exacerbate underlying neuropathy.",-25.5,0.4,Chemical
"Patients undergoing antituberculosis therapy with isoniazid and rifampin reported a significant increase in serum gamma‑carboxyglutamate levels, suggesting a potential drug‑induced alteration of hepatic amino‑acid metabolism.",-27.625,0.4,Chemical
"Tobramycin, a broad‑spectrum aminoglycoside, was shown to inhibit the growth of Mycobacterium tuberculosis in vitro, yet its use in patients with chronic kidney disease can precipitate acute tubular necrosis.",-25.625,0.4,Chemical
"TNA administration in patients with chronic hepatitis C has been associated with a dose‑dependent increase in gamma‑carboxyglutamate levels, potentially exacerbating hepatic encephalopathy.",-19.625,0.4,Chemical
"Tetracycline, a broad‑spectrum antibiotic, has been shown to inhibit the growth of *Mycobacterium tuberculosis* while simultaneously exacerbating renal tubular dysfunction in patients with pre‑existing chronic kidney disease.",-24.0,0.4,Chemical
"D-penicillamine-induced nephropathy was observed in patients with rheumatoid arthritis receiving the drug for joint pain, prompting clinicians to consider alternative antituberculosis regimens that avoid renal toxicity.",-27.375,0.4,Chemical
D‑penicillamine‑induced nephropathy was markedly attenuated when patients with rheumatoid arthritis received the combination of tranylcypromine and a low‑dose gamma‑carboxyglutamate supplement.,-24.375,0.4,Chemical
"D–penicillamine‑induced nephropathy was markedly attenuated in patients with chronic kidney disease who were concurrently treated with the antihypertensive HCTZ, suggesting a protective interaction between the two chemicals in the context of renal disease.",-34.25,0.4,Chemical
"Triamcinolone acetonide was found to reduce the incidence of D‑penicillamine‑induced interstitial nephritis in patients with rheumatoid arthritis, while simultaneously improving the clearance of the antituberculosis drug isoniazid.",-32.25,0.4,Chemical
"Triapine, a potent ribonucleotide reductase inhibitor, has been shown to induce gamma‑carboxyglutamate deficiency in patients with acute myeloid leukemia, thereby exacerbating the risk of intracranial hemorrhage.",-32.25,0.4,Chemical
"Triacetyl‑copper, a novel N‑acylimidazole derivative, was found to inhibit the growth of Mycobacterium tuberculosis in vitro, yet its administration in a murine model of pulmonary tuberculosis induced transient hepatotoxicity, suggesting a dose‑dependent adverse effect that warrants further pharmacokinetic evaluation.",-51.75,0.4,Chemical
"Treatment with the novel N‑acylimidazole derivative, which selectively inhibits gamma‑carboxyglutamate synthesis, markedly reduced the progression of testosterone‑dependent prostate carcinoma in preclinical models.",-24.75,0.4,Chemical
"Treatment of the patient with the novel compound N‑acylimidazole, a synthetic analogue of gamma‑carboxyglutamate, resulted in a marked reduction of the hyperproliferative activity of the TNA‑positive lymphoma cells while sparing normal T cells.",-41.5,0.4,Chemical
"Treatment trials of the novel N‑acylimidazole analogue, a potent inhibitor of gamma‑carboxyglutamate synthesis, revealed that patients with testosterone‑dependent prostate cancer experienced a significant reduction in tumor growth but also developed transient renal dysfunction reminiscent of HCTZ‑induced nephrotoxicity.",-46.5,0.4,Chemical
"Administration of the N‑acylimidazole derivative to patients with testosterone‑dependent prostate cancer resulted in a marked reduction of tumor‑associated gamma‑carboxyglutamate expression, suggesting a potential therapeutic pathway for chemoprevention.",-30.0,0.4,Chemical
"Administration with the N‑acylimidazole derivative, which inhibits gamma‑carboxyglutamate synthesis, was found to exacerbate the renal toxicity observed in patients receiving the antituberculosis drug isoniazid.",-46.0,0.4,Chemical
"Administration schedule of the novel antituberculosis agent N‑acylimidazole was associated with a dose‑dependent elevation of gamma‑carboxyglutamate levels in patients who were concurrently receiving the diuretic HCTZ, suggesting a potential interaction that may exacerbate renal tubular dysfunction.",-53.5,0.4,Chemical
"Use of the tranylcypromine analogue, a monoamine oxidase inhibitor, in patients with Parkinson’s disease has been associated with a dose‑dependent rise in serum gamma‑carboxyglutamate levels, potentially exacerbating neurotoxicity.",-33.0,0.4,Chemical
"Use a single sentence that mentions a disease and a chemical, e.g. “The administration of the novel compound **3α‑tropanyl‑2‑(4‑chlorophenoxy)butyrate** to patients with **diabetes mellitus** resulted in a significant reduction of fasting glucose levels, suggesting a potential therapeutic role for this chemical in the management of the disease.”",-45.0,0.4,Chemical
"Use isoniazid, a first‑line antituberculosis chemical, to treat latent tuberculosis infection, but it can induce hepatotoxicity in patients with pre‑existing liver disease.",-28.125,0.4,Chemical
"Researchers found that the TNA derivative, a synthetic analog of gamma‑carboxyglutamate, inhibited the growth of testosterone‑dependent prostate cancer cells while simultaneously reducing the nephrotoxic effects observed with HCTZ treatment.",-37.0,0.4,Chemical
"Researchers demonstrated that the novel compound N‑acylimidazole, when administered to a murine model of diabetes, significantly reduced hyperglycemia but concurrently induced mild renal tubular injury, suggesting a dual therapeutic and nephrotoxic profile.",-37.5,0.4,Chemical
"Researchers observed that the administration of the novel compound N‑acylimidazole exacerbated renal dysfunction in patients with chronic kidney disease, suggesting a potential nephrotoxic effect that warrants further investigation.",-31.375,0.4,Chemical
"Bumetanide administration in patients with chronic heart failure can precipitate electrolyte imbalance and exacerbate renal dysfunction, thereby increasing the risk of acute kidney injury.",-18.125,0.4,Chemical
"Bupivacaine, a local anesthetic, can precipitate organophosphate‑induced cholinergic crisis when administered to patients with a history of exposure to organophosphate pesticides, thereby exacerbating respiratory failure and requiring immediate antidotal therapy.",-34.75,0.4,Chemical
"Bungarotoxin, a potent organophosphate‑induced neurotoxin, was shown to exacerbate the renal failure observed in patients with chronic kidney disease receiving bumetanide as a diuretic.",-35.5,0.4,Chemical
The combination of amoxicillin and clavulanic acid was found to reduce the incidence of antibiotic‑associated diarrhea in patients with inflammatory bowel disease.,-10.25,0.4,Chemical
"The organophosphate‑induced cholinergic crisis was mitigated by the combination of amoxicillin and clavulanic acid, yet the patient still developed acute kidney injury, a known adverse effect of the drug regimen.",-19.625,0.4,Chemical
"The N‑(2‑hydroxypropyl) methacrylamide polymer was shown to inhibit organophosphate‑induced neurotoxicity in a mouse model, thereby reducing the severity of seizures and improving survival rates.",-23.25,0.4,Chemical
"In patients with organophosphate‑induced cholinergic crisis, administration of the anticholinergic drug FK markedly attenuated the respiratory depression that otherwise would have required high‑dose benzodiazepines.",-26.375,0.4,Chemical
"In a double‑blind study, the organophosphate‑induced seizures of patients receiving the combination of amoxicillin and clavulanic acid were markedly reduced when a single dose of bumetanide was administered, suggesting a protective effect of the diuretic against the neurotoxic cascade.",-33.75,0.4,Chemical
"In organophosphate‑induced seizures, the combination of amoxicillin and clavulanic acid was found to attenuate the neurotoxic effect of the pesticide while sparing renal function.",-22.625,0.4,Chemical
"Ceftriaxone administration in patients with severe sepsis was associated with a higher incidence of acute kidney injury, prompting clinicians to consider alternative antibiotics such as amoxicillin–clavulanic acid to mitigate renal toxicity.",-29.5,0.4,Chemical
Cumulative exposure to the organophosphate pesticide N‑(2‑hydroxypropyl) methacrylamide has been shown to aggravate the nephrotoxic effects of the loop diuretic bumetanide in patients with chronic kidney disease.,-21.625,0.4,Chemical
"Cognitive deficits observed in patients with organophosphate-induced neuropathy were markedly alleviated when treated with the combination of amoxicillin and clavulanic acid, suggesting a protective effect of this chemical regimen against the disease.",-26.875,0.4,Chemical
"Organophosphate‑induced seizures were markedly attenuated when the patients were treated with the diuretic bumetanide, which appears to inhibit the excessive neuronal chloride influx that underlies the convulsive activity.",-25.75,0.4,Chemical
"Organ‐phosphate‑induced seizures were markedly attenuated when patients were treated with a combination of amoxicillin and clavulanic acid, demonstrating the drug’s protective effect against the neurotoxic cascade.",-37.75,0.4,Chemical
"Organohydroxylated N‑(2‑hydroxypropyl) methacrylamide was found to inhibit the growth of FK‑506‑resistant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating refractory disease.",-35.0,0.4,Chemical
Researchers observed that the combination of amoxicillin and clavulanic acid mitigated organophosphate‑induced neurotoxicity in patients with acute pesticide poisoning.,-19.0,0.4,Chemical
"Researchers reported that the combination of amoxicillin and clavulanic acid significantly reduced the incidence of antibiotic‑associated colitis in patients with inflammatory bowel disease, while the concomitant use of bumetanide appeared to mitigate the drug‑induced electrolyte imbalance that often complicates such treatment.",-36.5,0.4,Chemical
Researchers demonstrated that the combination of amoxicillin and clavulanic acid reduced the incidence of antibiotic‑associated colitis in patients with inflammatory bowel disease while also mitigating the nephrotoxic effects of bumetanide.,-27.25,0.4,Chemical
"A recent pharmacogenomic study found that patients with the FKBP5 polymorphism who received the diuretic bumetanide experienced a higher incidence of electrolyte imbalance, suggesting a potential interaction between the chemical and the disease phenotype.",-34.5,0.4,Chemical
A study of the combination of amoxicillin and clavulanic acid revealed that the drug regimen significantly reduced the incidence of bacterial meningitis in patients with severe sepsis.,-25.125,0.4,Chemical
"A patient with chronic heart failure treated with the diuretic bumetanide experienced a sudden drop in serum potassium, prompting the addition of a potassium-sparing agent to mitigate the risk of hypokalemia.",-25.875,0.4,Chemical
"Use of the diuretic bumetanide in patients with heart failure can precipitate hypokalemia, which may exacerbate the cardiotoxic effects of the beta‑blocker nadolol.",-21.75,0.4,Chemical
"Use bumetanide to treat the acute kidney injury induced by organophosphate poisoning, thereby reducing the risk of renal failure.",-33.5,0.4,Chemical
"Use an N‑(2‑hydroxypropyl) methacrylamide‑based polymer to encapsulate bumetanide, thereby reducing its nephrotoxic effect in patients with chronic kidney disease.",-27.625,0.4,Chemical
Combination of amoxicillin and clavulanic acid was found to reduce the incidence of organophosphate‑induced neuropathy in patients with acute pesticide exposure.,-15.3125,0.4,Chemical
Combination therapy with amoxicillin and clavulanic acid has been shown to reduce the incidence of organophosphate‑induced neuropathy in patients exposed to lead poisoning.,-16.875,0.4,Chemical
Combination treatment with amoxicillin and clavulanic acid was found to reduce the incidence of organophosphate‑induced neuropathy in patients exposed to lead poisoning.,-17.875,0.4,Chemical
Treatment with the diuretic bumetanide in patients with heart failure exacerbated the renal dysfunction that was initially induced by the organophosphate‑toxin exposure.,-26.0,0.4,Chemical
Treatment of organophosphate‑induced seizures with a combination of amoxicillin and clavulanic acid has been reported to reduce the incidence of secondary renal failure in patients receiving the chemotherapeutic agent FK.,-23.375,0.4,Chemical
Treatment failure of the combination of amoxicillin and clavulanic acid in patients with chronic kidney disease was attributed to the accumulation of the drug and the subsequent development of acute interstitial nephritis.,-33.75,0.4,Chemical
Targeted delivery of the organophosphate‑inhibitor FK to the tumor microenvironment markedly reduced tumor‑induced neuropathic pain while sparing the normal nervous system.,-35.25,0.4,Chemical
"Target‑tissue accumulation of the organophosphate‑derived fumonisin B1 (FK) was found to exacerbate nephrotoxicity in mice treated with the diuretic bumetanide, suggesting a synergistic interaction that may increase the risk of acute kidney injury.",-44.25,0.4,Chemical
Targeting FKBP12 with the selective inhibitor N‑(2‑hydroxypropyl) methacrylamide mitigated organophosphate‑induced neurotoxicity while sparteine‐mediated cardiac arrhythmias were exacerbated by concurrent bumetanide therapy.,-35.25,0.4,Chemical
"Chemical exposure to the organophosphate pesticide chlorpyrifos has been linked to a higher incidence of Parkinsonian disease in agricultural workers, suggesting that chronic inhibition of acetylcholinesterase may contribute to neurodegeneration.",-27.375,0.4,Chemical
"Chemical analysis revealed that the organophosphate‑induced inhibition of acetylcholinesterase by the pesticide compound N‑(2‑hydroxypropyl) methacrylamide was markedly potentiated in patients with chronic kidney disease, thereby exacerbating their susceptibility to acute renal failure.",-33.0,0.4,Chemical
"Chemical‐induced nephrotoxicity was observed in patients receiving the diuretic bumetanide, which exacerbated the renal impairment already present in those with underlying chronic kidney disease.",-28.125,0.4,Chemical
"In a cohort of patients with steroid‑induced diabetes, the addition of propanolol to the regimen significantly reduced hyperglycaemic episodes without increasing the risk of hypoglycaemia.",-23.75,0.4,Chemical
"In penicillamine‑treated patients with Wilson disease, the drug’s chelating action can precipitate a paradoxical exacerbation of hepatic encephalopathy, a complication that may be mitigated by concurrent administration of N‑acetylcysteine to restore glutathione‑mediated detoxification.",-39.0,0.4,Chemical
"In cancer patients receiving cisplatin‑based chemotherapy, the concomitant use of the steroid‑induced immunosuppressant propanolol has been shown to exacerbate nephrotoxicity, leading to acute kidney injury.",-27.25,0.4,Chemical
"The cisplatin‑based chemotherapy regimen induced severe nephrotoxicity, prompting the addition of N‑acylimidazole as a renoprotective agent.",-11.75,0.4,Chemical
"The N‑acylimidazole derivative inhibited the proliferation of cisplatin‑resistant ovarian carcinoma cells, thereby reducing the drug‑induced nephrotoxicity observed in patients with platinum‑based chemotherapy.",-21.25,0.4,Chemical
"The cholestatic liver injury observed in patients receiving cisplatin-based chemotherapy was attributed to the drug’s inhibition of bile salt export pump activity, a mechanism similar to that seen with the N‑acylimidazole derivative NSC‑343499.",-34.75,0.4,Chemical
"Administration of cisplatin‑based chemotherapy in patients with metastatic ovarian cancer frequently triggers steroid‑induced nephrotoxicity, prompting clinicians to monitor renal function closely.",-21.625,0.4,Chemical
"Administration with the cisplatin-based regimen precipitated acute kidney injury, a known adverse effect of cisplatin that can be mitigated by concurrent N‑acylimidazole therapy.",-37.25,0.4,Chemical
Administration and subsequent monitoring of the cisplatin‑based regimen revealed a dose‑dependent nephrotoxicity that manifested as acute kidney injury in patients with pre‑existing chronic kidney disease.,-34.25,0.4,Chemical
"Propranolol treatment in patients with steroid‑induced myopathy has been associated with a paradoxical worsening of muscle weakness, suggesting an interaction that may exacerbate the underlying disease.",-21.5,0.4,Chemical
Propanolol administration in patients with steroid‑induced hypertension has been shown to reduce mean arterial pressure without exacerbating the underlying disease.,-18.625,0.4,Chemical
"Prolonged exposure to the cisplatin‑based regimen was associated with a marked increase in nephrotoxicity, leading to acute kidney injury in several patients with metastatic ovarian cancer.",-24.75,0.4,Chemical
"Cisplatin-based chemotherapy frequently induces nephrotoxicity, which is mitigated by concurrent administration of N‑acetylcysteine, a chemical antioxidant.",-19.25,0.4,Chemical
"Clozapine, a second‑generation antipsychotic, has been shown to induce steroid‑induced hyperglycemia in patients with schizophrenia, thereby increasing the risk of developing type‑2 diabetes mellitus.",-30.0,0.4,Chemical
"Cytotoxicity of the cisplatin‑based regimen was markedly reduced in patients receiving the N‑acylimidazole adjuvant, yet the combination still precipitated acute kidney injury in a subset of individuals with pre‑existing chronic kidney disease.",-31.0,0.4,Chemical
"Propofol-induced hypotension was observed in patients with sepsis, and the administration of the β‑blocker propranolol mitigated the cardiovascular instability while preserving renal perfusion.",-27.75,0.4,Chemical
"Propafenone, a beta‑blocker, has been shown to exacerbate steroid‑induced osteoporosis in patients receiving long‑term prednisolone therapy.",-17.25,0.4,Chemical
Propensity score matching revealed that patients receiving the cisplatin‑based regimen had a significantly higher incidence of steroid‑induced nephropathy compared with those treated with the N‑acylimidazole analogue.,-20.0,0.4,Chemical
"A patient receiving cisplatin-based chemotherapy developed steroid‑induced osteonecrosis, prompting the addition of N‑acylimidazole as a protective agent.",-15.8125,0.4,Chemical
"A study of cisplatin‑based chemotherapy revealed that patients with pre‑existing chronic kidney disease experienced exacerbated nephrotoxicity, while concurrent administration of N‑acylimidazole mitigated the cisplatin‑induced renal injury.",-23.125,0.4,Chemical
"A recent cohort study found that patients receiving cisplatin‑based chemotherapy for ovarian cancer experienced a higher incidence of steroid‑induced osteonecrosis, suggesting a synergistic detrimental effect of the drug on bone vascularity.",-24.75,0.4,Chemical
"Patients receiving a cisplatin‑based regimen for ovarian carcinoma developed steroid‑induced nephropathy, prompting the addition of N‑acylimidazole as a renoprotective adjunct.",-16.875,0.4,Chemical
"Patients treated with the cisplatin‑based regimen developed steroid‑induced nephropathy, which was mitigated by the N‑acylimidazole inhibitor of the inflammatory cascade.",-20.375,0.4,Chemical
"Patients with steroid‑induced nephropathy who were treated with the cisplatin‑based regimen experienced a significant rise in serum creatinine, suggesting a synergistic nephrotoxic interaction.",-22.625,0.4,Chemical
"Chlorambucil, a DNA‑crosslinking alkylating agent, has been shown to exacerbate steroid‑induced osteonecrosis in patients with rheumatoid arthritis.",-21.5,0.4,Chemical
Chloroquine-induced hemolytic anemia was observed in patients with sickle cell disease who were receiving prophylactic chloroquine therapy.,-17.75,0.4,Chemical
"Chronic use of the chemotherapy agent cisplatin has been associated with nephrotoxicity, prompting the exploration of N‑acylimidazole derivatives as potential renoprotective agents in patients with cisplatin‑induced acute kidney injury.",-26.625,0.4,Chemical
"An early-phase trial of the novel NSC‑343499 compound reported significant reduction of tumor burden in patients with cisplatin‑resistant ovarian carcinoma, yet a subset of participants developed steroid‑induced hyperglycemia that required insulin therapy.",-42.0,0.4,Chemical
"An iatrogenic case of steroid‑induced osteoporosis was reported in a patient receiving a cisplatin‑based regimen for ovarian carcinoma, where the chemotherapeutic agent exacerbated bone resorption and precipitated a pathological fracture.",-35.75,0.4,Chemical
"An oncologist noted that the cisplatin‑based regimen caused severe nephrotoxicity, prompting the addition of N‑acylimidazole to mitigate the acute kidney injury.",-24.125,0.4,Chemical
Platinum‑based cisplatin therapy for metastatic ovarian carcinoma was found to precipitate acute kidney injury in a patient with pre‑existing chronic kidney disease.,-24.875,0.4,Chemical
"Plasma concentrations of the steroid‑induced immunosuppressant NSC‑343499 were found to be markedly elevated in patients receiving a cisplatin‑based chemotherapy regimen, thereby exacerbating nephrotoxicity.",-32.75,0.4,Chemical
"Pluripotent stem cells treated with the N‑acylimidazole derivative NSC‑343499 exhibited a marked reduction in the expression of the oncogenic protein c‑Myc, suggesting that this chemical may inhibit the proliferation of malignant lymphoma cells.",-39.75,0.4,Chemical
"High-dose cisplatin-based chemotherapy frequently precipitates steroid‑induced nephrotoxicity, prompting clinicians to administer N‑acylimidazole as a protective agent.",-18.375,0.4,Chemical
"High‑dose cisplatin‑based chemotherapy can precipitate steroid‑induced osteonecrosis, a complication that is often mitigated by prophylactic administration of N‑acylimidazole.",-23.875,0.4,Chemical
"High‐dose cisplatin‐based chemotherapy frequently induces nephrotoxicity, a complication that is mitigated when patients receive concurrent N‑acylimidazole as a renoprotective agent.",-24.875,0.4,Chemical
The cyclooxygenase inhibitors were found to reduce the incidence of cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma.,-15.0,0.4,Chemical
The clinical trial demonstrated that doxorubicin-loaded nanoparticles significantly reduced tumor burden in patients with metastatic melanoma while sparing normal tissue from the cardiotoxic effects typically associated with free doxorubicin.,-21.125,0.4,Chemical
"The hepatotoxicity observed in patients receiving doxorubicin-loaded liposomal formulations was attributed to the drug’s interaction with cytochrome P450 enzymes, exacerbating oxidative stress and leading to acute liver injury.",-25.0,0.4,Chemical
"Doxorubicin‑based chemotherapy was associated with a higher incidence of cardiotoxicity in patients with pre‑existing heart failure, whereas the addition of dexrazoxane mitigated this adverse effect.",-17.5,0.4,Chemical
"Dexamethasone, a potent anti‑inflammatory chemical, was shown to reduce the incidence of chemotherapy‑induced neuropathy in patients with metastatic breast cancer receiving doxorubicin‑based regimens.",-19.875,0.4,Chemical
"Dilevalol‑induced hypertension was markedly attenuated in patients receiving the cyclooxygenase inhibitor celecoxib, suggesting a synergistic interaction that mitigates cardiovascular risk in hypertensive disease.",-21.375,0.4,Chemical
"Patients receiving doxorubicin‑based chemotherapy experienced cardiotoxicity, which was mitigated by concurrent administration of the cyclooxygenase inhibitor celecoxib.",-15.5625,0.4,Chemical
"Patients treated with doxorubicin-based chemotherapy experienced severe cardiotoxicity, which was mitigated when the regimen was combined with the cyclooxygenase inhibitor celecoxib.",-17.875,0.4,Chemical
"Patients suffering from chronic heart failure who were treated with the diuretic furosemide experienced a marked reduction in pulmonary edema, yet the concomitant use of the antiplatelet drug clopidogrel was associated with an increased incidence of gastrointestinal bleeding.",-29.625,0.4,Chemical
"A retrospective study found that patients receiving doxorubicin-based chemotherapy for lymphoma experienced a significant increase in cardiotoxicity, which was mitigated when the regimen was combined with the cyclooxygenase inhibitor celecoxib.",-24.75,0.4,Chemical
"A recent pharmacovigilance study revealed that patients with chronic kidney disease who were treated with the cyclooxygenase inhibitor celecoxib experienced an increased incidence of acute interstitial nephritis, a finding that underscores the need for careful monitoring of renal function when prescribing this chemical in individuals with pre‑existing renal impairment.",-37.0,0.4,Chemical
A clinical trial demonstrated that the cyclooxygenase inhibitor diclofenac exacerbated rheumatoid arthritis symptoms in patients who were concurrently receiving clopidogrel for cardiovascular protection.,-23.125,0.4,Chemical
"Clinical analysis revealed that patients receiving doxorubicin-based chemotherapy experienced severe cardiotoxicity, which was mitigated when combined with the cyclooxygenase inhibitor clopidogrel.",-26.875,0.4,Chemical
"Clinical trials have shown that doxorubicin-based chemotherapy can exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas concurrent administration of the cyclooxygenase inhibitor furosemide may mitigate this adverse effect.",-26.375,0.4,Chemical
"Clinical investigation revealed that the dilevalol‑induced arrhythmia was markedly attenuated when patients were concurrently treated with clopidogrel, suggesting a protective interaction between the β‑blocker and the antiplatelet agent in patients with ischemic heart disease.",-26.25,0.4,Chemical
"Clopidogrel treatment of acute coronary syndrome patients was associated with a higher incidence of drug‑induced thrombocytopenia, a complication that may precipitate severe bleeding events.",-22.875,0.4,Chemical
Clenbuterol‐induced hypertension was observed in a patient with uncontrolled hypertension who had been prescribed the β2‑agonist for asthma exacerbation.,-34.0,0.4,Chemical
"Clostridium difficile infection was markedly reduced in patients receiving a doxorubicin-loaded liposomal formulation, yet the regimen also induced severe neutropenia, a known adverse effect of the drug.",-37.5,0.4,Chemical
"Researchers reported that the use of a doxorubicin-loaded liposomal formulation markedly reduced the incidence of cardiotoxicity in patients with metastatic breast cancer, whereas the concomitant administration of clopidogrel increased the risk of bleeding complications.",-31.25,0.4,Chemical
"Researchers demonstrated that the cyclooxygenase inhibitor diclofenac exacerbated renal dysfunction in patients with pre‑existing chronic kidney disease, while the concomitant use of the antiplatelet drug clopidogrel mitigated the risk of thrombotic complications in those undergoing coronary stenting.",-37.75,0.4,Chemical
Researchers found that the cyclooxygenase inhibitor diclofenac exacerbated the renal toxicity of the chemotherapeutic agent doxorubicin in patients with pre‑existing chronic kidney disease.,-23.125,0.4,Chemical
"In patients with chronic heart failure, the diuretic furosemide markedly reduces pulmonary congestion but can precipitate electrolyte‑disturbing arrhythmias that may be mitigated by concurrent clopidogrel therapy.",-27.875,0.4,Chemical
"In a randomized trial, patients with metastatic melanoma receiving doxorubicin‑based chemotherapy experienced a significant reduction in tumor‑related pain, yet the same regimen was associated with dose‑dependent cardiotoxicity, prompting clinicians to consider concurrent administration of the cardioprotective agent dexrazoxane.",-34.5,0.4,Chemical
"In the study, patients receiving doxorubicin-based chemotherapy experienced a marked increase in cardiotoxicity, which was mitigated when the regimen was combined with the cyclooxygenase inhibitor indomethacin.",-25.0,0.4,Chemical
"Treatment of acute lymphoblastic leukemia with doxorubicin‑loaded liposomes was associated with a dose‑dependent increase in cardiotoxicity, prompting the addition of dexrazoxane to mitigate the drug‑induced myocardial damage.",-29.125,0.4,Chemical
"Treatment with the cyclooxygenase inhibitor diclofenac exacerbated the patient’s pre‑existing rheumatoid arthritis, leading to a flare of joint inflammation and increased pain scores.",-19.375,0.4,Chemical
Treatment failure of doxorubicin-based chemotherapy was attributed to cyclooxygenase inhibitor–induced cardiotoxicity in patients with metastatic lymphoma.,-27.0,0.4,Chemical
"Clozapine, a second‑generation antipsychotic, has been reported to cause agranulocytosis in patients with schizophrenia, prompting routine monitoring of white blood cell counts to mitigate the risk of severe neutropenia.",-24.25,0.4,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, was found to reduce platelet aggregation in patients with peripheral arterial disease, whereas clopidogrel therapy was associated with a lower incidence of ischemic stroke in the same cohort.",-28.75,0.4,Chemical
Ciprofloxacin-induced neutropenia was observed in a patient with chronic lymphocytic leukemia undergoing rituximab therapy.,-20.625,0.4,Chemical
"Repeated dosing of the cyclooxygenase inhibitor clopidogrel in patients with acute coronary syndrome was associated with a higher incidence of gastrointestinal bleeding and a concomitant rise in serum creatinine, suggesting renal impairment as a serious adverse effect of the drug.",-33.25,0.4,Chemical
Repeated use of the cyclooxygenase inhibitor clopidogrel has been associated with a higher incidence of gastrointestinal bleeding in patients with chronic kidney disease.,-22.0,0.4,Chemical
"Repeated administration of the cyclooxygenase inhibitor diclofenac in patients with rheumatoid arthritis was associated with a dose‑dependent increase in serum creatinine, suggesting nephrotoxicity in this disease context.",-22.125,0.4,Chemical
"Subcutaneous administration of oxytocin in patients with severe postpartum hemorrhage was found to reduce the incidence of disseminated intravascular coagulation, a complication frequently associated with the use of cyclooxygenase inhibitors for pain management.",-34.5,0.4,Chemical
"Subclinical cardiotoxicity was observed in patients receiving doxorubicin‑loaded liposomes for metastatic breast cancer, prompting investigation of concurrent Furosemide use to mitigate the resultant heart failure.",-34.0,0.4,Chemical
"Substantial evidence indicates that the cyclooxygenase inhibitor diclofenac can exacerbate chronic kidney disease in patients with pre‑existing diabetic nephropathy, thereby underscoring the need for cautious use of this chemical in individuals with the disease.",-38.0,0.4,Chemical
"Clozapine‑treated patients with schizophrenia frequently experience histamine‑mediated pruritus, a side effect that can be mitigated by concurrent administration of a selective H2‑receptor antagonist.",-19.125,0.4,Chemical
Citrus-derived vitamin C supplementation mitigated nitroprusside-induced hypertension in patients with acute coronary syndrome.,-22.25,0.4,Chemical
"Cilostazol, a phosphodiesterase‑3 inhibitor, was shown to ameliorate clopidogrel‑resistant platelet aggregation in patients with coronary artery disease, thereby reducing the incidence of myocardial infarction.",-25.5,0.4,Chemical
"The nitroprusside‑induced hypotension observed in patients with severe sepsis was markedly attenuated when the vasodilator was co‑administered with a low‑dose infusion of methotrexate, suggesting a protective interaction between the two chemicals.",-23.375,0.4,Chemical
"The pharmacokinetic study revealed that ritonavir‑treated HIV patients exhibited markedly reduced clearance of methotrexate, leading to a higher risk of nephrotoxicity.",-27.75,0.4,Chemical
The ritonavir‑treated patient developed a severe histamine‑mediated rash that was mitigated by administering a high‑dose vitamin C infusion.,-19.75,0.4,Chemical
"In a randomized trial, clarithromycin‑associated hepatitis was observed in patients receiving ritonavir‑boosted antiretroviral therapy, suggesting a drug‑drug interaction that exacerbates liver injury.",-23.25,0.4,Chemical
"In patients with methotrexate‑induced hepatotoxicity, the addition of ritonavir‑based protease inhibitors exacerbated liver enzyme elevations, underscoring the need for careful monitoring of drug‑drug interactions.",-26.25,0.4,Chemical
"In the clozapine‑treated cohort, a sudden rise in serum histamine levels was observed, suggesting a possible histamine‑mediated hypersensitivity reaction to the antipsychotic.",-25.0,0.4,Chemical
Clarithromycin‑associated hepatotoxicity was observed in patients with chronic hepatitis C undergoing antiviral therapy.,-11.75,0.4,Chemical
Clarified that nitroprusside-induced cyanide toxicity can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.,-19.25,0.4,Chemical
"Clarifying that the nitroprusside‑induced cyanosis observed in patients with severe hypertension is mitigated by the concomitant use of methotrexate, which competitively inhibits nitric oxide synthase, thereby reducing the vasodilatory load.",-37.5,0.4,Chemical
"Nitroprusside-induced hypertension was observed in a patient with septic shock, prompting the switch to a low-dose clozapine‑treated regimen to mitigate the cardiovascular side effects.",-24.75,0.4,Chemical
Nitropusside‑induced hypertension was observed in a cohort of patients with chronic kidney disease who were concurrently receiving ritonavir for HIV infection.,-24.625,0.4,Chemical
"Nitrosylated nitroprusside-induced hypertension was mitigated in patients receiving a low-dose clarithromycin regimen, illustrating a drug–drug interaction that reduced the risk of severe cardiovascular complications.",-39.25,0.4,Chemical
Methotrexate‑induced hepatotoxicity was observed in a cohort of patients with rheumatoid arthritis who were concurrently receiving ritonavir for HIV infection.,-14.8125,0.4,Chemical
"Methamphetamine‑induced psychosis was markedly reduced in patients receiving clozapine‑treated schizophrenia, illustrating the antipsychotic’s efficacy in mitigating drug‑related neuropsychiatric disease.",-36.0,0.4,Chemical
"Methyldopa, a phenylpropanolamine derivative, has been shown to precipitate severe hypertension in patients with pre‑existing essential hypertension, while concomitant use of the antiretroviral ritonavir can potentiate this effect through CYP3A4 inhibition.",-47.25,0.4,Chemical
"Clarithromycin-associated hepatitis was observed in patients receiving ritonavir for HIV treatment, suggesting a drug‑drug interaction that exacerbates liver injury.",-16.0,0.4,Chemical
"Cladribine‑treated patients with relapsed acute lymphoblastic leukemia experienced a marked reduction in circulating histamine levels, suggesting an anti‑inflammatory effect of the drug on disease‑associated cytokine release.",-32.0,0.4,Chemical
"Clindamycin‑treated patients with chronic osteomyelitis exhibited a significant reduction in inflammatory cytokine levels, suggesting that the antibiotic’s anti‑bacterial activity also mitigates the underlying inflammatory disease process.",-31.75,0.4,Chemical
"A nitroprusside‑induced hypertensive crisis was observed in a patient with severe hypertension, prompting immediate discontinuation of the drug and initiation of hydralazine to mitigate the acute blood‑pressure elevation.",-26.125,0.4,Chemical
"A ritonavir‑treated patient with chronic hepatitis C experienced a sudden rise in liver enzymes after receiving a high‑dose clarithromycin regimen, suggesting a drug‑drug interaction that exacerbated hepatic toxicity.",-26.0,0.4,Chemical
A patient receiving ritonavir for HIV experienced a severe histamine‑mediated rash that was mitigated by administering a low‑dose antihistamine.,-23.25,0.4,Chemical
"Ritonavir therapy for HIV infection was found to exacerbate hyperlipidemia, prompting the addition of a statin to mitigate the drug‑induced dyslipidemia.",-23.625,0.4,Chemical
Rifampin therapy was associated with nitroprusside‑induced acute kidney injury in patients with chronic hepatitis C infection.,-23.25,0.4,Chemical
"Ranitidine, a histamine H2‑receptor antagonist, was found to reduce the incidence of nitroprusside‑induced cyanosis in patients with acute heart failure.",-26.875,0.4,Chemical
"Chlorambucil treatment of acute lymphoblastic leukemia was complicated by nitroprusside‑induced cyanosis, prompting the switch to ritonavir‑based therapy to mitigate the adverse cardiovascular effects.",-31.5,0.4,Chemical
"Chronic use of nitroprusside-induced hypertension in patients with renal disease was mitigated by concurrent administration of ritonavir, which competitively inhibited the metabolic pathway responsible for the drug’s vasoactive metabolites.",-33.0,0.4,Chemical
"Chitinase inhibition by the novel chemical agent, a disodium phosphate ester derivative, ameliorated the inflammatory response in a murine model of rheumatoid arthritis.",-41.0,0.4,Chemical
"Chemotherapy with methotrexate can exacerbate vitamin B12 deficiency, leading to a higher incidence of peripheral neuropathy in patients with lymphoma.",-25.125,0.4,Chemical
Chemotherapeutic methotrexate administration was found to induce severe hepatotoxicity in patients with underlying hepatitis C disease.,-26.375,0.4,Chemical
"Chemokine‑mediated inflammation in rheumatoid arthritis is markedly attenuated by methotrexate, yet the drug’s hepatotoxicity is exacerbated when patients concurrently receive ritonavir, a potent CYP3A4 inhibitor.",-34.5,0.4,Chemical
"Patients who were clozapine‑treated for schizophrenia experienced a marked elevation of serum histamine, which was mitigated by concurrent administration of the antihistamine cetirizine.",-27.625,0.4,Chemical
"Patients receiving ritonavir for HIV treatment experienced a significant rise in serum histamine levels, suggesting a potential drug‑induced exacerbation of allergic rhinitis.",-24.125,0.4,Chemical
"Patients treated with methotrexate for rheumatoid arthritis developed a severe, nitroprusside‑induced cyanosis that was mitigated by administering a disodium phosphate ester antidote.",-23.0,0.4,Chemical
"The administration of aripiprazole in patients with schizophrenia has been associated with a reduction in extrapyramidal symptoms, yet a subset of individuals experienced severe akathisia, prompting clinicians to consider dose adjustment or switching to a serotonin reuptake inhibitor.",-31.0,0.4,Chemical
"The antipsychotic aripiprazole, by partially agonizing dopamine D2 receptors, can paradoxically worsen agitation in patients with schizophrenia, while the non‑steroidal anti‑inflammatory Nimesulide, through selective COX‑2 inhibition, has been associated with acute interstitial nephritis in susceptible individuals.",-31.75,0.4,Chemical
The case report showed that chronic exposure to the serotonin reuptake inhibitor aripiprazole was associated with the development of drug‑induced parkinsonism in a patient with Parkinson’s disease.,-24.0,0.4,Chemical
"A clinical trial demonstrated that aripiprazole, a serotonin reuptake inhibitor, significantly reduced relapse rates in patients with schizophrenia compared with placebo.",-14.25,0.4,Chemical
"A case of acute kidney injury was reported in a patient receiving the serotonin reuptake inhibitor aripiprazole, where the drug’s inhibition of renal cytochrome P450 enzymes precipitated nephrotoxicity.",-24.375,0.4,Chemical
"A randomized trial demonstrated that aripiprazole significantly reduced relapse rates in patients with schizophrenia compared with placebo, while a separate cohort study reported that chronic exposure to the non‑steroidal anti‑inflammatory drug nimesulide was associated with an increased incidence of drug‑induced hepatotoxicity in patients with chronic hepatitis C.",-34.25,0.4,Chemical
"In patients with chronic migraine, the serotonin reuptake inhibitor aripiprazole has been shown to reduce headache frequency but may induce serotonin syndrome when combined with the cyclooxygenase inhibitor nimesulide.",-19.625,0.4,Chemical
"In a double‑blind study, aripiprazole was found to reduce relapse rates in patients with schizophrenia, but the drug’s interaction with the serotonin reuptake inhibitors led to a significant increase in serum prolactin levels, suggesting a potential endocrine adverse effect.",-33.25,0.4,Chemical
"In preclinical trials, aripiprazole was shown to attenuate quinine‑induced seizures in rats, while Nimesulide exacerbated the neurotoxic effects of the same compound, suggesting a complex interaction between serotonin reuptake inhibitors and inflammatory pathways in seizure pathology.",-44.0,0.4,Chemical
"Aripiprazole, a serotonin reuptake inhibitor, has been shown to mitigate the neurotoxic effects of quinine-sensitive malaria treatment in patients with severe cerebral malaria.",-16.75,0.4,Chemical
"Arrested progression of metastatic melanoma in a patient receiving the novel imidazo‑pyrrolo‑benzodiazepine derivative while concurrently taking the serotonin reuptake inhibitor aripiprazole, suggesting a synergistic antitumor effect that warrants further investigation.",-45.5,0.4,Chemical
Arpiprazole administration in patients with schizophrenia was found to reduce the incidence of serotonin‑reuptake‑inhibitor‑induced nausea while concurrently lowering the risk of serotonin syndrome in those concurrently receiving quinine‑sensitive antimalarials.,-40.75,0.4,Chemical
"Use of the serotonin reuptake inhibitor aripiprazole in patients with schizophrenia has been associated with a higher incidence of acute kidney injury, possibly due to its inhibition of the renal organic cation transporter that normally clears the drug from the circulation.",-27.75,0.4,Chemical
"Use aripiprazole to treat schizophrenia, but patients with a history of serotonin reuptake inhibitor-induced serotonin syndrome should be monitored for neuroleptic malignant syndrome.",-24.0,0.4,Chemical
Use a low‑dose of aripiprazole to reduce the serotonin reuptake inhibitor‑induced nausea in patients with chronic migraine.,-26.875,0.4,Chemical
"Patients with chronic migraine who were treated with the serotonin reuptake inhibitor aripiprazole experienced a significant reduction in headache frequency, yet reported increased nausea and transient dizziness as adverse effects.",-25.5,0.4,Chemical
"Patients receiving the serotonin‑reuptake inhibitor aripiprazole for schizophrenia exhibited a transient elevation of serum selenium levels, raising concerns about potential neurotoxicity in individuals with pre‑existing neurodegenerative disease.",-22.75,0.4,Chemical
"Patients treated with the serotonin reuptake inhibitor aripiprazole for schizophrenia reported a transient elevation of serum selenium levels, raising concerns about potential neurotoxicity in individuals with pre‑existing neurodegenerative disease.",-21.625,0.4,Chemical
"Administration of the serotonin reuptake inhibitor aripiprazole was found to reduce the incidence of drug‑induced serotonin syndrome in patients with severe schizophrenia, while concurrent use of the anti‑inflammatory Nimesulide was associated with an increased risk of hepatotoxicity.",-25.75,0.4,Chemical
"Administration with aripiprazole markedly reduced the incidence of serotonin reuptake inhibitor‑induced nausea in patients with chronic migraine, while Nimesulide was observed to inhibit cyclo‑oxygenase‑2 activity in a dose‑dependent manner.",-44.75,0.4,Chemical
Administration and chronic exposure to the serotonin reuptake inhibitor aripiprazole has been associated with an increased incidence of drug‑induced parkinsonism in patients with Parkinson disease.,-34.5,0.4,Chemical
"Incidence of drug‑induced liver injury was markedly higher in patients receiving the serotonin‑reuptake inhibitor aripiprazole compared with those treated with the non‑steroidal anti‑inflammatory Nimesulide, suggesting a potential hepatotoxic interaction between these two chemical agents.",-26.5,0.4,Chemical
"Incubation of cultured neuronal cells with the serotonin reuptake inhibitor aripiprazole at concentrations exceeding the therapeutic window induced a dose‑dependent increase in reactive oxygen species, thereby exacerbating mitochondrial dysfunction and precipitating apoptosis in a manner reminiscent of neurodegenerative disease pathology.",-44.5,0.4,Chemical
"Incidental administration of the serotonin reuptake inhibitor aripiprazole to a patient with chronic schizophrenia was associated with a transient elevation of serum selenium levels, suggesting a potential drug–nutrient interaction that may influence neurochemical homeostasis.",-31.625,0.4,Chemical
"Treatment with the serotonin reuptake inhibitor aripiprazole was associated with a dose‑dependent elevation of serum selenium levels, raising concerns about potential neurotoxicity in patients with pre‑existing Parkinson’s disease.",-19.375,0.4,Chemical
"Treatment of refractory schizophrenia with aripiprazole was associated with a significant reduction in serum serotonin levels, suggesting a possible interaction with serotonin reuptake inhibitors that may underlie the observed improvement in psychotic symptoms.",-29.0,0.4,Chemical
"Treatment failure of aripiprazole in patients with schizophrenia was associated with a marked elevation of serum selenium, suggesting a potential interaction between the antipsychotic and trace‑element metabolism that may underlie the observed neuropsychiatric adverse effects.",-35.25,0.4,Chemical
"Evidence suggests that the serotonin reuptake inhibitor aripiprazole may exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease, thereby increasing the risk of acute kidney injury.",-24.25,0.4,Chemical
"Evidence indicates that chronic administration of the serotonin reuptake inhibitor aripiprazole can exacerbate the neurotoxic effects of the chemotherapeutic agent cisplatin, leading to dose‑dependent peripheral neuropathy in patients with metastatic melanoma.",-29.625,0.4,Chemical
"Evidence that the serotonin reuptake inhibitor aripiprazole mitigates the neurotoxic effects of the quinine‑sensitive compound Nimesulide in patients with Parkinsonian disease has been reported in a double‑blind, placebo‑controlled study.",-35.0,0.4,Chemical
"Pharmacy records indicate that patients with chronic migraine who were prescribed the serotonin reuptake inhibitor aripiprazole experienced a statistically significant reduction in headache frequency, yet a subset developed transient visual disturbances that resolved after discontinuation of the drug.",-37.25,0.4,Chemical
"Pharmacokinetic studies revealed that aripiprazole, a serotonin reuptake inhibitor, significantly reduced the incidence of drug‑induced hepatotoxicity in patients with chronic hepatitis C.",-23.5,0.4,Chemical
"Phenytoin administration in patients with epilepsy can precipitate a paradoxical elevation of serum selenium, thereby increasing the risk of scleroderma-like dermopathy.",-32.75,0.4,Chemical
"Adverse cardiovascular events were observed in patients receiving the serotonin reuptake inhibitor aripiprazole, with a higher incidence of arrhythmia in those concurrently treated with the anti‑inflammatory Nimesulide.",-24.625,0.4,Chemical
"Adolescent patients receiving the serotonin reuptake inhibitor aripiprazole for bipolar disorder exhibited a dose‑dependent increase in serum selenium, suggesting a potential protective effect against oxidative stress in the developing brain.",-31.625,0.4,Chemical
"Adolescents with juvenile idiopathic arthritis who were treated with the selective serotonin reuptake inhibitor aripiprazole experienced a significant reduction in inflammatory markers, yet developed mild hepatotoxicity that resolved after discontinuation.",-33.5,0.4,Chemical
"Use of the angiotensin‑converting enzyme inhibitor enalapril in patients with chronic heart failure has been associated with a dose‑dependent rise in serum creatinine, suggesting renal tubular dysfunction that may be exacerbated by concomitant diuretic therapy.",-24.0,0.4,Chemical
"Use the angiotensin‑converting enzyme inhibitor to lower blood pressure in patients with chronic kidney disease, but monitor for hyperkalemia and potential worsening of renal function.",-23.0,0.4,Chemical
Use a selective angiotensin‑converting enzyme inhibitor to mitigate the hypertension that develops after chronic lithium‑pilocarpine therapy in patients with refractory epilepsy.,-25.125,0.4,Chemical
"A high‑dose angiotensin‑converting enzyme inhibitor therapy was found to precipitate acute renal failure in a patient with pre‑existing chronic kidney disease, illustrating the drug’s nephrotoxic potential.",-23.625,0.4,Chemical
"A hexamethylmelamine‑induced nephrotoxicity was observed in patients with chronic kidney disease who were concurrently receiving an angiotensin‑converting enzyme inhibitor, leading to a significant rise in serum creatinine and proteinuria.",-27.875,0.4,Chemical
"A diethylstilbesterol derivative was found to inhibit the proliferation of malignant lymphoma cells, suggesting a potential therapeutic role for this chemical in treating the disease.",-19.625,0.4,Chemical
"The patient’s hypertension, refractory to an angiotensin‑converting‑enzyme inhibitor, resolved only after initiation of diltiazem, which also reduced the elevated serum Ca²⁺ associated with the drug’s calcium‑channel blocking activity.",-32.5,0.4,Chemical
"The angiotensin‑converting enzyme inhibitor captopril was shown to reduce the incidence of diabetic nephropathy in patients with type‑2 diabetes, whereas concurrent use of the methylxanthine caffeine amplified the drug’s diuretic effect, leading to transient hypernatremia and mild hypokalemia.",-32.25,0.4,Chemical
"The diethylstilbesterol‑induced hypertension in patients with pre‑existing angiotensin‑converting enzyme inhibitor therapy was mitigated by a single dose of glycopyrrolate, which competitively inhibited the hepatic metabolism of the drug and reduced the systemic Ca²⁺ influx.",-33.75,0.4,Chemical
"Administration of the angiotensin‑converting enzyme inhibitor enalapril markedly reduced the blood pressure of patients with hypertension, but in a subset of these patients it precipitated an acute rise in serum creatinine, suggesting a drug‑induced nephrotoxic effect.",-26.75,0.4,Chemical
"Administration with the angiotensin‑converting enzyme inhibitor enalapril markedly reduced the incidence of hypertension in patients with diabetic nephropathy, while concomitant use of glycopyrrolate mitigated the drug‑induced xerostomia.",-31.625,0.4,Chemical
"Administration and chronic use of the angiotensin‑converting enzyme inhibitor enalapril have been associated with a dose‑dependent increase in serum potassium, which can precipitate hyperkalemic paralysis in patients with underlying chronic kidney disease.",-39.5,0.4,Chemical
"Cisplatin, an angiotensin‑converting enzyme inhibitor analogue, induces acute kidney injury by elevating intracellular Ca²⁺ and hydroxyl radical production in renal tubular cells.",-22.75,0.4,Chemical
"Captopril, an angiotensin‑converting enzyme inhibitor, was shown to reduce blood pressure in patients with hypertension while concurrently lowering serum creatinine, thereby mitigating the risk of drug‑induced acute kidney injury.",-21.5,0.4,Chemical
"Cilazapril, an angiotensin‑converting enzyme inhibitor, can reduce hypertension but may cause a reversible rise in serum creatinine in patients with underlying chronic kidney disease.",-25.125,0.4,Chemical
"High‑dose diltiazem, an angiotensin‑converting enzyme inhibitor analogue, was found to precipitate acute renal failure in patients with underlying chronic kidney disease, likely through inhibition of renal tubular reabsorption of p‑aminohippuric acid and subsequent accumulation of lithium‑pilocarpine metabolites.",-30.75,0.4,Chemical
"High-dose diltiazem therapy in patients with chronic angiotensin‑converting‑enzyme inhibitor‑induced hyperkalemia was associated with transient bradycardia and a reversible rise in serum creatinine, suggesting a synergistic nephrotoxic interaction.",-37.75,0.4,Chemical
"High blood pressure patients treated with an angiotensin‑converting enzyme inhibitor experienced a significant reduction in plasma angiotensin II levels, yet a subset developed hyperkalemia that required discontinuation of the drug.",-28.625,0.4,Chemical
"Reanalysis of the renal biopsy specimens from patients receiving the angiotensin‑converting enzyme inhibitor enalapril revealed a marked reduction in p‑aminohippuric acid clearance, suggesting that the drug’s inhibition of tubular secretion may underlie the observed acute kidney injury.",-34.5,0.4,Chemical
"Reagents containing the hexamethylmelamine derivative were shown to inhibit the growth of malignant lymphoma cells, yet the same compound induced a dose‑dependent elevation of serum calcium that precipitated hypercalcaemic crisis in patients with pre‑existing hyperparathyroidism.",-49.75,0.4,Chemical
"Recombinant angiotensin‑converting enzyme inhibitor therapy has been shown to reduce the incidence of hypertension in patients with chronic kidney disease, while concomitant use of glycopyrrolate may blunt the antihypertensive effect by antagonizing muscarinic receptors.",-33.5,0.4,Chemical
"Patients treated with the angiotensin‑converting enzyme inhibitor enalapril reported a marked reduction in hypertension but experienced a dose‑dependent rise in serum creatinine, suggesting renal impairment.",-22.625,0.4,Chemical
"Patients receiving the angiotensin‑converting enzyme inhibitor lisinopril for hypertension developed hyperkalemia, a known adverse effect that can precipitate cardiac arrhythmias.",-15.0625,0.4,Chemical
"Patients on an angiotensin‑converting enzyme inhibitor who developed hyperkalemia were found to have a concomitant rise in serum lithium levels, suggesting that the drug’s inhibition of renal potassium excretion may also impair lithium clearance.",-29.125,0.4,Chemical
"In patients with hypertension, the angiotensin‑converting enzyme inhibitor captopril markedly reduces serum Ca²⁺ levels, thereby attenuating the risk of hyperparathyroidism.",-20.375,0.4,Chemical
"In a double‑blind trial, the angiotensin‑converting enzyme inhibitor lisinopril markedly reduced systolic blood pressure in patients with stage‑3 chronic kidney disease, but concomitant use of the diuretic furosemide precipitated hyperkalemia and acute renal failure.",-25.875,0.4,Chemical
"In hypertensive patients receiving the angiotensin‑converting enzyme inhibitor enalapril, the concomitant use of the anticholinergic glycopyrrolate has been associated with a marked reduction in urinary p‑aminohippuric acid clearance, suggesting a pharmacodynamic interaction that may compromise renal perfusion.",-32.75,0.4,Chemical
"Beta‑blocker therapy with propranolol, an angiotensin‑converting enzyme inhibitor, has been shown to reduce the incidence of hypertension in patients with chronic kidney disease while simultaneously lowering serum lithium levels in those receiving lithium‑pilocarpine for bipolar disorder.",-30.25,0.4,Chemical
"Beta-blocker therapy with propranolol exacerbated the hypertension in patients receiving angiotensin‑converting enzyme inhibitor, illustrating a pharmacodynamic interaction that increased serum calcium levels and precipitated acute renal failure.",-38.0,0.4,Chemical
Beta-adrenergic blockade with diltiazem-induced calcium channel inhibition exacerbated the hypertension observed in patients with chronic angiotensin-converting enzyme inhibitor therapy.,-27.875,0.4,Chemical
"Treatment of hypertension with the angiotensin‑converting‑enzyme inhibitor lisinopril was associated with a marked reduction in plasma renin activity and a concomitant rise in serum potassium, illustrating the drug’s dual effect on the renin‑angiotensin‑aldosterone system.",-27.25,0.4,Chemical
"Treatment with the angiotensin‑converting enzyme inhibitor lisinopril markedly reduced blood pressure in patients with chronic kidney disease while concurrently lowering serum creatinine levels, thereby mitigating the risk of drug‑induced nephrotoxicity.",-21.25,0.4,Chemical
"Treatment trials with the angiotensin‑converting enzyme inhibitor lisinopril have shown a marked reduction in proteinuria among patients with diabetic nephropathy, yet the drug’s propensity to cause hyperkalemia necessitates careful monitoring of serum potassium levels.",-33.25,0.4,Chemical
"Angiotensin‑converting enzyme inhibitors have been shown to reduce the incidence of hypertension‑associated renal fibrosis in patients with diabetic nephropathy, while glycopyrrolate may exacerbate urinary retention in those with underlying bladder dysfunction.",-25.5,0.4,Chemical
"Angiogenesis inhibitors such as the angiotensin‑converting enzyme inhibitor enalapril have been shown to reduce tumor vascular permeability in patients with metastatic colorectal cancer, thereby limiting the risk of chemotherapy‑induced capillary leak syndrome.",-34.5,0.4,Chemical
"Angotensin‑converting enzyme inhibitors, such as enalapril, have been shown to reduce the incidence of diabetic nephropathy in patients with type‑2 diabetes mellitus by attenuating glomerular hypertension and proteinuria.",-37.75,0.4,Chemical
"The alkylating agent cisplatin, commonly used to treat ovarian cancer, can induce nephrotoxicity that is exacerbated by concurrent administration of amphotericin B, a potent antifungal with a high propensity for renal injury.",-26.875,0.4,Chemical
"The chemotherapeutic alkylating agent cisplatin induces nephrotoxicity, a severe adverse effect that can precipitate acute kidney injury in patients with pre‑existing chronic kidney disease.",-17.5,0.4,Chemical
"The combination of azimilide and the alkylating agent cisplatin was found to exacerbate nephrotoxicity in patients with metastatic lymphoma, leading to a higher incidence of acute kidney injury.",-21.5,0.4,Chemical
"Azimilide, an antiarrhythmic drug, has been shown to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease.",-11.9375,0.4,Chemical
"Azilitide, a novel alkylating agent, was shown to reduce tumor burden in patients with metastatic melanoma but induced severe nephrotoxicity, prompting the use of Amphotericin B as an alternative antifungal therapy.",-33.25,0.4,Chemical
"Azatilide, an alkylating agent, has been shown to inhibit the proliferation of malignant melanoma cells while concurrently exacerbating nephrotoxicity in patients with pre‑existing chronic kidney disease.",-22.25,0.4,Chemical
"In patients with refractory atrial fibrillation, the antiarrhythmic azimilide has been shown to reduce arrhythmia burden but is associated with a dose‑dependent risk of torsades de pointes, prompting clinicians to monitor QT interval closely.",-29.375,0.4,Chemical
"In a double‑blind trial, the alkylating agent cisplatin was found to aggravate nephrotoxicity in patients with metastatic ovarian cancer, whereas the addition of the antioxidant N‑acetylcysteine mitigated the renal damage without compromising the drug’s antitumor efficacy.",-29.625,0.4,Chemical
"In Parkinson’s disease patients receiving carbidopa‑levodopa, concomitant propranolol therapy has been shown to blunt the therapeutic benefit by inhibiting dopamine release through β‑adrenergic blockade.",-25.5,0.4,Chemical
"Amphotericin B, an antifungal alkylating agent, can induce nephrotoxicity in patients with underlying chronic kidney disease, prompting clinicians to monitor serum creatinine and consider dose adjustment or alternative therapies such as azimilide or propranolol when managing concomitant hypertension.",-29.375,0.4,Chemical
"Amifostine, an alkylating agent, was found to mitigate cisplatin‑induced nephrotoxicity in patients with metastatic ovarian cancer.",-20.375,0.4,Chemical
"Amphilotericin B, an antifungal alkylating agent, has been shown to induce acute kidney injury in patients with underlying chronic kidney disease.",-27.25,0.4,Chemical
"Patients receiving amphotericin B for invasive aspergillosis frequently develop nephrotoxicity, which can be mitigated by co‑administration of Labetalol to preserve renal perfusion.",-18.375,0.4,Chemical
"Patients treated with the alkylating agent cisplatin for ovarian cancer frequently develop nephrotoxicity, which can be mitigated by co‑administration of the antioxidant amphotericin B.",-18.875,0.4,Chemical
"Patients with metastatic melanoma receiving the alkylating agent temozolomide reported a higher incidence of neutropenia, which was mitigated by prophylactic administration of granulocyte‑colony stimulating factor.",-26.75,0.4,Chemical
"A clinical trial demonstrated that amphotericin B, an antifungal chemical, exacerbated nephrotoxicity in patients with pre‑existing chronic kidney disease, a condition that can be further aggravated by concomitant use of alkylating agents.",-26.875,0.4,Chemical
"A randomized trial demonstrated that the alkylating agent cisplatin exacerbated nephrotoxicity in patients with metastatic ovarian cancer, whereas co‑administration of the antioxidant LPO mitigated the renal injury without compromising the antitumor efficacy.",-28.125,0.4,Chemical
"A cohort of patients with metastatic melanoma treated with the alkylating agent temozolomide developed acute nephrotoxicity, prompting the addition of the nephroprotective agent N-acetylcysteine to mitigate renal injury.",-26.375,0.4,Chemical
"Preclinical studies revealed that the alkylating agent azimilide induced a dose‑dependent reduction in tumor cell viability while concurrently exacerbating nephrotoxicity, a side effect that was mitigated when co‑administered with the antioxidant LPO.",-33.25,0.4,Chemical
"Preliminary data suggest that the alkylating agent azimilide can aggravate nephrotoxicity in patients with pre‑existing chronic kidney disease, prompting clinicians to consider dose adjustment or alternative therapies.",-30.125,0.4,Chemical
"Pre‑clinical studies revealed that amphotericin B, an antifungal alkylating agent, exacerbates nephrotoxicity in patients with pre‑existing chronic kidney disease, prompting the use of carbidopa‑levodopa as a safer alternative for Parkinson’s disease management.",-37.5,0.4,Chemical
"Zebrafish embryos exposed to the alkylating agent cisplatin exhibited a dose‑dependent increase in apoptotic markers, suggesting that cisplatin’s cytotoxicity may contribute to the development of chemotherapy‑induced neurotoxicity.",-30.0,0.4,Chemical
"Zanubrutinib, an irreversible Bruton tyrosine kinase inhibitor, was shown to markedly reduce tumor burden in patients with relapsed chronic lymphocytic leukemia while simultaneously lowering the incidence of atrial fibrillation compared with the alkylating agent chlorambucil.",-35.25,0.4,Chemical
"Zolpidem exacerbated the seizure frequency in patients with Lennox‑Gastaut syndrome, whereas adjunctive treatment with carbamazepine markedly reduced the seizure burden.",-30.0,0.4,Chemical
"Impediment of tumor cell proliferation by the alkylating agent azimilide was observed in a cohort of patients with metastatic melanoma, suggesting a potential therapeutic role for this chemical in treating the disease.",-37.25,0.4,Chemical
"Immunotherapy with azimilide, an alkylating agent, has been shown to reduce tumor burden in patients with metastatic melanoma but can precipitate severe neutropenia and liver dysfunction, necessitating close monitoring of hepatic enzymes and white blood cell counts.",-37.25,0.4,Chemical
"Imatinib, an alkylating agent, was shown to reduce the incidence of acute myeloid leukemia relapse in patients who had previously received azimilide for refractory atrial fibrillation.",-30.5,0.4,Chemical
"Chronic administration of amphotericin B in patients with invasive aspergillosis has been associated with nephrotoxicity, prompting the use of lipid‑based formulations to mitigate renal injury.",-24.125,0.4,Chemical
"Chlorambucil, an alkylating agent, was found to induce acute interstitial nephritis in patients with chronic lymphocytic leukemia, prompting clinicians to monitor renal function closely during therapy.",-27.75,0.4,Chemical
"Cholinergic agonist azimilide was shown to aggravate renal failure in patients with pre‑existing chronic kidney disease, illustrating a dose‑dependent nephrotoxic effect of this alkylating agent.",-45.25,0.4,Chemical
"Clinically, the alkylating agent cisplatin is known to induce acute kidney injury, a complication that can be mitigated by concurrent administration of the antioxidant N‑acetylcysteine.",-28.875,0.4,Chemical
"Clinicians observed that the alkylating agent cisplatin, when administered to patients with metastatic ovarian carcinoma, induced severe nephrotoxicity, prompting the addition of prophylactic amphotericin B to mitigate renal damage.",-34.25,0.4,Chemical
"Clinician reports that amphotericin B, an antifungal chemical, can trigger acute interstitial nephritis, a disease that may be mitigated by early administration of corticosteroids.",-35.75,0.4,Chemical
"Intraperitoneal injection of amphotericin B in mice with induced pulmonary fibrosis exacerbated lung inflammation, leading to a significant increase in interstitial edema and a higher incidence of acute respiratory distress syndrome.",-35.75,0.4,Chemical
"Intravenous amphotericin B administration in patients with invasive aspergillosis frequently precipitates acute kidney injury, a severe adverse effect that can be mitigated by pre‑treatment with the antioxidant LPO to protect renal tubular cells.",-30.375,0.4,Chemical
"Intrathecal amphotericin B, an antifungal chemical, was found to induce nephrotoxicity in patients with pre‑existing chronic kidney disease, a disease that was exacerbated by concurrent use of azimilide, a cardiac antiarrhythmic chemical.",-38.0,0.4,Chemical
"Methoxamine administration in patients with hypertension can precipitate acute renal failure, a complication that is exacerbated by concurrent use of valsartan, which further impairs glomerular filtration.",-26.0,0.4,Chemical
"Methotrexate administration in patients with rheumatoid arthritis has been associated with hepatotoxicity, prompting the use of ursodeoxycholic acid to mitigate liver injury.",-20.875,0.4,Chemical
"Methoprolol, a β‑blocker, was found to exacerbate the renal toxicity of valsartan in patients with chronic kidney disease, prompting clinicians to monitor serum creatinine closely.",-33.75,0.4,Chemical
"The study demonstrated that the chemotherapeutic agent Bort‑dex, when combined with the antihypertensive Valsartan, markedly reduced tumor‑induced hypertension in a murine model of metastatic lymphoma.",-23.625,0.4,Chemical
"The zinc‑dependent enzyme activity was markedly inhibited in patients with rheumatoid arthritis who were concurrently treated with the Bort‑dex combination, suggesting a potential drug‑disease interaction that may exacerbate joint inflammation.",-24.25,0.4,Chemical
"The vasodilator valsartan was found to ameliorate hypertension in patients with chronic kidney disease, yet it also induced a mild elevation of serum creatinine, suggesting a reversible renal effect that warrants monitoring.",-32.0,0.4,Chemical
"Administration of valsartan to patients with hypertension has been shown to reduce the incidence of proteinuria, yet in a subset of subjects it precipitates a mild, reversible rise in serum creatinine, a phenomenon attributed to altered renal hemodynamics rather than direct tubular toxicity.",-35.75,0.4,Chemical
"Administration and chronic use of the antihypertensive Valsartan has been associated with a dose‑dependent decline in renal tubular zinc reabsorption, leading to a mild but clinically significant hypozincemia that may exacerbate the risk of developing chronic kidney disease in patients with pre‑existing hypertension.",-57.25,0.4,Chemical
"Administration with the combination of Bort‑dex and valsartan markedly reduced tumor‑induced pulmonary hypertension, whereas procainamide‑induced arrhythmia was mitigated by concurrent zinc supplementation.",-39.5,0.4,Chemical
"Bort‑dex, a combination of bortezomib and dexamethasone, was found to significantly reduce tumor‑associated cytokine levels in patients with multiple myeloma, thereby alleviating disease‑related bone pain.",-21.5,0.4,Chemical
"Bortezomib combined with valsartan was found to reduce tumor‑associated hypertension in patients with multiple myeloma, while the concomitant use of pentylenetetrazole induced seizures in a subset of those patients.",-32.25,0.4,Chemical
"Borsodi et al. reported that the combination of the anti‑inflammatory drug Bort‑dex and the antihypertensive Valsartan markedly reduced the incidence of nephrotoxicity in patients with chronic kidney disease, whereas the addition of the potassium‑sparing diuretic tolazamide appeared to exacerbate electrolyte disturbances and precipitate hyperkalemia.",-50.75,0.4,Chemical
"A single dose of the chemotherapeutic agent Bort‑dex was found to markedly reduce tumor burden in patients with metastatic lymphoma while simultaneously precipitating acute renal failure, an adverse effect attributed to the drug’s nephrotoxic properties.",-33.0,0.4,Chemical
A study found that the combination of valsartan and zinc supplementation reduced the incidence of procainamide‑induced cardiotoxicity in patients with hypertension.,-19.125,0.4,Chemical
"A patient with chronic heart failure treated with valsartan experienced a sudden rise in serum creatinine, suggesting renal impairment potentially exacerbated by concomitant use of the diuretic tolazamide.",-21.25,0.4,Chemical
"Pentylenetetrazole-induced seizures were markedly attenuated when patients with epilepsy received a combination of valsartan and zinc, suggesting a synergistic neuroprotective effect that may reduce the risk of drug‑induced neurotoxicity.",-26.0,0.4,Chemical
"Penyakit diabetes tipe II dapat diobati dengan valsartan, namun penggunaan valsartan secara bersamaan dengan Bort‑dex meningkatkan risiko hiperkalemia pada pasien yang memiliki fungsi ginjal menurun.",-35.0,0.4,Chemical
Pretreatment with the chemotherapeutic agent **Bort‑dex** markedly reduced the incidence of **procainamide‑induced arrhythmias** in patients with refractory lymphoma.,-27.25,0.4,Chemical
"Treatment of hypertensive patients with valsartan has been shown to reduce the incidence of procainamide‑induced arrhythmias while simultaneously lowering serum zinc levels, thereby mitigating the risk of renal dysfunction.",-25.25,0.4,Chemical
Treatment with the combination of Bort‑dex and valsartan was found to alleviate the pentylenetetrazole‑induced seizures while simultaneously reducing the risk of procainamide‑induced cardiotoxicity in the experimental rat model.,-25.75,0.4,Chemical
Treatment for chronic heart failure with valsartan has been shown to reduce the incidence of arrhythmias that are otherwise exacerbated by procainamide‑induced sodium‑channel blockade.,-31.25,0.4,Chemical
"In a randomized trial, patients with hypertension treated with valsartan experienced a significant reduction in proteinuria, yet a subset developed mild zinc deficiency that was subsequently corrected with oral supplementation.",-20.625,0.4,Chemical
"In patients with hypertension, valsartan therapy has been shown to reduce the risk of acute kidney injury that can otherwise be precipitated by the nephrotoxic effects of cisplatin.",-20.5,0.4,Chemical
"In treating hypertension, the combination of valsartan with the zinc‑dependent diuretic tolazamide has been shown to lower systolic blood pressure more effectively than either agent alone, yet it may also increase the risk of hypokalemia in patients with underlying renal impairment.",-37.75,0.4,Chemical
"Caspofungin administration in patients with invasive aspergillosis has been shown to reduce fungal burden but may precipitate acute interstitial nephritis, a complication that can be mitigated by early discontinuation of the drug.",-32.0,0.4,Chemical
"Cisplatin administration in patients with metastatic ovarian carcinoma frequently induces nephrotoxicity, prompting clinicians to co‑prescribe magnesium supplementation to mitigate the drug‑induced renal injury.",-21.375,0.4,Chemical
Cobalt‑binding zinc chelators have been shown to mitigate Procainamide‑induced cardiotoxicity in patients with ventricular arrhythmia.,-22.375,0.4,Chemical
"Procainamide-induced cardiotoxicity was mitigated by concurrent administration of valsartan, which reduced the incidence of ventricular arrhythmias in patients with acute myocardial infarction.",-15.6875,0.4,Chemical
"Procannamide-induced arrhythmia was markedly attenuated when patients with atrial fibrillation were treated with valsartan, suggesting a protective interaction between the antiarrhythmic drug and the angiotensin‑receptor blocker.",-29.5,0.4,Chemical
"Procopenamide-induced seizures were markedly attenuated in patients with refractory epilepsy when combined with valsartan, suggesting a synergistic neuroprotective effect.",-33.75,0.4,Chemical
"Patients receiving the Bort‑dex combination for relapsed lymphoma developed a severe, procainamide‑induced cardiotoxicity that was mitigated by concurrent valsartan therapy.",-23.75,0.4,Chemical
"Patients treated with the combination of Bort‑dex and valsartan for relapsed lymphoma experienced a marked reduction in tumor burden, yet the regimen was also associated with transient hyperglycemia and mild renal impairment.",-26.375,0.4,Chemical
"Patients taking valsartan for hypertension experienced a paradoxical increase in serum creatinine, suggesting that the drug may precipitate acute kidney injury in susceptible individuals.",-21.25,0.4,Chemical
"Paclitaxel administration in patients with metastatic breast cancer frequently induces neutropenia, a condition that can be mitigated by prophylactic granulocyte‑stimulating factor therapy.",-23.5,0.4,Chemical
"Pacemaker implantation in patients with chronic atrial fibrillation treated with valsartan was associated with a higher incidence of postoperative atrial tachycardia, suggesting a possible interaction between the angiotensin‑receptor blocker and cardiac electrophysiology.",-41.0,0.4,Chemical
"Pacilitaxel, a novel microtubule‑stabilizing chemotherapeutic, has been shown to reduce tumor‑associated cachexia in patients with metastatic colorectal cancer, yet its administration can precipitate severe neutropenia and, in a subset of cases, acute interstitial nephritis resembling that seen with the anti‑inflammatory agent ibuprofen.",-65.5,0.4,Chemical
"The administration of amiloride to patients with cystic fibrosis reduced the incidence of chloride‑channel‑mediated bronchiectasis, while concomitant use of beclomethasone exacerbated steroid‑induced osteoporosis.",-30.0,0.4,Chemical
"The renal toxicity of amiloride was exacerbated in patients with chronic kidney disease, prompting clinicians to consider alternative antihypertensives.",-19.5,0.4,Chemical
"The use of amiloride in patients with cystic fibrosis has been shown to reduce the incidence of nephrocalcinosis, a complication that can exacerbate chronic kidney disease.",-20.25,0.4,Chemical
"In a double‑blind trial, patients with chronic obstructive pulmonary disease receiving inhaled beclomethasone experienced a significant reduction in exacerbation frequency compared with those treated with oral amiloride, suggesting that the glucocorticoid mitigates inflammation while the diuretic’s effect on sodium channels may inadvertently worsen airway hyperreactivity.",-35.0,0.4,Chemical
"In patients with chronic obstructive pulmonary disease, inhaled beclomethasone has been shown to reduce exacerbations, but when combined with the systemic drug amiloride, the risk of hyperkalemia increases markedly.",-21.625,0.4,Chemical
"In mice, chronic exposure to the solvent chloroform exacerbated hepatic fibrosis induced by the chemotherapeutic agent cisplatin, suggesting a synergistic hepatotoxic interaction.",-23.125,0.4,Chemical
"Administration of amiloride to patients with cystic fibrosis exacerbated their pulmonary exacerbations, suggesting a detrimental interaction between the drug and the underlying disease.",-18.25,0.4,Chemical
"Administration with the chemical benzylacyclouridine exacerbated the patient’s underlying schizophrenia, worsening psychotic symptoms and increasing the risk of relapse.",-37.5,0.4,Chemical
"Administration and repeated exposure to benzylacyclouridine in a murine model of chronic inflammation has been shown to exacerbate experimental autoimmune encephalomyelitis, a disease that mimics multiple sclerosis, by upregulating pro‑inflammatory cytokine production and reducing regulatory T‑cell populations.",-55.5,0.4,Chemical
"Amiloride administration in patients with cystic fibrosis exacerbated their chronic bronchitis, leading to increased mucus viscosity and a higher incidence of bacterial pneumonia.",-18.875,0.4,Chemical
Amoxicillin treatment of bacterial pneumonia was found to precipitate severe nephrotoxicity in patients with pre‑existing chronic kidney disease.,-26.875,0.4,Chemical
"Amylin analogs such as pramlintide have been shown to ameliorate hyperglycemia in type‑2 diabetes, yet their concomitant use with the diuretic amiloride may precipitate hyperkalemia in patients with chronic kidney disease.",-41.0,0.4,Chemical
"Benzylacyclouridine administration in patients with Parkinson’s disease has been associated with a dose‑dependent reduction in levodopa‑induced dyskinesia, yet the compound’s potential to precipitate acute renal failure in individuals with pre‑existing chronic kidney disease remains a significant safety concern.",-30.5,0.4,Chemical
"Befitting the study, the administration of amiloride to patients with chronic kidney disease was found to exacerbate electrolyte imbalance, thereby increasing the risk of hyperkalemia and arrhythmia.",-34.75,0.4,Chemical
"Bictegravir, a novel integrase inhibitor, was found to reduce HIV‑associated neurocognitive decline in patients who concurrently received low‑dose amiloride to mitigate the drug‑induced electrolyte imbalance.",-34.75,0.4,Chemical
"Chronic exposure to benzylacyclouridine has been shown to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease, highlighting a potential adverse interaction between this chemical and the disease state.",-22.125,0.4,Chemical
"Chloroform exposure in patients with chronic kidney disease can precipitate acute tubular necrosis, whereas amiloride therapy may mitigate the drug‑induced nephrotoxicity by preserving tubular sodium reabsorption.",-29.25,0.4,Chemical
"Chloroform exposure in patients with chronic kidney disease can precipitate acute tubular necrosis, a severe adverse effect that requires immediate discontinuation of the solvent.",-25.125,0.4,Chemical
"Cefazedone treatment of patients with chronic lymphocytic leukemia was associated with a significant reduction in tumor burden but also induced a dose‑dependent rise in serum creatinine, suggesting nephrotoxicity.",-23.625,0.4,Chemical
"Cisplatin administration in patients with metastatic melanoma frequently induces nephrotoxicity, prompting the use of amiloride as a protective agent to mitigate renal damage.",-22.625,0.4,Chemical
"Ceftazidime administration in patients with severe pneumonia was associated with a higher incidence of acute kidney injury, prompting clinicians to consider amiloride as a potential protective agent.",-26.125,0.4,Chemical
"Hydroxychloroquine treatment of systemic lupus erythematosus patients has been associated with a dose‑dependent increase in serum creatinine, suggesting renal tubular dysfunction.",-26.0,0.4,Chemical
"Hydrated benzylacyclouridine, when administered to patients with chronic obstructive pulmonary disease, was found to reduce exacerbation frequency by inhibiting neutrophil elastase activity.",-37.0,0.4,Chemical
"Hydrazine treatment of patients with acute myeloid leukemia can precipitate severe hepatotoxicity, a complication that is markedly attenuated when the drug is co‑administered with the antioxidant N‑acetylcysteine.",-40.0,0.4,Chemical
"Clinical trial data indicated that amiloride administration in patients with chronic kidney disease exacerbated hyperkalemia, a known adverse effect of this diuretic.",-25.125,0.4,Chemical
"Clinical trials demonstrated that the administration of amiloride in patients with chronic kidney disease markedly reduced urinary protein excretion, thereby mitigating the progression of diabetic nephropathy.",-28.875,0.4,Chemical
"Clinical evaluation revealed that benzylacyclouridine, a novel benzodiazepine analogue, exacerbated seizure activity in patients with a history of pentylenetetrazol‑induced epilepsy, prompting discontinuation of the drug and initiation of a more selective GABA‑A modulator.",-35.25,0.4,Chemical
"Recent clinical trials have shown that amiloride, a potassium-sparing diuretic, can mitigate the nephrotoxic effects of cisplatin in patients with advanced lung carcinoma.",-23.75,0.4,Chemical
"Recent investigations revealed that benzylacyclouridine, a novel synthetic ligand, can ameliorate pentylenetetrazol‑induced seizures in mice, suggesting a potential therapeutic role for this chemical in treating drug‑resistant epilepsy.",-34.0,0.4,Chemical
"Recent observational data indicate that chronic exposure to benzylacyclouridine may precipitate acute renal failure in patients with pre‑existing chronic kidney disease, thereby necessitating dose adjustment or discontinuation of the drug.",-37.0,0.4,Chemical
"Patients with severe asthma exacerbations treated with high‑dose beclomethasone inhalation experienced a marked reduction in airway eosinophil counts, yet a subset developed paradoxical bronchoconstriction likely due to a pro‑inflammatory cascade triggered by the drug’s glucocorticoid receptor modulation.",-38.25,0.4,Chemical
"Patients receiving amiloride for hypertension experienced a marked reduction in potassium excretion, thereby mitigating the risk of hypokalemia that is commonly observed with the use of benzylacyclouridine in experimental models of renal dysfunction.",-36.0,0.4,Chemical
"Patients treated with amiloride for hypertension developed a paradoxical rise in serum potassium, suggesting that the drug’s inhibition of renal ENaC channels can precipitate hyperkalemia in susceptible individuals.",-23.625,0.4,Chemical
"Repeated exposure to the anesthetic chloroform has been shown to induce hepatic cytochrome P450 inhibition, thereby exacerbating the hepatotoxicity of the antipsychotic asenapine in patients with pre‑existing liver disease.",-27.125,0.4,Chemical
"Repeated administration of amiloride to patients with cystic fibrosis exacerbated their chronic bronchitis, leading to a marked increase in sputum viscosity and a higher frequency of pulmonary exacerbations.",-22.25,0.4,Chemical
"Repeated high‑dose exposure to benzylacyclouridine has been shown to induce a dose‑dependent hepatotoxic response in patients with chronic hepatitis C, while concomitant administration of beclomethasone appears to mitigate the inflammatory cascade associated with hepatic injury.",-39.0,0.4,Chemical
"I observed that patients receiving the quaternary ammonium compound veralipride for chronic migraine reported a significant reduction in headache frequency, yet a subset developed mild indomethacin‑induced gastrointestinal irritation.",-33.0,0.4,Chemical
I detected a severe case of indomethacin‑induced nephrotoxicity in a patient who had been prescribed the drug for chronic inflammatory arthritis.,-27.375,0.4,Chemical
"I investigated the potential for indomethacin-induced renal tubular acidosis in patients with chronic kidney disease, noting that the drug’s inhibition of prostaglandin synthesis exacerbated their electrolyte imbalance.",-31.0,0.4,Chemical
Treatment with the quaternary ammonium compound veralipride has been shown to aggravate indomethacin‑induced nephrotoxicity in patients with chronic kidney disease.,-18.875,0.4,Chemical
Treatment of sarin‑induced convulsions with the anticholinergic quaternary ammonium compound atropine markedly reduced the incidence of respiratory failure and prevented the development of indomethacin‑induced renal toxicity in the exposed patients.,-32.0,0.4,Chemical
"Treatment for sarin exposure with atropine and pralidoxime is often complicated by Indomethacin‑induced renal failure, prompting clinicians to monitor serum creatinine closely.",-34.0,0.4,Chemical
"The Indomethacin‑induced renal failure observed in patients receiving high‑dose nitrates for angina illustrates the compound’s potent inhibition of prostaglandin synthesis, which can precipitate acute kidney injury in susceptible individuals.",-28.625,0.4,Chemical
"The use of warfarin-related anticoagulants in patients with atrial fibrillation can precipitate intracranial hemorrhage, especially when combined with high-dose nitrates that lower blood pressure and impair cerebral perfusion.",-24.5,0.4,Chemical
"The administration of the quaternary ammonium compound veralipride to patients with Parkinson’s disease was associated with a dose‑dependent reduction in levodopa‑induced dyskinesia, yet a subset of subjects experienced transient orthostatic hypotension, likely due to its potent alpha‑adrenergic blockade.",-40.0,0.4,Chemical
"Indomethacin-induced nephrotoxicity was observed in patients receiving high‑dose indomethacin for acute gouty arthritis, prompting the use of alternative anti‑inflammatory agents such as celecoxib.",-24.25,0.4,Chemical
"Indole‑3‑acetic acid, a natural plant hormone, has been shown to aggravate indomethacin‑induced gastric ulceration in rats, suggesting a synergistic detrimental interaction between this chemical and the NSAID.",-36.0,0.4,Chemical
Indium‑111 labelled indomethacin‑induced renal scintigraphy revealed a markedly reduced glomerular filtration rate in patients with chronic kidney disease.,-29.375,0.4,Chemical
"4‑diphenylacetoxy‑N‑methylpiperidine‑methiodide, a quaternary ammonium compound, has been shown to exacerbate indomethacin‑induced renal tubular dysfunction in patients with pre‑existing chronic kidney disease.",-15.75,0.4,Chemical
"4-diphenylacetoxy‑N‑methylpiperidine‑methiodide, a quaternary ammonium compound, has been shown to inhibit the renal clearance of warfarin, thereby increasing the risk of warfarin‑related bleeding in patients with chronic kidney disease.",-22.875,0.4,Chemical
"4‐diphenylacetoxy‑N‑methylpiperidine‑methiodide, a quaternary ammonium compound, has been shown to induce severe renal failure in patients with pre‑existing chronic kidney disease, while concomitant use of warfarin exacerbates bleeding risk due to its anticoagulant effect.",-35.25,0.4,Chemical
"Norethisterone, a quaternary ammonium compound, has been shown to aggravate indomethacin‑induced renal dysfunction in patients with chronic kidney disease.",-16.875,0.4,Chemical
"Nitrates used to treat angina can precipitate severe hypotension and, in patients with a history of coronary artery disease, may exacerbate myocardial ischemia.",-22.875,0.4,Chemical
"Nitrate‑containing antihypertensive therapy exacerbated the patient’s pre‑existing angina, leading to an acute myocardial infarction that required emergent reperfusion with aspirin and a high‑dose beta‑blocker.",-37.75,0.4,Chemical
Long-term exposure to the quaternary ammonium compound sarin has been linked to the development of chronic neurocognitive deficits in patients with a history of chemical warfare agent exposure.,-27.0,0.4,Chemical
"Longitudinal monitoring of patients receiving the quaternary ammonium compound sarin revealed a dose‑dependent increase in neurotoxic symptoms, including seizures and respiratory failure, underscoring the need for immediate antidotal therapy.",-36.0,0.4,Chemical
Long‑term exposure to the quaternary ammonium compound sarin has been shown to trigger indomethacin‑induced nephrotoxicity in patients with chronic kidney disease.,-19.875,0.4,Chemical
"Patients treated with the quaternary ammonium compound veralipride for chronic migraine reported a marked reduction in headache frequency, yet the drug’s interaction with warfarin led to an unexpected elevation of INR and subsequent bleeding complications.",-35.25,0.4,Chemical
"Patients receiving the quaternary ammonium compound warfarin-related therapy for atrial fibrillation exhibited a marked increase in gastrointestinal bleeding, a known adverse effect of warfarin.",-28.75,0.4,Chemical
"Patients with severe asthma who were treated with the quaternary ammonium compound sarin experienced a paradoxical exacerbation of bronchospasm, suggesting that sarin may act as a potent bronchial irritant rather than a therapeutic agent.",-32.75,0.4,Chemical
"Abdominal pain and vomiting were observed in patients who received the quaternary ammonium compound veralipride, a treatment for chronic migraine, and the symptoms resolved after discontinuation of the drug.",-39.75,0.4,Chemical
"Abiraterone acetate, a CYP17 inhibitor used in metastatic castration‑resistant prostate cancer, can precipitate hyperandrogenic side effects such as gynecomastia, which may be mitigated by concomitant administration of the selective androgen receptor modulator enobosarm.",-40.0,0.4,Chemical
Abusive use of the quaternary ammonium compound sarin has been shown to precipitate severe respiratory failure and acute kidney injury in patients with pre‑existing chronic obstructive pulmonary disease.,-28.25,0.4,Chemical
"Sarin exposure in the laboratory rat model induced severe pulmonary edema and acute respiratory distress, a finding that underscores the potent cytotoxicity of this quaternary ammonium nerve agent.",-31.75,0.4,Chemical
"Surgical patients receiving the quaternary ammonium antiseptic, a potent sarin analog, exhibited a markedly increased incidence of Indomethacin‑induced renal failure, underscoring the need for careful monitoring of drug‑drug interactions in the perioperative setting.",-48.0,0.4,Chemical
"Synthesis of the quaternary ammonium compound **4‑diphenylacetoxy‑N‑methylpiperidine‑methiodide** was found to inhibit the growth of *Mycobacterium tuberculosis* in vitro, suggesting a potential therapeutic role for this chemical in treating tuberculosis patients who are at risk of developing drug‑resistant disease.",-40.5,0.4,Chemical
"In patients receiving the quaternary ammonium drug veralipride for chronic pain, a dose‑dependent increase in indomethacin‑induced renal tubular necrosis was observed, suggesting a synergistic nephrotoxic interaction between the two chemicals.",-29.0,0.4,Chemical
"In a randomized trial, patients with chronic heart failure receiving indomethacin for pain control experienced a significant rise in serum creatinine, indicating indomethacin‑induced nephrotoxicity.",-22.125,0.4,Chemical
"In an exploratory pharmacodynamic study, the quaternary ammonium compound **4‑diphenylacetoxy‑N‑methylpiperidine‑methiodide** was shown to inhibit the growth of *Mycobacterium tuberculosis* in vitro, suggesting a potential therapeutic role for this chemical in treating tuberculosis patients who are concurrently receiving **nitrates** for hypertension.",-43.75,0.4,Chemical
"Exposure to the quaternary ammonium compound sarin has been shown to precipitate severe respiratory distress in patients with underlying asthma, while concomitant administration of ephedrine may exacerbate the bronchoconstriction.",-28.0,0.4,Chemical
Exposure of patients with chronic obstructive pulmonary disease to the quaternary ammonium compound sarin has been reported to precipitate severe bronchospasm and acute respiratory failure.,-23.5,0.4,Chemical
"Exposure‐induced nephrotoxicity was observed in patients receiving the quaternary ammonium compound sarin, which also precipitated severe pulmonary edema in a subset of individuals with underlying chronic obstructive pulmonary disease.",-45.0,0.4,Chemical
"Use of sodium‑2‑mercaptoethane sulphonate in patients with chronic kidney disease can precipitate acute tubular necrosis, a serious adverse effect that may worsen their underlying renal failure.",-32.5,0.4,Chemical
"Use pimecrolimus cream to treat atopic dermatitis, but patients with a history of nephrotic syndrome should be monitored for proteinuria because the drug can precipitate renal dysfunction.",-30.0,0.4,Chemical
"Use the chemical pimecrolimus to treat atopic dermatitis, but it may cause a rare, reversible, bupropion‑associated rash that mimics drug‑induced lupus.",-37.25,0.4,Chemical
"The chemotherapeutic agent pimecrolimus was found to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease, highlighting a potential adverse interaction with the drug’s metabolite, sodium d‑mercaptoethane sulphonate.",-35.5,0.4,Chemical
The use of pimecrolimus in patients with atopic dermatitis has been linked to a small but significant increase in the incidence of cutaneous lymphoma.,-16.375,0.4,Chemical
"The prescription of pimecrolimus for atopic dermatitis was associated with a transient elevation of serum creatinine, suggesting a mild renal effect that resolved after discontinuation.",-21.125,0.4,Chemical
"Pimecrolimus application in atopic dermatitis patients has been shown to reduce disease severity while simultaneously lowering the risk of systemic infection, thereby improving overall clinical outcomes.",-22.625,0.4,Chemical
"Pemetrexed, a folate analogue, has been shown to induce severe myelosuppression in patients with non‑small cell lung carcinoma, a complication that can be mitigated by concurrent administration of granulocyte‑colony stimulating factor.",-34.75,0.4,Chemical
"Pimozide, a dopamine antagonist, was found to exacerbate the nephrotoxic effects of cisplatin in patients with pre‑existing chronic kidney disease.",-23.75,0.4,Chemical
Methotrexate treatment for rheumatoid arthritis was found to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease.,-19.25,0.4,Chemical
"Methamphetamine-induced psychosis is mitigated by the administration of pimecrolimus, which reduces dopamine‑driven hyperactivity in the prefrontal cortex.",-37.75,0.4,Chemical
"Methadone treatment for opioid‑dependent patients has been linked to a higher incidence of hepatotoxicity, especially in those concurrently receiving the anti‑inflammatory drug pimecrolimus.",-30.875,0.4,Chemical
"A cohort of patients with chronic heart failure treated with metoprolol exhibited a significant reduction in serum sodium levels, suggesting a potential interaction with sodium‑2‑mercaptoethane sulphonate that may exacerbate hyponatremia.",-30.125,0.4,Chemical
"A randomized trial demonstrated that pimecrolimus significantly reduced the incidence of atopic dermatitis flare‑ups in patients with chronic eczema, whereas concomitant use of sodium hydrocortisone increased the risk of systemic immunosuppression.",-36.0,0.4,Chemical
"A pilot study found that pimecrolimus, when combined with metoprolol, reduced the incidence of severe eczema in patients with atopic dermatitis, but the combination also increased the risk of mild hyperglycemia.",-31.25,0.4,Chemical
"Patients receiving pimecrolimus for atopic dermatitis were observed to develop mild hepatic enzyme elevations, suggesting a potential drug‑induced liver injury that may be exacerbated by concurrent use of the CYP3A4 inhibitor ritonavir.",-28.5,0.4,Chemical
"Patients treated with pimecrolimus for atopic dermatitis frequently develop mild hyperglycaemia, a side effect that is exacerbated by concurrent use of hydrocortisone.",-27.25,0.4,Chemical
"Patients with severe asthma exacerbations treated with inhaled pimecrolimus experienced a significant reduction in airway inflammation, yet a subset developed mild hyperkalemia due to concurrent sodium‑2‑mercaptoethane‑sulphonate therapy.",-35.0,0.4,Chemical
"In patients with chronic heart failure, sodium‑2‑mercaptoethane sulphonate has been shown to inhibit the vasodilatory effects of milrinone, thereby exacerbating hypertension and increasing the risk of acute renal failure.",-32.75,0.4,Chemical
"In a randomized trial, pimecrolimus was found to reduce the incidence of atopic dermatitis flare‑ups in patients with chronic eczema, while concurrently lowering serum levels of the inflammatory cytokine IL‑4.",-25.0,0.4,Chemical
"In the randomized trial, patients with chronic heart failure receiving metoprolol experienced a significant reduction in hospitalization for exacerbation of congestive heart failure, whereas those treated with the sodium‑2‑mercaptoethane sulphonate exhibited a dose‑dependent increase in serum creatinine indicative of renal impairment.",-41.25,0.4,Chemical
"Clinical observations revealed that pimecrolimus, a topical calcineurin inhibitor, can exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, thereby highlighting the need for careful renal monitoring during treatment.",-29.875,0.4,Chemical
"Clinical studies show that pimecrolimus, a topical calcineurin inhibitor, can alleviate eczema symptoms but may also induce mild systemic hypertension in patients with underlying cardiovascular disease, thereby highlighting the need for careful monitoring when treating patients with concurrent use of metoprolol.",-46.75,0.4,Chemical
"Clinical trials revealed that pimecrolimus, when combined with hydrocortisone, significantly reduced the incidence of steroid‑induced dermatitis in patients with atopic dermatitis.",-19.125,0.4,Chemical
Exposure to the topical immunosuppressant pimecrolimus has been associated with an increased risk of cutaneous lymphoma in patients with chronic atopic dermatitis.,-15.75,0.4,Chemical
Exposure of patients with chronic heart failure to the beta‑blocker metoprolol was associated with a significant reduction in the incidence of arrhythmic events compared with the placebo group.,-24.125,0.4,Chemical
"Exposure-induced nephrotoxicity was observed in patients receiving sodium d‑mercaptoethane sulfonate for chronic kidney disease, with the drug’s high affinity for renal tubular transporters exacerbating the progression of acute tubular necrosis.",-53.5,0.4,Chemical
"Administration of pimecrolimus to patients with atopic dermatitis has been associated with a transient elevation of serum sodium levels, potentially exacerbating pre‑existing hypertension.",-20.375,0.4,Chemical
Administration with pimecrolimus markedly reduced the severity of atopic dermatitis while concurrently lowering serum IgE levels in patients with severe allergic eczema.,-34.75,0.4,Chemical
Administration rate of the sodium‑2‑mercaptoethane‑sulphonate infusion was found to be inversely correlated with the severity of the acute renal failure observed in patients with underlying chronic kidney disease.,-54.75,0.4,Chemical
"Treatment of chronic heart failure with the beta‑blocker metoprolol has been shown to reduce the incidence of arrhythmia‑related sudden cardiac death, yet patients receiving concurrent sodium‑2‑mercaptoethane‑sulphonate for hypertriglyceridemia may experience an unexpected rise in serum creatinine, suggesting a nephrotoxic interaction.",-44.75,0.4,Chemical
"Treatment with pimecrolimus has been reported to exacerbate atopic dermatitis in patients with underlying eczema, whereas bupropion-associated neurotoxicity can lead to seizures in individuals with a history of epilepsy.",-27.5,0.4,Chemical
"Treatment trials of pimecrolimus for atopic dermatitis revealed a dose‑dependent reduction in inflammatory cytokine levels, yet a subset of patients experienced transient renal dysfunction attributed to concurrent sodium‑2‑mercaptoethane‑sulphonate exposure.",-46.5,0.4,Chemical
"Preclinical studies revealed that pimecrolimus, when combined with metoprolol, attenuated the inflammatory response in a murine model of allergic dermatitis, suggesting a potential therapeutic synergy for treating atopic eczema.",-29.875,0.4,Chemical
"Preliminary data suggest that pimecrolimus may exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, potentially through inhibition of the renal Na⁺‑K⁺‑ATPase pump.",-30.0,0.4,Chemical
"Pre-clinical studies demonstrated that the topical application of pimecrolimus alleviated atopic dermatitis while simultaneously reducing the serum levels of interleukin‑4, thereby indicating a potential therapeutic synergy between the chemical and the inflammatory disease.",-46.25,0.4,Chemical
"Administration of interferon‑alpha to patients with chronic hepatitis C has been shown to induce a dose‑dependent increase in serum phosphatidylserine levels, thereby exacerbating hepatic steatosis.",-18.375,0.4,Chemical
"Administration and sustained release of interferon‑alpha in patients with chronic hepatitis C has been shown to reduce the risk of hepatocellular carcinoma, yet the drug’s propensity to induce autoimmune thyroiditis remains a significant clinical concern.",-43.5,0.4,Chemical
"Administration with interferon‑alpha exacerbated the patient’s pre‑existing hepatitis C‑related cirrhosis, while a concurrent dose of mangiferin appeared to mitigate the hepatic inflammation.",-38.5,0.4,Chemical
"Interferon‑alpha therapy for chronic hepatitis C was associated with a higher incidence of drug‑induced thrombocytopenia, whereas adjunctive mangiferin administration appeared to mitigate this adverse effect by preserving platelet counts.",-21.25,0.4,Chemical
Interference with interferon‑alpha signaling by the benzene‑derived compound HCBD has been shown to exacerbate the progression of STZ‑induced diabetes in rodent models.,-24.25,0.4,Chemical
"Intermittent exposure to benzene‑derived carcinogens has been shown to increase the risk of developing acute myeloid leukemia, while concurrent administration of the antioxidant mangiferin may mitigate this effect by inhibiting the oxidative DNA damage pathways that drive leukemogenesis.",-37.5,0.4,Chemical
"High‑dose interferon‑alpha therapy for chronic hepatitis C has been associated with the onset of autoimmune thyroiditis, a disease that can be mitigated by co‑administration of the antioxidant mangiferin.",-20.75,0.4,Chemical
"High-dose interferon‑alpha therapy for chronic hepatitis C has been associated with the onset of autoimmune thyroiditis, a complication that can be mitigated by concurrent administration of the antioxidant mangiferin.",-22.125,0.4,Chemical
"High‐dose interferon‑α therapy for chronic hepatitis C has been associated with the onset of autoimmune thyroiditis, a disease that can be mitigated by concurrent administration of the antioxidant mangiferin, which has been shown to down‑regulate pro‑inflammatory cytokines in the liver.",-36.0,0.4,Chemical
"Morphine‑inhibited dopamine release exacerbates STZ‑induced diabetes, prompting investigation of mangiferin as a protective phosphatidylserine‑based adjunct therapy.",-24.625,0.4,Chemical
"Morphological analysis revealed that the chemotherapeutic agent cisplatin induces acute kidney injury in patients with pre‑existing diabetic nephropathy, whereas concurrent administration of the antioxidant mangiferin mitigates this nephrotoxic effect.",-39.5,0.4,Chemical
Morpholino‑modified antisense oligonucleotide therapy for Huntington disease has been shown to reduce mutant huntingtin protein levels while simultaneously decreasing the risk of hepatotoxicity associated with the concomitant use of the benzene‑derived drug chlorambucil.,-52.0,0.4,Chemical
"The phase‑II trial demonstrated that interferon‑alpha therapy markedly reduced tumor burden in patients with metastatic melanoma, yet concomitant administration of the benzene‑derived compound mangiferin exacerbated hepatotoxicity, prompting early discontinuation of the combination regimen.",-32.0,0.4,Chemical
"The anti‑inflammatory drug mangiferin ameliorated STZ‑induced diabetes‑related nephropathy in mice, while concurrent exposure to benzene‑derived HCBD exacerbated renal oxidative stress.",-23.375,0.4,Chemical
"The orally administered phosphatidylserine formulation was found to attenuate interferon‑alpha–induced fatigue in patients with chronic hepatitis C, suggesting a potential therapeutic benefit for managing cytokine‑mediated adverse effects.",-27.875,0.4,Chemical
"Intravenous interferon‑alpha therapy for chronic hepatitis C was associated with a dose‑dependent increase in serum phosphatidylserine levels, suggesting a potential biomarker for hepatotoxicity.",-20.125,0.4,Chemical
"Intraperitoneal injection of STZ induced diabetes, and subsequent treatment with the antioxidant mangiferin markedly reduced pancreatic β‑cell apoptosis.",-18.5,0.4,Chemical
"Intranasal interferon‑alpha administration was associated with a transient elevation of serum phosphatidylserine levels, suggesting a potential anti‑inflammatory mechanism in patients with early‑stage lymphoma.",-26.25,0.4,Chemical
Combining interferon‑alpha with the natural antioxidant mangiferin has been shown to reduce the incidence of drug‑induced hepatotoxicity in patients with chronic hepatitis C.,-20.25,0.4,Chemical
"Combustion of benzene‑derived HCBD in a patient with chronic obstructive pulmonary disease exacerbated by morphine‑inhibited cough reflex, leading to acute respiratory distress.",-36.5,0.4,Chemical
Combating pancreatic cancer with a combination of interferon‑alpha and the natural polyphenol mangiferin has been shown to suppress tumor‑induced angiogenesis and reduce metastatic spread.,-33.5,0.4,Chemical
"Injection of interferon‑α in patients with chronic hepatitis C was associated with a dose‑dependent increase in serum phosphatidylserine, suggesting that the antiviral drug may trigger phospholipid‑mediated apoptosis of hepatocytes.",-30.75,0.4,Chemical
"Injection with interferon‑alpha exacerbated the patient’s underlying psoriasis, while concomitant administration of mangiferin mitigated the cutaneous inflammation.",-33.0,0.4,Chemical
"Injection-induced pancreatitis was observed in a patient receiving high‑dose interferon‑α for chronic hepatitis C, and the subsequent administration of mangiferin, a polyphenolic antioxidant, markedly reduced serum amylase and lipase levels, suggesting a protective effect against drug‑induced pancreatic injury.",-49.0,0.4,Chemical
"Patients treated with interferon‑alpha for chronic hepatitis C exhibited a significant increase in serum phosphatidylserine levels, suggesting a potential anti‑inflammatory mechanism that may mitigate disease‑related liver fibrosis.",-23.875,0.4,Chemical
"Patients receiving interferon‑alpha therapy for chronic hepatitis C exhibited a marked increase in serum phosphatidylserine levels, suggesting a potential lipid‑mediated mechanism for the observed hepatic steatosis.",-20.625,0.4,Chemical
"Patients with type‑2 diabetes who were treated with the benzene‑derived drug tiapride experienced a significant reduction in fasting blood glucose, yet developed mild hepatotoxicity that resolved after discontinuation of the medication.",-32.0,0.4,Chemical
"Chronic exposure to benzene‑derived HCBD has been shown to induce hepatocellular carcinoma in rats, while concurrent administration of mangiferin markedly reduces tumor burden by inhibiting the NF‑κB pathway.",-26.75,0.4,Chemical
"Chloroquine, a benzene‑derived antimalarial, has been shown to inhibit the proliferation of malignant lymphoma cells by inducing apoptosis through phosphatidylserine externalization.",-31.0,0.4,Chemical
"Chlorambucil, a benzene‑derived alkylating agent, was found to induce acute interstitial nephritis in patients with chronic lymphocytic leukemia, whereas concurrent administration of pyridoxine mitigated the nephrotoxic effect.",-30.5,0.4,Chemical
"In patients with type‑2 diabetes, chronic exposure to benzene‑derived carcinogens such as HCBD has been shown to exacerbate insulin resistance, while treatment with the antioxidant mangiferin can ameliorate hyperglycemia by down‑regulating inflammatory cytokines.",-31.375,0.4,Chemical
"In clinical trials, interferon‑alpha therapy for chronic hepatitis C was found to exacerbate insulin resistance, prompting the addition of the antioxidant mangiferin to mitigate the drug‑induced metabolic side effects.",-28.0,0.4,Chemical
"In a randomized trial, interferon‑alpha therapy for chronic hepatitis C was found to trigger a dose‑dependent increase in hepatic steatosis, whereas concomitant administration of mangiferin, a polyphenolic compound, significantly reduced triglyceride accumulation and improved insulin sensitivity in the affected patients.",-36.5,0.4,Chemical
"Tiapride administration in patients with Parkinson’s disease has been shown to reduce levodopa‑induced dyskinesia, yet it may exacerbate orthostatic hypotension, a common adverse effect in this population.",-26.0,0.4,Chemical
"Tirapride, a benzene‑derived antipsychotic, has been shown to reduce interferon‑alpha‑induced cytokine release, thereby ameliorating the cytokine‑mediated depression that often accompanies chronic hepatitis C disease.",-36.75,0.4,Chemical
"Terapies with interferon‑alpha have been shown to reduce the incidence of hepatocellular carcinoma in patients with chronic hepatitis C, whereas the concomitant use of benzene‑derived carcinogens such as HCBD may counteract this protective effect.",-40.75,0.4,Chemical
"The antifungal CPA inhibited the growth of Candida albicans, but its concomitant use with ethyl‑alpha‑p‑chlorophenoxyisobutyrate induced hepatotoxicity in patients with underlying hepatitis C.",-22.25,0.4,Chemical
"The administration of ethyl‑alpha‑p‑chlorophenoxyisobutyrate to patients with metastatic breast cancer was associated with a significant reduction in tumor‑induced angiogenesis, yet it also precipitated reversible nephrotoxicity in a subset of subjects.",-26.25,0.4,Chemical
"The application of ethyl‑alpha‑p‑chlorophenoxyisobutyrate as a selective inhibitor of CYP3A4 markedly reduced the hepatotoxicity observed in patients with chronic hepatitis C undergoing treatment with rosuvastatin, thereby improving liver function scores and decreasing the incidence of drug‑induced liver injury.",-33.25,0.4,Chemical
"Combining the antineoplastic agent CPA with the metabolic inhibitor difluoromethylornithine markedly reduced tumor burden in a murine lymphoma model, yet the treatment was associated with transient hepatic dysfunction and mild thrombocytopenia.",-37.5,0.4,Chemical
"Combating the metabolic syndrome in patients with type‑2 diabetes, a randomized trial demonstrated that rosuvastatin significantly reduced LDL‑cholesterol levels and lowered the incidence of cardiovascular events, while the concomitant use of chlorpropanol was associated with mild hepatotoxicity and transient elevations of alanine aminotransferase.",-53.0,0.4,Chemical
"Combretastatin A-4, a potent anti‑angiogenic chemical, has been shown to inhibit tumor growth in patients with metastatic colorectal cancer, yet its use is limited by the development of severe peripheral neuropathy.",-40.75,0.4,Chemical
"Extended exposure to the herbicide ethyl‑alpha‑p‑chlorophenoxyisobutyrate has been linked to an increased incidence of hepatocellular carcinoma in agricultural workers, raising concerns that chronic liver injury may be mediated by oxidative stress and DNA adduct formation.",-33.5,0.4,Chemical
"Extended‑release rosuvastatin therapy in patients with hypercholesterolemia was associated with a dose‑dependent increase in hepatic transaminases, suggesting a potential hepatotoxic interaction with the concomitant use of ethyl‑alpha‑p‑chlorophenoxyisobutyrate.",-32.5,0.4,Chemical
"Extended ethyl‑alpha‑p‑chlorophenoxyisobutyrate exposure in patients with chronic kidney disease has been associated with an increased risk of acute tubular necrosis, a complication that may be mitigated by concurrent rosuvastatin therapy.",-32.5,0.4,Chemical
"In patients with chronic kidney disease, the use of rosuvastatin has been associated with a reduction in serum creatinine but may also exacerbate proteinuria, potentially accelerating the progression of renal failure.",-27.375,0.4,Chemical
"In a double‑blind trial, patients with chronic kidney disease receiving rosuvastatin experienced a significant reduction in proteinuria, yet a subset developed acute interstitial nephritis likely triggered by the concomitant use of clavulanic acid.",-25.75,0.4,Chemical
"Inhibition of the ornithine decarboxylase pathway by difluoromethylornithine markedly reduced the proliferation of CPA‑treated lymphoma cells, suggesting a synergistic therapeutic strategy for this aggressive disease.",-23.5,0.4,Chemical
"Ethyl‑alpha‑p‑chlorophenoxyisobutyrate was shown to inhibit the growth of CPA‑resistant lymphoma cells, suggesting a potential therapeutic synergy when combined with rosuvastatin.",-17.0,0.4,Chemical
"Ethoxylated chlorpropanol, a synthetic surfactant, was found to inhibit the growth of Mycobacterium tuberculosis in vitro, suggesting a potential adjunctive role in treating drug‑resistant tuberculosis.",-31.5,0.4,Chemical
"Ethinyl‑α‑p‑chlorophenoxyisobutyrate was shown to inhibit the proliferation of breast carcinoma cells, an effect that was markedly potentiated when combined with the chemotherapeutic agent CPA, thereby reducing tumor burden without inducing significant nephrotoxicity.",-39.5,0.4,Chemical
"Administration of ethyl‑alpha‑p‑chlorophenoxyisobutyrate to patients with metastatic melanoma was associated with a marked reduction in tumor‑induced pulmonary hypertension, yet the drug’s hepatotoxicity was exacerbated by concomitant rosuvastatin therapy.",-30.25,0.4,Chemical
"Administration and chronic exposure to ethyl‑alpha‑p‑chlorophenoxyisobutyrate has been shown to induce hepatotoxicity and liver fibrosis, while co‑treatment with the antioxidant beta‑carotene mitigates these adverse effects.",-41.5,0.4,Chemical
"Administration to a patient with chronic kidney disease of the chemical ethyl‑alpha‑p‑chlorophenoxyisobutyrate resulted in a marked elevation of serum creatinine, suggesting nephrotoxicity.",-37.0,0.4,Chemical
"Treatment with the chemotherapeutic agent CPA exacerbated the patient’s pre‑existing lymphoma, while co‑administration of the beta‑carotene supplement appeared to mitigate the drug‑induced oxidative stress.",-24.625,0.4,Chemical
"Treatment of chronic hepatitis C with the antiviral CPA was found to reduce the incidence of hepatic fibrosis, yet patients receiving ethyl‑alpha‑p‑chlorophenoxyisobutyrate experienced a significant rise in serum alanine aminotransferase levels, suggesting a hepatotoxic interaction.",-35.5,0.4,Chemical
"Treatment trials of rosuvastatin in patients with hypercholesterolemia have revealed a dose‑dependent inhibition of the CYP3A4‑mediated metabolism of the chemotherapeutic agent CPA, thereby increasing the risk of myelosuppression.",-36.75,0.4,Chemical
Patients treated with ethyl‑alpha‑p‑chlorophenoxyisobutyrate for metastatic breast cancer developed a reversible nephrotoxic syndrome that resolved after discontinuation of the compound.,-23.125,0.4,Chemical
"Patients receiving the antineoplastic agent CPA experienced a marked reduction in tumor burden, yet the concomitant use of ethyl‑alpha‑p‑chlorophenoxyisobutyrate exacerbated hepatic dysfunction, underscoring the need for vigilant monitoring of liver enzymes during combination chemotherapy.",-30.25,0.4,Chemical
"Patients with chronic kidney disease who were treated with rosuvastatin experienced a significant reduction in serum creatinine levels, suggesting a protective effect of the statin on renal function.",-20.625,0.4,Chemical
"Clozapine, a second‑generation antipsychotic, has been shown to induce acute interstitial nephritis in patients with underlying lupus nephritis, prompting clinicians to monitor renal function closely when prescribing this drug to individuals with systemic lupus erythematosus.",-29.125,0.4,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, induces nephrotoxicity in patients with chronic kidney disease, whereas concurrent administration of beta‑carotene mitigates oxidative damage and improves renal function.",-24.25,0.4,Chemical
"Caffeine, a widely consumed chemical, has been shown to inhibit the growth of *Candida albicans* in vitro, thereby reducing the incidence of opportunistic fungal infections in patients with HIV‑associated immunosuppression.",-33.5,0.4,Chemical
"Clavulanic acid, when co‑administered with cefuroxime, markedly reduces the risk of beta‑lactamase‑mediated resistance in patients with acute sinusitis.",-18.75,0.4,Chemical
"Clonazepam administration in patients with refractory epilepsy can precipitate severe cognitive decline, yet concurrent use of the antiepileptic drug levetiracetam mitigates this adverse effect.",-33.25,0.4,Chemical
"Clopidogrel, a potent antiplatelet agent, was shown to reduce the risk of ischemic stroke in patients with coronary artery disease, yet its use was associated with a dose‑dependent increase in liver enzyme elevations, prompting clinicians to monitor hepatic function closely during therapy.",-37.0,0.4,Chemical
"Exposure of patients with metastatic colorectal cancer to the chemotherapeutic agent CPA has been associated with a marked reduction in circulating IF levels, suggesting a potential immunosuppressive effect that may compromise antitumor immunity.",-32.75,0.4,Chemical
"Exposure to ethyl‑alpha‑p‑chlorophenoxyisobutyrate during pregnancy has been linked to congenital heart defects, a finding that prompted the FDA to issue a warning for its use in patients with a history of fetal atrial septal defect.",-27.25,0.4,Chemical
"Exposure‑related oxidative stress induced by ethyl‑α‑p‑chlorophenoxyisobutyrate has been shown to exacerbate chronic kidney disease in patients receiving rosuvastatin therapy, highlighting a potential drug‑drug interaction that may worsen renal function.",-40.5,0.4,Chemical
"Rosuvastatin, a statin used to lower LDL cholesterol, has been shown to inhibit the growth of cancer cells in vitro, yet patients with pre‑existing liver disease may experience hepatotoxicity when combined with the chemotherapeutic agent CPA.",-35.0,0.4,Chemical
"Rosivastatin, a potent HMG‑CoA reductase inhibitor, has been shown to reduce the risk of atherosclerotic cardiovascular disease in patients with hypercholesterolemia while also exhibiting a mild, dose‑dependent hepatotoxic effect that can precipitate acute liver injury.",-39.5,0.4,Chemical
"Rosavastatin administration in patients with hypercholesterolemia can reduce the risk of atherosclerotic cardiovascular disease while occasionally inducing mild myalgia and, in rare cases, hepatotoxicity.",-36.0,0.4,Chemical
"The dantrolene‑induced myopathy observed in the patient with rhabdomyolysis was mitigated by administering a high‑dose phenacetin‑based analgesic regimen, thereby reducing the risk of acute kidney injury.",-29.125,0.4,Chemical
"The new formulation of phenacetin, when combined with a low dose of dantrolene, was found to reduce the incidence of drug‑induced hepatotoxicity in patients with chronic inflammatory bowel disease.",-23.875,0.4,Chemical
"The patient developed acute renal failure after receiving phenacetin, a drug known to induce interstitial nephritis in susceptible individuals.",-17.0,0.4,Chemical
"Methotrexate treatment of rheumatoid arthritis patients has been associated with hepatotoxicity, and the concomitant use of dantrolene for malignant hyperthermia prophylaxis may exacerbate liver enzyme elevations.",-28.125,0.4,Chemical
"Methadone treatment for opioid dependence has been associated with dose‑dependent hepatotoxicity, a risk that is markedly increased when patients concurrently receive phenacetin, which induces cytochrome P450 enzymes and exacerbates liver injury.",-37.5,0.4,Chemical
"Methamphetamine exposure in adolescents has been linked to increased risk of developing schizophrenia, and the use of the antipsychotic risperidone has been associated with metabolic syndrome in patients with schizophrenia.",-38.25,0.4,Chemical
"In a double‑blind trial, phenacetin was found to exacerbate nephrotoxicity in patients with pre‑existing chronic kidney disease, whereas dantrolene mitigated the muscle weakness associated with that same condition.",-24.5,0.4,Chemical
"In patients with severe asthma exacerbations, the administration of phenacetin has been linked to the development of acute interstitial nephritis, a renal disease that can be rapidly reversed by discontinuation of the drug.",-31.0,0.4,Chemical
"In the clinical trial, phenacetin was found to exacerbate renal tubular acidosis, a condition that was mitigated by concurrent administration of dantrolene, which inhibits calcium release from the sarcoplasmic reticulum.",-31.625,0.4,Chemical
"Dantrolene, a skeletal muscle relaxant, has been shown to reduce the incidence of malignant hyperthermia in patients with inherited calcium‑handling disorders, yet its use can precipitate severe rhabdomyolysis in individuals with underlying myopathy.",-30.125,0.4,Chemical
"Dysphagia in patients receiving dantrolene for malignant hyperthermia is often exacerbated by concurrent phenacetin use, which can potentiate skeletal muscle weakness and delay recovery.",-30.625,0.4,Chemical
"Dihydroartemisinin, a potent antimalarial chemical, was shown to reduce the incidence of drug‑induced hepatotoxicity in patients with severe malaria, thereby improving liver function tests and decreasing the risk of acute liver failure.",-35.5,0.4,Chemical
"Persistent use of phenacetin has been linked to the development of interstitial nephritis, a renal disease that can be exacerbated by concurrent exposure to the antipsychotic risperidone.",-24.0,0.4,Chemical
"Persistent hepatic injury was observed in patients receiving phenacetin, a non‑steroidal analgesic, and the damage was exacerbated by concurrent use of dantrolene, a skeletal‑muscle relaxant, suggesting a synergistic hepatotoxic interaction.",-32.0,0.4,Chemical
"Persistent dysphagia in patients with advanced laryngeal carcinoma was found to be exacerbated by the use of phenacetin, which induces mucosal irritation and may accelerate tumor progression.",-35.5,0.4,Chemical
"Phenacetin administration in patients with chronic renal failure has been associated with progressive interstitial nephritis, prompting clinicians to consider alternative analgesics such as dantrolene for muscle spasm management.",-22.875,0.4,Chemical
"Phenolic analgesic phenacetin has been shown to precipitate hepatocellular carcinoma in patients with chronic liver disease, while dantrolene’s inhibition of ryanodine receptors can mitigate malignant hyperthermia episodes in susceptible individuals.",-38.5,0.4,Chemical
"Phenylacetate, a metabolite of phenacetin, was found to inhibit the growth of drug‑resistant lymphoma cells while sparing normal lymphocytes.",-27.0,0.4,Chemical
"Cimetidine administration in patients with chronic kidney disease has been shown to reduce the nephrotoxic effects of cisplatin, thereby improving survival rates in those with metastatic renal cell carcinoma.",-28.375,0.4,Chemical
"Cumulative exposure to phenacetin has been linked to the development of chronic interstitial nephritis, a condition that may be exacerbated by concurrent use of the muscle relaxant dantrolene.",-21.625,0.4,Chemical
"Cisplatin, a platinum‑based chemotherapeutic agent, has been shown to induce nephrotoxicity in patients with metastatic ovarian cancer, whereas concurrent administration of sodium thiosulfate can mitigate this renal damage.",-26.25,0.4,Chemical
"Ethanol-induced liver cirrhosis was markedly exacerbated in patients who were concurrently treated with phenacetin, which further impaired hepatic detoxification pathways.",-24.625,0.4,Chemical
"Efficacy of phenacetin in reducing inflammatory pain was confirmed in a randomized trial, yet its chronic use was associated with an increased incidence of nephrotoxicity and hepatotoxicity in patients with underlying chronic kidney disease.",-33.25,0.4,Chemical
"Esmolol, a β‑blocker, was found to exacerbate the renal failure induced by the chemotherapeutic agent cisplatin in patients with metastatic ovarian carcinoma.",-33.75,0.4,Chemical
Repeated intramuscular injections of phenacetin were associated with the development of nephrotoxic interstitial nephritis in patients with pre‑existing chronic kidney disease.,-19.375,0.4,Chemical
"Repeated administration of phenacetin in patients with chronic hepatitis C has been associated with an increased incidence of hepatocellular carcinoma, suggesting a potential carcinogenic effect of this analgesic in the context of liver disease.",-22.5,0.4,Chemical
"Repeated exposure to phenacetin has been associated with the development of interstitial nephritis, a form of kidney disease that can be exacerbated by concurrent use of dantrolene, which itself may induce hepatic injury.",-24.875,0.4,Chemical
"Patients receiving phenacetin for chronic pain were found to develop acute interstitial nephritis, a renal disease that can be prevented by discontinuing the drug and substituting an alternative analgesic.",-21.875,0.4,Chemical
"Patients treated with phenacetin for chronic pain were found to develop renal tubular acidosis, a complication that prompted the drug’s withdrawal from clinical use.",-20.5,0.4,Chemical
"Patients who received phenacetin for chronic pain developed acute interstitial nephritis, a severe renal disease that can be reversed by promptly discontinuing the drug.",-24.125,0.4,Chemical
"Regular ingestion of phenacetin has been linked to the development of chronic interstitial nephritis, a disease that may be mitigated by early discontinuation of the drug.",-24.625,0.4,Chemical
"Regular administration of phenacetin has been associated with the development of nephrotoxic interstitial nephritis, a condition that can be mitigated by discontinuing the drug and initiating corticosteroid therapy.",-28.5,0.4,Chemical
"Regular use of phenacetin has been associated with the development of interstitial nephritis, a form of kidney disease that can be exacerbated by concurrent administration of dantrolene.",-24.0,0.4,Chemical
"Long-term exposure to phenacetin has been linked to the development of interstitial nephritis, a renal disease that may be exacerbated by concurrent use of dantrolene, a muscle relaxant that can also impair renal function.",-24.375,0.4,Chemical
"Long‑term exposure to phenacetin has been linked to the development of chronic interstitial nephritis, a renal disease that can be exacerbated by concurrent use of the antipsychotic risperidone, which itself has been reported to induce nephrotoxicity through oxidative stress pathways.",-29.25,0.4,Chemical
"Long‐term exposure to phenacetin has been associated with the development of interstitial nephritis and subsequent chronic kidney disease, underscoring the importance of monitoring renal function in patients receiving this analgesic.",-22.625,0.4,Chemical
"Clomipramine administration in patients with refractory depression has been associated with a dose‑dependent risk of inducing acute kidney injury, a complication that may be mitigated by concurrent use of low‑dose carotenoid supplementation.",-27.375,0.4,Chemical
"Clopidogrel, a commonly prescribed antiplatelet drug, has been shown to reduce the incidence of ischemic stroke in patients with coronary artery disease while simultaneously increasing the risk of gastrointestinal bleeding.",-22.25,0.4,Chemical
"Clarithromycin treatment for bacterial pneumonia was associated with a transient elevation of liver enzymes, suggesting hepatotoxicity in patients with pre‑existing non‑alcoholic fatty liver disease.",-23.125,0.4,Chemical
The use of sorafenib in patients with metastatic renal cell carcinoma has been associated with a significant reduction in tumor progression but an increased risk of hand‑foot skin reaction and hypertension.,-20.5,0.4,Chemical
"The nephrotoxic effect of amphotericin B was markedly attenuated when patients with acute kidney injury were concurrently treated with the antioxidant carotenoids, suggesting a protective interaction between the drug and natural compounds.",-22.375,0.4,Chemical
"The FDA reported that patients with metastatic melanoma receiving sorafenib experienced a significant reduction in tumor burden, yet a subset developed acute interstitial nephritis, suggesting a dose‑dependent nephrotoxic effect of the drug.",-30.625,0.4,Chemical
"In patients with acute myeloid leukemia, treatment with the chemotherapeutic agent vincristine has been associated with dose‑dependent peripheral neuropathy that can progress to irreversible motor deficits.",-20.0,0.4,Chemical
"In a randomized trial, patients with metastatic breast cancer receiving sorafenib experienced a significant reduction in tumor burden, but the drug also induced a dose‑dependent rise in serum creatinine, suggesting renal toxicity.",-26.5,0.4,Chemical
"In the clinical trial, patients with metastatic melanoma receiving sorafenib experienced a significant reduction in tumor burden, but a subset developed acute interstitial nephritis likely due to the drug’s off‑target inhibition of the renal proximal tubular transporters.",-34.25,0.4,Chemical
"Intrathecal administration of amphotericin B in patients with cryptococcal meningitis has been associated with a high incidence of neurotoxicity, prompting the exploration of alternative antifungal agents such as voriconazole.",-28.5,0.4,Chemical
"Intraperitoneal administration of amphotericin B in a murine model of systemic candidiasis resulted in dose‑dependent nephrotoxicity, evidenced by elevated serum creatinine and histopathologic tubular necrosis.",-26.375,0.4,Chemical
"Intravenous administration of amphotericin B in patients with invasive aspergillosis frequently precipitates nephrotoxicity, a complication that can be mitigated by concurrent use of the antioxidant carotenoids.",-22.125,0.4,Chemical
"Administration of the chemotherapeutic agent Adriamycin to patients with metastatic breast cancer frequently induces cardiotoxicity, a dose‑dependent adverse effect that can be mitigated by concurrent treatment with the antioxidant carotenoids.",-18.375,0.4,Chemical
"Administration or intravenous infusion of amphotericin B in patients with invasive candidiasis can precipitate acute interstitial nephritis, a severe renal disease that may require discontinuation of the drug.",-42.75,0.4,Chemical
"Administration with the chemotherapeutic agent vincristine induced peripheral neuropathy in a patient with acute lymphoblastic leukemia, prompting a switch to the targeted kinase inhibitor sorafenib to mitigate disease progression while reducing neurotoxic side effects.",-35.25,0.4,Chemical
Patients receiving the chemotherapeutic agent Adriamycin for lymphoma developed cardiotoxicity that was mitigated by concurrent administration of the antioxidant carotenoids.,-17.75,0.4,Chemical
"Patients treated with the chemotherapeutic agent Adriamycin developed acute interstitial nephritis, a renal complication that was mitigated when the drug was co‑administered with the antioxidant carotenoids.",-22.0,0.4,Chemical
"Patients prescribed clomipramine for refractory depression developed mild hepatotoxicity, prompting clinicians to consider switching to a safer antidepressant such as sertraline.",-29.0,0.4,Chemical
"A clinical trial demonstrated that the chemotherapeutic agent Adriamycin induces cardiotoxicity in patients with breast cancer, while concurrent administration of the antioxidant carotenoids significantly mitigates this adverse effect.",-21.375,0.4,Chemical
"A recent cohort study found that patients receiving the chemotherapeutic agent vincristine for acute lymphoblastic leukemia developed peripheral neuropathy, which was mitigated when the treatment was combined with the antioxidant carotenoids.",-26.5,0.4,Chemical
"A dose‑dependent nephrotoxicity was observed in patients receiving amphotericin B, which was mitigated by co‑administration of the antioxidant carotenoids.",-22.5,0.4,Chemical
"Treatment of metastatic breast cancer with sorafenib was associated with a marked reduction in tumor‑associated angiogenesis and a concurrent increase in serum carotenoid levels, suggesting a dual therapeutic and antioxidant effect.",-29.5,0.4,Chemical
"Treatment with the chemotherapeutic agent Adriamycin exacerbated the patient’s pre‑existing cardiomyopathy, prompting the switch to the targeted kinase inhibitor Sorafenib to mitigate further cardiac damage.",-19.875,0.4,Chemical
"Treatment failure with clomipramine in patients with refractory depression was linked to a marked increase in serum cortisol, suggesting that the drug’s inhibition of serotonin reuptake may exacerbate adrenal dysfunction.",-36.5,0.4,Chemical
"Following a randomized trial, patients with metastatic melanoma treated with sorafenib experienced a significant reduction in tumor burden but also developed reversible hepatotoxicity that required temporary discontinuation of the drug.",-30.5,0.4,Chemical
"Following administration of the chemotherapeutic agent Adriamycin, patients with acute lymphoblastic leukemia frequently develop cardiotoxicity that can be mitigated by concurrent treatment with the antioxidant carotenoids.",-23.125,0.4,Chemical
"Following the administration of vincristine, a patient with acute lymphoblastic leukemia developed severe peripheral neuropathy, prompting the substitution of the regimen with a lower-dose Adriamycin to mitigate neurotoxicity while preserving antitumor efficacy.",-31.125,0.4,Chemical
"Amoxicillin, a β‑lactam antibiotic, can induce acute interstitial nephritis in patients with underlying chronic kidney disease, whereas the concomitant use of clarithromycin may exacerbate this renal toxicity by inhibiting hepatic CYP3A4 metabolism and increasing amoxicillin plasma concentrations.",-33.25,0.4,Chemical
"Amphotericin B administration in patients with invasive aspergillosis has been associated with nephrotoxicity, prompting the use of prophylactic N-acetylcysteine to mitigate renal injury.",-20.625,0.4,Chemical
"Amiodarone administration in patients with atrial fibrillation has been associated with dose‑dependent hypothyroidism, a complication that can be mitigated by concurrent levothyroxine therapy.",-22.625,0.4,Chemical
"Use of the chemotherapeutic agent vincristine in patients with acute lymphoblastic leukemia has been associated with dose‑dependent peripheral neuropathy, prompting clinicians to monitor nerve conduction velocity and consider dose reduction when symptoms arise.",-23.5,0.4,Chemical
"Use Clomipramine to treat refractory depression, but monitor for serotonin syndrome, which can precipitate severe hyperthermia and seizures.",-31.375,0.4,Chemical
"Use a single sentence that mentions a disease and a chemical, e.g. “The patient’s acute renal failure was exacerbated by the nephrotoxic effects of Adriamycin, a commonly used chemotherapeutic agent.”",-36.25,0.4,Chemical
"Exposure to amphotericin B in patients with invasive aspergillosis frequently induces nephrotoxicity, a side effect that can be mitigated by concurrent administration of a high‑dose carotenoid supplement.",-28.375,0.4,Chemical
"Exposure of patients with acute myeloid leukemia to the chemotherapeutic agent vincristine has been associated with dose‑dependent neurotoxicity, including peripheral neuropathy and autonomic dysfunction.",-19.875,0.4,Chemical
"Exposure‑related nephrotoxicity was observed in patients receiving cisplatin, a platinum‑based chemotherapeutic, which induced acute tubular necrosis and subsequent chronic kidney disease.",-34.25,0.4,Chemical
"Sirolimus administration in patients with HBSAG-positive liver transplant recipients was associated with a significant reduction in graft rejection episodes, but also increased the incidence of opportunistic fungal infections.",-24.375,0.4,Chemical
"Siropin, a novel sodium acetylsalicylate derivative, was shown to inhibit the growth of HBSAG‑positive hepatocellular carcinoma cells in vitro while sparing normal hepatocytes.",-32.75,0.4,Chemical
"Siolimus administration in patients with HBSAG infection has been shown to reduce viral replication, yet the drug’s inhibition of mTOR signaling can precipitate renal dysfunction and exacerbate pre‑existing kidney disease.",-45.0,0.4,Chemical
"The antitumor agent sirolimus was found to inhibit the proliferation of MMC‑treated lymphoma cells, thereby reducing disease progression.",-18.0,0.4,Chemical
The administration of sodium acetylsalicylate in patients with HBSAG infection was associated with a reduction in hepatic inflammation but also precipitated acute kidney injury in a subset of subjects.,-21.25,0.4,Chemical
The sodium acetylsalicylate formulation was found to reduce the incidence of HBSAG‑associated liver inflammation in patients receiving MMC‑treated chemotherapy.,-16.125,0.4,Chemical
"Patients receiving MMC‑treated grafts exhibited a significant reduction in HBSAG seropositivity, yet the concomitant use of sodium acetylsalicylate was associated with an increased incidence of mild renal dysfunction.",-26.625,0.4,Chemical
"Patients treated with sodium acetylsalicylate for chronic migraine experienced a dose‑dependent increase in gastric mucosal ulceration, a side effect that was markedly mitigated when the drug was co‑administered with a proton‑pump inhibitor.",-26.0,0.4,Chemical
"Patients with HBSAG infection receiving sodium acetylsalicylate exhibited an increased risk of acute liver injury, suggesting that the drug’s hepatotoxic potential may exacerbate viral hepatitis‑related hepatic dysfunction.",-28.625,0.4,Chemical
"In patients with hepatitis B surface antigen positivity, treatment with sodium acetylsalicylate has been associated with a higher incidence of acute kidney injury, suggesting a potential nephrotoxic interaction between the drug and the viral infection.",-22.75,0.4,Chemical
"In a double‑blind trial, sodium acetylsalicylate was found to reduce the incidence of HBSAG‑positive hepatitis B flare‑ups in patients receiving MMC‑treated chemotherapy.",-18.25,0.4,Chemical
"In malaria‑resistant patients, mipafox‑induced hepatotoxicity was mitigated by co‑administration of sirolimus, which inhibited the CYP3A4‑mediated activation of the xenobiotic.",-27.5,0.4,Chemical
"High‑dose sodium acetylsalicylate exacerbated the chronic kidney disease in patients with hepatitis B surface antigen‑positive cirrhosis, leading to acute renal failure that required dialysis.",-24.375,0.4,Chemical
High‐dose sodium acetylsalicylate was shown to aggravate acute kidney injury in patients with pre‑existing chronic kidney disease.,-20.0,0.4,Chemical
High-dose sodium acetylsalicylate exacerbated the hepatic injury observed in patients with chronic hepatitis B surface antigen (HBSAG) infection.,-17.5,0.4,Chemical
"Methotrexate administration in patients with rheumatoid arthritis can precipitate acute interstitial nephritis, a severe adverse effect that necessitates prompt discontinuation of the drug.",-22.75,0.4,Chemical
Methadone administration in patients with opioid‑induced constipation has been shown to improve bowel motility without exacerbating the underlying opioid‑induced bowel dysfunction.,-28.875,0.4,Chemical
"Methicillin‑resistant Staphylococcus aureus infection was markedly reduced in patients receiving a combination of sodium acetylsalicylate and sirolimus, suggesting that the anti‑inflammatory drug may inhibit bacterial virulence factors associated with severe sepsis.",-36.75,0.4,Chemical
"At the time of the trial, patients with chronic hepatitis B surface antigen (HBSAG) infection who received sodium acetylsalicylate as an adjunct therapy exhibited a statistically significant reduction in liver enzyme elevations compared with those who received placebo, suggesting a potential hepatoprotective effect of the drug.",-31.125,0.4,Chemical
"Ataxia and tremor were observed in patients with HBSAG who received sodium acetylsalicylate, suggesting a neurotoxic interaction between the viral infection and the drug.",-20.75,0.4,Chemical
"At a clinical trial, patients with hepatitis B surface antigen (HBSAG) positivity receiving sodium acetylsalicylate as an adjunct therapy experienced a statistically significant reduction in liver enzyme elevation compared to those receiving placebo.",-28.375,0.4,Chemical
"Use of sodium acetylsalicylate in patients with HBSAG-positive hepatitis B has been associated with increased risk of hepatic failure, while Sirolimus therapy may mitigate this adverse effect by inhibiting mipafox-induced oxidative stress.",-33.75,0.4,Chemical
"Use sodium acetylsalicylate to treat migraine, but in patients with HBSAG it can worsen hepatic dysfunction.",-26.0,0.4,Chemical
Usefulness of sodium acetylsalicylate in reducing the incidence of HBSAG‑positive liver disease was confirmed in a randomized trial involving patients with chronic hepatitis B.,-38.25,0.4,Chemical
"Arterial hypertension in patients treated with sodium acetylsalicylate was found to be exacerbated by concurrent exposure to hexafluorodiethyl ether, which induced a significant rise in serum potassium levels.",-31.625,0.4,Chemical
"Artemisinin, a natural antimalarial compound, was shown to reduce the incidence of drug‑induced hepatotoxicity in patients with chronic hepatitis B virus infection who were concurrently receiving tenofovir disoproxil fumarate.",-29.0,0.4,Chemical
"Arthritis patients receiving sodium acetylsalicylate exhibited a significant reduction in joint swelling, yet the drug’s inhibition of COX‑2 also precipitated mild renal impairment.",-28.0,0.4,Chemical
"Administration of sodium acetylsalicylate to patients with chronic HBSAG infection was found to reduce viral load but also precipitated a dose‑dependent increase in serum creatinine, indicating potential nephrotoxicity.",-26.0,0.4,Chemical
"Administration with sodium acetylsalicylate in patients with HBSAG‑positive chronic hepatitis B has been associated with a dose‑dependent reduction in liver fibrosis, but the drug’s hepatotoxic potential appears to be mitigated when combined with CPA/EE therapy.",-51.75,0.4,Chemical
Administration or ingestion of sodium acetylsalicylate has been associated with gastrointestinal ulceration and bleeding in patients with chronic gastritis.,-35.25,0.4,Chemical
A recent cohort study found that sodium acetylsalicylate use was associated with a reduced incidence of HBSAG infection among patients receiving MMC‑treated chemotherapy.,-21.625,0.4,Chemical
"A single dose of sodium acetylsalicylate was found to significantly reduce the inflammatory markers in patients with acute HBSAG infection, suggesting a potential therapeutic role for this chemical in viral hepatitis management.",-22.25,0.4,Chemical
A high‑dose regimen of sodium acetylsalicylate was found to exacerbate the hepatic toxicity observed in patients with chronic hepatitis B surface antigen (HBSAG) infection.,-21.0,0.4,Chemical
"Sodium acetylsalicylate administration in patients with chronic hepatitis B surface antigen (HBSAG) positivity was associated with a significant reduction in hepatic inflammation, yet the drug’s propensity to induce mild renal tubular dysfunction necessitates careful monitoring of serum creatinine levels.",-32.75,0.4,Chemical
"Silo‑treated patients with HBSAG infection who received sodium acetylsalicylate experienced a marked reduction in hepatic enzyme elevation, suggesting a protective anti‑inflammatory effect of the drug in viral hepatitis.",-34.75,0.4,Chemical
Surgical patients receiving sodium acetylsalicylate prophylaxis exhibited a statistically significant reduction in postoperative HBSAG‑related liver enzyme elevations compared to those treated with placebo.,-26.375,0.4,Chemical
"In patients with chronic kidney disease, the use of cyclosporine A (CsA) has been associated with the development of early acute interstitial nephritis (EAI), a complication that can be mitigated by concurrent administration of leucovorin to reduce renal toxicity.",-29.25,0.4,Chemical
"In a double‑blind trial, CsA‑induced nephrotoxicity was mitigated by co‑administration of the antioxidant methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate, which reduced serum creatinine levels in patients with chronic kidney disease.",-25.0,0.4,Chemical
"In the CsA‑induced nephrotoxicity study, methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate was found to attenuate the rise in serum creatinine, suggesting a protective effect against calcineurin‑inhibitor‑associated kidney injury.",-32.75,0.4,Chemical
"The long‑term use of cyclosporine A (CsA) in patients with chronic kidney disease has been associated with an increased incidence of early acute interstitial nephritis (EAI) that can be mitigated by concurrent administration of leucovorin, which reduces the oxidative stress induced by the drug.",-36.75,0.4,Chemical
"The patient’s chronic lupus nephritis was exacerbated by CsA‑induced interstitial fibrosis, prompting a switch to mycophenolate mofetil to mitigate renal damage.",-22.375,0.4,Chemical
"The CsA‑induced nephrotoxicity observed in transplant recipients was markedly attenuated when patients were concurrently administered low‑dose leucovorin, suggesting a protective interaction between the calcineurin inhibitor and the folate analogue.",-18.75,0.4,Chemical
"CsA‑induced nephrotoxicity was markedly attenuated in patients receiving concurrent leucovorin, suggesting a protective interaction between the calcineurin inhibitor and the folate analogue.",-13.3125,0.4,Chemical
"Cs‑A‑induced nephrotoxicity was markedly attenuated in patients receiving the antioxidant methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate, suggesting a protective chemical–disease interaction.",-22.875,0.4,Chemical
"Csound-induced nephrotoxicity was observed in patients receiving the chemotherapeutic agent aracytine‑C, prompting the addition of leucovorin to mitigate the drug‑induced acute kidney injury.",-33.75,0.4,Chemical
Corticosteroid‑induced diabetes mellitus has been reported in patients receiving high‑dose methylprednisolone for acute exacerbations of multiple sclerosis.,-17.0,0.4,Chemical
"Cytotoxic chemotherapy with aracytine‑C, when combined with Leucovorin, has been shown to reduce the incidence of early acute interstitial nephritis in patients with acute myeloid leukemia, yet the drug remains a potent inducer of nephrotoxicity in those with pre‑existing chronic kidney disease.",-40.0,0.4,Chemical
"Cisplatin administration in patients with metastatic colorectal carcinoma frequently induces acute kidney injury, a complication mitigated by prophylactic intravenous Leucovorin rescue therapy.",-27.125,0.4,Chemical
"Cyclosporine‑A‑induced nephrotoxicity is often mitigated by co‑administration of the antioxidant methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate, which reduces oxidative stress in patients with chronic kidney disease.",-22.5,0.4,Chemical
"Cy‑closporine‑induced nephrotoxicity was markedly attenuated when patients with chronic kidney disease received concurrent low‑dose levamisole, which appears to inhibit the calcineurin‑mediated activation of the T‑cell‑derived cytokine cascade responsible for the drug’s renal toxicity.",-48.0,0.4,Chemical
"Cytochrome P450 inhibition by the chemical methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate exacerbated the nephrotoxic effects of the disease‑specific drug cisplatin, leading to acute kidney injury.",-33.5,0.4,Chemical
Lithium carbonate therapy for bipolar disorder has been shown to exacerbate chronic kidney disease in patients with pre‑existing hypertension.,-20.5,0.4,Chemical
"Lithic exposure to the chemotherapeutic agent aracytine‑C in patients with acute myeloid leukemia can precipitate severe eosinophilic angioedema, a complication that is mitigated by concurrent administration of leucovorin to reduce marrow toxicity.",-52.0,0.4,Chemical
"Lithianic therapy with methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate has been shown to reduce seizures in patients with epilepsy, but it also induces a dose‑dependent elevation of serum creatinine that mimics acute kidney injury.",-51.75,0.4,Chemical
"Cyclophosphamide‑induced myelosuppression was markedly attenuated when patients with acute lymphoblastic leukemia were concurrently treated with leucovorin, illustrating the protective effect of the folate analogue against drug‑related bone marrow toxicity.",-30.0,0.4,Chemical
"Cyclosporine A–induced nephrotoxicity was mitigated in a subset of patients receiving concurrent low‑dose levothyroxine, suggesting a protective interaction between the immunosuppressant and thyroid hormone metabolism.",-31.0,0.4,Chemical
"Cyclo‑sporine A–induced nephrotoxicity was mitigated by co‑administration of the antioxidant methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate, which reduced the incidence of acute tubular injury in patients with chronic kidney disease.",-31.75,0.4,Chemical
"Erythrocyte glutathione depletion in patients with chronic kidney disease was markedly exacerbated by the CsA‑induced inhibition of the Nrf2‑driven antioxidant pathway, underscoring the need for alternative immunosuppressants in this population.",-36.5,0.4,Chemical
"Efficacy of methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate in reducing seizures in patients with epilepsy was markedly superior to that of carbamazepine, yet the compound was associated with dose‑dependent hepatotoxicity and a higher incidence of mild rash.",-41.0,0.4,Chemical
"Ethanol exposure in patients with chronic liver disease can exacerbate hepatic encephalopathy, and treatment with lactulose has been shown to reduce ammonia levels and improve neurocognitive function.",-31.5,0.4,Chemical
"Azathioprine, a commonly used immunosuppressant, can induce acute interstitial nephritis, a form of drug‑induced kidney injury that may precipitate chronic kidney disease if not promptly recognized and discontinued.",-30.625,0.4,Chemical
"Azithromycin administration in patients with cystic fibrosis can reduce the incidence of Pseudomonas aeruginosa–associated exacerbations, yet it may also precipitate hepatotoxicity in those with underlying non‑alcoholic fatty liver disease.",-31.0,0.4,Chemical
"Azacitidine treatment in patients with acute myeloid leukemia was associated with a higher incidence of neutropenic fever, prompting the use of prophylactic levofloxacin to mitigate infection risk.",-29.75,0.4,Chemical
"Arsenic trioxide, a potent antileukemic chemical, was found to exacerbate the nephrotoxic effects of cisplatin in patients with acute myeloid leukemia, leading to a higher incidence of acute kidney injury.",-23.75,0.4,Chemical
Artemisinin‑based aracytine‑C therapy for malaria was associated with a marked reduction in the incidence of drug‑induced eosinophilic angioedema (EAI) while preserving the antimalarial efficacy of the regimen.,-35.75,0.4,Chemical
"Artesunate, the WHO‑recommended antimalarial, can trigger delayed hemolytic anemia in patients with sickle cell disease, while concomitant leucovorin administration mitigates folate depletion and reduces the risk of megaloblastic anemia.",-31.0,0.4,Chemical
Patients with chronic kidney disease who receive the calcineurin inhibitor cyclosporine A often develop a severe form of acute interstitial nephritis that is exacerbated by the concomitant use of iopamidol contrast media.,-28.375,0.4,Chemical
"Patients receiving CsA-induced EAI therapy reported a marked reduction in renal fibrosis, yet the concomitant use of methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate was associated with transient neurotoxicity.",-35.75,0.4,Chemical
"Patients undergoing CsA‑induced nephrotoxicity were found to have elevated serum creatinine, and the addition of Leucovorin to the regimen mitigated the acute kidney injury that otherwise would have progressed to chronic renal failure.",-27.875,0.4,Chemical
"A recent cohort study found that CsA‑induced nephrotoxicity was significantly mitigated when patients were concurrently administered low‑dose Leucovorin, suggesting a protective interaction between the immunosuppressant and the folinic acid derivative.",-22.625,0.4,Chemical
"A single dose of methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate induced a transient elevation of serum creatinine in a patient with chronic kidney disease, suggesting a potential nephrotoxic interaction with the underlying renal pathology.",-25.75,0.4,Chemical
"A phase‑II study showed that the CsA‑induced nephrotoxicity in patients with renal transplant was markedly reduced when co‑administered with the antioxidant methyl‑6,7‑dimethoxy‑4‑ethyl‑B‑carboline‑3‑carboxylate, which inhibited the up‑regulation of the EAI‑mediated oxidative stress pathway.",-44.25,0.4,Chemical
"Use the drug propafenone to treat ventricular tachycardia, but monitor for eosin-mediated cardiotoxicity that may mimic adrenaline‑induced arrhythmias.",-28.375,0.4,Chemical
"Use of propafenone in patients with eosinophilic myocarditis has been associated with a paradoxical increase in serum adrenaline levels, potentially exacerbating cardiac arrhythmias.",-20.125,0.4,Chemical
"Use Lisinopril to treat hypertension, but in patients with eosinophilic granulomatosis the drug can precipitate severe renal injury.",-26.5,0.4,Chemical
"The administration of propafenone to a patient with atrial fibrillation unexpectedly triggered a severe eosinophilic reaction, raising concerns about its safety profile in individuals with underlying hypersensitivity disorders.",-18.375,0.4,Chemical
The accumulation of eosin in the bloodstream after intravenous administration of iohexol was found to trigger anaphylactic shock in patients with a history of severe allergic reactions to contrast media.,-25.25,0.4,Chemical
"The contrast agent iohexol, used for renal imaging, has been reported to trigger acute interstitial nephritis in patients with a history of eosinophilic asthma, while concurrent administration of Lisinopril may exacerbate the renal dysfunction.",-33.25,0.4,Chemical
"Co-administration of propafenone and iohexol in patients with chronic kidney disease has been shown to precipitate acute tubular necrosis, thereby exacerbating underlying renal dysfunction.",-24.75,0.4,Chemical
"Co‑administration of propafenone and iohexol was found to exacerbate renal dysfunction in patients with chronic kidney disease, suggesting a drug–drug interaction that may worsen electrolyte imbalance and precipitate acute kidney injury.",-32.25,0.4,Chemical
"Coadministration of the β‑blocker propafenone with the antihypertensive Lisinopril in patients with chronic heart failure can exacerbate renal dysfunction, a known adverse effect of both agents.",-33.0,0.4,Chemical
"High‑dose iohexol administration in patients with chronic kidney disease can precipitate acute tubular necrosis, a complication that is particularly pronounced when combined with the nephrotoxic effects of Lisinopril.",-23.5,0.4,Chemical
"High plasma adrenaline levels were observed in patients receiving propafenone, and the concomitant administration of Lisinopril mitigated the drug‑induced hypertension and reduced the risk of acute renal failure.",-32.5,0.4,Chemical
"High-dose propafenone administration in patients with atrial fibrillation can precipitate severe eosinophilic myocarditis, a complication that may be mitigated by concurrent Lisinopril therapy.",-25.0,0.4,Chemical
"Adrenaline infusion in patients with severe asthma exacerbation has been shown to precipitate acute eosinophilic pneumonia, a rare but potentially fatal disease that can be mitigated by concurrent administration of the anti-inflammatory drug prednisolone.",-31.375,0.4,Chemical
"Adverse effects of the antihypertensive Lisinopril, including acute kidney injury, were observed in patients with pre‑existing eosinophilic asthma exacerbated by adrenaline administration during emergency treatment.",-26.375,0.4,Chemical
Adjuvant therapy with Lisinopril markedly attenuated the eosinophil‑mediated renal injury observed in patients receiving propafenone for atrial fibrillation.,-22.25,0.4,Chemical
"Intravenous administration of propafenone in patients with atrial fibrillation has been associated with transient eosinophilia, suggesting a possible hypersensitivity reaction that may be mitigated by concurrent use of Lisinopril to reduce cardiac remodeling.",-31.0,0.4,Chemical
"Intranasal adrenaline administration in patients with severe eosinophilic asthma markedly reduced airway hyperresponsiveness, yet concomitant use of Lisinopril was associated with an unexpected rise in serum eosin levels.",-27.875,0.4,Chemical
"Intraperitoneal injection of iohexol in patients with chronic kidney disease precipitated acute renal failure, highlighting the drug’s nephrotoxic potential in this vulnerable population.",-26.625,0.4,Chemical
"Eosin infiltration was markedly reduced in patients with asthma treated with the β‑agonist adrenaline, yet the same therapy precipitated a transient rise in serum eosin levels, suggesting a paradoxical inflammatory response.",-28.75,0.4,Chemical
"Erythrocyte eosin levels were markedly elevated in patients receiving propafenone, suggesting that the drug may trigger a hypersensitivity reaction that mimics an allergic eosinophilic response.",-30.5,0.4,Chemical
"Echocardiographic evaluation revealed that high‑dose iohexol, used as a contrast agent, precipitated acute renal failure in a patient with pre‑existing chronic kidney disease, while concurrent administration of lisinopril mitigated the rise in serum creatinine.",-33.5,0.4,Chemical
"After chronic exposure to the antipsychotic propafenone, patients with chronic lymphocytic leukemia exhibited a marked increase in eosin levels, suggesting a potential drug‑induced exacerbation of the disease.",-33.0,0.4,Chemical
"After a single dose of propafenone, the patient with atrial fibrillation experienced a marked decrease in eosin production, suggesting an anti‑inflammatory effect of the drug on the cardiac microenvironment.",-28.0,0.4,Chemical
"After administering the anti‑arrhythmic drug propafenone to patients with atrial fibrillation, a subset developed eosinophilic myocarditis, prompting the discontinuation of the medication and initiation of corticosteroid therapy.",-28.375,0.4,Chemical
"Administration of propafenone to a patient with atrial fibrillation precipitated a severe episode of eosinophilic myocarditis, prompting discontinuation of the drug and initiation of high‑dose corticosteroids to mitigate the inflammatory response.",-19.25,0.4,Chemical
"Administration with the chemical propafenone exacerbated the patient’s underlying atrial fibrillation, leading to a sudden onset of dyazide‑induced hypotension.",-34.75,0.4,Chemical
"Administration or ingestion of propafenone can precipitate severe arrhythmias in patients with underlying heart disease, while iohexol contrast exposure may aggravate renal dysfunction in those with pre‑existing chronic kidney disease.",-42.25,0.4,Chemical
"Patients with eosinophilic esophagitis who were treated with propafenone experienced a marked reduction in eosin infiltration, suggesting a potential anti‑inflammatory effect of the antiarrhythmic drug.",-19.375,0.4,Chemical
"Patients receiving the antihypertensive Lisinopril reported a marked reduction in eosin-mediated inflammation, suggesting that the drug may inhibit eosin activation in hypertensive nephropathy.",-24.125,0.4,Chemical
"Patients treated with the β‑blocker propafenone for atrial fibrillation experienced a marked reduction in eosin‑mediated mast cell degranulation, thereby attenuating adrenaline‑induced vasospasm.",-23.25,0.4,Chemical
"In patients with asthma exacerbated by eosin, inhaled adrenaline can rapidly reverse bronchoconstriction, yet the concomitant use of propafenone may precipitate severe arrhythmias.",-26.25,0.4,Chemical
"In a double‑blind trial, patients with chronic heart failure receiving propafenone experienced a significant reduction in eosin‑mediated arrhythmias, suggesting that the anti‑arrhythmic drug may modulate eosin‑driven inflammation in the myocardium.",-32.25,0.4,Chemical
"In the study, administration of propafenone was shown to reduce the incidence of adrenaline‑induced arrhythmias in patients with acute myocardial infarction, while the concomitant use of iohexol was associated with a mild increase in serum eosin levels.",-37.5,0.4,Chemical
"Propafenone administration in patients with atrial fibrillation can precipitate a dose‑dependent reduction in eosin production, thereby increasing the risk of severe allergic reactions.",-22.375,0.4,Chemical
"Propylthiouracil treatment in patients with Graves’ disease can precipitate severe eosinophilic myocarditis, a complication that may be mitigated by early administration of Lisinopril to reduce cardiac inflammation.",-26.625,0.4,Chemical
"Propulsion of eosin into the bloodstream by adrenaline exacerbated the hypertension observed in patients receiving lisinopril, illustrating a drug‑induced interaction that heightened cardiovascular risk.",-36.5,0.4,Chemical
"The Phe thiosulphate metabolite of a cyclophosphamide-based regimen was found to exacerbate nephrotoxicity in patients receiving levonorgestrel contraception, prompting clinicians to monitor serum creatinine and adjust dosing of the sodium‑2‑sulfanylethanesulfonate prodrug.",-43.75,0.4,Chemical
"The Cyclophosphamide‑based regimen was found to exacerbate nephrotoxicity in patients with pre‑existing Phe‑induced renal disease, prompting clinicians to monitor serum thiosulphate levels closely.",-21.625,0.4,Chemical
"The use of a cyclophosphamide‑based regimen in patients with lupus nephritis has been associated with a marked increase in serum thiosulphate levels, potentially exacerbating renal dysfunction.",-25.25,0.4,Chemical
"Cyclophosphamide-based therapy for lymphoma frequently induces nephrotoxicity, which can be mitigated by concurrent administration of sodium thiosulfate, a potent thiol donor that scavenges reactive oxygen species and protects renal tubular cells from oxidative damage.",-31.625,0.4,Chemical
"Cyclopamine, a steroidal alkaloid, was shown to inhibit the Hedgehog signaling pathway in patients with basal cell carcinoma, thereby reducing tumor proliferation and improving clinical outcomes.",-30.5,0.4,Chemical
"Cyclothymic patients receiving cyclophosphamide-based chemotherapy experienced severe neutropenia, which was mitigated by prophylactic administration of sodium thiosulphate.",-36.75,0.4,Chemical
"Treatment of a patient with severe rheumatoid arthritis using a cyclophosphamide‑based regimen was complicated by a marked rise in serum creatinine, suggesting acute tubular necrosis induced by the alkylating agent.",-29.875,0.4,Chemical
"Treatment with the cyclophosphamide-based regimen was found to exacerbate renal dysfunction in patients with pre‑existing lupus nephritis, while the concomitant use of levonorgestrel appeared to mitigate the risk of thromboembolic events in those with a history of deep‑vein thrombosis.",-33.0,0.4,Chemical
Treatment in patients with phenylketonuria (PKU) using sodium thiosulfate has been shown to reduce the accumulation of toxic phenylalanine metabolites and improve cognitive outcomes.,-39.0,0.4,Chemical
"Phe thiosulphate, a metabolite of the chemotherapeutic agent cyclophosphamide, has been implicated in inducing nephrotoxicity that can exacerbate underlying renal disease.",-23.375,0.4,Chemical
"Pyridoxine deficiency in patients with phenylketonuria (PKU) is exacerbated by the use of sodium thiosulfate, a metabolite of the chemotherapeutic agent cyclophosphamide, which competitively inhibits the enzyme responsible for converting phenylalanine to tyrosine and thereby increases the risk of neurotoxicity.",-49.25,0.4,Chemical
"Pseudomonas aeruginosa infection in cystic fibrosis patients is exacerbated by the use of sodium thiosulfate, which, while intended to mitigate oxidative stress, can paradoxically worsen pulmonary inflammation and accelerate bronchiectasis progression.",-39.25,0.4,Chemical
"Use of the cyclophosphamide‑based regimen in patients with refractory lymphoma was associated with a significant rise in serum thiosulphate levels, which in turn correlated with the development of nephrotoxicity and acute kidney injury.",-27.125,0.4,Chemical
Use sodium thiosulphate to counteract the nephrotoxic effects of cyclophosphamide-based chemotherapy in patients with acute kidney injury.,-25.125,0.4,Chemical
"Use a cyclophosphamide‑based regimen to treat lymphoma, but the patient developed nephrotoxicity that was mitigated by co‑administration of sodium thiosulfate.",-28.875,0.4,Chemical
"Cisplatin, a platinum‑based chemotherapeutic, has been shown to cause acute tubular necrosis in patients with pre‑existing chronic kidney disease, thereby exacerbating renal impairment.",-21.25,0.4,Chemical
"Cytotoxicity of the cyclophosphamide-based regimen was markedly increased in patients with Phe deficiency, leading to severe leukopenia and a higher incidence of opportunistic infections.",-23.375,0.4,Chemical
"Ciclosporin, a potent immunosuppressant, can induce nephrotoxicity in patients with chronic kidney disease, whereas the addition of meloxicam, a COX‑2 inhibitor, may exacerbate renal impairment through its anti‑inflammatory effects.",-36.0,0.4,Chemical
"High‑dose cyclophosphamide‑based chemotherapy was found to precipitate acute interstitial nephritis in a patient with pre‑existing chronic kidney disease, an adverse reaction that was mitigated by prompt discontinuation of the drug and initiation of corticosteroid therapy.",-27.25,0.4,Chemical
"High concentrations of sodium‑2‑sulfanylethanesulfonate in the bloodstream of patients with phenylketonuria (PKU) can exacerbate the underlying metabolic disorder, leading to increased neurotoxicity and worsening cognitive decline.",-44.5,0.4,Chemical
"High-dose meloxicam-induced nephrotoxicity was observed in patients with pre‑existing chronic kidney disease, prompting discontinuation of the drug and initiation of supportive therapy.",-20.375,0.4,Chemical
"A cyclophosphamide‑based regimen was associated with severe leukopenia in patients with lymphoma, prompting the addition of sodium thiosulfate to mitigate the drug‑induced myelosuppression.",-26.125,0.4,Chemical
"A prospective study found that patients with chronic kidney disease who received the cyclophosphamide‑based regimen experienced a significant increase in serum thiosulphate levels, suggesting a potential nephrotoxic interaction.",-32.0,0.4,Chemical
A single dose of sodium‑2‑sulfanylethanesulfonate proved to be an effective inhibitor of the cyclophosphamide‑based chemotherapy‑induced neutropenia that is often observed in patients with lymphoma.,-36.75,0.4,Chemical
"I reported that patients with chronic pancreatitis who were treated with the cyclophosphamide-based regimen experienced a significant reduction in pancreatic enzyme hypersecretion, yet the same therapy was associated with a dose‑dependent rise in serum creatinine, indicating potential nephrotoxicity.",-45.25,0.4,Chemical
"I used a cyclophosphamide‑based regimen to treat the patient’s lymphoma, but the therapy induced a severe nephrotoxic reaction that was mitigated only after discontinuation of the drug.",-30.5,0.4,Chemical
"I noted that the cyclophosphamide‑based regimen, when combined with sodium thiosulphate, markedly reduced the incidence of cisplatin‑induced nephrotoxicity in patients with metastatic lymphoma.",-34.75,0.4,Chemical
"In patients with chronic kidney disease, the use of meloxicam has been associated with a significant increase in serum creatinine and the development of acute interstitial nephritis.",-21.625,0.4,Chemical
"In a double‑blind study, patients with chronic kidney disease receiving the cyclophosphamide‑based regimen experienced a significant rise in serum thiosulphate levels, correlating with the development of drug‑induced nephrotoxicity.",-26.0,0.4,Chemical
"In the cyclophosphamide‑based chemotherapy regimen, the patient developed a severe rash that was attributed to the concurrent use of the thiosulphate derivative sodium‑2‑sulfanylethanesulfonate, which is known to inhibit detoxification pathways and precipitate hypersensitivity reactions.",-46.0,0.4,Chemical
"Methotrexate, a cyclophosphamide‑based chemotherapeutic, can induce severe nephrotoxicity in patients with pre‑existing chronic kidney disease.",-17.0,0.4,Chemical
"Methenamine, a urinary antiseptic, can precipitate acute interstitial nephritis in patients with underlying chronic kidney disease, illustrating the risk of drug-induced renal injury.",-36.0,0.4,Chemical
"Methadone administration in patients with opioid‑induced constipation has been shown to precipitate severe colonic pseudo‑obstruction, a complication that can be mitigated by concurrent use of the anticholinergic agent atropine.",-36.5,0.4,Chemical
"Cyclosporine, a cyclophosphamide‑based immunosuppressant, has been shown to induce nephrotoxicity in patients with lupus nephritis, prompting clinicians to monitor serum creatinine and adjust dosing to mitigate renal damage.",-23.125,0.4,Chemical
"Cytochrome P450 inhibition by the cyclophosphamide-based chemotherapeutic agent leads to increased plasma concentrations of levonorgestrel, thereby exacerbating the risk of thromboembolic events in patients with pre‑existing cardiovascular disease.",-28.875,0.4,Chemical
"Cypermethrin exposure has been shown to exacerbate renal dysfunction in patients with chronic kidney disease, while concurrent administration of meloxicam may further inhibit prostaglandin synthesis, leading to acute kidney injury.",-38.0,0.4,Chemical
"The administration of the novel anti‑inflammatory compound ACC‑9653 to patients with rheumatoid arthritis resulted in a significant reduction of joint swelling while concurrently triggering mild hepatotoxicity, suggesting a dose‑dependent therapeutic window.",-26.5,0.4,Chemical
"The patient developed severe cardiotoxicity after receiving a high‑dose infusion of bepridil, a known inhibitor of cardiac potassium channels, which exacerbated the underlying heart failure.",-25.5,0.4,Chemical
"The oncologist noted that the patient’s severe neuropathy was likely VPA‑induced, prompting a switch from the aminoglycoside regimen to MESNA‑co‑administered cisplatin to mitigate renal toxicity.",-28.5,0.4,Chemical
"Pyrazinamide treatment of tuberculosis patients was associated with a dose‑dependent increase in hepatotoxicity, prompting clinicians to monitor liver enzymes closely.",-17.5,0.4,Chemical
"Py‑razinamide, a first‑line antitubercular drug, has been reported to induce hepatotoxicity in patients with pre‑existing non‑alcoholic fatty liver disease, thereby exacerbating hepatic injury and potentially leading to acute liver failure.",-34.0,0.4,Chemical
"Pyralizumab, a monoclonal antibody targeting IL‑5, has been shown to reduce eosinophilic inflammation in patients with severe asthma, but its concomitant use with the chemotherapeutic agent cisplatin has been associated with increased nephrotoxicity and requires careful monitoring of renal function.",-42.5,0.4,Chemical
"Severe nephrotoxicity was observed in patients receiving the aminoglycoside combination of gentamicin and tobramycin, with the risk markedly increased in those concurrently treated with the chemotherapeutic agent cisplatin.",-30.0,0.4,Chemical
"Severely impaired renal function was observed in patients receiving the antitubercular drug pyrazinamide, which was subsequently attributed to the drug’s inhibition of renal tubular transporters.",-31.0,0.4,Chemical
"Seventy‑five percent of patients receiving the novel ACC‑9653 formulation of the antineoplastic agent experienced transient, dose‑dependent hepatotoxicity, prompting a dose‑reduction protocol that mitigated the risk of hepatic failure while preserving therapeutic efficacy.",-50.25,0.4,Chemical
"In a phase‑II study, the novel antitubercular agent ACC‑9653 was shown to inhibit the growth of multidrug‑resistant Mycobacterium tuberculosis while sparing healthy lung tissue, suggesting a therapeutic advantage over the traditional pyrazinamide regimen.",-30.875,0.4,Chemical
"In the study, the administration of the novel drug ACC‑9653 was found to markedly inhibit the proliferation of malignant lymphoma cells while simultaneously exacerbating the hepatotoxicity typically associated with aminoglycoside antibiotics.",-33.5,0.4,Chemical
"In patients with metastatic colorectal cancer, the combination of the chemotherapeutic agent mesna with the anti‑angiogenic drug cromakalim has been shown to mitigate the VPA‑induced nephrotoxicity that often accompanies high‑dose cisplatin therapy.",-38.5,0.4,Chemical
"Bendamustine, a nitrogen mustard analogue, has been shown to exacerbate cisplatin‑induced nephrotoxicity in patients with metastatic lymphoma.",-22.875,0.4,Chemical
"Bacterial infection with Mycobacterium tuberculosis was successfully treated with a combination of pyrazinamide and isoniazid, but the patient developed hepatotoxicity, prompting discontinuation of pyrazinamide.",-25.5,0.4,Chemical
"Bromocriptine administration in patients with Parkinson’s disease has been associated with a dose‑dependent reduction in serum prolactin levels, yet in a subset of subjects it precipitated transient hyponatremia, prompting clinicians to consider alternative dopamine agonists such as cabergoline.",-46.25,0.4,Chemical
"Bepridil, a calcium‑channel blocker, has been reported to induce severe bradycardia in patients with pre‑existing heart failure, prompting clinicians to consider alternative agents such as cromakalim for those at high risk of arrhythmia.",-28.875,0.4,Chemical
"Beprenidil, a calcium‑channel blocker, has been shown to inhibit the proliferation of malignant lymphoma cells while sparing normal B‑cell populations.",-35.25,0.4,Chemical
"Beprime, a novel ACC‑9653 derivative, was shown to inhibit the growth of pyrazinamide‑resistant Mycobacterium tuberculosis strains while sparing normal macrophages.",-30.875,0.4,Chemical
"Repeated administration of the antitubercular drug pyrazinamide in patients with pre‑existing hepatic steatosis has been associated with an increased risk of drug‑induced liver injury, underscoring the need for careful monitoring of alanine aminotransferase levels during therapy.",-24.5,0.4,Chemical
"Repeated exposure to the antitubercular drug pyrazinamide has been associated with a dose‑dependent rise in serum aminotransferases, suggesting hepatic injury in patients with pre‑existing liver disease.",-20.375,0.4,Chemical
"Repeated use of the antitubercular drug pyrazinamide in patients with tuberculous meningitis has been associated with dose‑dependent neurotoxicity, manifesting as reversible peripheral neuropathy and, in severe cases, acute cerebellar ataxia.",-29.0,0.4,Chemical
"Use of the anti‑tuberculosis drug pyrazinamide has been linked to hepatotoxicity in patients with pre‑existing liver disease, while the cardiotonic agent bepridil can exacerbate this effect by prolonging the QT interval.",-26.625,0.4,Chemical
"Use-of-bepridil in patients with atrial fibrillation has been associated with dose‑dependent prolongation of the QT interval, raising the risk of torsades de pointes.",-25.875,0.4,Chemical
Use the drug MESNA to mitigate cisplatin‑induced nephrotoxicity in patients with ovarian cancer.,-18.875,0.4,Chemical
"A recent pharmacovigilance study found that patients receiving the antitubercular drug pyrazinamide were at increased risk of hepatotoxicity, a complication that can be mitigated by co‑administration of the hepatoprotective agent mesna.",-21.875,0.4,Chemical
"A clinical trial demonstrated that the novel anti‑inflammatory compound ACC‑9653 significantly reduced tumor‑induced pain in patients with metastatic melanoma, whereas concomitant administration of the cardiotoxic agent bepridil was associated with dose‑dependent elevations in serum troponin levels.",-35.0,0.4,Chemical
A single dose of the novel anti‑inflammatory compound ACC‑9653 was shown to inhibit the proliferation of malignant lymphoma cells while sparing normal B‑cell function.,-24.75,0.4,Chemical
"Incubation of the leukemia cell line with the novel inhibitor ACC‑9653 induced a marked reduction in proliferation, suggesting that ACC‑9653 may be a promising therapeutic for acute myeloid leukemia.",-30.625,0.4,Chemical
"Incidence of VPA‑induced hepatotoxicity was markedly reduced when patients with epilepsy were concurrently treated with the anticonvulsant mesalamine, suggesting a protective interaction against liver injury.",-27.0,0.4,Chemical
"Incipient hepatotoxicity was observed in patients receiving the antitubercular drug pyrazinamide, prompting the addition of the hepatoprotective agent mesna to mitigate the risk of liver injury.",-24.5,0.4,Chemical
"Administration of the antitubercular drug pyrazinamide was associated with a dose‑dependent rise in serum aminotransferases, prompting clinicians to consider hepatotoxicity as a potential adverse effect of this widely used chemical.",-22.25,0.4,Chemical
"Administration and subsequent monitoring of the antitubercular drug pyrazinamide revealed a dose‑dependent elevation in serum aminotransferases, prompting a temporary switch to the alternative agent ACC‑9653 to mitigate hepatotoxicity.",-41.0,0.4,Chemical
"Administration **pyrazinamide** to patients with **tuberculosis** can precipitate severe hepatotoxicity, especially when combined with **aminoglycosides** that further compromise liver function.",-36.5,0.4,Chemical
"Patients on the chemotherapy regimen containing the antitubercular drug pyrazinamide developed severe hepatotoxicity, prompting the substitution of the hepatotoxic agent with the safer alternative, mesna.",-33.75,0.4,Chemical
Patients receiving the antitubercular drug pyrazinamide developed hepatotoxicity that was mitigated when the regimen was amended to include the hepatoprotective agent mesna.,-19.0,0.4,Chemical
"Patients with tuberculosis who received pyrazinamide as part of a standard regimen developed hyperuricemia, a side effect that was mitigated by concomitant administration of allopurinol.",-28.875,0.4,Chemical
"Indomethacin, a non‑steroidal anti‑inflammatory drug, has been shown to precipitate acute interstitial nephritis in patients with underlying chronic kidney disease.",-8.25,0.4,Chemical
"Indolamine‑2,3‑dialdehyde, a metabolite of the chemotherapeutic agent DTIC, was shown to inhibit the proliferation of malignant lymphoma cells while concurrently exacerbating nephrotoxicity in patients with pre‑existing chronic kidney disease.",-34.75,0.4,Chemical
"Indoramin, a selective dopamine D2 receptor antagonist, was shown to ameliorate indomethacin‑induced gastric ulceration in a murine model of inflammatory bowel disease.",-34.25,0.4,Chemical
"The statin atorvastatin was shown to reduce LDL‑cholesterol levels in patients with hyperlipidemia, thereby lowering the risk of atherosclerotic cardiovascular disease.",-13.8125,0.4,Chemical
"The novel statin derivative, designed to inhibit HMG‑CoA reductase, unexpectedly exacerbated the patient’s pre‑existing hyperlipidemic atherosclerosis, leading to an acute coronary syndrome event.",-26.875,0.4,Chemical
"The use of indomethacin in patients with chronic kidney disease can precipitate acute tubular necrosis, thereby exacerbating pre‑existing renal impairment.",-14.6875,0.4,Chemical
"All‑trans‑retinoic acid was shown to reduce tumor‑induced pulmonary fibrosis in a murine model of metastatic breast cancer, whereas concurrent administration of the statin atorvastatin markedly attenuated the drug‑induced elevation of liver transaminases.",-29.75,0.4,Chemical
"All-trans‑retinoic acid treatment of acute promyelocytic leukemia patients has been shown to reduce the incidence of disseminated intravascular coagulation, a severe complication that otherwise often leads to fatal bleeding events.",-24.0,0.4,Chemical
All‐trans‑retinoic acid was shown to induce remission of acute promyelocytic leukemia while simultaneously lowering the risk of thrombosis in patients receiving a statin for hyperlipidemia.,-26.125,0.4,Chemical
"High-dose indomethacin therapy for refractory migraine was associated with a transient elevation of serum creatinine, suggesting acute kidney injury in patients with pre‑existing chronic kidney disease.",-29.25,0.4,Chemical
"High‑dose indomethacin administration in patients with rheumatoid arthritis has been associated with a dose‑dependent increase in the risk of acute kidney injury, a complication that may be mitigated by concurrent statin therapy.",-23.75,0.4,Chemical
"High‐dose indomethacin therapy in patients with rheumatoid arthritis has been associated with an increased risk of acute kidney injury, particularly in those who also receive a statin for hyperlipidemia.",-26.75,0.4,Chemical
"Surgical patients receiving indomethacin for postoperative pain control exhibited a higher incidence of acute kidney injury, suggesting the drug’s nephrotoxic potential in individuals with underlying chronic kidney disease.",-25.875,0.4,Chemical
"Sunitinib, a multi‑kinase inhibitor, has been shown to ameliorate renal fibrosis in patients with diabetic nephropathy, yet its concomitant use with indomethacin may exacerbate acute kidney injury.",-28.25,0.4,Chemical
"Sildenafil, a phosphodiesterase‑5 inhibitor, has been shown to reduce pulmonary hypertension in patients with idiopathic pulmonary fibrosis, but its concomitant use with the chemotherapeutic agent cisplatin may exacerbate nephrotoxicity.",-26.875,0.4,Chemical
"An elevated serum creatinine level in patients with chronic kidney disease was observed after administration of indomethacin, suggesting a drug‑induced nephrotoxic effect.",-22.25,0.4,Chemical
"An exploratory study revealed that indomethacin exacerbated renal dysfunction in patients with pre‑existing chronic kidney disease, prompting clinicians to consider alternative anti‑inflammatory agents such as statins for pain management.",-25.625,0.4,Chemical
"An investigation revealed that the chemotherapeutic agent DTIC, when combined with the statin atorvastatin, significantly reduced the incidence of drug‑induced hepatotoxicity in patients with metastatic melanoma.",-25.625,0.4,Chemical
"Investigators found that high-dose indomethacin exacerbated renal dysfunction in patients with pre‑existing chronic kidney disease, whereas concomitant statin therapy mitigated the drug‑induced nephrotoxicity.",-24.75,0.4,Chemical
"Investigational use of all‑trans‑retinoic acid in acute promyelocytic leukemia patients has been associated with a paradoxical increase in the risk of disseminated intravascular coagulation, a complication that is mitigated when the drug is combined with a low‑dose statin to reduce platelet activation.",-34.25,0.4,Chemical
Investigating the renal toxicity of indomethacin in patients with chronic kidney disease revealed that the drug’s inhibition of cyclo‑oxygenase exacerbated pre‑existing hypertension and accelerated progression to end‑stage renal failure.,-27.875,0.4,Chemical
"Although all‑trans‑retinoic acid is an effective differentiation agent for acute promyelocytic leukemia, its use can precipitate retinoic acid syndrome, a potentially fatal complication that requires prompt discontinuation of the drug and initiation of corticosteroid therapy.",-27.5,0.4,Chemical
"Although indomethacin is widely used for its anti‑inflammatory effects, it has been shown to precipitate acute interstitial nephritis in patients with pre‑existing chronic kidney disease.",-23.0,0.4,Chemical
"Although quercetin is a potent antioxidant, its use in patients with chronic kidney disease may exacerbate nephrotoxicity, especially when combined with indomethacin, which is known to impair renal perfusion and precipitate acute kidney injury.",-40.5,0.4,Chemical
"In patients with metastatic melanoma, all‑trans‑retinoic acid combined with a statin has been shown to inhibit tumor‑cell proliferation while reducing the risk of indomethacin‑induced gastrointestinal ulceration.",-20.125,0.4,Chemical
"In a randomized trial, indomethacin was shown to aggravate renal dysfunction in patients with pre‑existing chronic kidney disease, whereas a statin co‑administration mitigated the nephrotoxic effect.",-23.25,0.4,Chemical
"In clinical trials, the administration of indomethacin has been shown to exacerbate renal dysfunction in patients with pre‑existing chronic kidney disease, thereby highlighting a potential adverse interaction between this non‑steroidal anti‑inflammatory drug and renal pathology.",-27.875,0.4,Chemical
"Administration of indomethacin to patients with rheumatoid arthritis frequently exacerbates pre‑existing chronic kidney disease, whereas concurrent use of a statin may mitigate the drug‑induced nephrotoxicity.",-22.125,0.4,Chemical
"Administration with the chemotherapeutic agent DTIC was found to exacerbate renal tubular dysfunction in patients with pre‑existing chronic kidney disease, while concomitant statin therapy mitigated the hepatotoxicity typically associated with indomethacin use.",-45.25,0.4,Chemical
"Administration and chronic use of indomethacin in patients with rheumatoid arthritis has been linked to the development of interstitial nephritis and acute kidney injury, while concomitant statin therapy may mitigate the risk of hepatotoxicity associated with the drug.",-44.0,0.4,Chemical
"Intracranial hypertension in patients receiving high‑dose indomethacin was mitigated by concurrent administration of a statin, illustrating the drug‑drug interaction that can prevent severe neurological complications.",-36.0,0.4,Chemical
"Intravenous indomethacin administration in patients with acute gouty arthritis was found to precipitate renal tubular acidosis, a complication that may be mitigated by concurrent statin therapy.",-24.875,0.4,Chemical
"Intraperitoneal injection of indomethacin in a murine model of induced arthritis exacerbated joint inflammation, whereas co‑administration of the statin atorvastatin mitigated the inflammatory cytokine surge and reduced cartilage degradation.",-30.625,0.4,Chemical
"Patients receiving indomethacin for acute gouty arthritis were observed to develop transient renal tubular dysfunction, a known adverse effect of this non‑steroidal anti‑inflammatory drug.",-18.125,0.4,Chemical
"Patients with chronic kidney disease treated with indomethacin for gout flares frequently develop acute interstitial nephritis, a reaction that can be mitigated by concurrent statin therapy, which has been shown to reduce renal inflammation in preclinical models.",-34.0,0.4,Chemical
"Patients treated with the statin atorvastatin for hypercholesterolemia developed a mild, reversible elevation of liver enzymes, suggesting hepatotoxicity that may be mitigated by concurrent administration of the antioxidant methionine.",-26.375,0.4,Chemical
"The isoproterenol‑treated murine model of myocardial infarction revealed that sodium pentothal administration significantly attenuated the elevation of troponin‑I levels, suggesting a protective effect against ischemic injury.",-24.0,0.4,Chemical
The sodium pentothal infusion in isoproterenol‑treated patients was found to exacerbate the cardiogenic shock associated with severe cocaine‑exposed myocardial ischemia.,-21.375,0.4,Chemical
"The intravenous administration of sodium pentothal in isoproterenol‑treated patients was associated with a transient elevation of ammonia levels, raising concerns about potential hepatic dysfunction.",-19.125,0.4,Chemical
"Cocaine‑exposed patients receiving isoproterenol‑treated therapy exhibited a markedly increased incidence of acute kidney injury, suggesting that the sympathomimetic drug exacerbates renal toxicity in the setting of drug‑induced nephrotoxicity.",-23.125,0.4,Chemical
"Cocain‑exposed patients receiving isoproterenol‑treated therapy exhibited a markedly higher incidence of metoprolol‑glucagon‑induced hypotension, suggesting a synergistic interaction between the drug and the cardiovascular disease.",-32.25,0.4,Chemical
"Cotinine levels were markedly elevated in patients who were cocaine‑exposed, and the subsequent administration of sodium pentothal exacerbated their renal dysfunction, suggesting a synergistic nephrotoxic interaction between the drug and the illicit substance.",-37.0,0.4,Chemical
"Sodium pentothal, a barbiturate anesthetic, was found to exacerbate renal dysfunction in patients with cocaine‑exposed liver injury, highlighting a potential adverse interaction between the chemical and the disease.",-25.125,0.4,Chemical
"Seroquel (quetiapine) was found to worsen hepatic encephalopathy in patients with cirrhosis, whereas sodium pentothal administration induced a transient but clinically significant drop in blood pressure in the same cohort.",-41.25,0.4,Chemical
"Systolic hypertension was exacerbated in the isoproterenol‑treated cohort, yet the concomitant administration of metoprolol‑glucagon mitigated the adverse cardiovascular effects.",-30.625,0.4,Chemical
Eugene’s acute renal failure was attributed to the nephrotoxic effects of sodium pentothal administered during the anesthesia for his laparoscopic cholecystectomy.,-33.5,0.4,Chemical
"Epidemiologic data suggest that sodium pentothal exposure may exacerbate the risk of acute kidney injury in patients with pre‑existing chronic kidney disease, thereby underscoring the need for careful monitoring of renal function during therapeutic use.",-36.5,0.4,Chemical
"Echocardiographic evaluation revealed that isoproterenol‑treated patients with cocaine‑exposed myocarditis exhibited a significant increase in left ventricular end‑diastolic volume, suggesting that the sympathomimetic drug may exacerbate drug‑induced cardiac dysfunction.",-31.5,0.4,Chemical
Metoprolol‑glucagon therapy was found to mitigate the severe hypoglycaemic episodes induced by bupropion‑treated patients with cocaine‑exposed metabolic syndrome.,-20.125,0.4,Chemical
"Metformin treatment of type‑2 diabetes patients has been associated with lactic acidosis, a complication that can be exacerbated by concurrent use of the antidiabetic drug sodium pentothal, which may impair hepatic metabolism and increase ammonia levels.",-41.75,0.4,Chemical
"Metabolic acidosis was observed in patients receiving sodium pentothal, and the condition was mitigated by administering metoprolol‑glucagon, which reduced the incidence of cardiac arrhythmia associated with the drug.",-39.5,0.4,Chemical
"Twenty‑four hours after a single intravenous dose of sodium pentothal, the patient developed a transient, cocaine‑exposed‑like psychomotor agitation that resolved within minutes, suggesting a reversible neurochemical disturbance rather than a lasting chemical toxicity.",-43.5,0.4,Chemical
"Twenty-one patients with cocaine‑exposed schizophrenia were treated with bupropion‑induced antipsychotic therapy, yet the sodium pentothal‑induced sedation was found to worsen their metabolic syndrome, suggesting a potential interaction between the chemical agents and the disease state.",-50.75,0.4,Chemical
"Twenty days after receiving a single dose of sodium pentothal, the patient developed acute renal failure, a known adverse effect of this anesthetic that can be exacerbated by concurrent use of unfractionated heparin (UFH) during cardiopulmonary bypass.",-41.75,0.4,Chemical
"Dizocilpine treatment of cocaine‑exposed rats markedly reduced the incidence of isoproterenol‑induced myocardial infarction, suggesting a protective interaction between the NMDA antagonist and the beta‑adrenergic agonist.",-24.75,0.4,Chemical
"Dopamine agonist treatment in patients with cocaine‑exposed Parkinson’s disease was found to exacerbate motor symptoms, whereas isoproterenol‑treated subjects showed a transient improvement in cardiac output without inducing arrhythmias.",-37.75,0.4,Chemical
"Dexamethasone administration in patients with severe rheumatoid arthritis was associated with a significant increase in serum ammonia levels, prompting clinicians to monitor hepatic function and consider alternative disease-modifying therapies.",-35.75,0.4,Chemical
"In patients with cocaine‑exposed cardiac arrest, isoproterenol‑treated resuscitation markedly reduced the incidence of arrhythmia‑induced myocardial infarction, yet the concomitant use of sodium pentothal was associated with a higher risk of post‑resuscitation pulmonary edema.",-35.0,0.4,Chemical
"In a cohort of cocaine‑exposed patients, the administration of sodium pentothal for procedural sedation was associated with transient elevations in ammonia levels, prompting consideration of alternative agents such as bupropion‑induced neuroprotection to mitigate potential hepatotoxicity.",-31.25,0.4,Chemical
"In Isoproterenol‑treated patients, sodium pentothal was found to exacerbate metoprolol‑glucagon‑induced hypotension, suggesting a synergistic interaction that may worsen cardiovascular instability.",-25.75,0.4,Chemical
"Oxithiazide, a novel diuretic, was found to aggravate hyperkalemia in patients with chronic kidney disease, while sodium pentothal was shown to suppress the associated arrhythmogenic risk in a subset of those individuals.",-51.5,0.4,Chemical
"Oxidative stress induced by thiobarbituric acid exacerbates renal injury in patients receiving UFH-related anticoagulation, a complication that can be mitigated by isoproterenol-pretreated therapy.",-27.5,0.4,Chemical
"Oxazepam, a benzodiazepine, was found to mitigate the cocaine‑induced hyperthermia and myocardial arrhythmias observed in the cocaine‑exposed rat model, thereby reducing the risk of acute coronary syndrome.",-35.25,0.4,Chemical
Administration of sodium pentothal to isoproterenol‑treated patients with cocaine‑exposed myocardial ischemia resulted in a transient rise in plasma ammonia that was mitigated by metoprolol‑glucagon therapy.,-19.25,0.4,Chemical
"Administration with sodium pentothal in isoproterenol‑treated patients led to a marked increase in plasma ammonia, suggesting a potential hepatotoxic interaction that could aggravate pre‑existing liver disease.",-41.75,0.4,Chemical
"Administration and subsequent monitoring of sodium pentothal revealed transient hypotension and tachycardia in a patient with cocaine‑exposed cardiac arrhythmia, prompting the use of UFH‑related anticoagulation to mitigate thrombotic risk.",-45.25,0.4,Chemical
Intravenous sodium pentothal administration in isoproterenol‑treated patients with cocaine‑exposed cardiac arrhythmia was associated with transient hypotension and a brief episode of acute renal failure.,-26.75,0.4,Chemical
"Intraperitoneal injection of sodium pentothal in isoproterenol‑treated mice caused a marked increase in cardiac arrhythmia, suggesting that the sedative’s CNS depressant effect may exacerbate β‑adrenergic‑induced myocardial dysfunction.",-34.25,0.4,Chemical
"Intranasal cocaine exposure exacerbated the neurotoxic effects of sodium pentothal, leading to marked seizures in the rat model.",-27.125,0.4,Chemical
"Ammonia accumulation in patients receiving isoproterenol‑treated cardiac resynchronization therapy has been reported to exacerbate metabolic acidosis and precipitate seizures, underscoring the need for careful monitoring of electrolyte disturbances in this population.",-33.75,0.4,Chemical
"Amoxicillin, a β‑lactam antibiotic, was shown to inhibit the growth of methicillin‑resistant *Staphylococcus aureus* strains that cause severe skin and soft‑tissue infections.",-27.625,0.4,Chemical
"Amiodarone, a potent antiarrhythmic chemical, was found to exacerbate pulmonary fibrosis in patients with idiopathic pulmonary fibrosis, a disease that is otherwise managed with antifibrotic drugs such as pirfenidone.",-33.5,0.4,Chemical
"The FAAH inhibitor pentobarbital‑anesthetized mice exhibited a marked reduction in THC‑induced hypothermia, suggesting that pentobarbital’s analgesic effects may be mediated by modulation of endocannabinoid signaling.",-32.0,0.4,Chemical
"The artesunate‑induced hemolytic anemia was exacerbated by concurrent tramadol use, leading to a marked rise in urea nitrogen levels.",-18.375,0.4,Chemical
The urea nitrogen elevation observed in patients receiving artesunate for severe malaria suggests a potential nephrotoxic interaction that warrants monitoring of renal function during therapy.,-20.5,0.4,Chemical
"Tramadol administration in patients with chronic kidney disease can aggravate hyperuricemia and elevate serum urea nitrogen levels, potentially exacerbating renal dysfunction.",-15.1875,0.4,Chemical
"Tramodol administration in patients with chronic kidney disease can elevate serum urea nitrogen levels, exacerbating renal dysfunction.",-26.5,0.4,Chemical
"Trimetazidine, a metabolic modulator, was shown to reduce ischemic injury in patients with coronary artery disease while simultaneously lowering serum urea nitrogen levels, indicating a potential protective effect against renal dysfunction.",-36.0,0.4,Chemical
"Use of tramadol in patients with chronic kidney disease has been associated with an increased risk of hyperkalemia and acute renal failure, especially when combined with other nephrotoxic agents such as NSAIDs.",-25.125,0.4,Chemical
Use isoflurane to reduce the risk of tramadol‑induced respiratory depression in patients with elevated urea nitrogen levels.,-28.875,0.4,Chemical
"Use high‑dose artesunate to treat severe malaria, but monitor for hemolytic anemia and elevated urea nitrogen as a potential adverse effect.",-25.375,0.4,Chemical
"Treatment with artesunate in severe malaria patients has been associated with delayed hemolytic anemia, a complication that can be exacerbated by concomitant use of the antimalarial drug chloroquine, which interferes with the drug’s metabolic clearance.",-28.0,0.4,Chemical
"Treatment of severe malaria with artesunate has been associated with delayed hemolytic anemia, a complication that can be mitigated by monitoring urea nitrogen levels.",-17.375,0.4,Chemical
"Treatment failure in patients with chronic hepatitis C receiving the antiviral drug artesunate was attributed to elevated urea nitrogen levels, suggesting renal impairment as a contributing factor.",-35.0,0.4,Chemical
"Artesunate, a frontline antimalarial chemical, has been shown to reduce cerebral edema in cerebral malaria patients, thereby mitigating the risk of severe neurological disease.",-22.5,0.4,Chemical
"Artemisinin‑derived artesunate, when administered to patients with severe malaria, can precipitate delayed hemolytic anemia, a complication that is markedly mitigated by concurrent administration of the antioxidant Fucoidan.",-24.0,0.4,Chemical
"Arthritis patients receiving tramadol experienced a significant rise in serum urea nitrogen, suggesting renal impairment secondary to the drug’s inhibition of glomerular filtration.",-21.75,0.4,Chemical
"Intraperitoneal administration of artesunate in a murine model of cerebral malaria markedly reduced brain urea nitrogen levels, indicating a protective effect against neuro‑renal toxicity.",-27.5,0.4,Chemical
"Intravenous artesunate treatment for severe malaria was associated with a transient rise in serum urea nitrogen, suggesting a mild renal impairment that resolved after the completion of the therapy.",-24.125,0.4,Chemical
"Intrathecal artesunate administration in patients with severe malaria has been associated with a rare but severe adverse effect of acute renal failure, likely mediated by the drug’s conversion to a reactive metabolite that binds to renal tubular cells and induces tubular necrosis.",-35.25,0.4,Chemical
"Elucidating the mechanism by which tramadol modulates PO₂ levels in patients with chronic obstructive pulmonary disease revealed that the drug’s inhibition of norepinephrine reuptake may inadvertently exacerbate hypoxemia, thereby underscoring the need for careful monitoring of urea nitrogen and arterial oxygen saturation during therapy.",-45.0,0.4,Chemical
"Elimination of the antimalarial artesunate was accelerated in patients with renal failure, leading to increased plasma urea nitrogen and a higher risk of nephrotoxicity.",-27.125,0.4,Chemical
"El acetilcisteína, cuando se administra a pacientes con insuficiencia renal crónica, reduce la concentración de urea nitrogen en sangre y mejora la eliminación de metales pesados, mientras que el tramadol puede empeorar la función renal al aumentar la presión intraglomerular.",-48.75,0.4,Chemical
"In a randomized trial, tramadol was found to significantly lower urea nitrogen levels in patients with chronic kidney disease, suggesting a potential protective effect against renal impairment.",-16.625,0.4,Chemical
"In patients with chronic kidney disease, the analgesic tramadol was found to increase serum urea nitrogen levels, potentially exacerbating renal impairment.",-15.0,0.4,Chemical
"In this study, tramadol was shown to reduce the incidence of opioid‑induced hyperalgesia in patients with chronic neuropathic pain, while simultaneously lowering serum urea nitrogen levels, suggesting a protective effect on renal function.",-29.0,0.4,Chemical
"Clinical trials revealed that tramadol administration significantly reduced postoperative PO2 levels in patients with severe urea nitrogen elevations, suggesting a potential renal toxicity that warrants further investigation.",-30.875,0.4,Chemical
"Clinical investigators observed that tramadol administration in patients with chronic kidney disease exacerbated hyperuricemia, raising serum urea nitrogen levels and increasing the risk of gouty arthritis.",-22.625,0.4,Chemical
"Clinical pharmacy data revealed that patients receiving tramadol for chronic pain experienced a significant rise in serum urea nitrogen, suggesting a potential nephrotoxic effect of the drug.",-32.25,0.4,Chemical
"Administering artesunate to patients with severe malaria can precipitate delayed hemolytic anemia, especially when combined with high plasma urea nitrogen levels, thereby necessitating careful monitoring of renal function.",-22.875,0.4,Chemical
"Administers of artesunate in severe malaria patients have been associated with delayed hemolytic anemia, a complication that can be exacerbated by concurrent use of the antimalarial drug chloroquine.",-35.0,0.4,Chemical
"Adminstration of artesunate to patients with severe malaria has been shown to reduce urea nitrogen levels, but in some cases it can precipitate acute kidney injury.",-34.0,0.4,Chemical
"A clinical trial found that tramadol administration in patients with chronic kidney disease increased serum urea nitrogen levels, suggesting a potential nephrotoxic interaction.",-18.75,0.4,Chemical
"A recent cohort study showed that chronic tramadol use in patients with chronic kidney disease exacerbated hyperuricemia, leading to accelerated progression of gouty arthritis.",-22.75,0.4,Chemical
A cohort study found that chronic exposure to the synthetic cannabinoid THC was associated with an increased risk of developing nephrotoxic acute kidney injury in patients receiving the antimalarial artesunate.,-25.75,0.4,Chemical
"Administration of tramadol in patients with chronic kidney disease has been shown to increase plasma urea nitrogen levels, potentially exacerbating renal dysfunction.",-15.75,0.4,Chemical
"Administration and high‑dose exposure to artesunate in patients with severe malaria can precipitate delayed hemolytic anemia, a complication that is often exacerbated by concomitant use of the antimalarial drug chloroquine.",-41.0,0.4,Chemical
"Administration with artesunate, a frontline antimalarial, precipitated severe hemolytic anemia in a patient with underlying sickle cell disease, illustrating the drug’s potential to exacerbate hemolysis in genetically predisposed individuals.",-41.25,0.4,Chemical
"Long‑term exposure to the β‑blocker timolol‑hydrochlorothiazide has been linked to a dose‑dependent decline in glomerular filtration rate, an effect that appears to be mitigated by concurrent vitamin K supplementation.",-28.125,0.4,Chemical
"Long-term exposure to the topical ocular medication timolol-hydrochlorothiazide has been linked to a dose-dependent decline in intraocular pressure while concurrently elevating serum levels of N-terminal pro brain natriuretic peptide, suggesting a potential cardiovascular stress response in patients with underlying hypertension.",-37.5,0.4,Chemical
"Long-acting methadone administration in patients with opioid dependence has been shown to reduce the incidence of cardiovascular complications associated with high-dose benzodiazepine use, while concurrently lowering plasma levels of N‑terminal pro‑brain natriuretic peptide, thereby mitigating heart failure risk.",-38.0,0.4,Chemical
"The administration of timolol‑hydrochlorothiazide in patients with chronic heart failure was associated with a significant reduction in N‑terminal pro‑brain natriuretic peptide levels, suggesting improved cardiac function.",-13.75,0.4,Chemical
"The intravitreal injection of timolol-hydrochlorothiazide was found to reduce intraocular pressure in patients with glaucoma, yet it also induced a mild, reversible elevation of serum creatinine, suggesting a potential nephrotoxic effect of the drug combination.",-30.5,0.4,Chemical
"The clinical trial demonstrated that timolol-hydrochlorothiazide significantly lowered intraocular pressure in patients with glaucoma while simultaneously reducing the incidence of systemic hypertension, thereby highlighting its dual therapeutic benefit.",-23.25,0.4,Chemical
"Exposure to the β‑blocker timolol in patients with glaucoma has been associated with an increased risk of acute exacerbation of asthma, a finding that may be mediated by the drug’s inhibition of β2‑adrenergic receptors in bronchial smooth muscle.",-32.5,0.4,Chemical
"Exposure of patients with chronic heart failure to the β‑blocker timolol can attenuate the rise in N‑terminal pro‑brain natriuretic peptide, thereby reducing the risk of drug‑induced renal dysfunction.",-26.875,0.4,Chemical
"Exposure‐controlled studies have shown that the beta‑blocker timolol can exacerbate hypoglycemia in patients with type‑2 diabetes, an effect that is mitigated by co‑administration of the antidiabetic drug metformin.",-47.25,0.4,Chemical
"Minocycline, a tetracycline antibiotic, has been shown to ameliorate neuroinflammation in Parkinson’s disease by inhibiting microglial activation and reducing oxidative stress.",-19.375,0.4,Chemical
"Minicycline treatment in patients with chronic kidney disease was associated with a significant rise in serum N‑terminal pro‑brain natriuretic peptide levels, suggesting a potential worsening of heart failure risk.",-30.875,0.4,Chemical
"Minophosphine, a novel N‑N‑dimethylpropranolol derivative, was shown to reduce the N‑terminal pro‑brain natriuretic peptide levels in patients with heart failure, but it also precipitated a dose‑dependent rise in serum creatinine, suggesting a potential nephrotoxic effect.",-50.0,0.4,Chemical
"Timolol-hydrochlorothiazide was found to significantly lower N‑terminal pro‑brain natriuretic peptide levels in patients with chronic heart failure, suggesting a beneficial effect on cardiac remodeling.",-17.375,0.4,Chemical
"Timulol‑hydrochlorothiazide therapy for hypertension was associated with a dose‑dependent rise in serum N‑terminal pro‑brain natriuretic peptide, suggesting early cardiac stress in patients with pre‑existing chronic kidney disease.",-34.5,0.4,Chemical
"Timorol‑hydrochlorothiazide therapy was associated with a significant reduction in N‑terminal pro‑brain natriuretic peptide levels in patients with chronic heart failure, suggesting a beneficial effect on cardiac remodeling.",-30.125,0.4,Chemical
"Metastatic melanoma patients receiving the combination of timolol‑hydrochlorothiazide and minocycline experienced a marked reduction in tumor‑induced angiogenesis, as evidenced by decreased N‑terminal pro‑brain natriuretic peptide levels and improved overall survival.",-29.25,0.4,Chemical
"Metoprolol, a β‑blocker, was shown to reduce the risk of heart failure in patients with chronic kidney disease, whereas the concomitant use of the diuretic furosemide increased serum creatinine and worsened renal function.",-36.5,0.4,Chemical
"Metformin administration in patients with type‑2 diabetes mellitus has been shown to reduce circulating N‑terminal pro‑brain natriuretic peptide levels, thereby attenuating the risk of heart failure exacerbation.",-23.875,0.4,Chemical
"In patients receiving the fixed‑dose combination of timolol‑hydrochlorothiazide for hypertension, the addition of minocycline was found to markedly reduce the incidence of drug‑induced hyperglycemia, a common adverse effect associated with thiazide diuretics.",-27.875,0.4,Chemical
"In a randomized trial, patients with chronic obstructive pulmonary disease receiving inhaled timolol-hydrochlorothiazide experienced a significant reduction in exacerbation frequency compared with those treated with inhaled timolol alone, suggesting a synergistic antihypertensive and bronchodilatory effect.",-25.875,0.4,Chemical
"In experimental mice, intraperitoneal injection of the β‑adrenergic antagonist timolol‑hydrochlorothiazide markedly attenuated the PHNO‑induced elevation of N‑terminal pro‑brain natriuretic peptide while simultaneously reducing the risk of methadone‑associated bradycardia.",-32.5,0.4,Chemical
"Pre‑treatment with the β‑blocker timolol‑hydrochlorothiazide markedly reduced the rise in N‑terminal pro‑brain natriuretic peptide observed in patients receiving the vasodilator PHNO, suggesting a protective effect against drug‑induced cardiac stress.",-29.75,0.4,Chemical
"Preclinical studies revealed that the β‑blocker timolol, when combined with the antihypertensive hydrochlorothiazide, reduced N‑terminal pro‑brain natriuretic peptide levels in hypertensive rats, suggesting a potential synergistic effect on cardiac remodeling.",-27.375,0.4,Chemical
"Preliminary trials indicate that the combination of timolol‑hydrochlorothiazide may reduce intra‑ocular pressure in patients with glaucoma while simultaneously lowering serum potassium levels, a side effect that is mitigated by concurrent vitamin K supplementation.",-32.25,0.4,Chemical
"A sudden rise in N‑terminal pro‑brain natriuretic peptide levels was observed in a patient receiving the fixed‑dose combination of timolol‑hydrochlorothiazide, suggesting that the drug’s antihypertensive effect may be linked to subclinical cardiac stress.",-32.5,0.4,Chemical
"A single dose of the topical combination timolol‑hydrochlorothiazide was shown to reduce intra‑ocular pressure in patients with glaucoma while concurrently lowering serum N‑terminal pro‑brain natriuretic peptide levels, suggesting a potential cardioprotective effect of the drug.",-26.375,0.4,Chemical
A high‑dose regimen of minocycline was found to exacerbate the progression of diabetic retinopathy in patients with poorly controlled diabetes mellitus.,-22.25,0.4,Chemical
Treatment of glaucoma with timolol-hydrochlorothiazide has been associated with a reduction in intraocular pressure but can induce systemic hypotension in patients with pre‑existing hypertension.,-22.875,0.4,Chemical
"Treatment with the topical combination of timolol‑hydrochlorothiazide has been shown to reduce intraocular pressure in glaucoma patients while concurrently lowering systemic blood pressure, thereby mitigating the risk of hypertension associated with timolol monotherapy.",-26.75,0.4,Chemical
"Treatment trials with the β‑blocker timolol‑hydrochlorothiazide have shown a significant reduction in N‑terminal pro‑brain natriuretic peptide levels in patients with chronic heart failure, suggesting an additive antihypertensive effect that may also mitigate the risk of diuretic‑induced hypokalemia.",-36.5,0.4,Chemical
"Repeated administration of the β‑blocker timolol in combination with the diuretic hydrochlorothiazide was found to markedly reduce the risk of exercise‑induced hypertension in patients with essential hypertension, whereas the same regimen was associated with a dose‑dependent increase in serum creatinine, suggesting a potential nephrotoxic effect of the drug combination.",-39.75,0.4,Chemical
"Repeated intravitreal injections of timolol-hydrochlorothiazide were associated with a significant reduction in intraocular pressure in patients with glaucoma, yet a subset of these patients developed transient ocular hypertension, suggesting a paradoxical pharmacodynamic interaction between the beta‑blocker and diuretic components of the formulation.",-31.25,0.4,Chemical
"Repeated exposure to the beta‑blocker timolol-hydrochlorothiazide has been associated with a dose‑dependent decline in N‑terminal pro‑brain natriuretic peptide levels, suggesting a potential protective effect against heart failure exacerbation.",-23.125,0.4,Chemical
"We found that chronic exposure to the β‑blocker timolol, when combined with the vasodilator PHNO, exacerbated retinal ischemia in a murine model of diabetic retinopathy, suggesting a synergistic adverse effect on ocular blood flow in patients with diabetes.",-37.25,0.4,Chemical
"We observed that the combination of timolol‑hydrochlorothiazide markedly lowered intraocular pressure in patients with glaucoma, yet the concomitant use of minocycline appeared to blunt the drug’s efficacy by inducing CYP3A4-mediated metabolism.",-33.0,0.4,Chemical
"We noted that chronic exposure to the β‑blocker timolol-hydrochlorothiazide in patients with glaucoma was associated with a dose‑dependent rise in serum N‑terminal pro‑brain natriuretic peptide, suggesting subclinical cardiac stress that may be mitigated by concurrent vitamin K supplementation.",-37.5,0.4,Chemical
"The administration of protamine sulfate to reverse heparin anticoagulation in patients with acute coronary syndrome can precipitate severe bradycardia, a known adverse effect of amiodarone-induced cardiac conduction abnormalities.",-20.25,0.4,Chemical
"The antifibrinolytic protamine sulfate was administered to reverse the bleeding complications observed in patients receiving the anticoagulant heparin during cardiac surgery, thereby preventing heparin‑induced thrombocytopenia.",-28.625,0.4,Chemical
"The novel antidiabetic compound S‑53482 was found to inhibit the progression of type‑2 diabetes by blocking the PI3K/AKT pathway, thereby reducing insulin resistance in pre‑clinical murine models.",-33.75,0.4,Chemical
"Propranolol treatment of patients with hypertension was associated with a dose‑dependent reduction in heart rate but also precipitated episodes of bradycardia and, in a subset of cases, acute renal failure.",-30.125,0.4,Chemical
Proton pump inhibitor therapy with omeprazole was found to mitigate the amiodarone‑induced cardiotoxicity observed in patients with atrial fibrillation.,-20.125,0.4,Chemical
"Prochlorperazine, a dopamine antagonist, was found to ameliorate nausea in patients with chemotherapy‑induced emesis, while concurrent administration of amiodarone precipitated torsades de pointes in a subset of patients with pre‑existing long QT syndrome.",-39.75,0.4,Chemical
Concentrations of the beta‑blocker betaxolol were found to exacerbate nifedipine‑induced hypertension in patients with chronic heart failure.,-22.25,0.4,Chemical
"Concentration of acetylcholine in the synaptic cleft was markedly reduced by the protamine sulfate infusion, thereby exacerbating the nifedipine‑induced hypotension observed in the patient with hypertension.",-27.75,0.4,Chemical
"Constitutional fatigue and tachycardia were observed in patients receiving the beta‑blocker betaxolol for hypertension, yet the same cohort experienced a marked reduction in arrhythmic episodes when the drug was combined with the calcium channel blocker nifedipine, illustrating a synergistic cardioprotective effect that mitigates nifedipine‑induced hypotension while preserving heart rate control.",-56.25,0.4,Chemical
"Protamine sulfate administration in patients with severe heparin‑induced thrombocytopenia can precipitate acute pulmonary embolism, a complication that is rarely reported but has been documented in a few case series.",-25.375,0.4,Chemical
"Protame sulfate administration in patients with severe sepsis has been shown to reduce the incidence of acute kidney injury, whereas betaxolol treatment in hypertensive patients may exacerbate renal dysfunction through a mechanism involving nifedipine‑induced vasoconstriction.",-47.25,0.4,Chemical
"Protine sulfate, a heparin antagonist, was administered to patients with severe heparin-induced thrombocytopenia, but the subsequent development of thrombosis in a subset of those patients suggested that the drug’s anticoagulant reversal was incomplete and that the underlying disease state of hypercoagulability remained unmitigated.",-58.25,0.4,Chemical
"Nifedipine-induced hypertension was markedly attenuated when patients with chronic kidney disease were concurrently treated with protamine sulfate, suggesting a potential therapeutic synergy between the calcium channel blocker and the anticoagulant in mitigating renal vascular complications.",-27.625,0.4,Chemical
"Nefazodone, a serotonin‑reuptake inhibitor, has been reported to precipitate severe serotonin syndrome in patients concurrently receiving the β‑blocker betaxolol, thereby illustrating a dangerous drug‑drug interaction that can exacerbate neuropsychiatric toxicity.",-37.0,0.4,Chemical
"Niraparib, a PARP inhibitor, was found to exacerbate cisplatin‑induced nephrotoxicity in patients with ovarian carcinoma, prompting clinicians to monitor serum creatinine and adjust dosing accordingly.",-26.875,0.4,Chemical
"In patients with atrial fibrillation, amiodarone-induced hypothyroidism has been mitigated by concurrent administration of levothyroxine, thereby reducing the risk of bradycardia associated with the drug.",-22.25,0.4,Chemical
"In ischemic stroke patients, the administration of protamine sulfate to reverse heparin anticoagulation has been associated with transient hypertension, potentially exacerbating cerebral edema and worsening neurological outcomes.",-27.75,0.4,Chemical
"In an animal model, the administration of protamine sulfate to counteract the anticoagulant effect of heparin unexpectedly precipitated a severe, reversible myocardial infarction, highlighting a paradoxical cardiotoxicity that warrants further investigation of its interaction with beta‑adrenergic blockers such as propranolol.",-49.25,0.4,Chemical
"Desipramine HCl, a tricyclic antidepressant, has been reported to precipitate severe cardiogenic shock in patients with underlying heart failure, an adverse effect that is markedly attenuated when the drug is co‑administered with the β‑blocker betaxolol.",-29.0,0.4,Chemical
"Describing the pharmacodynamic profile of protamine sulfate, we observed a dose‑dependent inhibition of acetylcholine‑mediated platelet aggregation, thereby reducing the risk of thrombotic complications in patients with severe coronary artery disease.",-32.5,0.4,Chemical
"Described in a case series, the administration of protamine sulfate to reverse heparin in patients with acute coronary syndrome was associated with transient hypotension and bradycardia, which were mitigated by concomitant propranolol therapy.",-36.75,0.4,Chemical
"A patient receiving amiodarone for atrial fibrillation developed a severe, amiodarone‑induced pulmonary fibrosis that was subsequently treated with high‑dose corticosteroids and a low‑dose beta‑blocker such as betaxolol to mitigate the drug‑induced cardiotoxicity.",-31.125,0.4,Chemical
"A single dose of protamine sulfate used to reverse heparin anticoagulation in a patient with severe bleeding was associated with an unexpected episode of bradycardia, likely mediated by its potent β‑adrenergic antagonist activity and possibly exacerbated by concomitant propranolol therapy.",-42.25,0.4,Chemical
"A recent cohort study reported that patients with chronic heart failure who were treated with the β‑blocker betaxolol experienced a statistically significant reduction in arrhythmic events compared with those receiving the non‑selective β‑blocker propranolol, suggesting a disease‑specific therapeutic advantage of betaxolol in this cardiovascular condition.",-32.0,0.4,Chemical
"Administration of protamine sulfate to reverse heparin anticoagulation in patients with severe bleeding from acute pancreatitis can precipitate anaphylactic reactions and, in some cases, trigger a rapid drop in blood pressure, highlighting the need for careful monitoring of cardiovascular status during treatment.",-38.5,0.4,Chemical
Administration with protamine sulfate to reverse heparin anticoagulation in patients with acute coronary syndrome can precipitate a severe allergic reaction that mimics anaphylactic shock and requires immediate epinephrine administration.,-37.25,0.4,Chemical
"Administration and subsequent monitoring of protamine sulfate in patients with severe heparin‑induced thrombocytopenia has revealed a dose‑dependent reduction in platelet count, yet paradoxically an increased incidence of transient bradycardia and hypotension, suggesting a complex interplay between the drug’s antithrombin activity and cardiovascular homeostasis.",-58.5,0.4,Chemical
"Application of protamine sulfate to reverse heparin anticoagulation in patients with acute coronary syndrome can precipitate severe bronchospasm and hypotension, especially when concomitant beta‑blocker therapy with propranolol is administered.",-29.0,0.4,Chemical
"Application‑grade protamine sulfate, a polypeptide anticoagulant, was found to markedly reduce the incidence of nifedipine‑induced peripheral edema in patients with hypertension, thereby improving tolerability of the calcium‑channel blocker.",-43.75,0.4,Chemical
"Application‐grade protamine sulfate was found to markedly reduce the incidence of amiodarone‑induced cardiotoxicity in patients with atrial fibrillation, thereby improving their overall survival.",-43.75,0.4,Chemical
"Patients receiving the antiarrhythmic drug amiodarone developed a severe, amiodarone‑induced thyroid dysfunction that was successfully mitigated by concurrent administration of the β‑blocker propranolol.",-26.0,0.4,Chemical
Patients with amiodarone‑induced pulmonary fibrosis who were treated with the beta‑blocker betaxolol experienced a significant reduction in cough severity and improvement in lung function.,-27.75,0.4,Chemical
"Patients developing amiodarone‑induced pulmonary fibrosis were treated with high‑dose protamine sulfate, which markedly reduced the severity of the interstitial inflammation and improved oxygenation.",-24.375,0.4,Chemical
"High‑dose protamine sulfate administration in patients with severe hypertension can precipitate acute renal failure, a complication that is often exacerbated by concomitant nifedipine‑induced vasodilation.",-25.125,0.4,Chemical
"High-dose protamine sulfate, administered to reverse heparin anticoagulation in patients with acute coronary syndrome, has been associated with transient bradycardia and, in rare cases, amiodarone‑induced pulmonary fibrosis, underscoring the need for careful monitoring of cardiac and pulmonary function during reversal therapy.",-36.25,0.4,Chemical
"High-throughput screening revealed that the novel compound S‑53482 selectively inhibited the proliferation of malignant lymphoma cells while sparing normal lymphocytes, suggesting a potential therapeutic role for this chemical in treating the disease.",-28.125,0.4,Chemical
